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ABSTRACT 
In recent years, a growing number of human pharmaceuticals have been detected in the 
aquatic environment, generally at low concentrations (sub-ng/L to low µg/L). These 
compounds are characterised by highly specific mechanisms of action, high potency and 
prolonged activity in order to minimise dosing requirements and potential toxicity in patients. 
Among the various classes of pharmaceuticals, steroids and anti-steroids are widely used, as 
shown by the analysis of their clinical use carried out at the beginning of this Ph.D. project. 
Although the amounts used are much lower than the amounts of some other pharmaceuticals 
(e.g. analgesics), their ability to affect important physiological processes in fish (e.g. 
reproduction) at very low concentrations (ng/L) suggest that this class of compounds should 
represent a high priority for ecotoxicological research. In particular, this Ph.D. project 
addressed the question of whether or not dutasteride, a human pharmaceutical mainly used to 
treat benign prostatic hyperplasia, may cause adverse effects in the teleost fathead minnow 
(Pimephales promelas) by inhibiting the activity of both isoforms of 5α-reductase (5αR), the 
enzyme which convert testosterone into dihydrotestosterone (DHT). The theoretical 
framework used to guide the design of the experimental studies was based on the combination 
of several conceptual approaches, including the study of the evolutionary degree of 
conservation and functionality of the drug target in non-target species, and the cross-species 
extrapolation of pharmacological and toxicological information generated during pre-clinical 
and clinical studies in mammals during drug development. The results obtained during the 
first phase of this Ph.D. project strongly suggested that DHT has a physiological role in the 
fathead minnow. In fact, 5αRs are evolutionary conserved in this species, 5αRs genes are 
expressed in tissues such as the testis, and DHT circulates in fathead minnow plasma at 
concentrations similar to those detected in humans. These findings represented the rationale 
for testing the effects of dutasteride in the fathead minnow. Dutasteride caused significant 
adverse effects in all the in vivo studies performed in order to evaluate its potential toxicity on 
fish, including early life stage and short term reproduction studies, and all the tested life 
stages were sensitive to the inhibition of 5αRs activity; however, none of the observed 
adverse effects occurred at concentrations of exposure lower than 32 µg/L (measured 
concentration). The results also showed that female fish are highly sensitive to disruption of 
the androgenic pathways, highlighting their utility for the evaluation of potential adverse 
effects caused by anti-androgens on fish. In conclusion, the results presented in this Thesis 
suggest that, at present, the potential presence of dutasteride in the environment does not 
represent a risk to wild fish populations, due to the high concentrations required to elict 
significant adverse effect (LOEC = 32 µg/L) and the low volume of drug prescribed every 
year (5.07 kg in UK in 2006). However, the high bioaccumulation factor of dutasteride 
suggest that further studies should be conducted to elucidate the role played by the 
bioaccumulation process in the toxicity responses observed in fish.  
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1.1 Human pharmaceuticals in the environment    
Pharmaceutical active compounds are a large and varied group of molecules showing 
different physiochemical and biological properties and functionalities (Kümmerer, 2008). 
These molecules are sometimes called “active pharmaceutical ingredients” (APIs), and 
constitute the active part of medicines, which in turn, are defined by the US Food and Drug 
Administration (US FDA) as “substances intended for use in the diagnosis, cure, mitigation, 
treatment, or prevention of diseases”. The importance and the wide usage of these compounds 
world-wide are easily deducible. According to IMS Health (Market Prognosis, 2011), the 
value of the global pharmaceutical market is expected to grow in 2011 up to US$ 880 billion. 
In OECD countries, spending on pharmaceuticals represents a significant proportion of total 
health spending. Among the European countries in 2008, Greece was at the top of the rank of 
“per capita spending” on pharmaceutical products, with spending of EUR 584, compared 
with an OECD average of EUR 376 (OECD, 2010) (Fig. 1.1). It has been estimated that over 
3000 APIs are licensed for human use in the UK, and only in England, the number of 
dispensed prescription items was 886 million (NHS, 2010), with an estimated usage 
exceeding 10 tonnes per year for all the 25 most used APIs and greater than 100 tonnes per 
year the for the top three compounds (paracetemol, metformin hydrochloride and ibuprofen) 
(Jones et al., 2002).  
An inevitable consequence of this large consumption of pharmaceuticals is their increased 
discharge into the environment, through patient use and disposal. Indeed, over the past years a 
growing number of studies have detected trace levels of various APIs in waste water 
treatment plant (WWTP) effluents, surface and ground waters, and, in some countries, even in 
drinking water supplies (e.g. Daughton and Ternes, 1999; Fent et al., 2006; Herberer, 2002; 
Loos et al., 2009; Jones et al., 2002; Kümmerer, 2009; Ternes, 2001). 
Other than the large consumption volume, APIs are designed and developed in order to have a 
highly specific biological activity in the body, and hence some of them can exert their effects 
at concentrations (few ng/L) much lower than the ones of other environmental pollutants 
(µg/L) (Kümmerer, 2008). Some APIs act through mechanisms of action (MoA) that can be 
evolutionary conserved across animal phyla, so that molecules designed to induce a specific 
effect in humans may also be biologically active in wildlife species (Gunnarsson et al., 2009). 
Furthermore, APIs are usually characterized by their ionic nature, and some of them have 
high lipophilicity (which increases their potential of bioaccumulation in the organism), and 
low biodegradability rate in the WWTPs (which increase their persistence in the environment) 
(Fent et al., 2006). These intrinsic properties represent the main reason for the concern of 
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potential adverse effects arising from the presence of human pharmaceuticals in the 
environment, both for human health and wildlife.  
 
 
Figure 1.1. Expenditure on pharmaceuticals per capita, 2008. 1, prescribed medicines only (from 
OECD, 2010). 
1.2 Sources of human pharmaceuticals in the environment  
Human pharmaceuticals and their metabolites are released into the environment via a number 
of routes. After administration to patients, pharmaceuticals face several changes in their 
chemical structure, as a consequence of the interaction with microorganisms in the digestive 
tract, or with enzymes of human metabolism, producing various metabolites. There is a large 
variability in the degree of metabolism of each drug, so that some pharmaceuticals are largely 
metabolized, others only partially metabolized, and others yet are completely unchanged by 
human metabolism (Bound & Voulvoulis, 2004; Lienert et al., 2007). The resulting 
metabolites show different pharmacological properties compared to the parent compound, and 
although it is normally assumed that drug metabolism will lead to decreased toxicity, 
sometimes metabolites show increased toxicity (eg. sulfatation can lead to mutagenicity), and 
play important roles in the mediation of toxic effects (Kümmerer, 2009; Ohbuchi et al., 2009). 
Expenditure per person (in Euro) Expenditure as a share of GDP 
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The metabolic pathways in the human body consist of Phase I and Phase II hepatic 
metabolism. Phase I reactions involve oxidation, reduction and/or hydrolysis, while Phase II 
involves conjugation (e.g. the addition of glucuronic acid, sulphate, acetic acid or amino 
acid), which produce water-soluble polar metabolites that can be more easily excreted from 
the body. Successively, the parent compound and its metabolites are excreted in urine or 
feces, reaching the sewage collection system (from hospitals, homes etc.), and shortly after 
that, the WWTPs, where, after unefficient or incomplete removal, are finally released into the 
collection water body (rivers, lakes, sea) through the WWTP effluents.  
Other than human consumption, other sources of release of APIs in the environment include 
accidental events (e.g. transport accidents), release from pharmaceutical manufacturer sites, 
disposal of pharmaceutical from the supply chain, and disposal of unused pharmaceuticals by 
patients or health care facilities (Bound and Voulvoulis, 2005; Kümmerer, 2009; Slack et al., 
2005). However, these sources are generally considered of modest impact when compared to 
the amount of APIs directly excreted by patients. For example, the activity of drug 
manufacturing sites in Western countries is regulated by Good Manufacturing Practice 
(GMP), and these sites are regularly inspected by the Medicines Control Agency (MCA) to 
ensure the quality and safety of products (Ayscough et al, 2000). This strict regulatory and 
controlling system usually minimizes the chances of release of APIs from these sites into the 
environment. Exceptions to this generally modest impact are present in India, where 
concentrations up to several mg/L for single compounds can be detected in effluents of local 
WWTPs (Larsson et al., 2007). In this country, the presence of several areas with high density 
of manufacturing sites and the lack of strict safety regulations mean that there is potentially a 
high risk situation for both human health and wildlife.  
Finally, the disposal of expired/unused drugs by household waste, or via sink or toilet, may 
represent a potentially significant source of release of APIs in the environment; for example, 
in the US, a significant proportion of prescribed drugs are not administered and are disposed 
directly into waste waters, so that an estimated $1 billion of prescription drugs are discarded 
each year from hospitals, care facilities, and pharmacies (Cunningham et al., 2008; Strom, 
2005). The significance of this environmental source could be strongly minimised by 
improving patient education (Kümmerer, 2009).   
1.3 Degradation processes in WWTPs  
Generally, the concentrations of pharmaceuticals detected in the aquatic environment are 
relatively low, usually in the ng/L to μg/L range (Daughton and Ternes, 1999; Fent et al., 
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2006; Halling-Sorensen et al., 1998; Kümmerer, 2009; William and Cook, 2007), and in 
surface waters their concentrations rarely exceed 100 ng/L (Trudeau et al., 2005).  In the last 
few years, the understanding of the occurrence of pharmaceuticals in the environment has 
been strongly enhanced thanks to the improvement of analytical techniques able to detect 
APIs at trace quantities in various matrixes, such as liquid chromathography or gas 
cromathography coupled to tandem mass spectrometry (LC-MS/MS and GC-MS/MS, 
respectively), but information about their fate in the environment is still limited (Fatta et al., 
2007; Fent et al., 2006). 
About 160 different APIs have been detected so far in WWTP‟s effluent, surface water, 
groundwater, and even drinking water (Fatta-Kassinos et al., 2010; Monteiro and Boxall, 
2010; Kümmerer, 2010; Santos et al., 2010), but very little is known about the occurrence and 
fate of APIs metabolites. In particular, a key issue would be to understand if conjugated 
forms, like glucoronides, methylates, glycinates, and sulphates can be deconjugated by 
microbial metabolism in WWTP sludge or in the environment, bringing back to full activity 
the parent APIs (Kumar et al., 2011; Kümmerer, 2008). 
In the WWTPs, the majority of drugs are removed during conventional secondary sewage 
treatments by biotransformation/biodegradation and abiotic removal by adsorption to 
suspended solid sludge particles (Jelic et al., 2011; Petrovic et al., 2009). Some APIs, 
however, such as the anticonvulsant carbamazepine, the lipid regulator gemfibrozil, and the 
analgesic diclofenac are not effectively degraded in most WWTPs (Zhang et al., 2008). For 
each API the hydrophobic properties and electrostatic interactions with particulate matter 
determine the predominance of one of the two main removal process, biodegradation or 
adsorption (Fent et al., 2006). For example, acidic pharmaceuticals such as the non-steroidal 
anti-inflammatory drug (NSAID) acetylsalicylic acid do not adsorb readily to particulate 
matter in the sludge, therefore elimination via microbial degradation is the most significant 
process (Ternes et al, 2004). 
Many studies have attempted to establish removal rates of APIs from WWTPs, but the values 
obtained are highly variable, since they depend on the specific operating parameters of 
individual WWTP, such as hydraulic retention time, sludge retention time, microbial 
community structure, treatment technology and performance, temperature, and atmospheric 
weather at the time (Fent et al, 2006; Tauxe-Wuersch et al., 2005; Vieno et al, 2007; 
Williams, 2005). Consequently, pharmaceutical elimination is often partial; for example, 
ibuprofen has a high elimination rate, generally >90%, and is rapidly degraded (Buser et al., 
1999; Metcalfe et al., 2003; Suarez et al., 2010), whereas, on the other hand, carbamazepine 
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has an elimination rate of only 4–8% (Herberer et al., 2002; Clara et al., 2004). Kanda et al. 
(2003) investigated the presence of a number of pharmaceuticals in six UK WWTPs, finding 
that many pharmaceuticals occurred in influent at ng/L levels and were removed by 
wastewater treatment processes with different efficiencies. Ibuprofen removal at different 
WWTPs was generally between 80% and 100%, with the exception of one site where removal 
was poor (14.4% to 44%). Moreover, Li et al. (2003) analyzed samples from eight WWTPs in 
Canada for 11 acidic drug compounds, including salicylic acid, ibuprofen, and diclofenac, 
recording removal rates from the influent between 0% and 98%. 
Improving each WWTP with additional treatment technologies, such as activated carbon, 
oxidation by chlorination or ozonation, and membrane filtration can increase APIs removal 
rates (Boyd et al., 2003; Heberer et al., 2002; Yoon et al., 2006; Ternes et al., 2003). 
However, the most persistent APIa may still not be completely removed, reaching the surface 
waters when the WWTP effluent is released.  
Contamination of soil and groundwater can also happen if WWTPs effluents are used for 
irrigation, as happens in some regions of the United States characterized by aridity and water 
depletion (Daughton, 2004; Kinney et al., 2006; Loraine and Pettigrove, 2006; Toze, 2006). 
In the case of hydrophobic APIs, the compound adsorbed on the sludge particles could be 
released into the environment if that sludge is used as agricultural fertilizer, since the API 
could transfer to surface waters via particulate matter runoff, to groundwater, or accumulate in 
soil (Boxall et al., 2002;  Diaz-Cruz et al., 2003; Golet et al., 2003; Heberer, 2002).  
The load of APIs received by WWTPs will vary among different regions according to several 
factors, including population density, average health status, average age, and economic status, 
which determine differences in the amount of pharmaceuticals used. For example, in 2002 in 
the U.S. the percentage of women of reproductive age using the Pill as contraception method - 
containing an estrogen, ethinyl estradiol (EE2), and a progestin, e.g. norethindrone - varied 
from 19% (Puerto Rico) to 42% (South Dakota) (Bensyl et al., 2005). 
1.4 Degradation processes in the environment 
Once the APIs reach surface water through WWTPs effluents, further degradation processes 
can occur. The abiotic transformation of a pharmaceutical in surface waters may occur mainly 
by photodegradation, caused by both ultraviolet (UV) and visible light (Kümmerer et al, 
2009), which can play a major role in the degradation of some drugs, like diclofenac (Buser et 
al., 1998). The direct photolysis of a compound can be modulated by the presence of humic 
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acids or nitrates, which can act as photosensitizers for some drugs, thanks to the formation of 
hydroxyl radicals and singlet oxygen (Andreozzi et al., 2003; Doll and Frimmel, 2003). The 
degree of photodegradation depends also on the strength of the solar irradiation, and therefore 
on latitude and season (Fent et al., 2006).  
The variations of pH occurring in different environments (e.g. transition freshwater/seawater) 
will influence the dissociation behaviour of APIs according to the acid dissociation constant 
(pKa) (Fent et al., 2006; Scheytt et al., 2005). This parameter will determine the ratio of 
ionized/un-ionized species of a compound present in solution, and the degree of ionization of 
the drug at a particular pH will affect its bioavailability, as well as its chemical and physical 
reactivity, since an ionized compound will be more water soluble than its un-ionized form 
(Kümmerer, 2009). Little information is available about the bioaccumulation potential of 
pharmaceuticals in food webs, with the exception of diclofenac, accumulating in the prey of 
vultures (Oaks et al., 2004), and fluoxetine, sertraline and their metabolites detected in fish 
(Brooks et al., 2005). Diclofenac bioconcentration factors were 10–2700 in the liver of fish 
and 5–1000 in the kidney, depending on exposure concentrations (Schwaiger et al., 2004). 
Finally, biotic degradation by microbial communities can occur, even if this process is 
generally considered of moderate importance when compared to abiotic degradation (Fent et 
al., 2006).    
1.5 Pharmaceutical concentrations in the aquatic environment 
The determination of APIs concentrations in aqueous environmental matrix is mainly based 
on solid phase extraction (SPE), followed by liquid or gas chromatography, combined with 
mass spectrometry for identification and sensitive quantification. In the past few years, the 
improvement of all the steps of this process has allowed a limit of quantification (LOQ) for 
LC-MS/MS in the low ng/L range to be obtained, while with GC-MS/MS coupled with a 
derivatization pre-treatment the LOQ further decreases by up to 10-fold (Kümmerer, 2009). 
Many studies are available in the literature concerning the screening of APIs residues in 
WWTP effluents and surface waters. Since the list grows at a very high rate, and new papers 
are continuously published, in this section only some general considerations about this issue 
we will provided (among the most recent papers see Fatta-Kassinos et al., 2010; Monteiro and 
Boxall, 2010; Kümmerer, 2010; Santos et al., 2010). 
 According to Monteiro and Boxall (2010), APIs concentrations in WWTP effluent are 
generally between “not detected” and a few µg/L, with some exceptions, like salicylic acid 
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(13 mg/L) (Spain). From the information provided into the paper, taking into account the 
highest concentrations reported, it is possible to outline of the following situation. In surface 
water, the concentrations are usually below 1 µg/L, often in the low ng/L range, except for 
acetaminophen (10 µg/L), ibuprofen (5.04 µg/L), naproxen (2 µg/L), diclofenac (4.2 µg/L), 
salicylic acid (8.8 µg/L), and oestrone (1.6 µg/L). Unsurprisingly, the concentration of 
analgesics and anti-inflammatory drugs were relatively high compared with other 
pharmaceutical classes, reflecting the higher volumes used by patients, thanks partly to the 
availability of a number of non-prescribed over-the-counter formulations. Groundwater can be 
contaminated by APIs up to a few µg/L, in particular the most frequently reported drugs in 
groundwater are in the classes of analgesic/anti-inflammatory (e.g. diclofenac, 
dimethylaminophenazone, propyphenazone), and sulphonamide antibiotics. Finally, in 
drinking water, the compounds detected at concentrations higher than the LOQ were the 
analgesic and anti-inflammatory phenazone (0.9 µg/L) and propyphenazone (0.12 µg/L), the 
antiepileptic carbamazepin (0.358 µg/L), the iodinated X-ray contrast media diatrizoate 
(0.085 µg/L), iopamidol (0.079 µg/L) and iopromide (0.086 µg/L); the lipid regulator 
benzafibrate (0.027 µg/L), and lipid regulator metabolites like colfibric acid (0.07 µg/L) and 
fenofibric acid (0.042 µg/L).  
1.6 Effects of pharmaceuticals in the aquatic environment 
1.6.1 Modes of action of pharmaceuticals 
Pharmaceuticals exert their therapeutic effect by interacting with high specificity with 
molecular targets in the organism. A drug target is classically defined as a molecular structure 
(chemically definable by a molecular mass) that specifically interacts with chemicals called 
“drugs” because they are administered to treat or diagnose a disease (Imming et al., 2006). 
However, this definition is sometimes too “static”, since the effects caused by drugs are 
highly dynamic, and all the drugs interfere somehow with signal transduction, receptor 
signalling and biochemical equilibrium. Moreover, many drugs interact with more than one 
target, causing simultaneous changes in several biochemical signals, and their relative 
feedback reactions. This dynamicity can be observed in many drugs, causing clinical effects 
that are not readily deducible from single molecular effects, and it is enhanced by drug 
combinations (Imming et al., 2006). 
In 2006, Imming et al. catalogued 218 molecular targets for approved drugs; in the same year 
Zheng et al. identified 268 targets in the Therapeutic Targets Database, and Overington et al. 
(2006), finally proposed a consensus number of 324 drug targets for all classes of approved 
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therapeutic drugs, combining all the earlier reports into a single comprehensive survey. The 
majority of drug targets are proteins, and these are classified into 4 major groups: receptors, 
ion channels, enzymes and transporters (Fig.1.2) (Rang et al, 2003). 
Knowledge of the mechanisms of action of different APIs detected in the environment has a 
critical importance in the risk assessment process, since the evolutionary conservation of drug 
targets in wildlife species would suggest the possibility that human pharmaceuticals present in 
aquatic environments, even if at low concentrations (ng/L), may cause toxicological effect 
acting through the same targets as they do in humans (Ankley et al., 2007; Christen et al., 
2010; Gunnarsson et al, 2008; Kostich and Lazorchak, 2008; Seiler, 2002). Knowledge of the 
degree of target conservation could help in elucidating the sensitivity of different taxa, or 
species, to each API, thus giving precious information in the risk assessment process 
(Christen et al., 2010; Owen et al., 2007). A more detailed discussion of this topic will be 
provided in Chapter 2. 
 
 
Figure 1.2. The majority of drug targets are proteins, and are classified into 4 major groups: 
receptors, ion channels, enzymes and transporters (from Rang et al., 2003). 
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1.6.2 Effects of pharmaceuticals on fish 
The story of pharmaceuticals in the environment started in 1978, after the accidental 
discovery of intersex fish in an English river (Sweeting, 1981). After that a link between 
intersex fish and estrogens (in particular EE2) was established, the issue of estrogenic 
chemicals in the aquatic environment, and of their possible effects on fish and other wildlife, 
became a topic of very considerable interest until today, as described in the fascinating story 
published by Sumpter and Johnson (2008) in their “Reflections on endocrine disruption in the 
aquatic environment: from known knowns to unknown unknowns”. Thousands of research 
papers have been dedicated to the varied aspects - both chemical and biological - of this issue 
(Matthiessen, 2003). 
The issue of EE2 in the aquatic environment could be considered as a general model of 
reference in the study of pharmaceutical in the environment. In fact, this synthetic estrogen is 
one of the active ingredients of the contraceptive “Pill.” EE2 is an extremely potent estrogen; 
concentrations less than 1 ng/L have adverse effects on reproduction of fish, and only slightly 
higher concentrations prevent fish reproducing (e.g., Lange et al., 2001; Nash et al., 2004; 
Parrott and Blunt, 2005), leading to population crashes (Kidd, et al. 2007). One of the key 
lessons to come out of all the environmental research on EE2 is that very biologically active 
chemicals can be present in the environment, and they have the capability to cause effects at 
extremely low concentrations (Sumpter and Johnson, 2005). This seems to be due to a 
combination of factors, specifically (1) that EE2 is readily taken up by fish from the water 
(Maunder et al. 2007; Scott et al. 2005), (2) that it bioconcentrates to a reasonable degree in 
fish (Lange et al. 2001), (3) that estrogen receptors (ERs) to which it binds very avidly exist 
in fish, just as they do in humans taking the drug as a contraceptive, and (4) that these 
receptors play key roles in regulating reproduction. 
These “lessons” can be translated into several general assumptions: 1) fish can take up 
pharmaceuticals from the surrounding environment in a number of ways, for example through 
dermal and gill surfaces, orally through the diet, or maternally, via the transfer of 
contaminants through the lipid reserve of eggs (Corcoran et al., 2010), and some of these 
drugs can be bioaccumulated in the organisms; 2) a medium-high degree of evolutionary 
conservation of drug molecular targets exists between fish and humans (Gunnarsson et al., 
2008); 3) the conservation of the targets suggest an high probability of functional interaction 
between drug and target, which in turn will cause some (potentially) negative physiological 
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effects. The latter point has been confirmed by several studies, and the amount of evidence is 
continuously growing (e.g. Giltrow et al., 2009; Kugathas and Sumpter, 2011; Paulos et al., 
2010; Runnalls et al., 2007; Winter et al., 2008).   
Finally, two more factors should be taken into consideration. Firstly, differences in the 
capacity of fish to metabolize specific xenobiotics compared to mammalian metabolism, in 
particular during early life stages, could also play a role in the response of fish to human 
pharmaceuticals (Wolf and Wolfe, 2005; Andersson and Forlin, 1992), and secondly, from the 
review of the studies concerning the effects of pharmaceuticals in fish, a potentially large 
inter-species variability seems to exist in fish with regard to the sensitivity of each species to a 
specific API, at least for some pharmaceuticals, such as flutamide (Jensen et al., 2004; 
OECD, 2006).   
Detailed reviews of the effects of human pharmaceuticals in fish have been published by Fent 
et al. (2006), and recently by Corcoran et al. (2010), whereas the effects of steroids and anti-
steroids in fish will be discussed in Chapter 2. Moreover, the effects of anti-androgenic drugs 
in fish and other animal models will be the main topic of discussion in Chapters 5 and 6. 
Hence, in this section only some general considerations will be provided. 
Among all the therapeutic classes, the largest set of toxicity data available for fish is the one 
concerning the effects of steroid agonists. Both natural and synthetic steroids show the lowest 
LOEC values in fish among all the tested drugs. For example, EE2 has been shown to act on 
fish even at sub-ng concentrations (Parrot and Blunt, 2005), inducing feminization of male 
fish and affecting reproduction (e.g. Kidd et al., 2007; Nash et al., 2004; Orn et al., 2003, 
2006); progestagens, like levonorogestrel and norethindrone, adversely affected fathead 
minnow reproduction at 0.8 ng/L and 1.2 ng/L, respectively (Paulos et al., 2010; Zeilinger et 
al., 2009), while androgens and glucocorticoids exerted their effect at higher concentration, 
but still in the low ng/L range; for example, trenbolone caused irreversible masculinisation of 
zebrafish at 9.2-15.5 ng/L (Morthorst et al., 2010) and the glucocorticoid beclomethasone 
dipropionate caused an increase of plasma glucose at 100 ng/L (Kugathas, personal 
communication). 
Anti-steroids, including steroid receptor antagonists (e.g tamoxifen, flutamide) and 
steroidogenic enzyme inhibitors (e.g. fadrozole, ketoconazole), generally produce adverse 
effects in fish only when their concentrations are in the range of µg/L (Ankley et al., 2007; 
Jensen et al., 2004; Panter et al., 2004; Sharpe et al., 2004; Sun et al., 2007; Williams et al., 
2007), except cyproterone actetate, which produced a decrease of plasma testosterone (T) and 
 12 
 
11-ketotestosterone (KT) in female mummichog (Fundulus heteroclitus) at concentrations as 
low as 10 ng/L (Sharpe et al., 2004), although it has never been tested on fish reproductive 
functions or other major endpoints. All the other therapeutic classes caused adverse effects on 
fish only at high concentrations (µg/L or mg/L), with few exceptions. Generally these 
concentrations are not environmentally relevant.   
The widely used nonsteroidal anti-inflammatory drugs (NSAIDs), such as diclofenac, 
naproxen and ibuprofen, act by inhibiting cyclooxygenases (COXs), the enzymes that catalyse 
the synthesis of prostaglandins, via the oxidation of arachidonic acid, inducing a reduction of 
inflammation and pain. Some NSAIDs have been reported to produce adverse effects on fish, 
but only at relatively high concentrations. For example, indomethacin disrupted the process of 
oocyte maturation and ovulation in zebrafish at 100 mg/L (Lister and van der Kraak, 2008) 
and ibuprofen altered the pattern of reproduction in Japanese medaka at concentrations of 100 
μg/L (Flippin et al., 2007). Diclofenac, which brought the collapse of Asian vulture 
populations by inducing renal failure in individual birds (Oaks et al., 2004; Green et al., 
2004), caused some effects also in fish exposed to the drug in the low µg/L range. For 
example, diclofenac induced glomeruloneophritis, necrosis of endothelial cells, and hyaline 
droplet degeneration in the kidney of rainbow trout, and also pillar cell necrosis, epithelial 
lifting, hyperplasia, and hypertrophy of epithelial chloride cells in gills at exposure 
concentrations between 1 and 5 μg/L (Triebskorn et al., 2004; Schwaiger et al., 2004). 
Also the selective serotonin reuptake inhibitor (SSRI) antidepressants, such as fluoxetine, are 
consumed in large amounts by humans and exert their therapeutic effects mainly through the 
inhibition of the reuptake of the neurotransmitter serotonin at presynaptic neuronal 
membranes (Hiemke and Hartter, 2000), causing an increase of serotonin concentration and 
the time when present in the synaptic gap (Fent et al., 2006). This alteration of serotonin 
levels in situ is generally considered beneficial to cure symptoms of depression and other 
psychiatric disorders (Brooks et al., 2003). Both serotonin and its receptors have been 
identified in several fish species (Caamano-Tubio et al., 2007; De Lucchini et al., 2001; 
Yamaguchi and Brenner, 1997). Furthermore, serotonin seems involved in the mediation of a 
number of physiological processes in fish, such as behaviour (aggression, appetite), and 
reproduction (Alanara et al., 1998; Overli et al., 1998; Winberg et al., 1997). With regard to 
the effects casued by SSRIs in fish, fluoxetine is the SSRI which has received the highest 
amount of attention. Exposure to this drug typically altered fish behaviour, such as 
territoriality and aggressiveness (at 6 μg/g/day for 2 weeks) (Perreault et al., 2003; Semsar et 
al., 2004), and feeding behaviour (between 23.2 and 170 μg/L) (Gaworecki and Klaine, 2008; 
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Stanley et al., 2007). Exposure of medaka to fluoxetine (0.1-0.5 µg/L) caused an increase in 
the concentrations of plasma E2, and impaired growth (Brooks et al., 2003), confirming the 
involvement of serotonin in the system of steroidogenic feedbacks (Khan and Thomas, 1992; 
Somoza and Peter, 1991). However, other studies did not confirm these effects in fish (Foran 
et al., 2004). 
Beta blockers, such as atenolol and propranolol, are used to treat or manage several 
conditions, including cardiac conditions (angina pectoris, heart failure, arrhythmia, 
hypertension), glaucoma, hyperhidrosis. They work as competitive β-adrenergic receptor (β-
AR) antagonists (Owen et al., 2007). β-ARs are present in both cardiac and extra-cardiac 
tissues in fish (e.g. gills, liver, brain, muscles) (Lortie and Moon, 2003; Nickerson et al., 
2001; Zikopoulos and Dermon, 2005). From the toxicological point of views, the studies 
available in the literature suggest that beta blockers produce adverse effect on fish only at 
high concentrations (µg/L or mg/L). For example,  propranolol caused decreased growth in 
medaka (500 µg/L) and juvenile rainbow trout (10 mg/L) (Huggett et al., 2002; Owen et al., 
2007), other than a decrease of  egg production and hatching success in medaka (5 μg/L), and 
egg production in fathead minnow (1 mg/L) (Huggett et al., 2002; Giltrow et al., 2009). 
Another beta-blocker, atenolol, affected growth in fathead minnow larvae, but only at very 
high concentrations (10 mg/L) (Winter et al., 2008). 
Lipid regulators, in particular fibrate drug and statins, are also commonly detected in surface 
waters. These compounds act as peroxisomal proliferators (PPs), and thanks to their ability to 
lower lipid levels in the blood, are used to treat hypercholesterolemia.  Fibrates are agonist of 
the peroxisomal proliferator-activated receptor alpha (αPPAR), a nuclear transcription factor. 
The activation of this pathway produces regulation of the expression of some genes coding for 
enzymes involved the lipid metabolism (Gervois et al., 2000), which when activated, coupled 
with increased peroxisomal volume, leads to the removal of fatty acids and cholesterol from 
the blood. There are only a few studies on the effects of fibrates on fish, but there is evidence 
that the PPAR pathway has an important function also in this taxon (Ruyter et al., 1997; 
Andersen et al., 2000; Ibabe et al., 2002). Runnalls et al. (2007) did not observe any effect on 
the lipid metabolism of fathead minnow exposed to clofibric acid (0.01–1 mg/L), however, 
the drug adversely affected the reproductive axis, in particular reducing sperm count and 
motility (at 1 mg/L). 
Finally, other therapeutic classes on which only very limited environmental research has been 
conducted include antibiotics, chemotherapy and antiepileptic drugs. There is no reported 
evidence of toxicity induced by antibiotics in fish, except for tetracyclines that can have a 
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suppressive effect on the immune systems in fish at µg/L concentrations (Grondel et al., 
1985), but it is unlikely that these compounds would have direct physiological effects on fish, 
since they mainly target physiological or molecular processes of bacteria. However, the main 
risk of antibiotics in the environment is their involvement in the development of antibiotic 
resistance in bacteria (Kim and Aga, 2007). Predicted environmental concentrations of 
cytotoxic chemotherapy drugs are in the range of 5-50 ng/L, but no toxicity data are available 
in the literature yet (Johnson et al., 2008). Similarly, no data are available for antiepileptic 
drugs toxicity.     
1.7 5α-Reductase and DHT 
5α-Reductase (EC 1.3.99.5, 3-oxo-5alpha-steroid 4-dehydrogenase, 5αR) is a microsomal 
enzyme that catalyzes the conversion of T into DHT. The discovery, functions, and clinical 
importance of 5αR and of its inhibitor drugs have been extensively described by Frye (2006) 
and Marks (2004). In the following sections the key aspects of 5αR biological relevance will 
be described, with the aim to provide a useful background for the interpretation of the 
experimental results described later in this thesis. 
1.7.1 History and clinical importance 
The rise of 5αR as a clinically important target in prostate diseases is due, as for many 
important scientific discoveries, to a casual observation made by Imperato-McGinley and 
colleagues at beginning of the 1970s, when they discovered the existence of pseudo-
hermaphrodite children in an isolated village of the Dominican Republic, locally called 
“guevedoces”, literally “penis at 12” (years of age). This term was used by locals to indicate 
biological males born with female looking external genitalia, which then develop typical male 
genitalia at puberty (Fig. 1.3). The explanation for this pathological condition was a 
congenital deficiency of the enzyme 5αR. Interestingly, in these individuals the prostate 
remained small throughout life (Imperato-McGinley et al., 1974, 1979, 1992; Peterson et al., 
1977). This discovery led to the synthesis of a new class of drugs, the 5α-reductase inhibitors 
(5αRIs). Finasteride was the first 5αRI, approved in 1992 (Gormley et al., 1992, 1994), 
followed by dutasteride, approved by US FDA in 2002 (Bakshi et al., 1995; Roehborn et al., 
2002). 
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Figure 1.3. “Guevedoces (literally, penis at 12) are biological males with female lacking external 
genitalia from birth until puberty; at puberty, they develop a penis, the testes descend, muscles and a 
male psychosexual orientation develop. Throughout life, the prostate remains small, because the 
congenital deficiency of 5αR leaves affected individuals with markedly suppressed levels of DHT, 
which is the major androgenic stimulus for the prostate” (from Peterson et al., 1977; Marks, 2004). 
Benign prostatic hyperplasia (BPH) and prostate cancer are both age-related proliferative 
diseases which result in significant morbidity and mortality in affected males (Geller, 1991; 
Isaacs, 1990). These conditions are extremely common in men; in fact, BPH occurs in the 
majority of individuals over the age of 60 and microscopic hyperplasia is a nearly universal 
finding on autopsy (Frye, 2006). Prostate cancer is the most common cancer in male 
population, and in 2008 around 37,000 men were diagnosed with prostate cancer in the UK, 
and around 338,000 in Europe. In the UK, it constitutes - after lung cancer - the second most 
common cause of cancer death in men, and in 2008 it causes 10,170 deaths, albeit more than 
80% of them occurred in men aged 70 and over (Cancer Research UK, 2011). Both the 
incidence of BPH and prostate cancer increase steadily from age 50 onward; current 
knowledge suggest that they originate in different regions of the prostate, although they share 
a common dependence upon androgens for development and progression (Frye, 2006).  
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In the prostate it is possible to recognize three anatomically distinct zones – the peripheral, the 
central and the transition zone. In BPH, the transition zone is the one that exhibits nodular 
expansion via proliferation and branching of epithelial glandular tissue and, to a lesser extent, 
prostatic stromal elements (Lee and Pheel, 2004). The growth of the transition zone causes the 
typical constriction of the urethra by compression, producing difficulty in urination, and 
sometimes acute urinary retention, which can be treated only by surgery (Fig. 1.4) (Frye et al., 
2006). BPH is strictly dependent on testicular function and androgen synthesis (Moore, 1944). 
T is converted into DHT by the two isoforms of 5αR, and DHT is the major androgen acting 
on the prostate. 5αR Type 2 deficiency, the same one as was observed in “guevedoces”, 
produced a dramatic decrease in the development and growth of the prostate (Imperato-
McGinley et al., 1974), confirming that DHT is involved in the aetiology of BPH. This 
observation led Petrow and Padilla (1984) to the theory that 5αR could be a target enzyme for 
treatment of prostate cancer. This intuition was confirmed by some results obtained from the 
Prostate Cancer Prevention Trial (PCPT), showing that treatment with finasteride caused a 
decrease of the incidence of prostate cancer by 25% when compared to a placebo (Thompson 
et al., 2003). Dutasteride was also proposed for prostate cancer prevention, and tested in a 
similar clinical trial called “Reduction by Dutasteride of Prostate Cancer Events” (REDUCE). 
However, in March 2011 the US FDA, following recommendations from its Oncologic Drugs 
Advisory Committee, rejected both proposals, since dutasteride, although reducing the 
incidence of prostate cancer in men at high risk of developing the disease, also caused a 
slightly higher risk of developing a more aggressive form of prostate cancer (NCI Cancer 
Bullettin, 2011). 
In addition to BPH and prostate cancer, DHT mediates also the development of some diseases 
of the skin, such as acne, idiopathic female hirsutism and androgenetic alopecia (male pattern 
baldness) (Tenover et al., 1991).  
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Figure 1.4. Benign prostatic hyperplasia, characterized by hyperplasia of prostatic stromal and 
epithelial cells, resulting in the formation of large nodules in the peri-urethral region of the prostate. 
When sufficiently large, the nodules compress the urethral canal to cause partial, or sometimes 
virtually complete, obstruction of the urethra, which interferes with the normal flow of urine. 
1.7.2 Role of 5α-reductase in human physiology 
The two isoforms of 5αR catalyse the NADPH-dependent reduction of Δ4,5 unsaturated 
steroids (Russel and Wilson, 1994). The Type 1 and 2 isozymes differ in their tissue 
distribution, optimum working conditions (e.g. pH), and sensitivity to inhibitors (Table 1.1) 
(Frye, 2006). Both isozymes are hydrophobic proteins of 259 and 254 amino acids, 
respectively, and present 50% of identity in their amino acid sequences. In men, 5αR Type 2 
is mainly expressed in genital tissues (prostate, epididymis, seminal vesicle, genital skin) and 
liver, while the Type 1 isozyme is predominantly expressed in sebaceous glands, liver and 
non-genital skin (Table 1.1) (Levine et al., 1996; Patel et al., 1996; Russel and Wilson, 1994). 
Inter-species comparisons of the amino acid sequences of 5αR Type 1 and Type 2 showed 
only moderate homologies, suggesting important differences in forms, functions, and/or 
regulation. For example, the Type 1 human and rat isozymes have approximately 61% amino 
acid sequence identity, while the two corresponding R Type 2 are 75% homologous. Tissue 
distributions of the two isozymes between rat and human also differ (Levy et al., 1995; 
Normington and Russe, 1992). 
Both expression of the 5αR genes and enzymatic activity are regulated by several factors, 
such as androgens, glucocorticoids and IGF1, in tissues such as prostate, epididymis, liver and 
brain (Antonipillai et al., 1995; Andersson et al, 1989; Henderson, 2006; Horton et al., 1993; 
Robaire and Henderson, 2006). Some evidence also suggests the occurrence of a significant 
regulation at the post-transcriptional level (El-Awady et al., 2004).  
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Table 1.1. Biochemical properties and localization of human 5a-reductase Type 1 and 2 (from Frye, 
2006). 
Properties 5αR Type 1 5αR Type 2 
kcat, s
-1
 (testosterone) 0.52 0.0001 
Km, µM (testosterone) 6.3 0.0063 
kcat/ Km M
-1
s
-1
 8.2 × 10
4
 1.6 ×10
4
 
pH optima 6-8.5 5 
   
Localization   
prostate, epididymis, seminal vescicle, genital skin absent abundant 
testis, ovary, adrenal, brain, kidney absent absent 
liver present present 
non-genital skin abundant absent 
 
The classic 5αR substrate is the androgen T, subsequently converted to DHT, a metabolite 
with higher androgenic potency (Fig. 1.5). Both androgens are essential for male phenotypic 
sexual differentiation and maturation, exerting their effects through the androgen receptor 
(AR) (Josso, 1994; Wilson; 1989). Initial male reproductive development depends on the 
synthesis of T and anti-müllerian hormone (AMH) by the fetal testes (Josso, 1994). The 
masculinization of the external genitalia is controlled by the conversion of T into DHT in the 
tissues of the urogenital sinus, and deficiency in 5αR (Type 2) causes an incomplete form of 
male pseudohermaphroditism (Andersson et al., 1991; Imperato-McGinley et al., 1974; 
Thigpen et al., 1992; Walsh et al., 1974). The 5αR deficient males undergo a partial 
masculinisation during puberty, including testicular descent, penal enlargement and 
development of male musculature; however, these individuals continue to present reduced 
body and facial hair, decreased temporal regression of the hairline (which regresses in non-
deficient men), and reduced size of the prostate (Imperato-McGinley et al., 1992).  
 
Figure 1.5. 5α-Reductase catalyses the conversion of T into DHT (from Frye, 2006). 
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The -reduction of T into DHT in the testis is important for the maintenance or restoration 
of spermatogenesis in adult rats affected by low levels of testicular T. Since in pubertal male 
rats T levels are lower than in adult males, it is possible to hypothesize that DHT may also be 
important for initiating spermatogenesis during puberty (Killian et al., 2003; O‟Donnell et al., 
1996, 1999). In female mice, 5 R deficiency shifts the steroidogenic pathway toward the 
conversion of androgen into estrogens, which when in excess can, in turn, cause fetal death by 
estrogen toxicity (Mahendroo et al., 1997). These findings lead to the conclusion that 5α-
reduced androgens are required for normal reproduction in female mice. Indeed, 5αR Type 1 
gene silencing causes a parturition defect in mice, and this defect can be reversed by 
administration of 5α-reduced androgens (Mahendroo et al., 1996). Some studies performed on 
the mouse also highlighted a potential sex-specific relevance of the two enzymatic isoforms, 
suggesting that the Type 1 enzyme may have a greater importance role in females, while 5αR 
Type 2 may be more important in males (Mahendroo and Russel, 1999).  
Other than sexual development, 5αRs and DHT are involved in other physiological processes, 
as suggested by the high activity of these enzyme in several tissues, including liver, skin, and 
central nervous system. The functions mediate by 5αRs in these organs are not completely 
clear: in the liver, the enzymatic activity could exert a catabolic function (Josso, 1994), in the 
skin has been shown to mediate sebum production (Imperato-McGinley et al., 1993), while in 
the brain it has been suggested that 5α-reduced metabolites of progesterone alter GABAA 
receptor function, playing a role in sexual differentiation of the fetal brain (Melcangi et al., 
1994). 
Other than the conversion of T into DHT, 5αR also catalyzes the reduction of other steroids 
with the 3-oxo-Δ4,5 structure, including progesterone, androstenedione, 11-
deoxycorticosterone, and cortisol (Fig. 1.6) (Tian et al., 1994; BRENDA Database). For 
example, it has been shown that 5αR Type 1 controls androstanediol formation in immature 
mouse testes (Mahendroo et al., 2004). Androstanediol seems to be involved in the regulation 
of male behaviour in some species (Mann et al., 1998, Mahendroo et al., 2004), and is present 
at high concentrations in the immature testes of species like mice (Chase and Payn, 1983) and 
golden hamsters (Frungieri et al., 1999). The 5α-reduction of T to DHT in target tissues is a 
key step in androgen action, but in some circumstances DHT is formed by an alternative 
steroidogenic pathway involving the oxidation of androstanediol synthesized in the testes 
(Shaw et al., 2000). Whether androstanediol has any specific biological action, other than 
being a precursor for DHT, is unclear (Frye et al., 1996). 
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5αRs also convert progesterone and deoxycorticosterone (DOC) to their respective 
5α reduced derivatives providing the substrates for 3α-hydroxysteroid dehydrogenase, the 
enzyme responsible for the formation of 3α-hydroxy 5α pregnan-20-one (allopregnanolone), 
and 3 ,21-dihydroxy- -pregnan-20-one (tetrahydroDOC).  These compounds can act as 
potent neurosteroids, whose action is mediated by allosteric modulation of the γ-aminobutyric 
acid–A receptor complex (GABAA-R) (Mellon and Griffin, 2002). 5α-reduced metabolites of 
progesterone have often been detected in in vitro metabolism studies performed using 
mammary tissue from mouse (Mori and Tamaoki, 1977, 1980), rat (Eechaute et al., 1983; 
Mori et al., 1978), cat (Shiota et al, 1991), dog (Shiota et al., 1991; Tanaka et al., 1994) and 
human (Lloyd, 1979; Verma et al., 1978; Wiebe et al., 2000). These 5α-reduced metabolites 
(5α-pregnanes) have been shown to be present at significantly higher concentration in human 
breast cancer tissue than in non-tumorous tissue, indicating an increased 5αR activity in the 
carcinoma (Lewis et al., 2004; Wiebe et al, 2000; Wiebe and Muzia, 2001,). 
Finally, the pathways of cortisol metabolism includes irreversible inactivation by R. 
Increased peripheral
 
inactivation of cortisol caused by enhanced 5α-reductase activity may 
interfere with negative
 
feedback suppression of adrenocorticotrophic hormone (ACTH) 
secretion, and it is involved in the aetiology of some human pathological conditions, like 
polycystic ovary syndrome (Tsilchorozidou et al., 2003).  
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Figure 1.6. Structure of neuroactive steroids. Metabolism of (A) progesterone, (B) 11 
deoxycorticosterone (DOC) or (C) T by the enzymes 5αR and 3α-hydroxysteroid dehydrogenase 
(3αHSD) leads to the production of the neuroactive steroids allopregnanolone, tetrahydroDOC or 
androstanediol. The chemical names for these steroids are shown below the trivial names. The dotted 
triangle indicates that the hydrogen or hydroxyl group at C3 or C5 is referred to as α; the solid 
triangle indicates that the hydrogen or hydroxyl group is referred to as β. The related structures of two 
synthetic steroids that are neuroactive (D) are shown for comparison with the endogenously 
synthesized neurosteroids (from Mellon and Griffin, 2001). 
1.8 Dutasteride, a dual inhibitor of 5α-reductases 
Dutasteride (CAS N°: 164656-23-9), a synthetic 4-azasteroid, is a competitive and specific 
inhibitor of both the Type 1 and Type 2 isoforms of 5αR; it is manufactured by GSK and 
marketed with the brand name “Avodart”, or “Combodart” when combined with tamsulosin, 
an α1a-selective alpha blocker. Its extended chemical name is (5α,17β)-N {2,5-
bis(trifluoromethyl)phenyl}-3-oxo-4-azandrost-1-ene-17-carboxamide, its molecular weight is 
528.5 and its chemical structure is characterized by the N substitute at C4, and by the 
bis(trifluoromethyl)phenyl group, which increase the stability and lipophilicity of the drug, 
and is involved in its mechanism of action (Fig. 1.7) (Tian et al., 1995). 
A) B) 
D) C) 
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Figure 1.7. Chemical structure of dutasteride. 
The crystallized form of dutasteride is a white to pale yellow powder with a very low 
solubility in water (solubility < LOD = 0.038 ng/ml). However, it is soluble in solvents like 
ethanol (44 mg/mL), methanol (64 mg/mL) and polyethylene glycol 400 (3 mg/mL). The drug 
is lipophilic, as indicated by the high octanol/water partition coefficient of 5.09 (logP), and is 
formulated as hard capsules or soft gelatine capsules containing 0.5 mg of dutasteride, alone 
or combined with tamsulosin hydrochloride (0.4 mg).  
During treatment, the recommended dose of Avodart is one capsule (0.5 mg) taken orally 
once a day. The official therapeutic use is the treatment of BPH, however it is also used, 
without official approval, for the treatment of androgenic alopecia (male baldness). 
All the data and information described in the following sections were provided by GSK 
(2001) during the drug approval process at US FDA (Application Number: 21-319), including 
pre-clinical and clinical toxicity data, and entirely reflect GSK interpretation of the results.  
1.8.1 Biopharmaceutics 
Absorption of dutasteride following oral administration of soft gelatin capsules was rapid, 
with Tmax of 1-4 hours (Tmax is defined as the time after administration of a drug when the 
maximum plasma concentration is reached). Food reduced the total amount of drug absorbed 
by the body by approximately 10-15%. The drug exhibits a large volume of distribution (300 
to 500 L) and was highly bound to plasma proteins (99.0%). The terminal elimination half-life 
of dutasteride was approximately 5 weeks; therefore, bioaccumulation of the drug is expected 
after daily administration. Following repeated doses of 0.5 to 5 mg, the dutasteride plasma 
level, after 28 days, wass about 14 to 16-fold higher than after a single dose (GSK, 2001). 
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1.8.2  Metabolism 
The only data concerning in vivo metabolism of dutasteride are based on a preliminary (pilot) 
metabolism study in vivo (ARIA10012) with unlabeled dutasteride. The results showed that 
the drug was extensively metabolized to approximately 10 metabolites (4 major and 6 minor). 
Overall, approximately 5% of the dose was excreted unchanged in the faeces and 
approximately 40% excreted as unidentified pooled metabolites. Approximately 55% of the 
dose was unaccounted for, confirming the hypothesis of high potential of bioaccumulation for 
this drug. No traces of metabolites related to dutasteride were detected in urine. 
The in vivo findings of extensive metabolism in humans were not in agreement with the 
results obtained in vitro, showing that the isoenzyme CYP 3A4 was the only active enzyme, 
accounting for only 5% of the metabolism, but none of the other tested isoenzyme or enzymes 
(CYP1A2, CYP2A6, CYP2C9, CYP2C19,CYP2D6 and CYP2E1, glucuronyltrasferase and 
sulphotraspherase) were found to be responsible for the metabolism of the drug, using either 
cDNA-expressed CYP450 enzymes, liver microsomes, or hepatocytes. Hence, the metabolic 
pathways of dutasteride remain unclear.  
Based on a US FDA request, the sponsor (GSK) submitted a proposed metabolic pathway in 
animals and human, which did not include any information on the potentially involved 
isoenzymes (Fig. 1.8). The main metabolites were 4-hydroxydutasteride and 6-
hydroxidutasteride, and the former was the major circulating metabolite in humans. The 
biological activity of these metabolites is mostly unknown. 
The average serum concentration of unchanged dutasteride was approximately 40 ng/ml, 
compared to the average concentration of 10 ng/ml of the major metabolite 4-
hydroxydutasteride (Table 1.2). 
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Figure 1.8. Proposed metabolic pathway of dutasteride in humans and animals (GSK, 2001). 
Table 1.2. Summary data for dutasteride metabolism (GSK, 2001). 
Matrices (Fluids) Dutasteride 4-hydroxydutasteride % Dose 
Serum (n = 8) 
40 ng/mL 
(16-78 ng/mL) 
10 ng/mL 
(2-30 ng/mL) 
- 
Urine (n = 8) < 0.1 ng/mL - 
< 0.06% 
(0-0.06%) 
Faeces (n = 8) 
80 µg 
(15-230 µg) 
- 
5% 
(1-15%) 
Faeces  
(parent + all metabolites) 
  
45% 
(6-97%) 
Note: 4-hydroxydutasteride concentration was not reported in urine or faeces. The total is for parent 
and all dutasteride-related materials. 
 
Dutasteride 
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1.8.3 Efficacy biomarkers and pharmacokinetics/pharmacodynamics relationship 
In terms of pharmacokinetics/pharmacodynamics (PK/PD) relationships relevant to DHT 
inhibition (the biochemical marker), the maximum effect caused by dutasteride was dose and 
time dependent. Daily administration of a 0.5 mg dose produced about 80% reduction in 
circulating concentrations of DHT after 7 days of treatment, and the maximum effect was 
observed within 1 to 2 weeks. The administration of a 5 mg dose caused almost complete 
inhibition of circulating DHT. Additional repeats of dose-response studies showed that the 
highest dose produced 80% reduction in DHT within one day, 95% reduction within one 
week and 98% reduction in 6 months. Steady-state dutasteride concentration (~40 ng/mL) was 
completely achieved within 6 months.  
1.8.4 Side effects and adverse reactions  
Approximately 19% of the 2167 patients who received dutasteride in the Phase III placebo-
controlled trials developed adverse reactions. The majority of events were mild to moderate 
and occurred in the reproductive system. No change to the adverse event profile was apparent 
over a further 2 years in open-label extension studies. Table 1.3 shows adverse reactions from 
controlled clinical trials and post-marketing experience. The listed adverse events from 
clinical trials are investigator-judged drug-related events reported with a higher incidence in 
patients treated with dutasteride compared with placebo during the first year of treatment. 
Adverse events from post-marketing experience were identified from spontaneous post-
marketing reports; therefore the true incidence is unknown. 
Table 1.3.  List of adverse reactions caused by treatment with dutasteride and their incidence. 
Organ system Adverse reaction Incidence from clinical trial data 
Incidence during year 1 
of treatment (n = 2167) 
Incidence during year 2 
of treatment (n = 1744) 
Reproductive system and 
breast disorders  
Impotence 6.0 % 1.7 % 
Altered (decreased) libido 3.7 % 0.6 % 
Ejaculation disorders 1.8 % 0.5 % 
Breast disorders (includes 
breast enlargement and/or 
breast tenderness) 
1.3 % 1.3 % 
Immune system disorders Allergic reactions 
including rash, pruritus, 
urticaria, localised 
oedema, and angioedema 
Incidence estimated from post-marketing data 
Unknown 
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1.8.5 Dutasteride toxicity - Preclinical safety data 
The available studies of general toxicity, genotoxicity and carcinogenicity did not show any 
particular risk posed by dutasteride administration to humans. Reproduction toxicity studies in 
male rats showed a decreased weight of the prostate and seminal vesicles, decreased secretion 
from accessory genital glands and a reduction in fertility indices (caused by the 
pharmacological effect of dutasteride). The clinical relevance of these findings is unknown. 
As with other 5αR inhibitors, feminisation of male fetuses in rats and rabbits occurred when 
dutasteride was administered during gestation. Dutasteride was found in the blood of female 
rats after mating with dutasteride treated males. When dutasteride was administered to 
primates during gestation, no feminisation of male fetuses was seen at blood exposure levels 
sufficiently in excess of those likely to occur via human semen. It is considered unlikely that a 
male fetus will be adversely affected following seminal transfer of dutasteride. 
1.8.5.1 Effects on male fertility 
The effects of dutasteride 0.5 mg/day on semen characteristics were evaluated in healthy 
volunteers aged 18 to 52 (n = 27 dutasteride, n = 23 placebo) throughout 52 weeks of 
treatment and 24 weeks of post-treatment follow-up. At 52 weeks, the mean percent reduction 
from baseline in total sperm count, semen volume and sperm motility in the dutasteride group 
were 23%, 26% and 18%, respectively. Sperm concentration and sperm morphology were 
unaffected. After 24 weeks of follow-up, the mean percent change in total sperm count in the 
dutasteride group remained 23% lower than baseline. While mean values for all parameters at 
all time points remained within the normal ranges and did not meet the predefined criteria for 
a clinically significant change (30%), two subjects in the dutasteride group had decreases in 
sperm count of greater than 90% from baseline at 52 weeks, with partial recovery at the 24 
week follow-up. The possibility of reduced male fertility cannot be excluded. In another 
study, Amory et al. (2007) demonstrated that healthy men receiving dutasteride (0.5 mg) (n = 
33) once a day for 1 year, showed a decrease of total sperm count compared to baseline at 26 
weeks (-28.6%) but not at 52 weeks (-24.9%) nor at the 24 week follow-up (-23.3%). At 52 
weeks, semen volume was decreased (-29.7%) as was sperm concentration (-13.2%). There 
was a significant reduction of 6–12% in sperm motility during treatment with dutasteride and 
at follow-up. The treatment did not have any effect on sperm morphology. 
In rats, effects on male fertility and reproductive organs were observed at 0.5 mg/kg/day 
(corresponding to 0.04-0.11 times the steady state clinical blood levels in humans) after 12 
weeks of treatments. Decreased weight of the prostate, seminal vesicles and epididymides 
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were observed at all doses, along with decreased secretory activity of the prostate and seminal 
vesicles and vacuolation of the epidydimal tubular epithelium.  
1.8.5.2 Dutasteride in semen 
Dutasteride was partially excreted in semen; about 12% of the serum concentration was 
present in semen following a 0.5 mg dose. In the study ARA10009, the average semen 
concentration at steady state was 3.3 ng/mL, while the highest concentration was 14 ng/mL. 
Based on this study, exposure of pregnant women to dutasteride appeared to be minimal; 
however, this depends on the degree of the toxicity of the drug and its metabolites. It should 
be noted that based on animal studies, the “no effect dose” on embryo fetal development of 
the male primate is 260 ng/kg; hence, exposure of the fetus to high levels of 5αR inhibitor 
may be associated with high risk of inadequate development of male genitalia. 
1.8.5.3 Effect on testosterone and other endocrine endpoints 
In healthy volunteers, 52 weeks of treatment with dutasteride (0.5 mg/day; n = 26) resulted in 
no clinically significant change compared with placebo (n = 23) in plasma concentrations of 
sex hormone-binding globulin, E2, luteinizing hormone, follicle-stimulating hormone, 
thyroxine (free T4), and dehydroepiandrosterone. Statistically significant, baseline-adjusted 
mean increases compared with placebo were observed for total T at 8 weeks (97.1 ng/dL, p < 
0.003) and thyroid-stimulating hormone at 52 weeks (0.4 mcIU/mL, p < 0.05). The median 
percentage changes from baseline within the dutasteride group were 17.9% for T at 8 weeks 
and 12.4% for thyroid-stimulating hormone at 52 weeks. After stopping dutasteride for 24 
weeks, the mean levels of T and thyroid-stimulating hormone returned to baseline in the 
group of subjects for which there were available data. In patients with BPH treated with 
dutasteride in a large randomized, double-blind, placebo-controlled study, there was a median 
percent increase in luteinizing hormone of 12% at 6 months and 19% at both 12 and 24 
months. 
1.8.5.4 Feminization of the male fetus  
No effects on feminization of the male fetus were observed in monkeys after exposure to 0.07 
and 0.28 ng/ml of dutasteride throughout gestation (4 to 16-fold the estimated blood levels of 
a partner-exposed woman).  
In a rabbit embryo-fetal study doses of 30, 100, and 200 mg/kg (28 to 93-fold the expected 
clinical exposure in men) were administered orally on days 7 to 29 of pregnancy to 
encompass the late period of external genitalia development. Histological evaluation of the 
genital papilla of fetuses revealed evidence of feminization of the male fetus at all doses. A 
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second embryo-fetal study in rabbits at doses of 0.05, 0.4, 3.0, and 30 mg/kg/day (0.3 to 53-
fold the expected clinical exposure) also produced evidence of feminization of the genitalia in 
male fetuses at all doses. It is not known whether rabbits or rhesus monkeys produce any of 
the major human metabolites. 
In an oral pre- and post-natal development study in rats, dutasteride doses of 0.05, 2.5, 12.5, 
or 30 mg/kg/day were administered. Unequivocal evidence of feminization of the genitalia 
(i.e., decreased anogenital distance, increased incidence of hypospadias, nipple retention) of 
F1 generation male offspring occurred at doses ≥ 2.5 mg/kg/day (14 to 90-fold the expected 
clinical exposure in men). At a daily dose of 0.05 mg/kg/day (0.05-fold the expected clinical 
exposure), evidence of feminization was limited to a small, but statistically significant, 
decrease in anogenital distance. Doses of 2.5 to 30 mg/kg/day resulted in prolonged gestation 
in the parental females and a decrease in time to vaginal patency for female offspring and a 
decrease in prostate and seminal vesicle weights in male offspring. Effects on the newborn 
startle response were noted at doses greater than or equal to 12.5 mg/kg/day. Increased 
stillbirths were noted at 30 mg/kg/day. 
In an embryo-fetal development study in female rats, oral administration of dutasteride at 
doses 10 times less than the maximum recommended human dose (MRHD) resulted in 
abnormalities of male genitalia in the fetus, and nipple retention, hypospadias, and distended 
preputial glands in male offspring. An increase in stillborn pups was observed at 111 times 
the MRHD, and reduced fetal body weight was observed at doses ≥ 15 times the MRHD. 
Increased incidences of skeletal variations, considered to be delays in ossification associated 
with reduced body weight, were observed at doses ≥ 56 times the MRHD. Abnormalities of 
male genitalia were also observed in an oral pre- and post-natal development study in rats and 
in 2 embryo-fetal studies in rabbits at one-third the MRHD. 
In an embryo-fetal development study, pregnant rhesus monkeys were exposed intravenously 
to a dutasteride blood level comparable to the dutasteride concentration found in human 
semen. The development of male external genitalia of monkey offspring was not adversely 
affected; however, reduction of fetal adrenal weights, reduction in fetal prostate weights, and 
increases in fetal ovarian and testis weights were observed. 
1.8.5.5  Neurotoxicity and effects on other organs 
In rats, after multiple administration of dutasteride resulting in a blood level higher than 
17,000 ng/ml, centrally mediated neurotoxicity was observed (hypoactivity, dilated pupils, 
uncoordinated behaviour), with no histopatological correlation. Adrenal effects were observed 
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in dogs and mice at relatively high dose. Effects on the thyroid, pituitary, female reproductive 
organs, mammary glands, spleen, bone marrow, lungs and liver were also observed at high 
doses in dogs. 
1.8.5.6 Genotoxicity   
Dutasteride showed no potential genotoxicity in standard test batteries. 
1.8.5.7 Other Effects 
The plasma lipid profile and bone mineral density were evaluated following 52 weeks of 
dutasteride 0.5 mg once daily in healthy volunteers. There was no change in bone mineral 
density as measured by dual energy x-ray absorbtiometry compared with either placebo or 
baseline. In addition, the plasma lipid profile (i.e., total cholesterol, low density lipoproteins, 
high density lipoproteins, and triglycerides) was unaffected by dutasteride. No clinically 
significant changes in adrenal hormone responses to ACTH stimulation were observed in a 
subset population (n = 13) of the 1-year healthy volunteer study. 
1.8.5.8 Dutasteride concentrations in tissues 
After daily exposure (7 days) of mice, dutasteride was found in the following organs: 
adrenals, gall bladder, Harderian glands, liver > pancreas, peri-renal fat, brown fat, inguinal 
fat, preputial gland, kidney > epididymis, lachrymal glands, thyroid, pituitary, brain, salivary 
glands > gastrointestinal system, nasal mucosa, prostate > blood. After 14 days: adrenals >> 
nasal mucosa > epididymis. Concentrations were higher in adrenal cortex than in medulla. 
1.9 The hypothalamic-pituitary-gonadal axis in teleost fish 
One of the key controlling systems of the teleost fish endocrine homeostasis - as in all the 
vertebrates - is the hypothalamic-pituitary-gonadal (HPG) axis. Its structure and function have 
been described in great detail in several reviews, books and book chapters (e.g., Ankley and 
Johnson, 2008; Kime 1998; Norris 2010; Van Der Kraak et al. 1998; WHO 2002), therefore 
here it will be provided only a brief and general description of the axis.  
The HPG axis consists of three components, physiologically connected by a complex multi-
level system of signalling molecules and their transducers. The anatomical components of the 
axis are hypothalamus, pituitary gland (or hypophysis) and gonads (testis and ovary). The 
cascade of signalling molecules can be basically described in the following way. 
Neurosecretory neurons in the hypothalamus directly innervate the pituitary gland and secrete 
several isoforms of gonadotropin-releasing hormone (GnRH) (Fernald and White, 1999; 
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Gothilf et al., 1996; Lethimonier et al., 2004; Powell et al., 1994), which act on specific 
gonadotropin secreting cells - the gonadotrophs – often located in the proximal pars distalis of 
the pituitary gland, stimulating the secretion of the pituitary tropic hormones, luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH). These tropic hormones are released 
into the circulatory system and this carries them to specific cells in peripheral endocrine 
tissues (i.e. gonads), which express key components of the steroidogenic pathways. 
Gonadotropins stimulates synthesis and secretion of steroid hormones (e.g. sex steroids), 
which are subsequently released into the intercellular spaces or into the circulatory system. 
Steroid hormones then affect many non-endocrine targets and induce negative or positive 
feedbacks on the hypothalamus and/or the pituitary (Fig. 1.9) (Norris, 2010; Schulz et al., 
2010). 
One of the main differences between the HPG axis of mammals and fish is the peculiar and 
unique anatomy of the hypothalamus/pituitary gland complex that characterizes fish. In fact, 
different from the situation in mammals, where the hypothalamus and pituitary gland are 
anatomically separate units connected by a vascular portal system, in teleost fish these two 
components are anatomically connected, and the hypothalamic neurons directly innervate the 
pituitary gland, secreting the GnRHs directly into the intercellular spaces of the pituitary 
(Norris, 2010). 
Communication within vertebrates can follow three dynamic patterns: 1) the signal (typically 
a neurohormone), is secreted by a neuron directly onto or near the surface of the cells 
receiving the signal, 2) the signal, a hormone, is secreted by specialized cells within the tissue 
into the extracellular space, and consequently into the blood stream, by which is transported 
and relocated throughout the body to specific cells within target tissues, and 3) the signal is 
synthesized and secreted by one cell type into the extracellular space where it diffuses to 
adjacent cells of a different type that respond to the signal (paracrine communication) (Schulz 
et al., 2010). 
The target cells respond to the signalling molecules through specific molecular receptors, 
which are the apical factor of a complex molecular response that leads to the final 
physiological effect. The dynamic of the system is capable of maintaining the homeostasis of 
the organism, defined by Cannon (1929) as “balanced physiological systems operating in the 
organism to maintain a dynamic equilibrium”, and when new external stimuli are received 
(e.g. temperature, light, presence of a potential sexual partner), the system responds by 
shifting toward a new dynamic state, necessary to mediate specific physiological processes 
such sex maturation, gamete development, reproductive behaviour, and reproduction.  
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The importance of the HPG axis in the environmental toxicology context is due to the 
potential interference caused by exogenous chemicals present in the environment, including 
some human pharmaceuticals, which can alter the normal functional equilibrium of the HPG 
axis, by disrupting the synthesis of one (or more) signalling molecules, or the functional 
interaction between signalling molecule and its receptor, and consequently the feedback 
responses. The disruption of the endocrine homeostasis could lead to the incapability of the 
system to respond in the appropriate way to normally occurring environmental stimuli that 
regulate critical processes such as sexual maturation or reproduction.  
 
Figure 1.9. Basic overview of the male teleost hypothalamic-pituitary-gonadal axis. The linkages 
between components of the axis illustrate how the system maintains a dynamic equilibrium.  GnRH, 
gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone. (from 
Ankley and Johnson, 2004). 
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1.9.1 HPG axis and sex differentiation 
Endocrine control of sex differentiation involves a complex bi-directional link between brain 
and gonad, along the HPG axis. This link is estabilished through signal molecules such as 
gonadotropins, produced by gonadotrope cells of the pituitary gland, and steroids produced in 
gonads and brain (Le Page et al., 2010; Nagahama, 1994; Nagahama, 2005). Sex steroids 
exert a local and direct action on germ-cell development, but also act by influencing other cell 
types and organs involved in sex differentiation. A large number of biochemical, 
neurological, and physiological pathways are involved in this complex multilevel control 
process, and this complexity is of critical importance to provide the necessary plasticity to the 
developing gonad, which allows it to proceed in a dynamic way with the influence of intrinsic 
and environmental factors, but at the same time, provides many levels at which the system 
can be disrupted by chemicals with endocrine interfering properties (Devlin and Nagahama, 
2002; Penman and Piferrer, 2008; Piferrer and Guiguen, 2008).  
A broad debate is occurring on whether sex steroids play a fundamental role in the sex 
determination mechanism of teleost fish, or if the process is only regulated by intrinsic 
genetic processes, independently from the surrounding endocrine environment. This issue will 
be described in detail in Chapter 5, which summarizes the great number of studies supporting 
the hypothesis that the action of sex steroids affects definitive sex determination of fish during 
a short period of the early developmental stage.  
1.9.2 HPG axis, sexual maturation and reproduction 
The three small fish species classically used as experimental models in toxicology (fathead 
minnow, medaka, zebrafish) are all asynchronous spawners, being able to spawn successively 
for a relatively long period when experiencing the appropriate stimuli and environmental 
conditions. Each spawning cycle also involves a number of hormonal, molecular, biochemical 
and physiological responses. The frequency of spawning is species-specific, when not 
dependent on the environmental conditions, and for fathead minnows kept in standard 
laboratory conditions is generally between 3 and 6 days (Ankley and Johnson, 2004). 
Detailed reviews of fish spermatogenesis and oogenesis have recently been published by 
Schultz et al. (2010) and Lubzens et al. (2010), respectively, beside which there are a large 
number of papers and books focusing on the same subject. Therefore, the following section 
will describe only the key events of gametogenesis, focusing on the endocrine control of these 
processes. 
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1.10 General structure of the teleost testis 
The testis of vertebrates, including fish, is composed of two main compartments, the germinal 
(or tubular) and the interstitial (or inter-tubular) compartments. The latter is composed of 
steroidogenic Leydig cells, macrophages, blood/lymphatic vessels, and connective tissue, all 
enclosed by the tunica albuginea, which form the testis‟s wall (Koulish et al., 2002; Schulz et 
al., 2010). The germinal compartment contains the germinal epithelium, formed by somatic 
Sertoli cells, and germ cells at different stages of development. In vivo, germ cells survival is 
strictly dependent on the interaction with Sertoli cells; the latter are an important target of the 
hormonal cascade regulating spermatogenesis (Matta et al. 2002). 
Teleost fish present a typical cystic type of spermatogenesis (Callard, 1996).  The 
spermatogenic cyst represents the basic functional unit of spermatogenesis, and is formed by a 
group of Sertoli cells surrounding one developing germ cell clone. Germ cell development 
occurs synchronously in each cyst, and different cysts host clones in different stages of 
development (Leal et al., 2009; Norbega et al., 2010; Schulz et al., 2010). Sertoli cells are 
essential for germ cell survival, development, and physiological functioning. Furthermore, 
they secrete the fluid that fills the tubular lumen, and present a highly active phagocytic 
activity toward apoptotic germ cells, residual bodies left by spermatids maturation, and 
residual sperm (Almeida et al., 2008; Billard, 1969; Grier and Taylor, 1998; Schulz et al., 
2010; Vilela et al., 2003). 
1.11 General structure of the teleost ovary 
The ovary, like the testis, is enclosed in the tunica albuginea. It shows asynchronous 
gametogenesis, and hence contains oocytes at all stages of development. An inner spherical 
layer of cells, called granulose cells, surround each developing oocyte, and mediate the 
incorporation of vitellogenin into the developing oocyte, whereas the outer layer contains 
another cell type, the thecal cells. Both cell types are involved in the synthesis of steroid 
hormones (Ankley and Johnson, 2004).  
1.12 Cell types involved in sex steroid production 
In both testis and ovary, the main roles of somatic cells are to sustain developing germ cells 
and to synthesize sex steroids, providing the correct hormonal environment to support either 
spermatocyte or oocyte development (Devlin and Nagahama, 2002). 
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In testis, Leydig cells represent the main site of androgen synthesis, whereas in ovaries, the 
two somatic cell layers of the follicle play complementary roles in steroid biosynthesis (Hoar 
and Nagahama, 1978; Nagahama et al., 1982). Generally, thecal cells, after stimulation by 
LH, produce T and other androgens, whereas granulosa cells convert T to estrogen via the 
enzyme aromatase, whose activity is induced by FSH (Nagahama, 1997).  
Immunohistochemical studies with trout testes showed that the steroidogenic enzymes 
P450scc, P450c17, 11β-hydroxylase, and 3β-hydroxysteroid dehydrogenase are active in 
Leydig cells, but not in germ or Sertoli cells (Kobayashi et al., 1998; Morrey et al., 1998), 
suggesting that Leydig cells are the major site of steroid synthesis in fish testis. Although 
aromatase levels in the testis are often undetectable, there is evidence for E2 biosynthesis 
(Pasmanik and Callard, 1988), suggesting the involvement of estrogen in the normal 
functioning of the testis (Devlin and Nagahama, 2002). 
The brain also contains active steroidogenic components, such as aromatase, the enzyme 
responsible for the conversion of T into E2, which has been identified in brain and pituitary 
tissues (Melamed et al., 1999; Pasmanik and Callard, 1988). Brain aromatase activity is 
induced by in vivo treatment with T and E2, and its activity showed a good correlation with 
seasonal changes in gonadal activity and growth in goldfish (Pasmanik and Callard, 1988; 
Pasmanik et al., 1988), suggesting its involvement in the mediation of feedback responses 
induced by sex steroids in the brain.  
The presence of aromatase activity and estrogen production in testis (Pasmanik and Callard, 
1988) may be involved in the mediation of feedback responses between the gonad and brain. 
Both E2 and its receptor have been found in fish brain tissue, supporting the hypothesis of a 
functional role for brain estrogens (Begay et al., 1994; Fine et al., 1990; Pakdel et al., 1990; 
Zhang et al., 2008). 
1.13 The spermatogenic process – an overview 
Spermatogenesis starts with diploid spermatogonia that proliferate and progress toward a 
series of differentiation steps until the formation of mature haploid spermatozoa. The process 
can be divided in three different phases: 1) the mitotic or spermatogonial phase, characterized 
by the occurrence of different generations of spermatogonia in different differentiation stages; 
2) the meiotic phase, during which primary and secondary spermatocytes are produced; and 3) 
the spermiogenic phase with the meiosis process generating spermatids, which in turn 
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differentiate – without further proliferation – into motile spermatozoa (Fig. 1.10) (Nóbrega et 
al., 2009; Schulz et al., 2010). 
The spermatogenic process progresses with the sequential appearance of undifferentiated type 
A spermatogonia, differentiated type A spermatogonia, and then type B spermatogonia, which 
increase in number in the maturation process by exhibiting several generations. The number 
of generations is species-specific (Ando et al., 2000) and genetically determined. For 
example, 9 generations were observed in zebrafish (Leal et al., 2009), and 14 in the guppy 
(Billard, 1969). Considering a signle cyst, after the first spermatogonial division cytoplasmic 
bridges appear between germ cells, generating a clonal syncytium (Loir et al., 1995). The type 
B spermatogonia divide more rapidly than the type A spermatogonia (Schulz et al. 2005), and 
after the final mitosis, they differentiate into primary (pre-leptotene) spermatocytes. The 
following developmental stages are primary spermatocytes (1
st
 meiotic division), secondary 
spermatocytes (2
nd
 meiotic division), spermatids (differentiation without proliferation), and 
spermatozoa (Schulz et al., 2010). 
 
Figure 1.10. Comparison of mammalian (A, mouse) and fish (B, zebrafish) testis. Segments of 
spermatogenic tubules are shown to illustrate the differences in Sertoli/germ cell relation between 
cystic (B) and non-cystic (A) spermatogenesis. The germinal epithelium contains Sertoli (SE) and germ 
cells, delineated by a basal lamina (BL) and peritubular myoid cells (MY). The interstitial Leydig cells 
(LE) and blood vessels (BV) are shown. (A) spermatogonia (SG); spermatocyte (SC); round spermatid 
(RST); and elongated spermatid (EST). (B) Type A undifferentiated* spermatogonia (Aund*); type A 
undifferentiated spermatogonia (Aund); type A differentiated spermatogonia (Adiff); spermatogonia 
type B [B (early–late)]; leptotenic/zygotenic primary spermatocytes (L/Z); pachytenic primary 
spermatocytes (P); diplotenic spermatocytes/metaphase I (D/MI); secondary spermatocytes/metaphase 
II (S/MII); early (E1), intermediate (E2) and final spermatids (E3); spermatozoa (SZ) (from Schulz et 
al., 2010). 
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1.13.1 Extrinsic regulation of spermatogenesis 
1.13.1.1 Pituitary hormones and growth factors 
The gonadotropins, LH and FSH, play key roles in the regulation of testicular physiology.  In 
mammals FSH and LH, at physiological concentrations, interact with their receptors (FSHR 
and LHR, respectively) with high specificity. LH mediates Leydig cell steroidogenesis, while 
FSH regulates Sertoli cell activities, including nutritional and regulatory support of germ cell 
development (Huhtaniemi and Themmen, 2005). The described dichotomy of functions is less 
clear in teleost fish. In fact, in the majority of the studies where the binding characteristics of 
FSHR and LHR have been characterized using hormones from the same species (African 
catfish: Garcia-Lopez et al., 2009; Channel catfish: Kumar et al., 2001; Japanese eel: Kazeto 
et al., 2008; zebrafish: So et al., 2005), FSHR showed a higher affinity for FSH, but was also 
activated by LH, even if the concentrations of LH required to observe the cross-activation 
were relatively high, but nonetheless similar to the ones detected during the spawning season. 
On the other hand, LHR can be cross-activated by FSH, but at concentrations much higher 
than the maximum plasma FSH concentrations, so that the LHR can be considered specific 
for LH (Schulz et al., 2010).  
Leydig cells in fish testis express the FSHR gene (Garcia-Lopez et al., 2008), and FSHR has 
also been detected in both Leydig and Sertoli cells of eel testis using immunological 
techniques (Ohta et al., 2007). Combining the available data it is possible to hypothesize that 
LH and FSH regulate Leydig cell steroidogenesis, while FSH mainly mediates Sertoli cell 
functions, although LH could also play a role in the FSHR activation when circulating at high 
concentrations, such as during the spawning season (Schulz et al., 2010). Other evidence 
suggests that FSH-mediated steroidogenesis stimulates the early stages of spermatogenesis. 
The other roles played by FSH in mammals, such as stimulation of Sertoli cell 
proliferation/terminal differentiation during puberty, support of terminal phases of 
spermiogenesis and spermiation (Huhtaniemi and Themmen, 2005), have not been confirmed 
yet in fish.  
Sertoli cells also produce several growth factors that regulate germ cell proliferation, for 
example activin, growth and differentiation factors (GDFs), anti-mullerian hormone (AMH) 
and its receptor (Miura and Miura, 2001; Miura et al., 2002; Morinaga et al., 2007; Sawatari 
et al., 2007). It is currently not known if FSH can regulate the expression of these growth 
factors in fish.  
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Other than LH and/or FSH, other pituitary hormones can modulate testicular steroidogenesis, 
in particular growth hormone (GH) (Singh et al., 1988); indeed, cross-talk between the 
reproductive and growth axes occurs via the modulation exerted by sex steroids on the release 
of GH from the pituitary (Melamed et al., 1995). In some fish species, like in the Chinook 
salmon (Oncorhynchus tshawytscha), the start of spermatogonial proliferation occur 
simultanously with the elevation of FSH, androgens, and insulin-like growth factor 1 (IGF1) 
(Campbell et al., 2003); the latter is released by the liver in response to GH stimulation. 
Moreover, GH receptors have been detected in trout testis and Sertoli cell (LeGac et al., 1993; 
Gomez et al., 1998), the expression of IGF1 mRNA and IGF-I receptors occurs in germ and 
Sertoli cells in trout (LeGac et al., 1996) and tilapia testis (Berishvili et al., 2006), and IGF1 
stimulates the proliferation and/or differentiation of spermatogonia (Loir and LeGac, 1994; 
Vinas and Piferrer, 2008). Therefore it is possible to hypothesize that GH can modulate 
testicular steroidogenesis and/or germ cell proliferation directly and/or through locally 
produced IGF1 (LeGac et al., 1996; Loir, 1999). 
1.13.1.2 Steroid hormones 
Concentrations of sex steroids show important variations during sexual maturation. In male 
teleosts, E2 plasma concentrations are generally low (Amer et al. 2001; Chaves-Pozo et al., 
2007; Miura et al. 1999), and show a transitory increase at the beginning of the reproductive 
cycle in trout (Gomez et al., 1999). Concentrations of androgens (T, KT) increase with the 
proceeding of spermatogenesis and decrease at spermiation. During the reproductive cycle of 
salmonid fish, two peaks of the progestin 17α,20β-dihydroxy-4- pregnen-3-one (DHP) levels 
have also been observed. A big peak occurs during the spawning season, and a small peak 
during the progression of spermatogonial proliferation (Depeche and Sire, 1982; Scott and 
Sumpter, 1989; Vizziano et al., 1996).  
Estrogens 
Three ER subtypes (α, β1 and β2) are expressed in several tissues of teleost fish, including in 
the testis, where ER expression has been detected in the somatic testicular cells and in haploid 
male germ cells (Bouma and Nagler, 2001; Chang et al. 1999; Ito et al., 2007; Menuet et al., 
2002; Miura et al., 1999; Wu et al., 2001). 
A number of studies indicate that estrogens may play an important role in regulating gene 
expression in the testis, for example by regulating the expression of genes involved in the 
steroidogenic pathway or in its regulation (i.e. Star, 3βHSD, aromatase), and in the 
spermatogenic process (Alsop et al., 2008; Song and Gutzeit, 2003).  
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Androgens 
One or two AR subtypes (α and β) have been described in several fish species, and the testis is 
a major site of expression (Takeo and Yamashita, 1999; Todo et al., 1999; Ikeuchi et al., 
2001). Differently from germ cells, Sertoli and interstitial cells express AR (Ikeuchi et al., 
2001), suggesting a functional interaction with androgens (Schultz et al., 2010). Androgens 
strongly influence the expression of testicular genes involved in spermatogenesis and 
steroidogenesis (LeGac et al., 2007), and distinct androgens (e.g. T, KT) up/down regulate 
gene expression in a steroid-specific fashion (Schulz et al., 2010).  This suggests that different 
steroids may regulate different processes during testis maturation and spermatogenesis 
(Schulz et al., 2010). 
Androgens are capable of inducing the whole spermatogenic process, or at least some critical 
steps such as spermatogonial multiplication and spermatocyte formation or maturation 
(Billard et al., 1982; Billard, 1986; Borg, 1994; Fostier et al., 1983; Nagahama, 1994). They 
may also play an important role in the initiation of puberty (Cavaco et al., 1998; Miura et al., 
1991), and in the induction of spermiation in some species, although they are less effective 
than progestins (Ueda et al., 1985). 
Progestins 
Both nuclear and membrane progestin receptors are expressed in the testis of fish (Hanna et 
al., 2010; Hanna and Zhu, 2009; Todo et al., 2000; Tubbs et al., 2011; Zhu et al., 2003). 
Circulating progestin concentrations have a peak during the entire spermiation process and 
these hormones can regulate several testicular functions. In some species it has been shown 
that progestins such as 17,20β-dihydroxypregn-4-en-3-one (17,20β-P) or, in certain species, 
17,20β,21-trihydroxy-pregn-4-en-3-one (17,20β,21-P), can induce spermiation in Salmonidae 
and Cyprinidae (Ueda et al., 1985), increase milt production (Baynes and Scott, 1985; Yueh 
and Chang, 1997), stimulate spermatozoa motility (Miura et al., 1992; Tubbs and Thomas, 
2008), and initiate meiosis (Miura et al., 2006). For a detailed review of the roles of 
progestins in male fish, see Scott et al., (2010). 
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1.14 Oogenesis in teleost fish  
1.14.1 From primordial germ-cells to mature oocytes 
During the advancement of oogenesis, the developing oocyte acquires the capability of 
forming a viable embryo after fertilization. This process occurs with significant structural and 
functional changes (Lubzens et al., 2010).  
Major stages of oocyte development include formation of primordial germ cells (PGCs), the 
transformation of PGCs into oogonia and subsequently, with the beginning of meiosis, their 
transformation into primary oocytes (Fig. 1.11) (Patiño and Sullivan, 2002). The first meiotic 
division remains arrested at the end of the prophase in the diplotene stage, for a few days or 
months in most teleost fish (Babin et al., 2007). During this arrest, vitellogenesis occurs and 
the oocyte exhibits a dramatic growth, during which it accumulates nutritional (e.g. 
vitellogenin, lipids, vitamins) and informational (maternal mRNA) reserves needed for the 
development of the embryo, and completes the differentiation of its cellular and non-cellular 
envelopes. At maturation the accumulation process progressively slows down or stops, 
meiosis restarts, the nucleus (called germinal vesicle) breaks down (GVBD), cortical alveoli 
form a monolayer under the oocyte plasmatic membrane, and the hydration of the oocytes 
occurs (Lubzens et al., 2010). The first meiotic division generates two cells of different size: 
one small cell (first polar body), which degenerates, and one large secondary oocyte which 
continues the maturation process, and undergoes the second meiotic division, which is 
arrested in the metaphase until fertilization (Babin et al., 2007). At the end of the maturation 
process, ovulation takes place by enzymatic degradation and rupture of the follicle, and 
expulsion of the oocyte from the surrounding follicular cell layers into the ovarian lumen or 
abdominal cavity (depending on the species). At this stage the female gamete is haploid and 
ready to be fertilized (Lubzens et al., 2010). 
 
Figure 1.11. A schematic description of the development stages of oocytes in relation to meiosis in 
teleost fish. From left to right: from primary oocytes, to vitellogenic and mature oocytes (from Lubens 
et at.,2010).  
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1.14.2  Endocrine control of oocyte growth 
Early vitellogenesis is characterized by increases in the plasma concentrations of FSH and E2, 
and increased expression of ovarian FSH receptor (e.g. Breton et al., 1998; Kwok et al., 2005; 
Kobayashi et al., 2008, 2009; Oba et al., 2001; Santos et al., 2001; Tyler et al., 1997). Thecal 
cells synthesize the androgen substrate used by the ovarian granulosa cells to produce E2, via 
the enzymatic activity of the cytochrome P450 aromatase (Nagahama, 1994; Senthilkumaran 
et al., 2004; Young et al., 2005). In turn, E2 stimulates hepatic synthesis of VTG, while FSH 
increase VTG uptake by ovarian follicles, as demonstrated in vitro by Tyler et al. (1991). GH 
enhances the effects of E2 in stimulating VTG synthesis (Peyon et al., 1996), and also plays a 
role in stimulating E2 synthesis by ovarian tissue (Singh et al., 1988; Singh and Thomas, 
1993). 
Also IGF-1 seems to be involved in the regulation of ovarian steroidogenesis, although its 
mechanisms of action are unclear (Berishivili et al., 2006; Kagawa et al., 1995; Perrot et al., 
2000; Schmid et al., 1999). For example IGF-1 inhibited steroid production in thecal cells of 
coho salmon ovarian follicles, and at the same time stimulated steroid production in granulosa 
cells (Maestro et al., 1997).  
Other growth factors are involved in the control of oogenesis, like GDF9 (Halm et al., 2008), 
and activins (βA and βB) (Wang and Ge, 2004). Activin βA seems to be involved in promoting 
ovarian follicle growth, while activin βB appears to play an important role in the processes of 
oocyte maturation and/or ovulation. In zebrafish, the expression of both activin βA and βB has 
been shown to be stimulated by the “epidermal growth factor” (EGF) produced in the oocytes 
(Lubzens et al., 2009; Wang and Ge, 2004).  
1.14.3 Endocrine control of oocyte maturation 
The last phase of oocyte maturation is characterized by termination of vitellogenesis and 
resumption of the first meiotic division, and is associated with increased plasma LH 
concentrations, and increased expression of LH receptor. During this process there is a change 
in the dynamics of the ovarian steroidogenic pathways, resulting in a switch from E2 
synthesis to maturation-inducing steroids (MIS) synthesis (Nagahama and Yamashita, 2008). 
MIS are species-specific derivatives of progesterone and act by binding to oocyte membrane-
specific receptors, activating the maturation promoting factor (MPF), which in turn causes the 
breakdown of the germinal vesicle and the resumption of meiosis (Lubzens et al., 2010). The 
synthesis of MIS by the follicle is coupled with the acquisition of sensitivity of the oocyte to 
respond to the MIS, thanks to the increases expression of membrane MIS receptors and to the 
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enhanced cell-cell communication through gap junctions. This process is known as 
maturational competence, and is induced by gonadotropins (Babin et al., 2007; Patiño and 
Sullivan, 2002; Weber et al., 2007; Yamamoto and Yoshizaki, 2008). Also at this stage, a 
number of other ovarian factors are involved in the maturation processes, such as activin, 
follistatin (Ge, 2000; Pang and Ge, 1999, 2002), EGF and TGF-b (Pang and Ge, 2002). 
1.15 Test organism: the fathead minnow (Pimephales promelas) 
The fathead minnow is a small freshwater teleost fish belonging to the Cyprinidae family, 
with a ubiquitous distribution across North America (Fig. 1.12). Together with zebrafish and 
Japanese medaka, fathead minnow is one of the most commonly used fish species in 
ecotoxicological research. Its basic biology has been described by several authors, including 
Scott and Crossman (1974), Jensen et al. (2001), and Watanabe et al. (2007). The species is 
gonochoristic and sexually dimorphic; sexually mature males are easily distinguished from 
the females for the larger body size (3-7 g versus 2-3 g respectively), and in particular for the 
presence of several male secondary sexual characteristics (SSCs), including vertical dark 
bands on the body, nuptial tubercles on the snout, and prominent fatpad on the dorsal area of 
the body, between the head and the dorsal fin (Fig. 1.13). Male fish are also characterised by 
the presence of dark spots on the dorsal fin and at the base of the tail fin. These SSCs can be 
expressed with variable intensity, reaching the peak during the breeding period. On the other 
hand, females are olive/silver in colour, have a more pointed head, and present an ovipositor, 
a female egg laying organ, just anterior to the anal fin (Fig. 1.13). 
 
 
Figure 1.12. Illustration of sexually mature male (left) and female (right) fathead minnows (Pimphales 
promelas) (from Yonkos et al., 2000). 
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Figure 1.13. Fathead minnow is a sexually dimorphic species. Males are characterized by specific 
SSCs, including (A) dorsal fatpad (arrow), and (B) nuptial tubercles on the snout (arrows). On the 
other hand, females show (C) ovipositor just anterior to anal fin (from the Behavioral Studies 
Laboratory, University of Maryland, USA, http://aquaticpath.umd.edu/behavior). 
Under standard laboratory conditions the fathead minnow reaches sexual maturity at four to 
six months post-hatch. The sexually mature males select and prepare the nest site, which is 
typically located on the under-surface of a U-shaped PVC tile, and exhibit territorial 
behaviour. Females spawn every 2-12 days (typically 3-4 days) (Watanabe et al., 2007), 
deposing clutches of eggs (approximately 50-400 eggs per spawning event) that stick on the 
surface of the nesting site. The males show territorial behaviour and protect the eggs from 
cannibalism; moreover, using their caudal and dorsal fins enhance water circulation in 
proximity of the egg mass, increasing oxygen availability. The spongy dorsal fatpad is used to 
scrub the nest site to remove parasites (e.g. fungi). Embryos hatch within 4-5 days depending 
on temperature (Harries et al, 2000; Yonkos et al, 2000; Jensen et al, 2001). A detailed 
description of sexual differentiation and development of fathead minnow will be provided in 
Chapter 4. 
1.15.1 Role of the fathead minnow in ecotoxicological research 
The fathead minnow is used as a model test species in routine regulatory toxicity tests by 
several environmental or regulatory agencies including the American environmental 
protection agency (US EPA), the European environment agency (EA) and the organisation for 
economic cooperation and development (OECD).  
In particular, this species represent one of the most important models for determining the 
reproductive and developmental effects of exposure to endocrine disrupting chemicals (e.g. 
Ankley et al., 2001; Ankley & Villeneuve, 2006; Harries et al, 2000; Leino et al, 2005; Panter 
et al., 2002; Paulos et al., 2010; Zerulla et al, 2002). The reasons justifying its utility include:  
- a body mass larger than that of zebrafish or medaka, which allow to collect a volume 
of blood large enough to perform the analytical quantification of several circulating 
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steroid hormones (e.g. T, KT, E2), allowing a deeper understanding of the effects of 
chemicals on steroid hormone dynamics; 
- the expression of SSCs driven by sex-steroids (e.g. androgens stimulate the expression 
of male SSCs);  
- a rapid spawning rate which, in optimal condition, can remain constant for several 
weeks;  
- a good characterization of it basic biology and endocrinology, and the growing 
quantity of –omic information available in the bioinformatics databases, which can 
improve the design of mechanistic studies;  
- the high degree of evolutionary similarity to zebrafish, which in turn presents a high 
degree of evolutionary conservation of human drug targets. 
For all these reasons, the fathead minnow was considered an ideal test species for the 
experiments described later in this thesis. 
1.16 Aim of the Thesis 
The aim of my Ph.D. project was to test the hypothesis that the human pharmaceutical 
dutasteride induces in fish effects similar to those caused in men taking the drug to treat 
prostatic diseases, by specifically inhibiting the activity of 5αRs, the enzymes which convert 
T into DHT. The experimental studies performed, using fathead minnow as the model species, 
had the following objectives:  
- Determine whether or not 5αRs are expressed and functional in fish;  
- Determine if the product of 5αRs biosynthetic activity, the androgen DHT, circulates 
in the plasma of fish, and at what concentrations; 
- Determine whether or not DHT has any role in regulating spermatogenesis in fish; 
- Determine if dutasteride affects embryo development, and survival and growth of fish 
exposed to the drug during early life stages; 
- Determine if dutasteride affects sexual maturation of adult fish exposed during early 
life stages; 
- Determine if dutasteride affects the reproductive performances of fish. 
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CHAPTER 2 : CLINICAL USE AND 
ECOTOXICOLOGICAL RELEVANCE OF STEROIDS 
AND ANTI-STEROIDS IN THE UK 
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2.1 Introduction 
Many human pharmaceuticals have been shown (or predicted) to occur in aquatic 
environments; the question arising is, then, what are the consequences of the exposure to 
these substances in non-target species?  
Modes of action and mechanisms of toxicity of any chemical compound are generally defined 
by the interaction between the toxicant and one or more targets, according the so called 
“toxicant-target paradigm”. Targets can be represented by receptors, enzymes, genetic 
material, and transport molecules. Differences in the toxicological profile of different 
chemicals acting through the same mode of action may derive from differences in the 
interaction properties with their targets (Rabinowitz et al., 2009). 
Considering the importance of the interaction between toxicant and target, analysis of the 
phylogenetic and functional conservation of molecular targets across taxa should be a key 
procedure to apply in the risk assessment of environmental pollutants (Ankley et al., 2007). 
This approach is relatively straightforward when applied to the group of human 
pharmaceuticals, since the mechanism of action, and the metabolism, of each active 
pharmaceutical ingredient (API) is extensively studied in several species (Wishart et al., 
2006). Information on target conservation could help in elucidating the sensitivity of different 
taxa, or species, to each API, and, as suggested by several authors, represent a key aspect in 
the development of more efficient testing strategies (Ankley et al., 2007; Christen et al., 2010; 
Gunnarsson et al, 2008; Kostich and Lazorchak, 2008; Seiler, 2002).  
Gunnarsson et al. (2008) predicted the presence of orthologous genes coding for 1318 human 
drug targets in sixteen species, from frogs to bacteria, including two fish species, zebrafish 
and stickleback (Fig. 2.1). Orthologs, or orthologous genes, are genes in different species that 
are similar to each other because they originated from a common ancestor, and represent an 
estimate of the degree of conservation of a target among different species. Their results 
showed how fish and frog were predicted to have the greatest number of human drug target 
orthologs, with the highest degree of similarity, suggesting a very high sensitivity of these two 
taxa to low APIs in the environment. The authors also highlighted the fact that the presence of 
a conserved drug target in a species does not guarantee that a functional interaction with the 
drug will occur. On the other hand, functional interactions between a drug and other non-
orthologous (or non-target) proteins are also possible. A classic example is represented by the 
ER. Its ortholog has been described in several mollusc species, but it is not activated by 17β-
estradiol (E2) or other vertebrate steroids (Kohler et al., 2007; Thornton et al., 2003). 
However, EE2 can induce reproductive responses in molluscs at low ng/L concentrations 
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(Jobling et al., 2003), suggesting that “EE2 could act via either a non-ortholog receptor or 
possibly via a non-characterized ortholog” (Gunnarsson et al., 2008). 
It is important to note that, in some species, conserved pathways of action can be involved in 
the mediation of physiological effects different than the ones occurring in humans. For 
example, thyroid hormones regulate the timing of metamorphosis in amphibians (Tata, 1998), 
a physiological process without counterparts in humans. In other cases, APIs may activate 
pathways that in humans lead to side-effects; while in other species these pathways mediate 
critical physiological effects, which may assume significant ecotoxicological relevance, as in 
the case of vulture populations decimated by diclofenac (see Chapter 1). However, despite the 
potential variability of functions, the presence in a species of conserved molecular targets 
should still indicate if a potential response to an API exposure is likely to occur (Gunnarsson 
et al., 2008; Searls, 2003), and should have a significant influence in the prioritization process 
for toxicity testing. 
 
 
Figure 2.1. Overview of the predicted conservation of drug targets in humans and in other 
vertebrate/invertebrate species, classified according to the gene ontology in five categories (enzyme, 
receptor, ion cannel, transporter, other). Note the high similarity of the targets in H. sapiens and fish 
species (G. aculeatus, D. rerio) (from Gunnarsson et al., 2008).   
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As discussed in Chapter 1, from an ecotoxicological perspective, EE2 is the steroid on which 
the scientific community has focused the greatest attention, but it is not the only steroidal 
pharmaceutical in widespread use. The contraceptive “Pill” also contains a synthetic 
progestogen, which is present at a considerably higher dose than EE2. Various synthetic 
androgens and androgen antagonists are used in the treatment of some common diseases, such 
as androgen deficiency and prostate cancer, respectively. A wide range of synthetic 
corticosteroids are in use to treat the symptoms of very common illnesses such as 
inflammation and asthma. All these pharmaceutical steroid agonists and antagonists act via 
their respective receptors. Fish possess these same receptors, and hence it is possible that, if 
these pharmaceuticals reached the aquatic environment, they could cause effects to fish, just 
as EE2 can (Table 2.1). Given this fairly logical and straightforward line of argument, it is 
perhaps surprising that no systematic search for the presence of any steroidal pharmaceuticals 
(agonists or antagonists) other than estrogens in the aquatic environment appears to have been 
conducted.  
In this Chapter I will provide information on the clinical use of synthetic progestogens, 
androgens, glucocorticosteroids, and mineralocorticosteroids and also their antagonists 
(including antagonists that do not operate via a receptor, but instead inhibit synthesis of the 
natural steroid). It will be also discussed in general terms what effects we would expect these 
pharmaceuticals to have on fish, should they reach the aquatic environment at high enough 
concentrations to cause effects, highlighting the fact that this group of pharmaceuticals should 
be a high priority for research. 
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Table 2.1. Gene similarity between human and fish steroid receptors. Multiple values derive from 
multiple sequences available in Gene Bank classified as “complete coding sequences”, obtained by 
different laboratories and characterized by different lengths (Table modified from Christen et al., 
2010). 
Human receptor Species Similarity to 
human sequence (%) 
Estrogen receptor 1 (alpha) 
 
Zebrafish (Danio rerio)  
Fathead minnow (Pimephales promelas) 
Rainbow trout (Oncorhynchus mykiss)  
Salmon (Salmo salar)  
Killifish (Fundulus heteroclitus) 
 
53/56 
58 
57.1/48.3 
56 
50.4 
Estrogen receptor 2b (beta) 
 
Zebrafish (Danio rerio)  
Fathead minnow (Pimephales promelas) 
Rainbow trout (Oncorhynchus mykiss) 
Japanese medaka (Oryzias latipes) 
 
56.2/68.8 
52.5 
54.8/62.5/58.9 
53.8 
Progesterone receptor Zebrafish (Danio rerio) 64 
Androgen receptor 
 
Zebrafish (Danio rerio)  
Fathead Minnow (Pimephales promelas) 
Rainbow-trout (Oncorhynchus mykiss) 
Japanese medaka (Oryzias latipes) 
 
69.3/71.3/73.5/69.3  
68.8 
70.6/68.5 
68.5 
Glucocorticoid receptor 
 
Zebrafish (Danio rerio)  
Fathead minnow (Pimephales promelas) 
Rainbow trout (Oncorhynchus mykiss)  
 
49 
50 
53/52 
Mineralcorticoid receptor 
 
Zebrafish (Danio rerio)  
Rainbow trout (Oncorhynchus mykiss) 
 
58.8/50 
57.6 
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2.2 Materials and methods 
The data in this chapter were, for the most part, obtained from a publicly accessible and free 
database (http://www.ic.nhs.uk/) maintained by the National Health Services (NHS) of the 
United Kingdom (U.K). Occasionally, specific information on one particular pharmaceutical 
was obtained directly from the manufacturer or distributer of that drug. Prescriptions Cost 
Analysis (PCA) data for England, Wales, Scotland, and Northern Ireland were obtained from 
the regional NHS websites. All regional data referred to the year 2006, except the data from 
Scotland, which referred to the year ending on 31 March 2007. According to the NHS, the 
PCA data „were based on information obtained from prescriptions sent to the Prescription 
Pricing Division of the Business Services Authority (PPDBSA) for payment‟. PCA data 
covered all prescriptions dispensed to the community; that is, by community pharmacists, 
appliance contractors, dispensing doctors, and items personally administered by doctors.  
As the NHS provides healthcare for the vast majority of citizens of the UK, it is generally 
considered that most medicines prescribed in the UK will be prescribed within the NHS. 
Medicines prescribed in hospitals, by private doctors, or purchased via the internet will not 
feature on the database we used. Nor will drugs taken illegally (e.g., anabolic steroids taken 
by some athletes). Although it is not possible to know with a high degree of accuracy what 
proportion of pharmaceuticals used in the UK are prescribed or otherwise obtained from 
outside the NHS (and hence are not covered by the database we used), we consider that it will 
be relatively low. Thus, although the information on amounts prescribed in this paper will be 
under-estimates of actual use, we do not consider that our data are compromised to any 
significant extent. 
The PCA data are based on the therapeutic grouping used in the British National Formulary 
(September 2005; edition 50). For each macro-region, the following data were considered (the 
NHS definition is provided for each element): 
- Drug name: The drug was shown by individual preparation name, which may be 
proprietary or generic, followed by form and strength. 
- Items dispensed (PXS): A prescription item referred to a single item prescribed by a 
doctor (or dentist/nurse) on a prescription form. 
- Quantity (QTY): The quantity of a drug dispensed was measured in units specified on 
the information supplied with the product. 
- Standard quantity unit (SQU): The code indicated the form of the drug and the units in 
which quantity is measured: 
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Code 1 – a unit (e.g., one tablet, capsule, pack, aerosol, etc.) 
Code 3 – millilitres 
Code 6 – grammes 
Code 0 – individually formulated (unit varies) 
 
The total amount of active principal prescribed was calculated for each individual preparation, 
multiplying the value in the QTY column by the amount of active principal in each unit 
(according to the class). For example, 129,213 tablets of „Arimidex Tab 1 mg‟ were 
prescribed by the NHS in England during 2006. Each tablet contained 1 mg of Anastrozole 
(an aromatase inhibitor). According to our methodology, 129.213 g of Anastrozole were 
dispensed. 
If the active principal was conjugated with further chemical groups, the parental active 
principal was considered. For example, Novaldex D Tab 20 mg contained 30.4 mg of 
tamoxifene citrate, equivalent to 20 mg of tamoxifen. When the drug was dispensed as a gel 
or topical cream, the percentage of active principal was calculated. In the case of multiphase 
drugs, containing units with different strengths and compositions in each pack, the different 
compositions were taken into account. When the value in the QTY column referred to a 
blister or a pack, that value was multiplied by the number of tablets or patches contained in 
each blister or pack, according to the British National Formulary 2006. Similarly, the value 
was multiplied by the number of doses in a single prescription for the inhaler drugs. By 
combining the data obtained for each active principal, the total amount of active principal 
prescribed during 2006 was obtained, and expressed in kilograms. 
Experimental Log P values for each chemical were obtained from the Physical Properties 
Database (PHYSPROP, On-Line Interactive Demo Version, http://www.srcinc.com/what-we-
do/databaseforms.aspx?id=386). When an experimental value was not available, the estimated 
Log P was calculated using ALOGPS (v2.1) software (Tetko et al. 2005; VCCLAB 2005). 
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2.3 Results 
2.3.1 Annual Usage in the UK 
The amounts of all steroid and anti-steroid pharmaceuticals dispensed by the NHS of the UK 
in year 2006 were determined. Data were grouped by class (e.g., estrogens/anti-estrogens, 
androgens/anti-androgens), and each class considered in turn below. 
2.3.2 Estrogens/anti-estrogens 
Both natural and synthetic estrogens are widely used. Estrogens are prescribed alone or in 
combination with progestogens in hormone replacement therapy (HRT), and as a treatment 
for estrogens deficiency symptoms in post and perimenopausal women. Estrogens are also 
used for oral contraception (in conjunction with a progestogen), and for treatment of several 
conditions including hypogonadism, primary ovarian failure, and acne. The most prescribed 
estrogen in the UK is the natural estrogen 17β-estradiol (Table 2.2). In comparison, a 
relatively small amount of the very potent synthetic estrogen EE2 is used: about 23 kg per 
year, as opposed to 320 kg of E2. 
Selective estrogen receptor modulators (SERMs) are used in large amounts (more than 1 ton 
in total). SERMs are distinguished from pure agonists and antagonists in that their actions are 
different in different tissues, thereby providing the possibility to selectively inhibit or 
stimulate estrogen-like action in various tissues. They are used in the treatment of breast 
cancer (e.g., tamoxifen), in HRT (e.g., raloxifene), and to treat anovulation (e.g., clomifene).  
Aromatase inhibitors (which inhibit the synthesis of estrogens) are used principally in the 
treatment of breast and ovarian cancer. Significant quantities of these pharmaceuticals (more 
than 100 kg) are prescribed annually (Table 2.2). All the SERMs and Aromatase inhibitors are 
synthetic compounds.  
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Table 2.2. Estrogens/Antiestrogens prescribed in 2006 in the UK for clinical use, classified by Mode 
of Action.  
Mode of Action Principal Name CAS Number Log P Amount Prescribed (kg) 
Agonist Estradiol 50-28-2 4.01 320.60 
Agonist Conjugated Estrogens†   438-67-5§ 2.75§* 66.01 
Agonist Tibolone 5630-53-5 2.69* 64.16 
Agonist Ethinylestradiol 57-63-6 3.67 22.99 
Agonist Estrone 53-16-7 3.13 7.19 
Agonist Estriol 50-27-1 2.45 6.33 
Agonist Diethylstilbestrol 56-53-1 5.07 2.11 
    Total     488.79 
 
SERM Tamoxifen 10540-29-1 5.93* 720.57 
SERM Raloxifene 84449-90-1 5.45* 486.74 
SERM Clomifene   911-45-5 6.08* 33.36 
SERM Toremifen 89778-26-7 5.65* 1.65 
    Total    1242.32 
 
Aromatase Inhibitor Exemestane 107868-30-4 2.67* 68.07 
Aromatase Inhibitor Anastrozole 120511-73-1 2.31* 19.87 
Aromatase Inhibitor Letrozole 112809-51-5 1.86* 12.79 
    Total     100.73 
(†) Conjugated estrogens containing the sodium sulphate forms of estrone, equilin, 17 -estradiol, 
17 -dihydroequilin, 17 -dihydroequilin, 17 -dihydroequilenin, 17 -dihydroequilenin, equilenin, 17 -
estradiol, and 
8,9
-dehydroestrone (CAS Numbers: 438-67-5, 16680-47-0, 16680-48-1, 56050-04-5, 
4999-79-5, 56050-05-6, 16680-49-2, 56086-66-9, 16680-50-5). (§) Data referred to the sodium estrone 
sulphate, which represents 52.5% - 61.5% of the mixture. (*) Estimated Log P value (by ALOGPs). 
Abbreviations: SERM, Selective Estrogen Receptor Modulator. 
2.3.3 Androgens/anti-androgens 
As with estrogens/anti-estrogens, this group includes agonists, receptor antagonists, and 
compounds that inhibit the synthesis of androgens (Table 2.3). Fairly similar amounts of these 
three groups of androgens/anti-androgens were used as the same groups of estrogens/anti-
estrogens. As with the estrogen agonists, the androgen agonists used in the greatest amount 
was the main natural androgen, testosterone. Synthetic androgens were used in considerably 
smaller amounts, although the most widely prescribed synthetic androgen, stanozolol, was 
prescribed in approximately the same amounts as the main synthetic estrogen, EE2 (17 vs. 23 
kg, respectively). Androgen agonists are prescribed mainly as replacement therapy in males 
with a deficiency or absence of endogenous testosterone associated with hypogonadism. 
Much of the testosterone prescribed is in the form of esters. The aim of esterification is to 
improve the lipophilicity of the molecule, which slows the release of testosterone from the 
site of entry into the body.  
Anti-androgenic pharmaceuticals are prescribed in large amounts – more than 1 ton – each 
year (Table 2.3). Two different sub-classes of anti-androgenic pharmaceuticals are available: 
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AR antagonists (e.g., Bicalutamide) and inhibitors of the enzyme 5-alpha reductase, which 
converts T into DHT (e.g., Finasteride). The use of large amounts of anti-androgenic 
pharmaceuticals reflects the high incidence of prostatic diseases amongst the male population; 
in fact, prostate cancer is the most common cancer of men in the UK (ONS, 2007), and it is 
dependent on endogenous androgen for development, growth and survival (Culig and Bartsch 
2006). All anti-androgenic pharmaceuticals on the market are synthetic.  
Table 2.3. Androgens/Antiandrogens prescribed in 2006 in the UK for clinical use. 
Mode of Action Principal Name CAS Number Log P Amount Prescribed (kg) 
Agonist Testosterone 58-22-0 3.32 280.98 
Agonist Stanozolol 10418-03-8 4.06* 17.00 
Agonist Mesterolone 1424-00-6 3.75* 8.15 
Agonist Prasterone 53-43-0 3.23 0.39 
Agonist Nandrolone 434-22-0 2.62 0.08 
Agonist 5α-Dihydrotestosterone 521-18-6 3.55 0.02 
    Total     306.62 
     
AR Antagonist Bicalutamide 90357-06-5 2.70* 606.37 
AR Antagonist Cyproterone 2098-66-0 3.81* 401.17 
AR Antagonist Flutamide 13311-84-7 3.35 258.61 
    Total    1266.15 
     
5αR Inhibitor Finasteride 98319-26-7 3.03 242.21 
5αR Inhibitor Dutasteride 164656-23-9 5.45* 5.07 
    Total     247.28 
(*) Estimated Log P value (by ALOGPs). Abbreviations: AR, Androgen Receptor; 5αR, 5-alpha 
Reductase. 
2.3.4 Progestogens 
Only progesterone receptor (PR) agonists were prescribed by the NHS; no PR antagonists or 
pharmaceuticals that target the synthesis of progesterone were prescribed, as far as we can 
ascertain. Many different progestogens were prescribed. The 10 most widely prescribed 
progestogens (by weight) are listed in Table 2.4. Nine of these are synthetic progestogens. In 
total, 1700 kg of progesterone agonists were prescribed, which is considerably more than both 
estrogen agonists (less than 500 kg) and androgen agonists (300 kg). This dominance is 
considerably more pronounced if the synthetic hormones alone are compared; the amounts of 
synthetic estrogens, androgens, and progestogens prescribed were approximately 70, 25, and 
1560 kg, respectively.  
Progestogens are most commonly and widely used for contraception, either alone or in 
combination with estrogens. They are also used for treatment of a number of other conditions, 
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including HRT, menstrual problems, endometriosis, anorexia, cancer, and assisted 
reproduction. They are administered via a variety of routes, including pills, patches, injection, 
implant, gels, creams, and suppositories.  
At least one PR antagonist, Mifepristone, is used in the UK, as an abortifacient during the first 
2 months of pregnancy. It is also used in „morning-after treatment‟, to prevent possible 
pregnancy. This pharmaceutical is not prescribed through the NHS, and hence no information 
on its use was available via the NHS website that we used as the main source of our 
information. However, it has been established through other sources (Exelgyn, personal 
communication, 2008) that in 2006 about 18.6 kg of Mifepristone was used in the UK (Table 
2.4), and in 2007 this increased to about 21 kg. 
Table 2.4. The major progestogens prescribed in 2006 in the UK for clinical use. 
Mode of Action Principal Name CAS Number Log P  Amount Prescribed (kg) 
Agonist Medroxyprogesterone 520-85-4 3.52* 529.70 
Agonist Norethindrone 68-22-4 2.97 440.16 
Agonist Dydrogesterone 152-62-5 3.27* 209.02 
Agonist Drospirenone 67392-87-4 2.36* 153.19 
Agonist Megestrol 3562-63-8 3.71* 146.69 
Agonist Progesterone 57-83-0 3.87 141.56 
Agonist Norgestimate 35189-28-7 3.80* 24.12 
Agonist Levonorgestrel 797-63-7 3.25* 19.59 
Agonist Desogestrel 54024-22-5 4.30* 13.87 
Agonist Ethynodiol Diacetate 297-76-7 3.99* 13.85 
Agonist Others**    / / 12.90 
    Total    1704.65 
     
PR Antagonist Mifepristone 84371-65-3 5.33* 18.6 
    Total      18.6 
(*) Estimated Log P value (by ALOGPs). (**) Others include: Norelgestromin, 56016-31-2; 
Norgestrel, 6533-00-2; Etonogestrel, 54048-10-1; Gestodene, 60282-87-3; Gestrinone, 16320-04-0; 
17α-Hydroxyprogesterone, 630-56-8. 
2.3.5  Corticosteroids 
Corticosteroids are either glucocorticosteroids (interacting primarily with the 
glucocorticosteroid receptor, or GR) or mineralocorticosteroids (interacting principally with 
the MR). Synthetic corticosteroids are used to treat a wide variety of conditions including 
adrenocortical insufficiency, hypersensitivity, asthma, rheumatic disease, inflammatory skin 
disorders such as eczema and psoriasis, contact dermatitis, inflammatory eye and ear 
conditions, immunosuppression in patients with lymphomas and leukemia, allergic rhinitis, 
Cushing‟s disease, and adrenal replacement therapy.  
 55 
 
The large number of conditions treated with corticosteroids, together with the increasing 
prevalence of some of these illnesses (e.g., asthma), explains the high usage of corticosteroids 
(Tables 2.5 and 2.6). In total, more than 7000 kg of corticosteroid agonists and antagonists 
were prescribed in 2006. The wide range of conditions that are treated with corticosteroids 
also explains why so many (about 30) different glucocorticosteroids are in use (c.f. synthetic 
estrogens, only two of which were prescribed).  
Almost all use of corticosteroids refers to synthetic compounds. In most of the synthetic 
corticosteroids, H on the 9th carbon is substituted by F. In others it is substituted by Cl. These 
substitutions increase the stability of the compounds in the human body, so that frequent 
administration is avoided.  
Only GR agonists were prescribed (Table 2.5); no glucocorticosteroid antagonists, or 
pharmaceuticals that inhibit synthesis of endogenous glucocorticosteroids (e.g., cortisol, 
corticosterone), were prescribed. The total use of synthetic glucocorticosteroids prescribed – 
more than 4,300 kg – was far in excess of the amounts of synthetic estrogens, androgens, and 
progestogens prescribed (or the combined total of these three groups).  
Only a single mineralocorticosteroid was prescribed, and this in a very small amount (2 kg). 
In contrast, a very significant amount of mineralocorticosteroid antagonist (more than 2500 
kg) was prescribed, which was accounted for almost entirely by a single pharmaceutical, 
spironolactone (Table 2.6). 
 
 
 
 
 
 
 
 
 
 56 
 
Table 2.5. Glucocorticosteroids prescribed in 2006 in the UK for clinical use. 
Mode of Action Principal Name CAS Number Log P Amount Prescribed (kg) 
Agonist Hydrocortisone 50-23-7 1.61 1810.91 
Agonist Prednisolone 50-24-8 1.62 1488.30 
Agonist Betamethasone 378-44-9 1.94 305.33 
Agonist Beclometasone 4419-39-0 2.12* 273.96 
Agonist Fluticasone 90566-53-3 2.69* 176.29 
Agonist Budesonide 51333-22-3 2.42* 89.46 
Agonist Mometasone 105102-22-5 2.81* 51.81 
Agonist Clobetasone 54063-32-0 2.61 44.72 
Agonist Methylprednisolone 83-43-2 2.06* 28.98 
Agonist Dexamethasone 50-02-2 1.83 27.26 
Agonist Clobetasol 25122-41-2 2.48 21.60 
Agonist Triamcinolone 124-94-7 1.16 16.61 
Agonist Cortisone 50-06-5 1.47 15.72 
Agonist Others** / / 16.77 
    Total     4367.72 
(*) Estimated Log P value (by ALOGPs). (**) Others include: Deflazacort, 14484-47-0; Flumetasone, 
2135-17-3; Fluocinolone, 807-38-5; Diflucortolone, 2607-26-9; Fluocinonide, 356-12-7; 
Fluocortolone, 152-97-6; Rimexolone, 49697-38-3; Alclometasone, 66734-13-2; Fluorometholone, 
426-13-1; Flunisolide, 3385-03-3; Fludroxycortide, 1524-88-5; Ciclesonide, 141845-82-1; 
Fluprednidene, 1255-35-2; Desoximetasone, 382-67-2; Halcinonide, 3093-35-4. 
Table 2.6. Mineralcorticosteroids prescribed in 2006 in the UK for clinical use, classified by mode of 
action. 
Mode of Action Principal Name CAS Number Log P Amount Prescribed (kg) 
Agonist Fludrocortisone 127-31-1 1.67 2.18 
    Total      2.18 
 
MR Antagonist Spironolactone 52-01-7 2.78 2536.78 
MR Antagonist Eplerenone 107724-20-9 1.67* 33.46 
    Total   2570.24 
(*) Estimated Log P value (by ALOGPs). Abbreviation: MR, Mineralcorticosteroid Receptor. 
2.3.6 Environmental Concentrations 
A representative summary of current knowledge about the environmental concentrations of 
natural and synthetic steroid hormones and their antagonists is provided in Table 2.7. Effluent 
concentrations are reported much more frequently than surface water (river) concentrations. 
In both cases, variability in concentrations would be expected. In the case of effluents, the 
efficiency of the STW will be a major factor in determining effluent concentrations of “down-
the-drain” micropollutants (Johnson et al. 2007). In the case of river water concentrations, the 
degree of dilution of the WWTP effluent in the river, which can be highly variable, will play a 
major role in determining concentrations. Yet despite these variables, the general message is a 
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very consistent one: concentrations of both natural and synthetic steroid hormones are in the 
low ng/L range, or even in the pg/L range. 
The estrogens can serve as an example because much more is known about them than any 
other group of steroid hormones. In the case of the synthetic estrogen EE2, the annual usage 
of around 23 kg in the UK leads to effluent concentrations in the low ng/L range (Johnson et 
al. 2005; Kanda and Churchley 2008), with river water concentrations, even in rivers heavily 
impacted by effluent, less than this (Williams et al. 2003). Such low concentrations can be 
difficult to measure reliably, which has led to some erroneous (high) concentrations being 
reported (discussed in Johnson et al. 2008). A very comprehensive recent analysis of both 
measured and modelled concentrations of EE2 in rivers (Hannah et al. 2009) demonstrates 
convincingly that the maximum likely concentration is 1ng/L, with average concentrations 
being one or even two orders of magnitude below this. 
There are many less data available on measured concentrations of androgens, progestogens, 
glucocorticoids and mineralocorticoids, but those which there are fit well with the data on 
estrogens. All published data suggest that, in both effluents and rivers, concentrations of 
individual steroids are in the low ng/L, or sub-ng/L, range (Table 2.7). However, it should be 
kept in mind that quite a few (possibly even ten or more) different progestogens or 
glucocorticoids will probably be present simultaneously, and hence the total concentration, 
certainly in effluents, may reach a hundred ng/L, or more. Nevertheless, concentrations in the 
μg/L range, even in effluents, seem extremely unlikely, except possibly in unique locations. 
Environmental concentrations of steroid hormone antagonists are currently very poorly 
documented. In most cases (e.g., antagonists of androgens, progestogens and 
mineralocorticoids) no data are available, either for effluents or rivers. A very limited amount 
of data is available for the ER antagonist Tamoxifen (Roberts and Thomas 2006), which 
suggests that the environmental concentration is in the low hundreds of nanograms/L range. 
Although this concentration is possible, because a considerable amount of this pharmaceutical 
is in use (720 kg annually), further work is needed to confirm this value. 
In summary, aquatic wildlife are probably exposed, albeit continuously, to very low ng/L, or 
even sub-ng/L, concentrations of both natural and synthetic steroid hormones and their 
antagonists: these are the “environmentally-relevant” concentrations that need to be assessed 
for potential effects. 
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2.3.7 Effect Concentrations  
Summarized in Table 2.8 is a representation of current knowledge on the effects of natural 
and synthetic steroid hormones and their antagonists on fish. Fish have been chosen as the 
target species because almost all available data relate to effects on fish. When data on other 
groups of organisms are available, they seem to be considerably less sensitive to these 
pharmaceuticals than fish (Caldwell et al. 2008). 
Effect concentrations of the different steroids and their antagonists appear to be reasonably 
variable, although all are relatively low (in the μg or ng/L ranges). Fish are extremely 
sensitive to EE2, with effects occurring in the very low ng/L range. For example, a number of 
comprehensive, thorough studies have shown that concentrations as low as a few ng/L prevent 
fish reproducing (Länge et al. 2001; Kidd et al. 2007) , and even lower concentrations can 
produce biochemical changes. Similarly, recent data on synthetic progestogens (Paulos et al., 
2010; Zeilinger et al. 2009) shows that at least some representatives of this class of 
pharmaceutical will inhibit egg laying of fish at extremely low concentrations, possibly less 
than 1 ng/L. Androgens may be somewhat less potent, but are still having an effect in the 
range of a few tens of ng/L (see Chapter 4). There are no published effects data for synthetic 
mineralocorticoids at environmentally relevant concentrations, and only one publication is 
available for synthetic glucocorticoids (Kugathas and Sumpter, 2011).  
A reasonable amount of information is available on the effects of both estrogen and androgen 
antagonists on fish. Both types of estrogen antagonists (receptor blockers and aromatase 
inhibitors) have been studied in well executed studies (e.g., Williams et al. 2007; Sun et al. 
2007), and in both cases it has been found that μg/L concentrations are required to produce 
measurable responses in fish, with the LOEC being in the low μg/L, but not ng/L, range. The 
AR receptor blocker flutamide has also been reasonably well studied, and appears to be 
relatively inactive in fish, with the LOEC being in the high μg/L range (Table 2.8). In 
contrast, the AR antagonist Cyproterone Acetate appears quite potent, and has anti-
androgenic effects in the low ng/L range. The only data available on the effects of 5α-
reductase inhibitors (anti-androgens) in fish are presented in this Ph.D. Thesis, and confirm a 
LOEC in the μg/L range. Currently no data are available or on the mineralocorticoid inhibitor 
spironolactone, despite the very high annual usage (more than 2500 kg) of this drug.  
In summary, although there is a significant degree of variability in effect concentrations 
between the different steroid hormones, and also between different antagonist (even within 
one class of pharmaceutical), plenty of high quality data shows that μg/L concentrations will 
always cause major effects, ng/L concentrations often will (especially those of the synthetic 
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steroids), and even sub-ng/L concentrations of some steroids can cause major adverse effects 
(for example, lack of reproduction). 
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Table 2.7. Representative concentrations of natural and synthetic steroid hormones and their antagonists in the aquatic environment. 
 
 
Mode of Action Name Effluent (ng/L) 
Surface water 
(ng/L) 
Reference 
ESTROGENS 
Agonist 
Ethinyl Estradiol 0.8-2.8  Johnson et al. (2005) 
Ethinyl Estradiol  4.6 max Williams et al. (2003) 
Estradiol < 0.4-4.3 ND Williams et al. (2003) 
Estrone < 0.4-12.2 0.32-2.12 Williams et al. (2003) 
Conjugated 
Estrogens 
0.07-2.6 Not measured Tyler et al.(2009) 
Antagonists Tamoxifen 146 27-212 Roberts and Thomas (2006) 
Aromatase 
Inhibitor 
 No data No data  
ANDROGENS 
Agonist 
Testosterone 0.3 - 8 Not measured Kolodziej et al. (2003) 
Testosterone Not measured 2.8 - 6.0 Vulliet et al. (2008) 
Antagonists  No data No data  
5α-Reductase 
Inhibitor 
 No data No data  
PROGESTOGENS 
Agonists 
Norethindrone 5.2-41 Not measured Vulliet et al. (2007) 
Levonorgestrel 0.9-17.9 Not measured Vulliet et al. (2007) 
Antagonists Mifepristone No data No data  
GLUCOCORTICOIDS Agonists 
Triamcinolone 14 ± 1 Not measured Schriks et al. (2010) 
 Not measured < 0.63 Tölgyesi et al. (2010) 
Cortisone 0.13-0.58 0.06-4.2 Chang et al. (2007) 
Prednisolone 0.47-0.72 0.03-0.64 Chang et al. (2007) 
MINERALOCORTICOIDS 
Agonists  No data No data  
Antagonists  No data No data  
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Table 2.8. Representative effect concentrations of natural and synthetic steroid hormones and their antagonists. All reliable data concerns effects on freshwater fish LOEC  = 
Lowest Observed Effect Concentration. 
 Mode of Action Name Effects LOEC ( g/L) Species Reference 
ESTROGENS 
Agonist 
Ethinyl Estradiol 
Secondary sexual characteristics / Altered sex 
ratio / feminisation / VTG 
0.004 Pimephales promelas Länge et al. (2001) 
Estradiol Reduction in reproductive output 0.78 Pimephales promelas Thorpe et al. (2003) 
Estrone 
VTG / Sex ratio / Reproduction / secondary 
sexual characteristics 
0.10 
0.005-0.025 (VTG) 
Danio rerio Brion et al. (2004) 
Antagonist Tamoxifen 
Inhibition of Reproductive output/ VTG / 
Gonadal histology 
5.60 Pimephales promelas Williams et al. (2007) 
Aromatase 
inhibitor 
Fadrozole GSI / VTG 24.80 Pimephales promelas Panter et al (2004) 
Letrozole Fecundity / fertility / VTG 5 Oryzias latipes Sun et al. 2007 
ANDROGENS 
Agonist 
Testosterone - - - - 
5α-Dihydrotestosterone 
Growth increase in males/T increase in males and 
decrease in females/ovary histopathology/ 
masculinisation of females 
0.02 
Pimephales promelas 
Margiotta-Casaluci and 
Sumpter (2011) 
Growth increase in females/stimulation of 
spermatogenesis 
0.20 
Masculinisation of females/ Vtg induction in 
females 
6.00 Pimephales promelas Panter et al. (2004) 
AR Antagonist 
Cyproterone 
Plasma T and KT reduction in males 0.10 Fundulus heteroclitus 
 
 
Sharpe et al. (2004) 
 
 Plasma T reduction in females 0.01 
Flutamide 
Spiggin inhibition 500 
 
Gasterosteus aculeatus 
 
Sebire et al. (2008) 
Nest building behaviour / Male courtship 
behaviour 
100 
Testis histopathology/ Ovary histopathology 62.70 
Pimephales promelas Jensen et al. (2004) 
Plasma E2 increase in males / Vtg induction in 
males and females / T increase in females / 
fecundity / hatching 
651 
5αReductase 
Inhibitor 
Dutasteride 
Decreased larval growth/Long term retardation of 
oogenesis/plasma T and KT decrease in 
males/ovary histopathology 
32 
Pimephales promelas 
Margiotta-Casaluci and 
Sumpter (in prep.)  
Decreased larval survival/Long term retardation 
of spermatogenesis/decreased egg 
production/decreased male SSCs/plasma E2 
decrease and T increase in females 
100 
PROGESTOGENS Agonist 
Norethindrone 
Inhibition of reproduction/ masculinisation of 
females / steroid levels 
25 
 
1-10 
 
Oryzias latipes 
 
Pimephales promelas 
 
Paulos et al, (2010) 
 
Levonorgestrel 
Inhibition of reproduction/ masculinisation of 
females 
0.0008 Pimephales promelas Zeilinger et al. (2009) 
GLUCOCORTICOID Agonists  
Plasma glucose increase/VTG gene 
downregulation/Linphocytes reduction 
1 Pimephales promelas 
Kugathas and Sumpter 
(2011) 
MINERALOCORTICOID 
Agonists  No Data    
Antagonists  No Data    
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2.4 Discussion 
This Chapter deals with the (potential) ecotoxicological problems caused by the presence of 
human pharmaceuticals in the environment, particularly the aquatic environment.   
2.4.1 Clinical use of steroid/anti-steroids in the UK and their environmental 
concentrations 
The results show that steroid hormones and antagonists of endogenous steroids are widely 
used as pharmaceuticals, although the amounts used are much lower than the amounts of 
some other pharmaceuticals in widespread use, such as some analgesics, cardiovascular drugs, 
anti-inflammatories, and antibiotics. Nevertheless, it should not be forgotten that although the 
annual use of EE2 in the UK is less than 25 kg, this pharmaceutical is of ecotoxicological 
concern (Caldwell et al. 2008); this pharmaceutical demonstrates that founding environmental 
risk assessment strategies on amounts of drugs used is not wise or defensible. Even amongst 
the synthetic estrogens in use as pharmaceuticals, EE2 is not the one used in the greatest 
amount in the UK: Tibolone occupies that position. When use of synthetic estrogens is 
compared to the use of synthetic steroids in other classes (e.g., androgens, progestogens and 
glucocorticosteroids), it is found that the amount of estrogen used is small compared to these 
other groups of steroids. For example, about 20-times more Medroxyprogesterone acetate and 
Norethindrone, more than 80-times as much Hydrocortisone, and more than 50-times as much 
Prednisolone, is used.  
As demonstrated in Table 2.7, although much is still to be learnt about concentrations of 
steroid hormones in the aquatic environment, the picture that is emerging is a reasonably 
consistent one. Effluent concentrations are likely to be in the low ng/L range, which in most 
cases would give rise to sub-ng/L concentrations in rivers. Only in situations where the degree 
of dilution of effluent is low (as it can be in densely-populated areas with relatively small 
rivers) are river concentrations of steroid hormones likely to be in the ng/L range (Sumpter 
and Johnson 2005). However, the total concentration (of the different progestogens or 
glucocorticoids, for example) is probably the most relevant exposure parameter, because 
pharmaceuticals with similar mechanisms of action are likely to act additively (Brian et al. 
2005). Thus, environmentally-relevant concentrations of some steroid hormones may be in 
the tens of ng/L range in heavily impacted locations.  
A key parameter controlling the concentrations of synthetic steroids in the environment is 
their degradation rate in WWTPs. If they are readily degraded, then that will lead to much 
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lower concentrations in rivers than would otherwise occur. In the case of estrogens, natural 
ones (especially E2) appear to be relatively readily biodegraded in WWTPs, whereas EE2 is 
much less easily removed (Kanda and Churchley 2008). It seems likely that the ethinyl group 
(C2H5) attached to carbon 17 of EE2 (Figure 2.2A) very effectively blocks degradation in 
WWTPs (and probably the wider environment). The ethinyl group is attached specifically to 
do just that in the human body; it dramatically reduces the rate of metabolism and excretion, 
hereby increasing the half-life of EE2 in the body, and its potency. Unsurprisingly, the same 
or similar „chemical tricks‟ have been used to increase the half-life of synthetic progestogens 
and glucocorticosteroids, hereby making them more effective pharmaceuticals. The addition 
of chlorine or fluorine atoms to a pharmaceutical has the same effect (Muller et al. 2007) of 
stabilizing the molecule: this „trick‟ is especially prevalent in the case of many of the 
synthetic glucocorticosteroids in widespread current use.  
In Figure 2.2 the structures of a few of the synthetic steroids used in significant amounts are 
illustrated, to show how various atoms and functional groups have been added to the basic 
structure of that particular class (e.g., estrogens, androgens, etc) in order to produce useful 
pharmaceuticals. Hence, it can be hypothesized that many synthetic steroids will be poorly 
removed in WWTPs, and hence they will enter rivers in effluents.  
 
Figure 2.2. Chemical structure of (A) Ethinylestradiol, (B) Norethindrone, (C) Betamethasone, and 
(D) Fluticasone propionate. Note the ethinyl group attached to the carbon 17 of the synthetic estrogen 
Ethinylestradiol and the synthetic progestogen Norethindrone, and the single or multiple fluorine 
atoms attached to the glucocorticosteroids Betamethasone and Fluticasone propionate. Chemical 
structures obtained using KEGG 47.1 (Goto et al. 2002).  
This view is supported by some thorough studies of Labadie and Budzinski (2005), who 
assessed the stability of various natural and synthetic steroids in effluent using a spiking 
A) 
D) C) 
B) 
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approach. They found that whereas natural steroids (e.g., E1, E2, progesterone) were 
reasonably rapidly removed (especially progesterone), presumably by biodegradation, 
synthetic steroids (EE2, Levonorgestrel, Norethindrone) were fairly recalcitrant. Even after 7 
days, little or no loss of these synthetic steroids occurred (Labadie and Budzinski 2005). But 
in contrast, Chang et al. (2007) report high removal rates of 5 of the 6 natural and synthetic 
glucocorticosteroids they studied. These apparently conflicting results only serve to illustrate 
how little is established about removal rates of natural and synthetic steroids in WWTPs. 
More research on this issue is urgently needed.  
Very little information is available presently regarding the presence or absence of steroid 
hormone antagonists in either WWTP effluents or the wider aquatic environment. These 
pharmaceuticals vary considerably in structure: some are based on the basic steroid nucleus 
(e.g., the aromatase inhibitor Exemestane), but others have more complex structures and are 
not steroidal in nature (e.g., Tamoxifen, Raloxifene). This variability, combined with a 
complete lack of data on ease of biodegradation, makes it very difficult, if not impossible, to 
predict likely environmental concentrations. Furthermore, a significant technical challenge is 
the accurate determination of these compounds by analytical chemistry, yet without that 
information, it is impossible to know if these particular pharmaceuticals merit 
ecotoxicological attention.  
2.4.2 Ecotoxicological relevance of steroids/anti-steroids in the environment 
Even if biologically extremely active chemicals such as pharmaceuticals are present in the 
aquatic environment, this does not mean that they pose a threat to aquatic organisms. To do 
so, they must first get into those organisms, and then reach (internal) concentrations high 
enough to elicit effects. Extremely little is known about how readily the pharmaceuticals 
mentioned in this paper can get into the aquatic organisms; only a little information on a few 
of these pharmaceuticals is available. However, some general „rules‟ (McKim and Schmieder 
1985) are available that can be used to predict whether or not a chemical will readily cross the 
gills of a fish. Key characteristics include the hydrophobicity of a chemical, its charge, and its 
size. In general, the more hydrophobic a chemical (which is usually expressed as log Kow or 
log P), the more readily it bioconcentrates in aquatic organisms. As far as size is concerned, if 
the molecular weight is less than 600, the chemical will cross the cell membrane unhindered; 
above this value, and its passage could be hindered to varying degrees (the larger the 
molecule is, the less easily it passes through cell membranes; e.g. Zitko and Hutzinger, 1976).  
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These „rules‟ would suggest that most of the pharmaceuticals covered in this paper should 
readily pass across the gills of fish, and get into the blood stream. However, recent research 
has shown that other factors besides degree of hydrophobicity and size affect the rate of 
uptake of chemicals from the water into fish. Scott et al. (2005) were the first to show that the 
rate of uptake of sex steroids (estrogens and androgens) from the water into fish was 
dramatically affected by their affinity for sex steroid binding protein (SHBG). The rate of 
uptake of sex steroids can be extremely fast (Maunder et al. 2007). The mechanism 
responsible for this very rapid uptake of sex steroids was recently elucidated: fish gills contain 
very high amounts of SHBG (Miguel-Queralt and Hammond 2008). That latter study also 
demonstrated that fish SHBG also has a high affinity for synthetic sex steroids, such as EE2 
and some progestogens. Collectively, the results in these papers probably explain why sex 
steroids, including synthetic ones, are so potent, and affect fish physiology at extremely low 
environmental concentrations (Länge et al. 2001; Purdom et al. 1994; Paulos et al. 2010; 
Zeilinger et al. 2009).  
Once these pharmaceuticals get into aquatic organisms and reach concentrations high enough 
to cause effects, it seems likely that the effects will be similar to those occurring in people 
taking those pharmaceuticals. This is because the targets of these drugs (such as receptors and 
enzymes) are well conserved phylogenetically, at least across all the vertebrates (Gunnarsson 
et al. 2008). Thus, for example, the synthetic estrogen EE2 binds to the estrogen receptor in 
fish, just as it does in woman, and thereby causes estrogenic effects, including adversely 
affecting reproduction (Länge et al. 2001). Taking a comparative molecular approach, in 
which genomic and proteomic databases are used to look for conservation of targets, seems 
sensible. However, even if some potential effects can be predicted, many important unknowns 
remain.  
It is likely that some unique effects, that do not occur in people taking the drug, will manifest 
in aquatic organisms: vitellogenin synthesis in response to estrogens is an example. Others 
will undoubtedly occur. Many pharmaceuticals have multiple modes of action: for example, 
some synthetic progestogens are also androgenic, and hence may induce androgenic effects as 
well as progestogenic effects (Paulos et al. 2010), and SERMs can be both agonists and 
antagonists, and hence have multiple modes of action (Smith and O‟Malley 2008). A range of 
complex issues are raised by the fact that all these pharmaceuticals are present simultaneously 
in the aquatic environment, and hence aquatic organisms are exposed to mixtures of 
pharmaceuticals. It is very likely that pharmaceuticals with similar mechanisms of action (for 
example, a mixture of the many glucocorticosteroids in use) will act in an additive manner, as 
 66 
 
has already been demonstrated for a mixture of estrogenic chemicals (Brian et al. 2005). 
However, it is much more difficult to predict whether or not antagonists might attenuate the 
effects of agonists when both groups are present simultaneously, or whether androgen 
agonists might neutralise the effects of estrogen agonists.  
There is one further biological issue that merits consideration when attempting to rank 
pharmaceuticals based on the degree of environmental hazard they present. Different groups 
of steroids and steroid antagonists will produce a range of effects with different 
ecotoxicological relevance. For example, preventing reproduction would undoubtedly be 
considered a catastrophic effect, whereas reducing inflammation would probably not be 
considered a serious, adverse effect. Thus it is possible to argue that pharmaceuticals such as 
estrogens and progestogens, which can prevent fish reproducing at low environmental 
concentrations (Länge et al. 2001; Zeilinger et al. 2009; Paulos et al. 2010), are of more 
concern, and merit greater attention from environmental scientists, especially 
ecotoxicologists, than do pharmaceuticals such as many glucocorticosteroids, which 
(probably) primarily target the immune system.  
Recent evidence strongly supports the argument that amongst the pharmaceuticals in use 
today, steroid hormones merit particular attention from ecotoxicologists. Both Johnson et al. 
(2008) and Besse and Garric (2009) have identified progestogens as requiring hazard 
assessment for the aquatic environment. Their concerns are confirmed by two recently 
published independent studies, which have demonstrated that some synthetic progestogens 
can inhibit fish reproduction at very low (ng/Litre, or even sub-ng/L) environmental 
concentrations (Paulos et al. 2010; Zeilinger et al. 2009).  
Another recently published paper suggests that environmentally-relevant concentrations of 
glucocorticoids may cause effects in fish (Kugathas and Sumpter, 2011), and even the very 
well researched “estrogens in the aquatic environment” issue continues to produce surprises; 
such as Tyler et al. (2009) showing that equine estrogens used in hormone replacement 
therapy are present in the aquatic environment, and very potent in fish. 
2.5 Conclusions 
The information provided in this Chapter suggests that when attempting to prioritize 
pharmaceuticals for potential environmental impact, and hence research, then synthetic 
steroid hormones merit serious attention. This is based on the fact that they are present in the 
aquatic environment, and that they can affect fish at low concentrations. Currently, 
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knowledge of the risk posed by steroid hormones (and possibly also their agonists) is limited; 
a lot is known about EE2 (e.g., Caldwell et al. 2008), but very little, if anything, is known 
about the other groups of steroid hormones. Research on potential chronic effects of these 
pharmaceuticals is urgently required, in order that an informed, balanced assessment of their 
(potential) ecotoxicological effects can be formed.  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68 
 
CHAPTER 3 : OCCURRENCE AND FUNCTIONALITY 
OF 5 -REDUCTASE IN THE FATHEAD MINNOW        
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3.1 Introduction: 5-alpha reductase and teleost fish 
 Mode of action and mechanism of toxicity of any chemical compound are generally defined 
by the interaction between the toxicant and one or more targets, according to the so-called 
“toxicant-target paradigm” (Rabinowitz et al., 2009). In the assessment of (eco)toxicological 
risk of APIs to target species, the presence of drug-specific functional targets in those species 
should be considered a key factor for the prediction of potential adverse effects caused by 
exposure to the drug, and for the design of ad hoc toxicological test which maximize the 
chances of detecting predicted effects (Ankley et al., 2007; Christen et al., 2010; Gunnarsson 
et al, 2008; Kostich and Lazorchak, 2008; Seiler, 2002; Winter et al., 2010). 
The API object of studied in the present Thesis was dutasteride, which exerts its clinical effect 
by inhibiting the activity of the two isoforms of 5αR, the enzyme that convert T into DHT, 
causing a sharp decrease of circulating concentration of DHT (>80%). At the beginning of 
this Ph.D. project, a significant theoretical issue came to light, since a general assumption in 
fish endocrinology is that DHT is not synthesized in teleosts, or if it is, it has a modest or no 
physiological relevance (Borg, 1994). Hence, the question arising was: “why study the effects 
of dutasteride, a 5αR inhibitor, in fathead minnow, if this species seems to lack the 
biochemical apparatus targeted by the drug?”  
In order to find an objective answer to this question, the preliminary phase of the project was 
aimed at clarifying if 5αRs are present and functional in the fathead minnow. The occurrence 
and functionality of the enzyme 5αR in teleost fish has been scarcely investigated so far; 
however, sparse information available in the scientific literature, based on studies carried out 
mainly during the 1980s, indicated that 5αR activity can be detected in the tissues of several 
teleost species, such as the testes of the urohaze-goby (Glossogobius olivaceus) (Asahina et 
al., 1985), the brain of male and female goldfish (Carassius auratus) and toadfish (Opsanus 
tau) (Pasmanik and Callard, 1988, 1985), the ovary of European eel (Angiulla anguilla), 
common carp (Cyprinus carpio) and grey mullet (Mugil cephalus) (Eckstein and Azoury, 
1979; Querat et al., 1987), and the skin of rainbow trout (Oncorhynchus mykiss) (Latz and 
Reinboth, 1993). After injection of labelled T in flounder (Pseudopleuronectes americanus) 
and Atlantic salmon (Salmo salar), metabolites in the bile were primarily forms of DHT 
(Truscott, 1983), which was also a major metabolite in a similar experiment performed with 
fathead minnow (Parks and LeBlanc, 1998), indicating that 5αR activity appears to be 
involved in androgen metabolism in these species. Also, the results of some in vitro 
experiments suggested that teleost fish can synthesise DHT (Joss et al., 1996; Lee et al., 
1995), even if the relevance of these in vitro results to the in vivo situation is unclear.   
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3.2 Aim of the study 
Considering the poor knowledge about presence and functions of 5αR in the fathead minnow, 
the preliminary phase of this Ph.D. project focused on determining if 5αR is present and 
functional in this species. This aim was pursued by using two different approaches:  
- Detection of 5αR gene expression in the testis of male adult fathead minnows; 
- Quantification of the biosynthetic product of 5αR activity, the androgen DHT, in 
fathead minnow plasma by analytical chemistry (Ultrasensitive GC-MS/MS). 
3.3 Approach 1: Detection of 5αR gene expression in the testis of fathead minnow 
The major site of DHT production in male vertebrates is the testis. In men, about 25% of 
circulating DHT is synthesised by testicular tissue, and the remainder by other tissues, such as 
liver, kidney, muscle, prostate, and skin. Therefore, the testis represents a major target tissue 
for dutasteride. Considering the low levels of gene expression expected in fish, in order to 
maximize the chances of detecting the presence of 5αR mRNA, attention was focused on 
male fish, and the testis was chosen as the target organ to assess if 5αR genes (srd5a1 and 
srd5a2) were expressed in the fathead minnow.       
3.3.1 Materials and Methods 
The following methodological steps were performed in order to confirm srd5a1 and srd5a2 
gene expression in the testis: 
1) Screening of bioinformatics databases of teleost fish looking for genes, expressed 
sequence tags (ESTs), and proteins showing medium to high degree of similarity to 
mammals 5αRs; 
2) Identification of two fathead minnow ESTs similar to zebrafish 5αRs, and 
experimental assessment of gene expression by RT-PCR; 
3) Confirmation of the identity of the amplified DNA targets by direct sequencing; 
4) RACE PCR in order to amplify, isolate and sequence the full length of the genes; 
5) Computational and phylogenetic analysis. 
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3.3.1.1 Tissue acquisition 
Testis tissues were dissected from adult male fathead minnow. Fish were sacrificed with 500 
mg/L Ethyl 3-aminobenzoate methanesulfonate salt (MS-222) (Sigma), buffered with 200 
mg/L NaHCO3. Testes were dissected and transferred into individual clean microcentrifuge 
tubes and snap frozen in liquid nitrogen. All microcentrifuge tubes were subsequently stored 
at -80 °C to prevent RNA degradation.  
3.3.1.2 RNA extraction 
Total Ribonucleic Acid (RNA) was isolated from testes of three different fathead minnow 
males using the RNeasy Kit (Qiagen Ltd.). The testes were homogenized in lysis buffer and 
β-mercaptoethanol using an electric Rotor Homogenizer (Fisher Scientific Ltd.) for 20-40 
seconds. The tissue homogenate was centrifuged, and the supernatant was collected and 
mixed with 70% ethanol in order to provide appropriate binding conditions. Samples were 
subsequently applied to RNeasy Mini spin columns, which were washed and eluted according 
to the kit instructions. The extracted RNA was solubilised in 20μL of RNase-free H2O; 
quantification and purity of each RNA sample were determined by spectrophotometry 
(Nanodrop, Fisher Scientific Ltd.), and the RNA integrity was visually checked by agarose 
gel electrophoresis. All samples were stored at – 80 °C. 
3.3.1.3 Generation of complementary DNA by reverse transcription 
Complementary cDNA was synthesised using the SuperScript III First-Strand synthesis 
system for reverse transcription-PCR kit (Invitrogen). For each sample, 1μL of 50 μM 
oligo(dT) primer, 1 μL of 10 mM deoxyribonucleotide triphosphate (dNTP) mix and 5 μg of 
mRNA were combined together, briefly centrifuged, incubated at 65 °C for 5 minutes and 
then placed on ice for 1 minute. This step allowed the annealing of the oligo(dT) primer to the 
mRNA poly-A tail. Successively, 2 μL of 10X RT buffer, 4 μL of 25 mM MgCl2, 2 μL of 
0.1M DTT, 1 μL of RNase (40 U/μL) and 1 μL of SuperScriptTM III RT (200 U/μL) were 
added, mixed and briefly centrifuged. The mixture was subsequently incubated at 50 °C for 
50 minutes to allow the synthesis of the cDNA. The reaction was terminated by incubation at 
85 °C for 5 minutes. Residual RNA was removed by adding 1 μL of RNase H (2 U/μL) to the 
reaction and incubating it at 37 °C for 20 minutes. 
cDNA samples were stored at -20 °C until further analysis. To verify successful cDNA 
synthesis, RT-PCR for β-actin was run for each sample. β-actin primers were designed by Dr. 
Tamsin Runnalls (Brunel University) (Forward 5‟ – GAT ATG GAG AAG ATC TGGC- 3‟ 
and Reverse 5‟ – GTT GGC TTT GGG GTT CAG G – 3‟). 
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3.3.1.4 RT-PCR 
Neither srd5a1 nor srd5a2 mRNA sequences for fathead minnow were available in the NCBI 
databases; however, the screening of NCBI Expressed Sequence Tags (ESTs) database lead to 
the identification of two ESTs, DT087910 and DT25933, which showed a high similarity, 
respectively, with srd5a1 and srd5a2 expressed in other species. These sequences were 
subsequently used to design the primers for the amplification of fathead minnow putative 
srd5a1 and srd5a2.  
Primers were designed using PRIMER3 web software (www.biotools.umassmed. 
edu/bioapps/primer3_www.cgi). The general rules for primer design were followed. All 
primers were between 16 and 30 nucleotides long and were purchased from Sigma Genosys. 
Stock primer solutions were made in autoclaved MilliQ water (100μM). Each primer was 
designed to have a guanine and cytosine (G and C) content of 40-60%, G and/or C nucleotide 
at the 3‟ end, and melting point between 55-64 °C. 
Each primer pair was designed to have the same, or similar, melting point (ΔT < 1 °C); the 
characteristics of each primer, including melting temperature, likelihood to form hetero-
dimers, self-dimers and hairpin, were assessed using the oligo-calculator available on the 
Sigma Genosys website (www.sigmaaldrich.com/life-science/custom-oligos.htmL), and the 
java tool OligoAnalyzer 3.1 (www.eu.idtdna.com/analyzer/Applications/ OligoAnalyzer). The 
primer sets used for the amplification of fathead minnow putative srd5a1 and srd5a2 are 
shown in Table 3.1. 
The AccuPrime Taq DNA Polymerase System (Invitrogen) was used in the RT-PCR 
reactions. All the reactions were performed according to the basic RT-PCR protocol, as 
indicated by the Kit‟s manifacturer.  A typical 25 µL reaction mixture was prepared by 
mixing: 
- 10.0 µL 10X AccuPrime PCR Buffer I 
- 0.25 µL Forward primer (10 µM) 
- 0.25 µL Reverse primer (10 µM) 
- 1.0 µL cDNA 
- 0.5 µL AccuePrime Taq DNA Polymerase 
- 8.0 µL autoclaved Millipore H2O 
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Table 3.1. Primer sets used to isolate srd5a1 and srd5a2 from the fathead minnow. 
 Gene 
Primer ID srd5a1 srd5a2 
 First round of amplification 
Forward 
Reverse 
5‟ AATGTCAAGTTCGCCTGGTTC 3‟ 
5‟ AGGTATCTTATAGCCCGTCTCTCC 3‟ 
5‟ GAAACACCTGATGCTCTGGAC 3‟ 
5‟ CTGTGATGGTGATAGGCTCTTG 3‟ 
 5’ RACE 
Forward 
Reverse1 
Reverse 2 
Kit Anchor Primer 
5‟ CCATCCCAGGAACCACATACA 3‟ 
5‟ TTAGCCTTCCTCGAAATAAGCA 3‟ 
 
5‟ CACGTACTCAAATAAGCCGCC 3‟ 
 5’ RACE NESTED 
Forward 
Reverse 
Kit Anchor Primer 
5‟ CCAGAGCAAACGAGATGAATG 3‟ 
 
 3’ RACE 
Forward 1 
Forward 2 
Forward 3 
Reverse 
5‟ CCAATGTATTAGTGTCCAACTC 3‟ 
5‟ ATTAGCCTTCCTCGAAATAAGC 3‟ 
5‟ TCCAATGTATTAGTGTCCAACT 3‟ 
Kit Anchor Primer 
 
5‟ CCAAGAGCCTATCACCATCAC 3‟ 
 3’ RACE NESTED 
Forward 
Reverse 
5‟ CAGGGTATCACTGTTTATTGCT 3‟ 
Kit Anchor Primer 
 
 
     
The optimal annealing temperature for each primer pair was determined by performing RT-
PCR reactions with a gradient of temperatures (Δ = 0.8 °C). After gel electrophoresis of the 
PCR products, the temperature at which the amplification of the target fragment had an 
apparent better yield and specificity was chosen for the subsequent reactions.   
 
   
 74 
 
Generally, PCR amplifications were performed as follow: 
- Denaturation : 94 °C for 15-30 seconds 
- Annealing: 55-64 °C for 15-30 seconds                  25-35 cycles 
- Extension: 68-72 °C for 1 minute per kb 
 
- Final elongation: 68-72 °C for 5 minutes 
- Final hold: 15 °C  
 
3.3.1.5 Rapid amplification of cDNA ends (RACE) PCR 
After the successful amplification of fragments of both srd5a1 and srd5a2, it was possible to 
attempt the amplification of the entire sequences by RACE PCR.  
The SMART RACE cDNA amplification kit (Clonetech, Cat # 634914) was used to amplify 
both the 5‟ and 3‟ ends of the genes. This kit integrates Marathon® cDNA Amplification Kit 
(Chenchik et al., 1995; 1996) with SMART (Switching Mechanism At 5' end of RNA 
Transcript) cDNA synthesis technology. A detailed illustration of the procedure is illustrated 
in Figure 3.1 and 3.2. The cDNA synthesis starts by the annealing of a modified oligo dT 
primer to the poly-A tale at the 3‟ end of mRNA. The Moloney Murine Leukemia Virus 
Reverse Transcriptase (MMLV RT) synthesizes the cDNA, and upon reaching the end of a 
RNA template, exhibits terminal transferase activity, adding 3–5 residues (predominantly dC) 
to the 3' end of the first-strand cDNA. 
The SMART oligonucleotide contains a terminal stretch of G residues that anneals to the dC-
rich cDNA tail and serves as an extended template for RT. MMLV RT switches templates 
from the mRNA molecule to the SMART oligo, generating a complete cDNA copy of the 
original RNA with the additional SMART sequence at the end. Since the dC-tailing activity 
of RT is most efficient if the enzyme has reached the end of the RNA template, the SMART 
sequence is typically added only to complete first-strand cDNAs. 
Following reverse transcription, the first-strand cDNA is used directly in 5'- and 3'-RACE 
PCR reactions, where the amplification is achieve by using gene specific primers and 5‟ or 3‟ 
end-specific primers.  5‟ and 3‟ RACE were also performed using nested primers, specifically 
designed to amplify a shorter fragment. This analysis help to determine if any multiple bands 
1 cycle 
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are a result of correctly primed PCR or non-specifically primed PCR. If bands are real (i.e., 
the result of correct priming), they should be slightly shorter in the reaction using the nested 
gene specific primers. 
 
  
Figure 3.1. Detailed mechanism of the 5’ RACE reaction. 
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Figure 3.2. Detailed mechanism of the 3’ RACE reaction. 
3.3.1.6 Gel electrophoresis 
The DNA fragments amplified by PCR were visualized by gel electrophoresis. The gel was 
made by adding 1.5 g of certified biological agarose (Bio-Rad) to 100 mL of 1X Tris borate 
ethylenediaminetetraacetic acid (EDTA) (TBE) buffer. The latter was prepared by adding 9 
parts of autoclaved deionized H2O to 1 part of autoclaved 10X TBE stock containing: 
- 108 g Tris Base 
- 55 g Boric acid 
- 9.3 g Na2EDTA.H2O (pH 8.3) 
  made up in 1 L deionized water 
 77 
 
The mixture was prepared in conical flasks (250 mL) and heated in a microwave for 
approximately 2 minutes until it reached its boiling point. The conical flask was subsequently 
removed from the microwave, shaken and reheated in order to ensure a full dissolution of the 
agarose powder. Once cooled at room temperature, 5 μL of ethidium bromide (Sigma) were 
added and mixed to the solution (0.005%). The gel was decanted into a plastic mould with a 
comb inserted, in order to create empty wells. The gel was left to cool and solidify for 
approximately 30 – 45 minutes.  
2.5 µL of gel-loading buffer were added to 25μL of each sample. The gel-loading buffer was 
prepared by mixing: 
- 750 μL 40% Ficol (Fisher Scientific) 
- 100 μL 10 x TBE  
- 150 μL dH2O 
- 8 μL 0.1% xylene cyanol (Sigma)  
The gel-loading buffer increased the density of the sample, preventing the settlement of the 
PCR product in the gel‟s well. The dye (xylene cyanol) is negatively charged in neutral 
buffers and migrates in the gel in the same direction as the DNA during electrophoresis. This 
allows the monitoring of the progress of the electrophoresis.  
12 µL of each sample were loaded into the gel. According to the size of the gel, one or two 
wells were also loaded with 5 µL of 1 Kb DNA ladder (Fermentas Life Sciences Ltd.). The 
gels were typically run at 80 Volts for 40-60 minutes, and successively examined under UV 
illumination. Visualisation was achieved by ultraviolet (UV) illumination. Each sample was 
analyzed for the presence of amplified fragments having the expected size, as calculated 
during the phase of primers design. 
3.3.1.7 Extraction of PCR product from the gel 
If a band of the correct size was observed, it was excised from the agarose gel under UV light 
using a clean, sharp scalpel (Swan-Morton, Sheffield) and transferred into a clean 2.0 mL 
microcentrifuge tube. The gel slice was weighed and the DNA extracted from the gel using 
the MinElute gel extraction kit (Qiagen), following the protocol indicated by the manifacturer.  
Three volumes of digestion buffer were added to 1 volume of gel. The mixture was then 
incubated at 50 °C for 10 minutes to enhance the dissolution process. One gel volume of 
isopropanol was added to the sample and mixed by inverting the tube several times. The 
mixture was then transferred to a MinElute column placed inside a 2 mL collection tube, 
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which was centrifuged at 17,900 x g for 1 minute at room temperature. The flow-through was 
discarded and 500 μL of a wash buffer were added to the spin column. A further step of 
centrifugation was performed at 17,900 x g for 1 minute at room temperature. The flow 
through was again discarded and 750 μL of a second wash buffer were added to the column, 
which was left standing for 5 minutes and centrifuged at 17,900 x g for 1 minute at room 
temperature. The flow through was discarded and the spin column was centrifuged for an 
additional minute. Finally, the MinElute column was placed into a clean 1.5 mL 
microcentrifuge tube, 10 μL of sterile autoclaved Millipore H2O were added to the column, 
which was centrifugated at 17,900 for 1 minute at room temperature. The eluted DNA was 
collected, quantified by spectrophotometry, and stored at -20 °C until further analysis. 
3.3.1.8 Sequencing 
The purified DNA products of the correct size were diluted to a concentration of 30-120 ng in 
90 µL of autoclaved Millipore H2O. Forward and reverse primers were also prepared at a 
concentration of 32 picomoles in 10 µL of autoclaved Millipore H2O. Both diluted samples 
and primers were sent to the Sequencing Service at Dundee University (www.dnaseq.co.uk) 
for direct sequencing analysis. The results from the sequencing were provided as a chromas 
plot indicating the nucleotide sequence of the DNA product, as shown in Figure 3.3. The 
quality of the sequencing at the beginning of the process is usually low, as indicated by the 
modest height and definition of the peaks. A sequence considered reliable was taken from the 
point where the nucleotide peaks had become higher, sharp and well defined. The sequences 
obtained were analyzed by computational methods, including Blast and alignment with the 
EST sequences used to design the specific primers.  
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Figure 3.3. Example of a chromatogram file indicating the nucleotide sequence of a fragment of 
srd5a2 expressed in fathead minnow testis analysed without cloning. Note the increasing quality of the 
peaks, indicated by the quality bar at the top of the graph going above the green line threshold. The 
arrow indicates where the strength of sequence peaks was judged to be satisfactory. The direct 
sequencing of the fragment causes a loss of information at the beginning of the process, at the primer 
annealing site. Typically the first 20-40 sequenced bases show low quality peaks. For this reason, to 
obtain a high quality full sequence of the isolated nucleotides it is necessary to insert the fragment in a 
plasmid, so that the sequencing process will start outside the target sequence. Due to the cloning 
method being very time demanding, the direct sequencing method is only used to confirm that the 
amplified DNA is the target of interest.    
3.3.1.9 Computational analysis 
Sequence alignments and database screening 
Nucleotide and aminoacid sequences were analysed for similarity to other 5αR sequences 
from other species using the software ClustalW2, available at 
http://www.ebi.ac.uk/Tools/msa/clustalw2/. A number of online bioinformatic databases and 
tools were used to collect information on 5αR genes and proteins, and to analyze the 
nucleotide sequences obtained by RACE PCRs, including: 
 NCBI databases and tools: 
-nucleotide, protein, expressed sequence tags (ESTs) databases; 
-nucleotide basic local alignment search tool (blast) (search a nucleotide 
database using a nucleotide query); 
-blastx (search protein database using a translated nucleotide query); 
-tblastx (search translated nucleotide database using a translated 
nucleotide query); 
-conserved domain database (CDD), which include a number of external 
source databases (Pfam, SMART, COG, PRK, TIGRFAM). 
Quality threshold (green line) 
& 
peak quality indicator (grey bars) 
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 Kyoto Encyclopedia of Genes and Genomes (KEGG) 
 Ensembl Genome Browser (EMBL-EBI) 
 BRENDA, the Comprehensive Enzyme Information System 
 
When an aminoacid sequence was required for the computational analysis, the related 
nucleotide sequence was translated into protein sequence using the ExPASy proteomics 
server of the Swiss Institute of Bioinformatics (www.expasy.ch/tools/ dna.htmL). The 
translation process normally generated six possible reading frames. Frame 1 was obtained 
from translating from the first nucleotide, frame 2 from the second and frame 3 from the third. 
Frames 4 to 6 were the same as frames 1 to 3 but in the reverse direction. The frame that 
produced the longest reading frame with no stop codons was selected, and its correctness was 
double checked by blast analysis.   
Phylogenetic analysis 
Phylogenetic trees were constructed using the software CustalX, using as source data the 
multiple sequence alignment file obtained by ClustalW2, and applying the neighbour-joining 
(NJ) method. Trees were visualized using the software NJplot (Perriere and Gouy, 1996). The 
results were presented in the form of a rectangular tree. To evaluate the reliability of the 
inferred tree, a bootstrap analysis was performed and bootstrap values were presented on each 
node of the tree, providing the degree of confidence in the node. The bootstrap values were 
provided as percentages, and were calculated by re-sampling each alignment 1000 times. 
3.3.2 Results 
3.3.2.1 Database screening 
The screening of several online bioinformatic databases provided both full length or partial 
mRNA sequences coding for several isoforms of 5αR in teleost fish, including zebrafish, 
Atlantic salmon (Salmo salar), stickleback (Gasterosteus aculeatus), and medaka (Oryzias 
latipes) (Table 3.2).  No mRNA sequences were available for fathead minnow. However, the 
screening of the NCBI ESTs database lead to the identification of two ESTs, DT087910 and 
DT25933, which showed a high similarity, respectively, with srd5a1 and srd5a2 of other 
species. The BLAST of the EST similar to srd5a1 highlighted a significant evolutionary 
conservation of the srd5a1 and srd5a2 genes, not only in vertebrates, but also in invertebrates 
like the nematode (Caenorhabditis elegans), in unicellular eukaryotes like trypanosome 
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(Trypanosoma cruzi), and in bacteria, fungi and plants (Arabidopsis taliana). According to 
the InterPro database (EMBL-EBI), the conserved C-terminal domain characteristic of 5αRs 
protein sequences also followed the same distribution.  
Table 3.2. Access numbers for srd5a1 and srd5a2 of the species used in the multiple alignment 
analysis and in the phylogenetic analysis. 
 
3.3.2.2 Amplification, isolation and sequencing of fathead minnow srd5a1 and srd5a2 
Using the two fathead minnow ESTs, similar to srd5a1 and srd5a2, as reference sequences 
for the design of primers, a first PCR round was carried out, leading to the amplification of 
two fragments of 475 pb and 474 pb for srd5a1 and srd5a2, respectively (Fig. 3.4). The 
sequencing of the fragments performed at the University of Dundee confirmed a 100% 
identity between the amplified fragments and the ESTs identified in the database. 
Successively a new cDNA from testicular tissue was synthesised for RACE PCR, and new 
sets of primers were designed in order to attempt the amplification of the 5‟ and 3‟ ends of the 
genes.  
Accession number srd5a1 srd5a2 
Human 
(Homo sapiens) 
NM_001047 NM_000348 
House mouse 
(Mus musculus) 
NM_175283 NM_053188 
Rat 
(Rattus norvegicus) 
NM_017070 NM_022711 
Cow 
(Bos taurus) 
NM_001099137 NM_001205937 
Frog 
(Xenopus tropicalis) 
NM_001006840 NM_001017113 
Fathead minnow 
(Pimephales promelas) 
DT087910 DT259333 
Zebrafish 
(Danio rerio) 
NM_001076653 NM_001017703 NM_001017693 
Medaka 
(Oryzias latipes) 
EF537018 EF537017 
Stickleback 
(Gestreotus aculeatus) 
ENSGACG00000008961 / 
Atlantic salmon 
(Salmo salar) 
/ BT125262 
Fugu 
(Tetroaodon nigroviridis) 
CR711491 
 
NM_077670 
 
XM_814384 
 
U53860 
Nematode 
(Caenorhabditis elegans) 
Trypanosome 
(Trypanosoma cruzi) 
Plant 
(Arabidopsis taliana) 
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Targeting srd5a1, 5‟RACE produced a fragment of 627 pb, and the specificity of the reaction 
was confirmed by a Nested RACE PCR performed with a new set of primers designed to 
produce a fragment 150 pb shorter than the first one (Fig. 3.5). The fragments obtained were 
sequenced and the result showed the presence of the 5‟ tale anchor sequence added during the 
synthesis of cDNA with the SMART RACE cDNA amplification kit, plus 7-8 bases, mainly 
G and C, indicating the successful amplification of the 5‟end of srd5a1 (Fig. 3.6). On the 
other hand, 3‟RACE produced a high number of amplified fragments, and a “smear” of 
amplification, which made further isolation of specific bands difficult (Fig. 3.5).   
Targeting srd5a2, both 3‟ and 5‟ RACE did produced low quality reactions, with a high 
amount of unspecific smear. Both reactions did not produce fragments of the expected size; 
two fragments of approximately 700 pb and 300 pb were isolated, purified and sequenced, but 
once the results were analyzed by BLAST, they did not show any similarity to any of the 5αR 
gene isoforms available in the NCBI databases. This result was confirmed also by the very 
low similarity value obtained aligning the sequenced fragments with the fathead minnow EST 
used as the starting reference sequence, confirming that the amplified fragments were a 
product of non-specific amplification.  
In conclusion, srd5a1 and srd5a2 were both expressed in the testis of fathead minnow, a 
major target for the action of dutasteride. Isolation attempts lead to the sequencing of 627 bp 
of Srd5a1 gene (Fig. 3.6), including the 5‟end of the gene, and 474 pb of srd5a2 (Fig. 3.7).    
  
   
Figure 3.4. Example of UV image of the products of 1
st
 round PCR performed to target fathead 
minnow srd5a1 and srd5a2 in testes of two different fish. The product bands obtained are clean, clear 
and at approximately the correct size of 475 bp. Both products were successively extracted from the 
gel and sequenced. 
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Figure 3.5. Example of UV image of the products of (A) 3’RACE PCR and 5’ RACE PCR performed to 
target fathead minnow srd5a1 in the testes of two different fish. The 3’RACE PCR produced a smear 
plus several bands of different size. On the other hand, 5’ RACE PCR produced a product of the 
expected size (approx. 650 bp). (B) Further 5’RACE PCRs were performed using nested primers 
designed to produce a fragment of approx 500 bp. The results confirmed the specificity of the longer 
5’RACE PCR product. Both products were successively extracted from the gel and sequenced. 
5’CTAATACGACCCCTTTTAGGGCAAGCAGTGGTATCAACGCCGAGTACGCGCGGGGAGT
CCGTTTGTGCACGAGAATGAAGTTACACACTTTCTTCTGCTCATAAGTATAATTTCCATAA
GCAACTATGGACGCTATTCTGAAGATATTATTTTCTTCGGAGGAGGAAGAACGTACGTTC
TGGATTGTTTATCGTACTTGATGATGGTGATGGCGTTCATAACTTTTGTGACTTTACTCTTT
GAGCACGTGCCATACGGCAGATATGCATCCAGCAGGTATGGATTCCCTGTAAATGTCAAG
TTCGCCTGGTTCGTTCAAGAATTGCCGGCTTTTCTGGTGCCTTTGTGTTTGGTACTATGGA
GTCCATGTGCAAAGCTAATGCACCTGCCCAACCAATTGCTTCTTCTCATGTTCTGTTGCCA
TTACGCGCAAAGGTCCCTCATCTACCCATTTTTAATTCGAGGAGGAAAATCAACACCATT
CATCTCGTTTGCTCTGGCCTTTGTCTTCTGCATCTATAATGGGTATCTGCAGGCAAGATA
CCTGAGTCACTATGCAGATTACCCACCTGATTGGGTTACACATCCTATTTCATCACAGGTT
CTTGTATGTGGTTCCTGGGATGG 3’ 
Figure 3.6. Partial sequence (627 bp) of fathead minnow srd5a1. The red highlighted sequences 
represent the primers used to confirm the sequence in the 5’ direction by the Sequencing service. 
Despite the fact that the fragment was not inserted in a plasmid and cloned, and the sequencing quality 
at the ends of the fragment was not very high, there is a high probability that the amplification reached 
the 5’ end of the gene. In fact, at the beginning of the sequence it is possible to recognize the 
“Adaptor” added by the Clonetech RACE Kit to the 5’end during the cDNA synthesis (highlighted in 
blue), and a sequence of 8-10 bases (mainly G or C) added by the MMLV reverse transcriptase 
(highlighted in green).  
B) 
B) 
A) 
 84 
 
5’GAAACACCTGATGCTCTGGACCTTCTGCTTGCATTACTTCCAAAGGAGCTGCATCTGA
GCTGCATCTACTCTCTGCTGACCAAAGGGCGCCCGTATCCGTTCAACATCATGCTGTTAGG
GATGGGGTTTTGCTCAATTAACGGCTTCCTGCAGGCACACTATTTGCTGCATTGTGCTACA
TATAACAACACATGGTTTTCCGATGCCTGTTTGCTAGCCGGCCTGATCATATTCTTCATAG
GAATGGGAGTCAATATTCACAGTGACCACATTCTTCGCAGCCTGAGAAAACCTGGAGAA
ATTACCTATAAAATCCCGAGAGGCGGCTTATTTGAGTACGTGTCTGGTGCAAATTTCTTTG
GGGAGATAGTACAGTGGCTGGGTTACGCGGTTGCTACCTGGTCCTTACCCACATTTGCTTT
TGCTTTTTTCACAATTTGCTTCATAGGCCCAAGAGCCTATCACCATCACAGG  3’ 
Figure 3.7. Partial nucleotide sequence (474 bp) of fathead minnow srd5a2. The sequences 
highlighted in red represent the primers used to confirm the sequence in the 5’ and 3’ direction by the 
Sequencing service.  
3.3.2.3 Computational and phylogenetic analysis of fathead minnow srd5a1 and srd5a2  
After translating the sequenced fragments into estimated aminoacid sequences, the latter were 
analysed by InterPro, a database able to identify protein "signatures" used for the 
classification and automatic annotation of proteins and genomes. InterPro classifies sequences 
at superfamily, family and subfamily levels, predicting the occurrence of functional domains, 
repeats and important sites. Both fathead minnow putative srd5a1 and srd5a2 were 
characterised by the presence of a functional domain typical of “steroid oxidoreductase 
(Steroid_dh) superfamily” (PFAM database), which includes several enzymes, such as steroid 
dehydrogenases and isoprenylcysteine carboxyl methyltransferase enzymes (Fig. 3.8). These 
proteins also contain a varying number of transmembrane regions. Furthermore, the 
PANTHER (Protein ANalysis THrough Evolutionary Relationships) Classification System 
recognized specifically the domains typical of 3-oxo-5-alpha steroid 4 dehydrogenase (5αR) 
isoforms 1 and isoform 2, respectively, in the fathead minnow putative 5αR Type 1 and 5αR 
Type 2. 
Only in the sequence of fathead minnow putative 5αR Type 2, the ProfileScan database 
identified the domain “5α-reductase”, and the TMHMM database, which predicts 
transmembrane helices in proteins, identified three transmembrane regions. 
All the InterPro results confirmed that the isolated and sequenced fragments coded for fathead 
minnow 5αR Type 1 and 5αR Type 2. 
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Figure 3.8. The DNA fragments amplified by targeting fathead minnow ESTs were isolated, and their 
nucleotide sequences were translated into aminoacid sequences. The latter were analyzed using 
InterPro, an online bioinformatic tool able to identify protein "signatures", such as functional 
domains, repeats and important sites. The analysis identified the functional domains characteristic of 
5αR in both fathead minnow putative 5αR Type 1 and 5αR Type 2.  
Considering the perfect identity match between the isolated fragments and the fathead 
minnow ESTs used as reference sequence, the latter were used for the phylogenetic analyses. 
Fathead minnow sequences were first aligned to srd5a1 and srd5a2 present in other teleost 
fish species, showing a medium to high degree of interspecies similarity (Fig. 3.9 & 3.10; 
Table 3.3). The highest degree of similarity was found when the sequences were aligned to 
the zebrafish sequences (srd5a1: 81%; srd5a2: 89%). Zebrafish also had a third isoform of 
5αR gene, classified as srd5a2b, which showed only a medium degree of similarity to fathead 
minnow srd5a2 (61%). 
A phylogenetic analysis was performed in order to broaden the range of comparisons to other 
taxa, including human, domestic mouse, rat, frog, nematode, trypanosome, and plant. The 
analysis of the nucleotide sequences lead to the phylogenetic tree shown in Figure 3.11. The 
tree was characterized by low bootstrap values, indicating a modest reliability of the result. 
However, the analysis did give a good classification of the two isoforms of srd5a, with a clear 
Fathead minnow 5αR1  
Fathead minnow 5αR2 
 86 
 
dichotomy that separated srd5a1 from srd5a2. Furthermore, the fish sequences were 
evolutionary closer to each other than to the mammalian ones. The low bootstrap values were 
probably due to the fact that the length of the analyzed sequences was not the same in all the 
species. In fact, some sequences represented full-length genes, while others where only partial 
sequences, with a consequent loss of evolutionary information.    
The reliability of the result was strongly improved by the use of the aminoacid sequences, 
which are typically more conserved than the nucleotide ones. The phylogenetic tree obtained 
for the protein sequences showed, in fact, highly significant bootstrap values, confirming the 
good degree of similarity among 5αRs in different species (Fig. 3.12). 
Interestingly, the putative 5αR of trypanosome and plant were classified in a separate 
subgroup, while the nematode 5αR was evolutionary closer to the vertebrate ones. 
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Figure 3.9. ClustalW alignment of the fathead minnow srd5a1 sequence versus the one of zebrafish, 
medaka, and stickleback. Sequences similarity are showed in Table 3.3. * indicates identical 
nucleotide in all four species of fish. 
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Figure 3.10. ClustalW alignment of the fathead minnow srd5a2 sequence versus the one of zebrafish (2 
isoforms), and Atlantic salmon. Sequences similarities are showed in Table 3.3. * indicates identical 
nucleotide in all four species of fish.  
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Table 3.3. Percentage similarity scores of srd5a1 and srd5a2 gene sequences between fathead 
minnow, human and other teleost fish. 
Species srd5a1 srd5a2 
Human 79 65 
Rat 81 66 
Frog 69 70 
Zebrafish 81 67 (a)* 89 (b)* 
Medaka 63 72 
Stickleback 61 / 
* Two isoforms of srd5a2 have been characterized in zebrafish. 
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Figure 3.11. Phylogenetic tree of the genes srd5a1 and srd5a2 coding, respectively, for the enzymes 
5αR Type 1 and 5αR Type 2. The tree was generated using ClustalX (neighbour joining method). The 
out-group used in the analysis was Arabisposis. Percentage bootstrap values are provided for each 
node (n = 1000). The number at the end of the name of the species indicates the specific isoforms (1 or 
2). The absence of a number indicates that only one isoforms was available for that species. The 
database accession ID for each sequence is shown in Table 3.2. 5αR genes were classified into two 
main categories, srd5a1 and srd5a2. Considering the non-vertebrate taxa, the gene sequences of 
trypanosome and nematode were evolutionary closer to vertebrate srd5a1 than the gene sequence 
present in the plant Arabidopsis.  
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Figure 3.12. Phylogenetic tree of the proteins 5αR Type 1 and 5αR Type 2. The protein sequences 
were obtained from NCBI and were estimated. The tree was generated using ClustalX (neighbour 
joining method). The out-group used in the analysis was Arabisposis. Percentage bootstrap values are 
provided for each node (n = 1000). The number at the end of the name of the species indicates the 
specific isoforms (1 or 2). The absence of a number indicates that only one isoforms was available for 
that species. The enzyme 5αR was classified into two main categories, 5αR Type 1 and 5αR Type 2. 
Considering the non-vertebrate taxa, the protein sequence of nematode was evolutionary closer to the 
vertebrate isoforms than the protein present in the trypanosome and in the plant Arabidopsis.  
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3.4 Approach 2: Detection of DHT in fathead minnow plasma by ELISA and 
Ultrasensitive GC-MS/MS 
In order to confirm the occurrence of a functional 5αR in fathead minnow, attention was 
focused on the detection of the product of its enzymatic activity - the androgen DHT - in fish 
plasma.  A preliminary assay was performed testing the plasma of 3 mature males and 3 
mature females with a DHT ELISA kit (Demeditec, Germany, Cat No. DE2330). The assay 
detected the presence of DHT at mean concentrations of 1.96 ± 0.09 ng/mL in male fish and 
1.26 ± 0.12 ng/mL in female fish (data not shown). However, despite the fact that the cross-
reactivity values provided by the Kit‟s manufacturing company (Demeditec) were very low 
(T: 8.7%; 5β-DHT: 2.0%; Androstenedione: 0.2%), some concerns remained about the 
specificity of the assay to detect DHT in fish plasma. In order to obtain an incontrovertible 
quantitative result, fish plasma was analyzed using analytical chemistry techniques instead of 
immunoassay. In particular, the aim was achieved by quantifying the concentrations of 
circulating DHT, T, and KT in adult and juvenile fathead minnows by Ultrasensitive GC-
MS/MS, in collaboration with the Laboratory for the Study of Residues and Contaminants in 
Food (LABERCA) group, located in Nantes, France.    
LABERCA‟s group developed a highly sensitive analytical method to quantify circulating 
androgens in pre-pubertal boys and girls, who normally have very low concentrations of 
circulating sex steroids (Courant et al., 2010). The high sensitivity of the method was 
considered of great potential utility to clarify if DHT circulates in fathead minnow plasma, 
even at very low concentrations.   
3.4.1 Materials and Methods 
The steroids analysed by GC-MS/MS were specifically DHT, T and KT. For simplicity, in the 
following sections the same steroids will be defined respectively as DHT, T and KT.  
3.4.1.1 Plasma samples 
Blood samples were collected from the caudal peduncle of fish using heparinised capillary 
tubes and transferred into eppendorf tubes containing the enzyme inhibitor Aprotinin (Sigma). 
Blood samples were kept on ice until plasma was separated by centrifugation at 14000 × g for 
5 min, removed and stored at −20 °C until steroid analyses. Two different experiments were 
performed. In the first preliminary experiment, several blood samples were collected from 
juvenile male fathead minnows (80-90 dph) and from sexually mature male and female 
fathead minnows (150-180 dph), obtained from a stock maintained at Brunel University, 
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London (UK). Fish at both ages were kept in stock tanks (150 L) containing a number of 
mixed sex individuals, between 150-200 for juveniles and 50-100 for adult fish. A resume of 
the morphometric data and male SSCs of the sampled fish is shown in table 3.4. Samples 
were pooled at LABERCA according to the sex, and the first results indicated that a minimum 
of 200 µL were required for the analysis; hence in the second experiment plasma samples 
were directly pooled at Brunel University, in order to obtain the required 200 µL.  
In the second experiment, plasma samples were taken from adult fish (160-200 dph) kept at 
two different densities and breeding conditions:  
1) Mixed sex fish were kept in stock tanks (150 L) containing between 50 and 100 fish 
(mixed sex); 
2) Fish were transferred from highly populated stock tanks into single 30 L tanks 
containing 2 males and 4 females, and allowed to actively breed for 3 weeks before 
the blood sampling.  
The aim of the second experiment was to assess if an active breeding behaviour was 
correlated with a potential increase of circulating DHT. A resume of morphometric data and 
male SSCs of fish used in the second experiment is shown in Table 3.4.   
The final number of analyzed samples, obtained from pooling 3-5 different plasma samples 
from different individuals, was: 
1 Juvenile Males 
4 Adult males from stock tanks 
3 Adult Breeding Males 
3 Adult Breeding Females 
In order to exclude the possibility that the food used to sustain fathead minnow stock at 
Brunel University was the source of DHT detected in fish plasma, two samples of food were 
processed and steroid extraction was performed in ethyl-acetate, as described by Beresford et 
al. (2011). Steroid extraction was performed on both adult brine shrimp (Tropical Marine 
Centre, Gamma irradiated) and flake food (King British Tropical flake food, Lillico, Surrey). 
Additionally, DHT was quantified in two flake food samples spiked with 100 ng of DHT, and 
on one blank sample. 
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Table 3.4. Morphometric data and male SSCs of fish used in Experiment 1 and Experiment 2. 
Experiment 1 
Group & 
Sex 
Length 
(mm) 
Weight 
(g) 
No. of 
Tubercles 
Tubercles 
Grade 
Fatpad 
Grade 
Plasma 
volume per 
sample (µL) 
No. of 
Samples 
Immature 
Males 
54.1±0.3 2.7±0.6 / / / 16.5±2.7 4 
 
Mature 
Males 
64.7±4.2 6.3±0.9 17±1.7 4.5±0.5 3.2±0.8 55.2±17.2 6 
 
Mature 
Females 
55.3±0.3 2.7±0.6 / / / 42.2±14.3 6 
 
Experiment 2 
Group & 
Sex 
Length 
(mm) 
Weight 
(g) 
No. of 
Tubercles 
Tubercles 
Grade 
Fatpad 
Grade 
Plasma 
volume per 
sample (µL) 
No. of 
Samples 
Adult 
Breeding 
Males 
69.1±6.5 7.4±2.1 18±1.2 4.7±0.3 3.8±0.4 65.2±27.9 12 
 
Adult 
Stock 
Males 
64.8±3.0 6.1±1.3 17±1.9 4.2±0.4 3.1±0.6 53.3±13.7 12 
 
Adult 
Breeding 
Females 
55.8±5.1 3.2±0.7 / / / 36.6±18.1 16 
 
All the following experimental steps were performed at LABERCA by its staff, according to 
the methods described by Courant et al. (2010).  
3.4.1.2 Reagents and chemicals 
All solvents and reagents were of analytical or grade quality
 
and purchased from Solvent 
Documentation Synthesis (SDS, Peypin,
 
France). Solid phase extraction cartridges (SPE) 
(ChromP, SiOH) were
 
also provided by SDS. Purified Helix pomatia
 
enzymatic preparation 
was used for steroid deconjugation (Sigma
 
Chemical Co., St. Louis, MO). Derivatization 
reagents included
 
N-methyl-N-(trimethylsilyl)-trifluoroacetamide, N,O-bis (trimethylsilyl)-
trifluoroacetamide,
 
and pentafluorobenzylbromide were purchased from Fluka (Buchs,
 
Switzerland). Dithiothreitol and trimethyliodosilane were purchased
 
from Sigma-Aldrich (St. 
Quentin Fallavier, France). Standard
 
reference steroids were purchased from Sigma (St. 
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Louis, MO).
 
The deuterated internal standard 17α- methyltestosterone-d3 was provided
 
by 
Steraloids (Wilton, NY).
 
 
3.4.1.3 Sample preparation 
The sample preparation procedure (extraction and purification)
 
used for the isolation of target 
steroids has previously been described by Courant et al. (2007). Quantification was
 
performed 
by isotopic dilution. Plasma samples (200 µL) were spiked
 
with 17α-methyltestosterone-d3 
(200 pg in Experiment 1; 500 pg in Experiment 2), which was used as the internal standard. 
An enzymatic
 
hydrolysis (with H. pomatia enzymes) was performed before the extraction
 
of 
non-polar compounds with diethylether. The quantification of plasma steroids is commonly 
conducted by the analysis of the un-conjugated steroids, since conjugated metabolites 
(glucuronidated and sulfated) are generally considered biologically inactive. In this study, an 
enzymatic hydrolysis was performed before measurement of steroid levels to quantify total 
steroid concentrations (unconjugated plus conjugated). 
Measuring the total steroid levels increases the chance of obtaining measurable values (higher 
than LOQ) in samples with extremely low concentrations. Furthermore, although circulating 
conjugated metabolites may not be active, their presence is nevertheless evidence of sex 
steroid production. The role of unconjugated steroids is not fully understood, in fact it has 
been shown that local deconjugation and conversion into more active compounds may occur 
in certain hormone-responsive tissues (Thijssen, 2004).  
A first purification
 
step was performed on a ChromP SPE cartridge. Then, androgens were 
separated by a liquid/liquid
 
partitioning with n-pentane. Extracts were finally purified on a 
silica
 
SPE cartridge. 
3.4.1.4 Derivatization reaction 
Derivatization of the androgen fraction was carried out with
 
a N-methyl-N-(trimethylsilyl)-
trifluoroacetamide/trimethyliodosilane/dithiothreitol
 
mixture (1000:5:5; vol/vol/wt) for 40 
min at 60ºC. 
3.4.1.5 GC-MS/MS measurement 
GC-MS/MS involves two steps: a separation phase (gas chromatography or GC) and an 
analytical phase (tandem mass spectrometry or MS/MS). The gas chromatographer separates 
the different chemicals in a sample based on their physical and/or chemical properties (e.g. 
volatility). The sample containing a mixture of compounds, including the target ones, is 
injected in the machine, vaporized and carried by a mobile phase (e.g. helium) through a 
capillary column, having on its internal surface a stationary phase, which, in our case, was a 
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special arylene polymer (Arylene Matrix Technology™). GC is based on partition 
equilibrium of analyte between the solid stationary phase and the mobile gas. Chemicals with 
high volatility travel through the column more quickly than chemicals with low volatility. 
Once the sample has travelled through the GC, the separated chemicals reach the mass 
spectrometer. A mass spectrometer is a machine which ionizes and fragments different 
molecules by blasting them with electrons. As the ions continue into the mass spectrometer, 
they travel through a magnetic field toward a detector, which detects the charge or current 
created by each ionized particle, quantifying them as mass-to charge ratios (m/z). Each 
fragment has a specific m/z.  
A tandem mass spectrometer (MS/MS) is one capable of multiple rounds of mass 
spectrometry, usually separated by some form of molecule fragmentation. In particular, the 
triple quadrupole mass spectrometer, as the one used in this study, is a tandem mass 
spectrometer consisting of two quadrupole mass spectrometers in series, with a (non mass-
resolving) radio frequency (RF) only quadrupole between them to act as a collision cell for 
collision-induced dissociation. The first (Q1) and third (Q3) quadrupoles serve as mass filters, 
whereas the middle (q2) quadrupole serves as a collision cell. This collision cell uses an inert 
gas such as Ar, He, or N2 gas to provide collision-induced dissociation of a selected precursor 
ion that is selected in Q1. Subsequent fragments are passed through to Q3 where they may be 
filtered or scanned. This configuration is often abbreviated QqQ, here Q1q2Q3. 
The MS also quantifies the amount of each chemical detected in a sample as a peak. Based on 
the peak area, the mass spectrometer determines the concentration of each chemical in the 
sample by comparing it to the peak areas of the standards run at the beginning and end of each 
GC-MS/MS run. 
In this study, measurements were carried out by GC-EI-MS/MS with positive electrical 
ionization. Electron energy was set at 70 eV. An Agilent 7890A gas chromatograph coupled 
to a 7000 GC triple-quadrupole device (Agilent, San José, USA) was used for analyte 
detection and quantification. Injector and transfer line temperatures were set at 250°C and 
280°C, respectively. Source and analyzer temperatures were set to 220°C and 150 °C, 
respectively. GC column was a 15 m x 0.25 mm id., film thickness 0.1 µm (Restek). 
Temperature programme was set as follows: 120°C (1 min), 10°C min 1 until 220°C (1 min), 
2°C min 1 until 225°C (0 min) and 15°C min 1 until 320°C (2 min). The mass spectrometer 
was operated in the selected reaction monitoring (SRM) acquisition mode (Table 3.5). Argon 
was used as the collision gas. 
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Table 3.5. GC-MS/MS acquisition parameters used for the measurement of androgens and 
estimated LOD and LOQ. 
Steroid Transition 
Collision 
energy (eV) 
LOD 
(pmol/L) 
LOQ 
(pmol/L) 
RT 
(min) 
T 432.4 > 417.4 5 0.03 0.07 27.73 
 432.3 > 209.2 12    
 
DHT 
 
434.4 > 405.4 
 
8 
 
0.05 
 
0.10 
 
27.08 
 434.4 > 195.1 12    
 
17α-Methyltestosterone-d3 
(IS) 
 
449.3 > 301.2 
 
15 
  
 
29.48 
For conversion purposes, 1 pmol/L = 0.288 ng/L for 17β-testosterone; 1 pmol/L = 0.290 ng/L for 
DHT. IS, internal standard; RT, retention time. 
3.4.1.6 Performance of the method 
The limit of detection (LOD) is defined as the lowest concentration
 
or amount of an analyte 
that can be reliably identified as being
 
quantitatively present in the sample. The limit of 
quantification
 
(LOQ) is defined as the lowest concentration or amount of analyte
 
that can be 
reproducibly quantified in a sample. In this experiment, LOD and LOQ
 
for each analyte were 
determined as the concentration
 
inducing a signal to noise ratio of 3 and 6, respectively (Table 
3.5).
 
The repeatability was calculated on the basis of methyltestosterone-d3 internal standard 
signals for 20 replicates. 
3.4.2 Results 
3.4.2.1 Experiment 1 
Identification was performed according to European analytical criteria (2002/657/CE). 
Standard extracted calibration curves were established by adding fixed amount of 17α-
methyltestosterone-d3 (200 pg) to 200 μL water and increasing quantities of the target 
analytes from 40 to 1000 pg (i.e. 0.2 to 5 ng/mL). The response linearity (R² values) was 
higher than 0.99 for both T and DHT. 
T was identified and quantified in all the 3 pooled samples, while DHT was identified and 
quantified in pooled samples from males (Fig. 3.13) and females. Conversely, this compound 
was not detected in pooled sample from juveniles, but this result may be due to the very 
restricted sample size (i.e. 70 μL). A summary of these quantitative results is presented in 
Table 3.6.  
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Figure 3.13. Example of diagnostic ion chromatograms of DHT (434.4 > 405.4 and 434.4 > 195.1), T 
(432.4 > 417.4 and 432.4 > 209.2), and methyltestosterone –d3 detected in the plasma of male fathead 
minnows sampled from fish stock tanks.  
3.4.2.2 Experiment 2 
The objective of this second study was to measure T, DHT, and KT in fish plasma and to 
confirm the absence of DHT in the food used to feed the fathead minnow stocks at Brunel 
University. Standard extracted calibration curves were established by adding fixed amount of 
17α-methyltestosterone-d3 (500 pg) to 200 μL water and increasing quantities of the target 
analytes from 40 to 1000 pg (i.e. 0.2 to 5 ng/mL). The response linearity (R² values) was 
higher than 0.99 for DHT and 17β-T. However, the R² value was much lower for KT. Indeed, 
this compound showed significant different chemical properties than DHT and T and required 
a different labelled internal standard. Therefore, only semi-quantitative observations were 
made on KT.  
DHT and T were identified and quantified in all samples (Fig. 3.14; Table 3.6). DHT 
concentrations were approximately 8% of the circulating T concentrations in both males and 
females. The average DHT concentration in males was 0.59 ± 0.17 ng/mL versus 7.53 ± 2.80 
Dihydrotestosterone 
Methyltestosterone – d3 (IS) 
Testosterone 
Testosterone 
Dihydrotestosterone 
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ng/mL of T. In juvenile males, the concentration of T (3 ng/mL) was lower than the 
concentration measured in adult fish. DHT was below the LOQ for this sample, probably due 
to the small volume of plasma available (70 µL). On the other hand, in female fathead 
minnow, both T and DHT were measured at concentrations of 5.18 ± 3.31 ng/mL and 0.42 ± 
0.17 ng/mL, respectively. A summary of the quantitative results is presented in Table 3.6. 
 
Figure 3.14. Example of diagnostic ion chromatograms of T (432.4 > 417.4 and 432.4 > 209.2) and 
DHT (434.4 > 405.4 and 434.4 > 195.1) detected in the plasma of breeding male fathead minnows. 
 
 
 
 
 
Testosterone 
Testosterone 
Methyltestosterone – d3 
(IS) 
 
Dihydrotestosterone 
Dihydrotestosterone 
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Table 3.6. Quantification of the concentrations of DHT and T in fathead minnow plasma samples. 
Experimental group 
Sample ID & 
Experiment No. 
Testosterone 
(ng/mL) 
Dihydrotestosterone 
(ng/mL) 
Mature males 
M1 - Exp. 1 7.79 0.78 
M2 - Exp. 2 6.16 0.28 
M3 - Exp. 2 4.63 0.59 
M4 - Exp. 2 5.28 0.65 
Average ± SD  5.97±1.37 0.58±0.21 
    
Mature breeding males 
M5 - Exp. 2 13.29 0.57 
M6 - Exp. 2 6.31 0.46 
M7 - Exp. 2 7.04 0.57 
 M8 - Exp. 2 9.71 0.83 
Average ± SD  9.09±3.16 0.61±0.16 
    
All mature males 
Average ± SD 
 7.53±2.80 0.59±0.17 
    
Juvenile males M9 – Exp. 1 3.00 < LOD 
    
Mature females F10 – Exp. 1 2.77 0.40 
    
Mature breeding 
females 
F11 – Exp. 2 8.96 0.48 
 F12 – Exp. 2 22.69 0.61 
 F13 – Exp. 2 3.81 0.20 
Average ± SD  6.39±3.64 0.43±0.21 
    
All mature females 
Average ± SD  
 5.18±3.31 0.42±0.17 
 
KT was identified in all samples from male fathead minnows (between 2 and 60 ng/mL). It 
was not detected in any female samples (Fig. 3.15). 
Two food samples, one spiked food sample, and one blank sample were analysed using the 
same protocol. DHT was identified at high levels only in the food spiked with 100 ng of 
DHT, but was not identified in any of the other samples (Fig. 3.16). 
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Figure 3.15. Example of diagnostic ion chromatograms of KT (503.4 > 169.1, 503.4 > 323.3 and 
503.4 > 413.4) detected in (A) the plasma of a male fathead minnow (sample M7) and (B) the plasma 
of female fathead minnow (sample F1). 
 
Figure 3.16. Example of diagnostic ion chromatograms of DHT (434.4 > 405.4 and 434.4 > 195.1) 
detected in (A) a flake food sample spiked with DHT (100 ng), and (B) a unspiked flake food sample. 
3.5 Discussion  
The demonstration that the genes coding for 5αR Type 1 and Type 2 were expressed in 
mature testis of fathead minnow provided strong evidence of the presence of a functionally 
active 5αR in this species. This hypothesis was supported by the strong correlation found 
between 5αR enzymatic activity and its mRNA level, for both Type 1 and Type 2, in human 
prostate tissue (Shirakawa et al., 2004; Soderstrom et al., 2001).  
From an evolutionary persepective, an important finding was that  5αR is conserved in a 
broad range of phyla, including bacteria, plants, fungi, and humans. Although plants and 
animals diverged more than 1 billion years ago, it is remarkable that poly-hydroxylated 
steroidal molecules
 
are used as hormones in both of these kingdoms. Brassinosteroids are a 
class of plant-specific
 
steroid hormones, and control many developmental and physiological
 
processes, including regulation
 
of gene expression, cell division, differentiation,
 
programmed 
11-ketotestosterone 11-ketotestosterone 
Dihydrotestosterone Dihydrotestosterone 
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(IS) 
 
Methyltestosterone – d3 
(IS) 
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cell death, photomorphogenesis, and homeostasis (Basse et al, 2002; Clouse, 2011; Thummel 
and Cory, 2002). 
Recombinant Arabidopsis steroid 5αR, encoded by the det2 gene, can be expressed in human 
embryonic kidney 293 cells, where it is able to reduce several mammalian steroids with a 3-
oxo structure, including T, androstenedione, and progesterone (Li et al. 1997). Arabidopsis 
5 R and the mammalian enzyme show similar affinities for animal steroids, with similar Km 
values (Li et al. 1997). Therefore, both the structural and functional conservation between 
Det2 and mammalian steroid 5αR suggest that they evolved from a common ancestor. Chory 
et al. (1991) isolated Arabidopsis with a det2-1 mutation, which caused defective brassinolide 
biosynthesis. The mutant plants were characterized by dwarfism, increased number of 
chloroplasts in a reduced cell volume (causing the appearance of dark green leaves), reduced 
male fertility, and delayed senescence and flowering (Chory et al., 1991; Li et al., 1996; 
Altmann, 1998; Clouse and Sasse, 1998).  
Fathead minnow srd5a1 showed a high degree of similarity to the homologous gene in 
humans, rat and zebrafish; on the other hand, srd5a2 showed a high degree of similarity only 
when compared to the zebrafish enzyme (89%), while this value was lower when considering 
the human and rat srd5a2 (respectively 65% and 66%). When considering only teleost fish, 
the zebrafish gene was evolutionary closest to the fathead minnow gene, whereas, for 
example, the medaka and stickleback gene showed only a medium degree of similarity 
(~60%).  
The second approach used to determine if 5αR was functional in fathead minnow focused on 
the detection of plasma circulating DHT. This approach was considered to be more suitable 
than the analysis of 5αR enzymatic activity, since it could provide definitive evidence of the 
presence of DHT in fish plasma.  
T and DHT are crucial to the development of male reproductive organs and male 
characteristics in adults, as described in Chapter 1. From a clinical point of view, the 
measurement of serum T is an important endpoint in the diagnosis and treatment of male 
hypogonadism and pubertal delay, while measurements of serum DHT and the T/DHT ratio 
are used to monitor androgen replacement therapies, 5αRs deficiency, 5αR inhibitor treatment 
of BPH, and for the prevention of prostate cancer (Shiraishi et al., 2008; Mohler et al., 2004; 
Wang et al., 2000). 
Historically, several radioimmunoassays (RIAs) have been developed to measure 
concentrations of circulating sex steroids in fish (Scott et al., 1984). The same technique, 
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together with other immunoassay methods (e.g. ELISA), has also been used in the clinical 
field to measure steroids concentrations in human plasma. However, the majority of these 
assays were designed to measures relatively high levels of target steroids; this, together with 
the potential cross-reactivity of the antibodies employed with non-target steroids, may make 
these assays unsuitable to detect very low concentrations of hormones in biological matrixes, 
like plasma. 
From a clinical point of view, the development of accurate and sensitive steroid assays is 
important to define exact reference ranges in women and men for the diagnosis of endocrine 
dysfunctions, like hormone deficiency or excess states (e.g. hyperandrogenism), or to monitor 
the effectiveness of hormonal therapy, like hormone replacement therapies. Several studies 
have compared the concentrations of steroids measured by RIAs or other immunoassay, with 
the ones obtained using analytical techniques, like LC or GC coupled with mass-spectrometry 
(Hsing et al., 2007; Santen et al., 2008; Wang et al., 2008; Rothman et al., 2011). The general 
conclusion arising from these studies was that immunoassays tend to over-estimate steroid 
concentrations in biological matrixes, such as plasma. For example, Santen et al. (2008) 
compared E2 levels measured by RIA and LC-MS/MS or GC-MS/MS, showing that when 
samples contain very low concentrations of E2 (close to the LOD of RIA), estrogen 
metabolites may interfere with RIA, elevating the measured E2 concentration, which in turn 
could lead to wrong clinical interpretations (e.g. in cases of breast cancer). Also Rothman et 
al. (2011) concluded that serum levels of sex hormones - including T, DHT and E2 - were 
lower when measured with LC-MS/MS compared with RIA, and LC–MS/MS provided more 
accurate and precise measurements, in particular when the measured concentration where 
close to the RIA‟s LOD. This technical issue assumed an important relevance in clinical 
endocrinology, hampering the understanding of the physiological role of the low 
concentrations of DHT circulating in women (typically below 0.2 ng/mL) (Rothman et al., 
2011). 
According to the preliminary analysis performed on fathead minnow plasma using a 
commercial DHT ELISA Kit, the concentrations of circulating DHT in this species were 
expected to be very low, in the low ng/L range or even below 1 ng/L. Therefore highly 
sensitive technique was required in order to obtain a definitive result. In this study, our 
objective was to demonstrate that DHT circulates in fathead minnow, even if at low 
concentrations; therefore, the Ultrasensitive GC-MS/MS available at LABERCA represented 
an optimal methodology, eliminating the concerns of non-specificity arising from the use of 
ELISA. Indeed, the methodology used in this study was developed by Courant et al. (2010) to 
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detect the low concentrations of androgens and estrogens circulating in pre-pubertal boys and 
girls, and it could detect T and DHT with LODs of 0.288 pg/mL and 0.290 pg/mL, 
respectively.  
The results demonstrated that DHT is present in fish plasma at a concentration comparable to 
the human one (Table 3.7), and in the case of male fish, DHT concentrations are in the same 
range as in male humans, providing a good comparative background for the study of the 
effects of dutasteride in fathead minnow. On the other hand, DHT concentrations in female 
fish were approximately between 2 and 15 times higher than the ones measured in women, 
leading to the hypothesis that DHT has an important physiological role also in female fathead 
minnow, and that the inhibition of its synthesis would cause adverse effects. The higher 
concentration of DHT in female fathead minnows when compared to humans is probably due 
to the high concentration of T circulating in female fathead minnow (median value 3.25 
ng/mL, according to Watanabe et al., 2007), very different from pre-menopausal human 
females, where T plasma concentrations are in the range of 0.1-0.6 ng/mL (Table 3.7). A 
further significant result was that circulating DHT concentrations in both sexes of fathead 
minnow were approximately 7-8% of circulating T concentrations, and this value is very close 
to the typical 10% observed in humans (Becker, 2001).          
In men, about 25% of circulating DHT is synthesised by the testicular tissue, and the 
remainder by other tissues, such as liver, kidney, muscle, prostate, and skin. However, 
circulating concentrations of sex steroids are not the only parameter to take into consideration, 
since the local concentration of the same hormones in tissues where there is an active 
biosynthesis can be higher than the circulating values. Indeed, in human prostate, the DHT 
concentration is 5 to 10-fold higher than in the peripheral blood (Becker, 2001; McConnell et 
al., 1992).  
The downside of the technique employed in this study was that the minimum volume of 
plasma required for the analysis was 200 µL, versus the few µL required for RIAs. The 
volume of plasma that it is possible to obtain from an individual fathead minnow is about 20-
100 µL for adult males, and 15-60 µL for adult females. In order to obtain the 200 µL of 
plasma required, plasma samples from different individual fish (3-5 individuals) were pooled. 
This approach probably hid the variability of DHT concentrations among different 
individuals, making this technique, as it was used in this study, unsuitable for routine analysis 
of plasma steroid concentrations in small laboratory fish (e.g. fathead minnow, zebrafish, 
medaka) used in (eco)toxicological studies; however, this experiment represented the first 
attempt, to our knowledge, to quantify circulating plasma DHT concentrations in fathead 
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minnow, and in teleost fish in general, by analytical chemistry, so it should be seen as a first 
step to confirm the presence of circulating DHT in fish, whose biosynthesis is inhibited by the 
drug studied in this Thesis.  
Table 3.7. Concentrations of T and DHT in plasma of humans and fathead minnows. 
Species Testosterone (ng/mL) Dihydrotestosterone (ng/mL) Reference 
 ♂ ♀ ♂ ♀  
Human 
3.82±1.0  0.33±0.90  Hsing et al., 2007 
2.60-9.70 
 
0.09-0.58 
Pre-menopausal 
0.14-0.77 
 
0.03-0.26 
Pre-menopausal 
Shiraishi, 2008 
 
0.15-0.23 
Pre-menopausal 
 
0.08-0.09 
Pre-menopausal 
Rothman et al., 2011 
 
0.10-0.11 
Post-menopausal 
 
0.026-0.036 
Post-menopausal 
Rothman et al., 2011 
4.57±0.05    Labrie et al., 2009 
Fathead 
minnow 
7.53±2.80 5.18±3.31 0.59±0.17 0.42±0.17  
 
When plasma steroids are quantified by GC- or LC-MS/MS, a common strategy is to analyze 
only the un-conjugated steroids, since conjugated metabolites (glucuronidated and sulfated) 
are considered biologically inactive. In this study, an enzymatic hydrolysis was performed 
before measurement of steroid levels, in order to quantify total steroid concentrations (un-
conjugated plus conjugated), with the aim of increasing the chance to detect and quantify with 
high confidence (concentrations higher than LOQ) even very low concentrations of DHT 
(Courant et al., 2007, 2010). The de-conjugation step performed in this work was justified not 
only by methodological reasons, but also by biological ones. In fact, despite conjugated 
steroids being considered inactive, their role is not fully understood, and it has been shown 
that in certain tissues these metabolites can be de-conjugated and converted into active 
steroids (Thijssen, 2004), suggesting that the pool of steroids in an organism should be 
considered as a dynamic system, rather than as a static one (conjugated or un-conjugated) 
(Courant et al., 2010). Several authors have suggested that the conjugation of steroids (e.g. 
with glucuronic acid) may play a critical role in the regulation of the intracellular ratio 
between un-conjugated and conjugated steroids, determining their biological activity in 
tissues (Belanger et al., 2003; Labrie et al., 1997; Rittmaster, 1993), and that the 
quantification of both specific androgens and their metabolites appears to be the most suitable 
approach to accurately estimate the total androgen pool in an individual (Vandenput et al., 
2007). Finally, independently from their potential activity, the presence of conjugated steroids 
represents evidence of active sex steroid production (i.e. DHT) (Courant et al., 2010).   
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In conclusion, a number of pieces of evidence collected during the preliminary phase of the 
project – both experimentally and from the literature - strongly suggest that DHT may have a 
physiological role in the fathead minnow. The evidence includes the expression of 5αR genes 
in tissues such as the testis and the occurrence of circulating DHT at concentrations similar to 
the ones detected in humans (as previously described in this Chapter), the high affinity of 
DHT for the fathead minnow AR (Wilson et al., 2007), the high potency of DHT to induce 
the transcription of teleost fish AR (Ikeuchi et al., 1999; Katsu et al., 2007; Olsson et al., 
2005; Takeo and Yamashita, 2000; Todo et al., 1999), and the paracrine action of DHT in 
specific tissues (Griffiths et al., 1997). This conclusion constitutes the rationale for testing the 
effects of dutasteride, a dual 5αR inhibitor, in the fathead minnow.  
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CHAPTER 4 : COMPARATIVE STUDY OF THE IN VIVO 
ANDROGENIC POTENCY OF 11-KETOTESTOSTERONE 
AND 5 -DIHYDROTESTOSTERONE IN THE FATHEAD 
MINNOW 
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4.1 Introduction   
Androgens regulate a wide range of physiological processes in male vertebrates, mediating 
their action through the androgen receptor (AR) (Brinkmann et al., 1999; Heinlein and Chang, 
2002; Li and Al-Azzawi, 2009). DHT is one of the most physiologically important androgens 
in many male vertebrates (George and Wilson, 1994), with the exception of teleost fish, in 
which T and KT are generally considered the major circulating male androgens, as well as the 
most potent ones (Borg, 1994). KT, in particular, shows a low affinity to fish sex hormone 
binding globulins (SHBGs) (Miguel-Queralt et al., 2004, 2005), and higher levels of free 
circulating hormone in the blood when compared to other androgens (Borg, 1994). KT is 
involved in fish gonad differentiation (Piferrer et al., 1993), regulation of development of 
secondary sex characteristics (SSCs) (Borg et al., 1993; Borg, 1994), and modulation of 
behaviour (Brantley et al., 1993a, 1993b; Kobayashi and Nakanishi, 1999), and was the only 
sex steroid able to induce all stages of spermatogenesis in species such as the Japanese eel 
(Anguilla japonica) and the African catfish (Clarias gariepinus) (Borg, 1994; Cavaco et al., 
1998, 2001; Miura et al., 1991).  
 
 
Figure 4.1. Chemical structures of 5α-dihydrotestosterone and 11-ketotestosterone. 
ARs have been isolated and characterized from a number of teleost species; however, none of 
these receptors are specific for KT (Ikeuchi et al., 1999; Olsson et al., 2005; Sperry and 
Thomas, 1999; Takeo and Yamashita, 2000; Todo et al., 1999; Touhata et al., 1999; Wells 
and Van der Kraak, 2000). Therefore, the molecular mechanisms explaining the high 
androgenic potency of KT in teleost fish are not understood. Furthermore, the presence, in 
some species, of multiple AR isoforms with different binding specificities and tissue 
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distributions suggest that androgens different than KT may be involved in the mediation of 
the androgenic response in different target tissues (Sperry and Thomas, 1999, 2000).  
The roles played by DHT in teleost fish have scarcely been investigated, and the general 
assumption seems to be that DHT does not have any major physiological role. For example, 
DHT didn‟t induce any spermatogenic activity in the eel (Borg, 1994), and inhibited testicular 
growth and spermatogenesis in the African catfish, without stimulating male SSCs (Cavaco et 
al., 1998). However, all the components involved in DHT biosynthesis and action are present 
and evolutionary conserved in teleost fish. In particular, the genes coding for the enzymes that 
convert T into DHT, namely 5-alpha reductase 1 and 5-alpha reductase 2 (5αR1, 5αR2), have 
been sequenced in zebrafish and medaka (GeneID: 767715, 550398, 550388, 100125491, 
100125532), and are expressed in several tissues in the fathead minnow (see Chapter 3); 5αR 
activity has been detected in the testes of the urohaze-goby  (Asahina et al., 1985), the brain 
of male and female goldfish and toadfish (Pasmanik and Callard, 1988, 1985), and the skin of 
rainbow trout  (Latz and Reinboth, 1993), and 5α-reduced androgen metabolites were found 
in gonads and peripheral tissues of both male and female teleosts (Kime, 1993). After 
injection of labelled T in flounder and Atlantic salmon , metabolites in the bile were primarily 
forms of DHT (Truscott, 1983), which was also a major metabolite in a similar experiment 
performed with fathead minnow (Parks and LeBlanc, 1998), indicating that steroid 5αR 
activity appears to be involved in androgen metabolism in these species. The results of some 
in vitro experiments suggest that teleost fish can synthesise DHT (Joss et al., 1996; Lee et al., 
1995), even if the relevance of these in vitro results to the in vivo situation is unclear. Lastly, 
an androgen receptor with high binding affinity to DHT is present in many teleost species, 
and DHT is often one of the most potent inducers of AR transcriptional activity in vitro 
(Fitzpatrick et al., 1994; Olsson et al., 2005; Sperry and Thomas, 1999a; Todo et al., 1999). 
4.2 Aim of the study 
The fathead minnow is one of the most frequently used fish models in aquatic toxicology; its 
basic biology and endocrine system are well characterized, and the presence of discrete SSCs 
make this species very useful in the study of mechanisms of action and effects of endocrine 
disrupting chemicals (Ankley and Villeneuve, 2006). Since all the components required for 
DHT synthesis are present in this species, and the fathead minnow AR has a high binding 
affinity to DHT, we investigated the effects of KT and DHT exposure in vivo on fathead 
minnow juveniles, with the aim of clarifying the comparative effects of the two androgens on 
critical physiological processes, such as gonad maturation, growth, and SSCs development.  
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4.3 Materials and methods 
4.3.1 Test species 
Juvenile fathead minnows were obtained from a stock maintained at Brunel University, 
London (UK). Fish age at the beginning of the experiment was between 60 and 65 days post-
hatch (dph), and wet weight was approximately 140 ± 50 mg (Fig. 4.2). The aim was to 
expose fish to KT and DHT during the sexual development and gonad maturation phases, 
which are very susceptible to endocrine interference (van Aerle et al., 2002). The choice of 
age, weight and exposure duration were based on results obtained from a study of the sexual 
development of the fathead minnow stock maintained at Brunel University (van Aerle et al., 
2004). A lab-specific choice was required, since fathead minnows maintained at different 
laboratories can have different rates of sexual maturation and growth. The period of exposure 
from 60 to 105 dph was driven by the hypothesis that both androgens would stimulate fish 
spermatogenesis, and terminating the experiment with control fish at an early stage of gonad 
maturation (i.e. testis with only spermatogonia) would allow us to more easily distinguish any 
stimulating effects caused by androgens from the ones due to normal sexual maturation (i.e. 
presence of more advanced stages of germ cells). Fish was acclimated to experimental 
conditions for 7 days prior to the start of the exposures. 
 
Figure 4.2. Fathead minnow juveniles (60 dph) at the beginning of the experiment. 
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4.3.2 Test substances and dilution water 
KT (CAS number 564-35-2) was purchased by Sigma-Aldrich, Gillingham (UK), and DHT 
(CAS number 521-18-6) from Steraloids Inc., Newport (USA). Concentrated stock solutions 
were prepared in HPLC grade N,N-Dimethilformamide (DMF) 99+% (Fisher Scientific, UK; 
CAS number 68-12-2).  
The dilution water was monitored daily for general parameters (e.g. pH, temperature, 
dissolved oxygen). During the exposure studies, mean water pH ranged from 7.5 to 8.2, 
temperature from 23.9 to 25.1ºC, and dissolved oxygen from 6.4 to 8.9 mg/L. 
4.3.3 Experimental design and protocol 
The experiment was carried out using a continuous flow-through system. Thermostatically 
heated (25 ± 1
o
C) dechlorinated carbon filtered (5 and 10 µm) tap water, from a header tank, 
flowed through 12 flow-meters into 12 mixing chambers via medical grade silicon tubing 
(VWR, UK) at a rate of 300 mL/min. Test chemical stock solutions dissolved in DMF (300 
μg/L and 3000 μg/L for both KT and DHT) were pumped by a Watson Marlow (Cornwall, 
UK) Multi channel peristaltic pump into the respective mixing chambers at a rate of 0.02 
mL/min, in order to achieve nominal concentrations in the fish tanks of 20 and 200 ng/L for 
both androgens. The solvent control (SC) tank received DMF at the same rate, such that the 
water in all tanks contained DMF at 0.0067% (OECD suggested limit: 0.0095%). From each 
mixing chamber, the water was distributed into the fish tank through silicone rubber tubing. In 
total there were 12 glass fish tanks with a working volume of 30 L. Each tank was aerated and 
received approximately 14 tank volume renewals per day. During the exposure period, 
dilution water and chemical stock solutions flow rates were checked daily. Stock solutions 
were replaced every 4 days to avoid any potential chemical degradation. The stability of the 
stock solutions of KT and DHT over different times and temperatures was established prior to 
the commencement of the study (data not shown). 
The 45 days androgen exposure experiment consisted of six treatments: dilution water control 
(DWC), SC, 20 ng KT/L, 200 ng KT/L, 20 ng DHT/L, and 200 ng DHT/L. Each treatment 
was tested in duplicate, each fish tank contained 14 randomly allocated juvenile fathead 
minnows (28 fish per treatment), where the sex of the juvenile fish was unknown. Fish were 
fed ad libitum twice a day with a combination of pellet and brine shrimp and were maintained 
in a photoperiod of 16 hours of light followed by 8 hours of dark with a 20 minutes 
dawn/dusk transition.  
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At 105 dph, fish were humanely sacrificed according to UK Home Office procedures, using 
an overdose of ethyl 3-aminobenzoate methanesulfonate (500 mg MS222/L, adjusted to pH 
7.5 using 1 M NaOH), followed by trans-spinal severance.  Blood samples were collected 
from the caudal peduncle using heparinised capillary tubes and transferred into eppendorf 
tubes containing the enzyme inhibitor Aprotinin (Sigma). Blood samples were kept on ice 
until plasma was separated by centrifugation at 14000 × g for 5 min, removed and stored at 
−20 °C until steroid analyses. Fish were weighed and measured (fork length), and the 
condition index (CI) was calculated (CI = body weight (g) / fork length (cm) × 100). The 
presence of secondary sexual characteristics (SSC) was recorded for every fish, including 
number and prominence of nuptial tubercles, black dorsal fin spot occurrence, fatpad presence 
and weight (Smith, 1978). Fish were then cut ventrally in order to allow penetration of the 
fixative into the body cavity, fixed in toto in Bouin‟s solution for 24h and subsequently 
transferred to 70% industrial methylated spirits (IMS) and stored for histopathological 
analyses. 
4.3.4 Analysis of water samples 
Water samples (200 mL) were collected from each tank on day 0, 4, 7 and subsequently every 
seven days until the end of the experiment. The target steroids were extracted from the water 
by solid-phase-extractions (SPE). Briefly, the Sep-Pak Plus C18 extraction cartridges (Waters 
Ltd., UK), pre-conditioned with 5 ml methanol and 10 ml deionized water (Milli-Q), were 
placed on a vacuum Manifold, and the water samples were drawn through methanol-washed 
Teflon-lined tubes, and through the cartridges at an approximate rate of 3-9 mL/min. Once all 
the water samples had passed through the SPE cartridges, they were dried with air for 30 
minutes, and then eluted with 5 ml HPLC-grade methanol (Fisher Scientific, UK) into clean 
glass vials. The methanol was successively evaporated under a stream of nitrogen at room 
temperature. Once dry, each sample was reconstituted with 1 ml of ethanol, sealed with 
parafilm, and stored at 4ºC until further analysis.  
KT concentrations were determined by a specific radioimunassay (RIA) (Scott et al., 1984), 
while DHT concentrations were measured using a DHT ELISA kit (Demeditec, Germany, Cat 
No. DE2330). For the latter analysis, the samples were prepared according to the methods 
used by Swart and Pool (2007), and the analysis was performed following the instructions 
provided by the manufacturer. The extraction efficiency for each androgen was tested in 4 
independent experiments performed using tank water samples spiked with known amounts of 
KT and DHT (20 and 200 ng/L), before processing and analyzing the experimental samples.  
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4.3.5 Measurement of sex steroids in the plasma by radioimmunoassay 
The concentrations of sex steroids in the plasma of fathead minnow were measured by 
radioimmunoassay (RIA). The principle of RIA, illustrated in Figure 4.3, is based upon the 
equal competition between a radiolabelled ligand (e.g. tritiated T) and an unlabelled ligand 
(the target steroid; e.g. T in the plasma sample) for binding to a limited amount of specific 
antibody over 24h. The amount of radiolabelled ligand and antibody used in the assay are kept 
constant, so that the amount of radiolabelled ligand bound to the antibody will be inversely 
proportional to the amount of unlabelled ligand in the mixture. At the end of the RIA, the free 
unbound label is separated from the antibody-ligand complex, by the use of activated 
charcoal, to which small molecules will be adsorbed. Unlabelled ligand will thus be adsorbed 
and this complex will be precipitated by centrifugation. The antibody (with bound labelled or 
unlabelled hormone attached) remains in the supernatant, which is decanted directly into beta 
scintillation vials and retained for counting. The radioactivity, or beta rays, emitted from the 
samples are measured using a scintillation counter.  
 
 
Figure 4.3. Depiction of the principle of radioimmunoassay. (A & B) Over time the antigens bind to 
the limited amount of antibody in proportion to the amounts of each that are present. (C) The unbound 
steroids are removed with activated charcoal, and (D) the sample is placed into a vial with 
scintillation fluid which fluoresces when β-particles are emitted by the radiolabelled steroid; the 
fluorescence is quantified by a β-counter (from Aoki, 2010). 
 
 
 
 
(A) (B) (C) (D) 
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Materials and components: 
- Steroid Assay Buffer (SAB):  
1 litre dH20 made to a concentration of 0.05 M phosphate buffered saline (PBS, 10 
tablets, Dubelco Ltd.), 1 g gelatine (Type A from porcine skin; Sigma-Aldrich Inc.), 1 
g sodium azide (Sigma-Aldrich Inc.).   
Using a heated stirrer, gelatine and PBS tablets were dissolved in the water. Once 
cooled sodium azide was added and mixed. The buffer was then stored at 4ºC. 
- Antibody:  
Dilutions for each steroid of interest were prepared in SAB as follows: 
T antibody was diluted 1:50,000 
     KT antibody was diluted 1:50,000 
E2 antibody was diluted 1: 40,000 
- Radiolabel:  
Tritiated steroids (T, KT, E2) were prepared purchased from Amersham International. 
Working aliquots were prepared in SAB at radioactivities of approximately 6000 dpm 
per 100 μl, and stored at -20ºC. 
 
- Standard:  
Solutions of T, KT, and E2 were prepared at concentrations of 10 ng/L and stored at   
–20ºC. 
- Activated Charcoal Solution:  
200 mL prepared at 0.5% activated charcoal (Sigma-Aldrich Ltd.) with 0.05% dextran 
(Sigma-Aldrich Ltd.) at least 15 minutes prior to use. 
- Liquiscint Scintillation Fluid (National Diagnostics Ltd.) 
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Radioimmunoassay method: Day 1 
Radiolabelled steroid, antibody and steroid standard were removed from the freezer and 
defrosted on ice. Tubes were prepared in duplicate in batches of no more than 50 tubes (25 
samples). An entire assay generally consisted of no more than 4 batches. Steroids were 
extracted from each plasma sample through the addition of ethyl acetate. According to the 
standard protocol 40-100 µL of plasma were placed into a polypropylene tube (LP3P, 
Luckham) followed by 0.4-1 mL of ethyl acetate. The tube was capped, shaken thoroughly, 
and centrifuged at 2,500 g for 5 minutes, in order to separate the ethyl acetate (containing the 
extracted steroids; upper phase) from the plasma (lower phase). The ethyl acetate (upper 
phase) was carefully separated from the lower phase, and duplicate of extractions (100 µL 
each) were placed into clean tubes. The aliquots of extracted samples that were not used on 
the same day were stored at -20ºC until further analysis. Modifications to this steroid 
extraction method were required when the volume of plasma available for the analysis was 
very low (e.g. plasma collected from juvenile fish). If applied, these modifications will be 
described in the correspondent methods section in each chapter.  
The ethyl acetate was then evaporated using a concentrator (miVac, Genevac Ltd.), and the 
extracted steroids were re-dissolved in 100 μL SAB.  
The standard curve samples were prepared by serially diluting the steroid standard 11 times to 
yield nominal concentrations of 10, 5, 2.5, 1.25, 0.625, 0.313, 0.156, 0.078, 0.04, 0.02, 0.01, 
and 0.005 ng/ml.  
Other than standard and unknown samples, in each assay additional tubes were set up in order 
to determine: 
Maximum Binding (MB), by incubating the labelled ligand and the antibody alone;  
Non Specific Binding (NSB), some small amount of label will also act as bound ligand, even 
when there is no antibody, due to binding of label to other assay components, trapping of 
label to the bound complex, impurities in the label, absorption of free tracer to the reaction 
tube, or incomplete aspiration of the unbound fraction from the tube. 
Specific volumes of SAB, antibody and label were also added to the test tubes according to 
their identity (e.g. sample, standard, Non Specific Binding, Maximum Binding, Total Counts), 
as shown in Table 4.1. Tubes were whirl mixed and briefly centrifuged to ensure that all the 
reagents were at the bottom, covered with a clean paper towel, and incubated overnight at 
4ºC. 
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Table 4.1. Volumes of various components added to the different tubes in the steroid RIA. 
 
Tube 
Volume (µL) 
SAB Antibody Label Standard Sample 
Total Counts 200  100   
Non-Specific 
Binding 
 
200  100   
Maximum 
Binding 
 
100 100 100   
Standards 100 (not in the 
first tube) 
100 100 100 (1
st
 and 
2
nd
 tubes only) 
 
Samples / 100 100  100 (in SAB) 
 
Radioimmunoassay method: Day 2 
After 24 hours incubation, the tubes were removed from the fridge and placed on ice; 500 μl 
SAB was added to the Total Counts Tubes. Then, 500 μl activated charcoal solution (0.5%) 
was added as quickly as possible to each tube of one batch. All tubes were vortexed, and 
incubated on ice for 10 minutes (counted from the addition of the charcoal solution to the first 
tube), prior to centrifuging at 2,500 g for 15 minutes at 4ºC. The supernatant was carefully 
removed, and decanted into a clean scintillation vial. Four millilitres of scintillation fluid were 
added to each vial, and the vials were shaken vigorously.  
Measurement and analysis 
Radioactivity in the samples was counted for 5 minutes using a Liquid Scintillation Counter 
(Packard Bioscience Co.). The amount of radiolabel which binds to the antibody in the 
standards and sample tubes is expressed as a percent of the normalized Maximum Binding for 
each batch. This was determined using the following calculation:  
 
                      (mean sample decays per minute – mean Non-Specific Binding)  
                            (mean Maximum Binding – mean Non-Specific Binding). 
 
The standard curve was plotted on log-normal scale, and the unknown values were read from 
the linear part of the curve, usually between 20% and 80% binding. 
 
× 100 % Binding = 
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Plasma testosterone measurement 
An optimised RIA protocol for T measurement (Scott et al., 1984) was required for the small 
volume of plasma available from fathead minnow juveniles (6-20 μl/fish) (Jensen et al, 2001). 
Frozen plasma samples were thawed on ice, and reconstituted to a working volume of 100 μl 
with 0.1 M phosphate buffered saline (PBS; 0.1 M NaPO4 , 0.15 M NaCl, pH 7.6). Sex 
steroids were extracted through the addition of ethyl acetate, and T concentrations were 
measured by specific RIA. Detection limit, EC50, and intra-assay variations (CV%) were 
respectively 0.04 ng/mL, 0.17 ng/mL, and 2.3% (n = 20).  
4.3.6 Histological processing and quantitative analysis of gametogenesis 
Samples were stored in Bouin‟s solution, which was replaced by 70% industrial methylated 
spirits (IMS) after 24 hours, and again after 48 hours. Whole bodies of each fish were cut 
transversally in three transverse sections ∼0.5 cm in order to separate the gonad into anterior, 
median and posterior regions. These sections were then processed according to standard 
histological methods, and slices were prepared for histopathology analyses according to the 
methods briefly detailed hereinafter. 
Tissues were processed according to the protocol in Table 4.2, using the automatic tissue 
processor (TP 1020, Leica Inc.), and subsequently embedded into wax blocks. Tissues were 
sectioned to 3 μm thickness using the RM 2235 microtome (Leica Inc.), and placed onto 
microscope slides coated with Histobond (RA Lamb, UK). They were dried for ~48 h before 
staining with Eosin and Haematoxylin according to the protocol in Table 4.3. Finally, the 
stained sections were mounted using Histomount (National Diagnostics, USA) and covered 
with coverslips. The slides were examined under an Olympus BX51 compound light 
microscope and photographs were taken using a digital camera and the Q-Capture Pro v. 
5.1.1.14 program (Media Cybernetics Inc.). All gonads were examined to identify the 
developmental stage, for the presence of cells in all stages of gametogenesis, and for any 
evidence of intersex (spermatogenic cells in the ovaries, or oogenic cells in the testes). The 
evaluation of the histopathological alterations was conducted according to the EPA guidelines 
(EPA, 2006), and the diagnostic criteria used for the analysis are described in the following 
Section.  
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Table 4.2. Summary of the tissue processing method of the Leica Tissue Processor, indicating the 
various solutions used and the time of each step. 
Order Solution Time (hours) 
1 70% IMS 3 
2 90% IMS 2.5 
3 95% IMS 1.5 
4 100% IMS 1.5 
5 100% IMS 1.5 
6 100% IMS 1.5 
7 100% IMS 1.5 
8 Histoclear (National Diagnostics, USA) 1.5 
9 Histoclear 1.5 
10 Histoclear 1.5 
11 Paraffin Wax (RA Lamb Inc.) 1.25 
12 Paraffin Wax 1.25 
Table 4.3. The staining protocol for histological slides of whole-body cross sections of fish. 
Solution Time Function 
Histoclear 15 minutes Dissolves wax 
100% IMS 2 minutes 
Rehydration 
90% IMS 2 minutes 
70% IMS 2 minutes 
Water 2 minutes 
Haematoxylin (VWR Inc.) 15 minutes Stains nuclear material 
Water 15 minutes Wash 
Acid Alcohol [HCl/70% IMS (1:99)] 5-30 seconds Resolves stain 
Water 20 seconds Wash 
Saturated Solution of Li2CO3 
(Sigma-Aldrich, UK) 
20 seconds 
Raises pH and removes any 
Bouin‟s residue 
Eosin (RA Lamb, UK) 5-20 seconds Counter-stains 
Water 5 minutes Wash 
70% IMS 2 minutes 
Tissue dehydration 90% IMS 2 minutes 
100%IMS 5 minutes 
Histoclear 5 minutes Helps mounting coverslip 
 
4.3.6.1 Diagnostic Criteria 
 
Males: 
- Altered proportion of spermatogenic stages; 
- Change in gonadal staging: 
Criteria for Staging Testes: 
• Juvenile: gonad consists of spermatogonia exclusively; 
• Stage 0 – Undeveloped: entirely immature phases (spermatogonia to spermatids) 
with no spermatozoa; 
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• Stage 1 – Early spermatogenic: immature phases predominate, but spermatozoa may 
also be observed; the germinal epithelium is thinner than it is during Stage 2; 
• Stage 2 – Mid-spermatogenic: spermatocytes, spermatids, and spermatozoa are 
present in roughly equal proportions; the germinal epithelium is thinner than 
Stage 1 but thicker than Stage 3; 
• Stage 3 – Late spermatogenic: all stages may be observed, however, mature sperm 
predominate; the germinal epithelium is thinner than it is during Stage 2; 
• Stage 4 – Spent: loose connective tissue with some remnant sperm. 
 
- Presence of intersex (both ovo-testis and testis-ova): The presence of one or more 
individualized or clustered oogenic cells within the testis, or of spermatogenic tissue into the 
ovary, showing multiple stages of spermatogenesis. 
- Increased testicular degeneration: Testicular degeneration is characterized by individual or 
clustered apoptotic germ cells, vacuolated germ cells, and/or multinucleated (syncytial) cells 
in the germinal epithelium or testicular lumen. Apoptotic germ cells are characterized by cell 
shrinkage, nuclear condensation, and fragmentation into spherical, membrane-bound bodies, 
which are often phagocytized by neighboring cells. There is no inflammation associated with 
these cells.  
- Interstitial cell (Leydig cell) hyperplasia/hypertrophy: An increase in number and/or size of 
the interstitial cells responsible for producing androgens. Interstitial cells may have larger, 
more rounded nuclei, and interstitial cell aggregates may occupy and expand some interstitial 
spaces. 
 
Females: 
- Increased oocyte atresia: An increase in degradation and resorption of oocytes at any point 
in development. Atresia is characterized by clumping and perforation of the chorion, 
fragmentation of the nucleus, disorganization of the ooplasm, and/or the uptake of yolk 
materials by perifollicular cells.  
- Perifollicular cell hyperplasia/hypertrophy: Increase in the size or number of granulosa, 
theca, and/or surface epithelium cells involved in a developing follicle. Abnormal 
perifollicular cell hypertrophy must be distinguished from the normally enlarged granulosa 
and theca cells of a post-ovulatory follicle.  
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- Decreased yolk formation: A decrease in the amount of vitellogenic/yolk material that is 
deposited in the developing oocyte. Decreased vitellogenesis is characterized by the presence 
of oocytes in which yolk material is not present despite their relatively large size.  
- Change in gonadal staging:  
Criteria for Staging Ovaries: 
• Juvenile: gonad consists of oogonia exclusively; 
• Stage 0 – Undeveloped: entirely immature phases (oogonia to perinucleolar 
oocytes); no cortical alveoli; 
• Stage 1 – Early development: vast majority (e.g., >90%) are pre-vitellogenic  
follicles, predominantly perinucleolar through cortical alveolar; 
• Stage 2 – Mid-development: at least half of observed follicles are early and mid-
vitellogenic; 
• Stage 3 – Late development: majority of developing follicles are late vitellogenic; 
• Stage 4 – Late development/hydrated: majority of follicles are late vitellogenic 
and mature/spawning follicles; follicles are larger as compared to Stage 3; 
• Stage 5 – Post-ovulatory: predominately spent follicles, remnants of theca externa 
and granulose; 
 
- Interstitial fibrosis: The presence of increased fibrous connective tissue (collagenous fibers 
and fibrocytes or fibroblasts) within the ovarian interstitium (stroma). 
  
Each section of testis or ovary was analyzed in toto; sex was assigned according to the 
presence of male or female germ cells, the occurrence of sex specific gonad morphology (i.e. 
ovarian cavity), and number of mesenteric attachments of the gonad to the peritoneal wall, 
since a double attachment is characteristic of the female reproductive tract, while a single 
attachment is the typical condition in males (van Aerle et al., 2004). When spermatogenic 
tissue was present in an ovary, the gonad was classified as intersex (Jobling et al., 1998). The 
dominant germ cell and the most advanced stage of gametogenesis were also recorded. In 
order to evaluate the effect of KT and DHT on oocyte growth, the cross sectional area of each 
oocyte was calculated using the software ImageTool (v 2.00), and the final measurements 
were pooled by oocyte class and maturation stage. The following classes were considered: 
perinucleolar oocyte (PNO), corticoalveolar oocyte (CAO), early vitellogenic oocyte (EVO), 
and mid-late vitellogenic oocyte (MLVO).      
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4.3.7 Statistical analysis 
The data for wet weight, standard length, condition factor, SSC and plasma T concentrations 
(log transformed) were analysed by analysis of variance (ANOVA). Where assumptions of 
normality and homogeneity were met, ANOVA was followed by the Dunnett's test to 
compare the treatment means with the respective controls. Where the assumptions were not 
met, data were analysed using a non-parametric test (Kruskal–Wallis), followed by Dunn‟s 
post-hoc test (Zar, 1999). Effects of the treatments on gonadal maturation stage and dominant 
germ cell type were analysed using a variation of the chi-squared test, the randomization test 
of goodness of fit with Montecarlo simulation (n = 10,000) (McDonald, 2009).  The results 
are reported as means ± standard deviations, or percentages (gonadal sex ratio). Ovaries 
presenting an intersex condition were grouped with female fish for the purpose of the 
statistical analyses, except for the analysis of ovary maturation stage and oocyte cross-section 
area. Oocyte cross section area was statistically compared and analyzed between similar ovary 
maturation stages, in order to avoid the effect of gonad maturation on oocytes dimensions.    
4.4 Results                                                                         
4.4.1 Measured water concentrations of KT and DHT   
Water analysis showed that fish were exposed to the test substances in the expected range of 
concentrations and that there was no contamination of control tanks with steroids. KT and 
DHT concentrations ranged, respectively, from 74.8% to 148.5% and from 68.45% to 153.5% 
of the nominal concentrations, except on day 28, when a minor problem with the peristaltic 
pump occurred, accounting for the unexpected high concentrations in all the treatment tanks 
(Table 4.4); however, the problem was quickly fixed, and fish were exposed to the elevated 
concentrations for no more than 9-12 hours. The extraction efficiency was above 90% for 
both steroids, thus no correction was applied (KT: 91.1 ± 12.0%; DHT: 93.4 ± 17.9%).   
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Table 4.4. Measured water concentrations (ng/L) of KT and DHT during the exposure period. 
Steroids concentrations were measured by RIA and ELISA, respectively. 
ND = Not Detected. 
4.4.2 Somatic growth (standard length, wet weight, condition factor)  
Male fish exposed to 20 and 200 ng/L of both KT and DHT had significantly higher wet 
weights and fork lengths when compared to the fish in DWC and SC groups (p < 0.01), while 
female fish showed a significant increase of the same endpoints only when exposed to 200 
ng/L of both androgens (p < 0.01)  (Fig. 4.4). Thus, both fork length and wet weight data 
showed a dose-related response in both sexes, with males responding at lower concentrations 
than females. This trend was not seen in the condition factor data for both sexes, where there 
were no statistically significant differences between treatment groups. 
 
Exposure 
Day 
Replicate 
Nominal concentrations of 11-ketotestosterone (KT) and dihydrotestosterone (DHT) (ng/L) 
Controls KT DHT 
*DWC *SC 20 200 20 200 
0 
A           
B 
ND 
ND 
 
ND 
ND 
 
28.1 
25.6 
 
192.5 
191.5 
 
25.0 
26.0 
 
210.0 
220.0 
 
3 
A 
B 
ND 
ND 
ND 
ND 
 
29.7 
21.9 
 
230.0 
258.1 
 
24.1 
27.3 
 
207.6 
220.4 
 
7 
A 
B 
ND 
ND 
 
ND 
ND 
26.6 
29.7 
 
203.3 
225.1 
 
26.8 
29.0 
 
136.9 
196.9 
 
14 
A 
B 
ND 
ND 
 
ND 
ND 
 
24.8 
23.8 
 
211.7 
266.0 
14.5 
22.0 
 
210.0 
241.0 
 
21 
A 
B 
ND 
ND 
 
ND 
ND 
 
20.1 
21.8 
 
191.9 
221.6 
 
19.0 
25.0 
 
151.0 
155.0 
 
28 
A 
B 
ND 
ND 
 
ND 
ND 
 
40.1 
57.0 
 
328.0 
348.4 
 
46.0 
52.0 
 
456.0 
429.0 
 
35 
A 
B 
ND 
ND 
 
ND 
ND 
 
22.8 
28.7 
 
202.0 
217.9 
 
28.3 
29.0 
 
191.0 
199.0 
 
42 
A 
B 
ND 
ND 
 
ND 
ND 
 
21.1    
22.2 
148.2  
165.2 
22.6 
31.0 
267.0  
307.0 
Mean Values (ng/L) ND ND 27.7 ± 9.2 225.1 ± 53.3 28.3 ± 9.9 240.7 ± 96.7 
Mean Values 
(excluding Day 28) 
(ng/L) 
ND ND 24.8 ± 3.3 210.2 ± 32.8 24.9 ± 4.7 207.1 ± 48.7 
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Figure 4.4. Box plots of (A,C,E)length, weight and condition index of fathead minnow males  and 
(B,D,F) females  exposed to KT and DHT between 60 and 105 dph. Boxes represent median (full line), 
and mean (dashed line) with 25th and 75th percentiles. The bars extend to the 10th and 90th 
percentiles, with outliers represented as dots. * p < 0.05 compared to the Solvent Control group. 
Sample size is indicated above each treatment label on the x-axis. 
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4.4.3 Secondary sexual characteristics 
Both KT and DHT caused the appearance of male SSCs in both males and females (Table 
4.5); fish in the DWC and SC groups had no male SSCs, with the exception of one male in the 
DWC group, which had a dorsal fin spot. The latter endpoint was particularly affected by 
DHT, indicated by the fact that 92% of males and 75% of females exposed to 200 ng/L 
developed this characteristic. Nuptial tubercles were present on some of the fish exposed to 
the androgens and fatpad presence was recorded only in one male exposed to KT (200 ng/L) 
and one male exposed to DHT (20 ng/L). 
Table 4.5. Expression of secondary sexual characteristics in fish exposed to KT and DHT between 60 
and 105 dph. For each treatment the number of fish with nuptial tubercles (NT) and dorsal fin spot 
(FS) is indicated. 
Endpoint Sex Treatment 
  DWC SC 
KT 
20 ng/L 
KT 
200 ng/L 
DHT 
20 ng/L 
DHT 
200 ng/L 
Fish with NT M 0  0          0           3          1          2 
 F 0  0          1           0          0          2 
Fish with FS M 1  0          4           4          2         11 
 F 0  0          1           0          1         11 
Sample Size M 16  18         12          14         13         12 
 F 11  8         12          13         15         15 
        
 
4.4.4 Plasma testosterone concentrations 
Effects on plasma T were different in males and females (Fig. 4.5). Males exposed to KT 
showed an increase in plasma T at both exposure concentrations, although the increase was 
statistically significant only at 20 ng/L (p < 0.01), whereas males exposed to DHT had 
significantly higher plasma T concentrations at both 20 and 200 ng/L (p < 0.01). In contrast, 
females showed a general decrease of circulating plasma T when exposed to the androgens. 
The decrease was statistically significant (p < 0.01) in females exposed to the highest dose of 
KT and to both doses of DHT. Furthermore, females in the DWC group had significantly 
lower plasma T level than the SC (p < 0.05). 
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Figure 4.5. Plasma testosterone concentrations of (A )male and (B) female fathead minnows exposed 
to KT and DHT between 60 and 105 dph. Boxes represent median (full line), and mean (dashed line) 
with 25th and 75th percentiles. The bars extend to the 10th and 90th percentiles, with outliers 
represented as dots. * p < 0.05 compared to the Solvent Control group. Sample size is indicated above 
each treatment label on the x-axis. 
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4.4.5 Histopathology 
4.4.5.1 Males 
At the end of the study, the majority of males in the DWC and SC groups were in the early 
stages of sexual maturation (Fig. 4.6). All the fish presenting only gonia-stage cells were 
classified as juvenile males, based on the pattern of distribution of somatic and germ cells, the 
absence of an ovarian cavity, the presence of the efferent duct (sperm duct) and the single 
attachment of each gonad to the peritoneal wall (Fig. 4.7). Additionally, at 106 dph, fathead 
minnow ovaries normally contain perinucleolar oocytes (PNOs) or Corticoalveolar oocytes 
(CAOs), and have two attachments to the peritoneal wall (van Aerle et al., 2004).  
Immature testis (Juvenile and Stage 0) were present in 93.75% and 77.8% of the fish in the 
DWC and SC groups, respectively. Both KT and DHT stimulated maturation of the testis and 
progression toward advanced stages of spermatogenesis. This effect was only significant at 
200 ng/L for both androgens (p < 0.01). KT caused an increase of the percentage of fish 
where spermatozoa were the most advanced stage of spermatogenesis, from 22.2% in the SC 
group to 36.36% and 35.71% in the 20 and 200 ng/L groups, respectively. At the same time, 
spermatocytes represented the most advanced stage of spermatogenesis in 16.67% of fish in 
the SC group, and in 36.36% and 50% of fish in the 20 and 200 ng/L groups, respectively, 
with a correspondent decrease in the proportion of fish with only spermatogonia in their testis 
(Fig. 4.6). 
Males exposed to DHT followed the same pattern; however, at the highest dose (200 ng/L), 
there was a stronger effect on the spermatogenic process, where 80% of fish exposed to this 
concentration had spermatozoa in their testis (Fig. 4.6 & 4.7). 
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Figure 4.6. Effect of KT and DHT exposure on (A) testis maturation stage, (B) dominant germ cell, 
and (C) most advanced stage of spermatogenesis. Juvenile (Juv): gonad consists of exclusively 
spermatogonia; Stage 0: Undeveloped, entirely immature phases (spermatogonia to spermatids) with 
no spermatozoa; Stage 1: Early spermatogenic: immature phases predominate, but spermatozoa may 
also be observed; Stage 2: Mid-spermatogenic: spermatocytes, spermatids, and spermatozoa are 
present in roughly equal proportions; Stage 3: Late spermatogenic, mature sperm predominate (US 
EPA, 2006). * p < 0.05 compared to the Solvent Control group. Sample size is indicated on the top of 
each treatment stacked bar. 
 128 
 
 
Figure 4.7. Transverse sections of testes from male fathead minnows from the (A, D) Solvent Control, (B,E) KT (200 ng/L), and (C, F) DHT (200 ng/L) 
groups. The gonads in figures A (indicated by the arrow) and D had only spermatogonia distributed in cystic structures, somatic cells scattered among germ 
cells, and only one attachment to the peritoneal wall; all these characteristics are typical of developing testis (Van Aerel et al., 2004). Gonads presenting this 
pattern of development were classified as male juveniles, and this maturation stage was present in 68.8% and 50.0% of all male gonads, respectively, in the 
DWC and SC groups. The testes of fish exposed to 200 ng/L of KT and DHT (B,C,E,F) typically contained spermatogenic cell types at more advanced 
developmental stage (spermatocytes through to spermatozoa). In particular, 81.8% of fish exposed to 200 ng DHT/L had spermatozoa in their testis.
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4.4.5.2 Females 
KT at 20 ng/L did not induce any significant effect on the stage of maturation of the ovary or 
on the most advanced stage of oogenesis. On the other hand, fish exposed to 200 ng/L of KT 
showed a significant regression (p < 0.01) of the stage of maturation of the ovary, with an 
evident increase of females at stage 1 (early development), from 12.5% in the SC group, to 
53.90% in the group exposed to KT. The same treatment caused a significant decrease in the 
proportion of fish with vitellogenic oocytes as the most advanced stage of oogenesis (Fig. 
4.8). 
DHT had a severe effect on the ovarian tissue at both concentrations. The most evident effect 
was the occurrence of testicular tissue in the ovaries (Fig. 4.9). Most (86.7%) of females 
exposed to DHT at 200 ng/L developed the intersex condition (Fig. 4.8), and one female with 
a masculinised ovary was also found at 20 ng/L. The extent of the testicular tissue varied from 
10% to 95% of the ovary in longitudinal cross section, and in some samples, a concomitant 
proliferation of macrophages and interstitial tissue was found. In fish with a lower severity 
intersex condition, the disruption was typically found around the area where the gonads attach 
to the body wall. 
It is important to note that histological sections taken from left or right side ovary, or at 
different places along the ovary longitudinal axis, sometimes showed totally different 
conditions, ranging from totally normal to high severity intersex. This variability along the 
longitudinal axis of the ovary is probably due to the fact that the intersex condition develops 
as a local disruption. This underlines the importance of screening the ovary at different places 
along the longitudinal axis when looking for this kind of disruption in juvenile fish. 
The occurrence of testicular tissue in the ovaries influenced all the histopathological 
endpoints analyzed, with a general regression toward the early stages of oogenesis, 
characterized by previtellogenic oocytes rather than vitellogenic ones. In particular, the 
incidence of previtellogenic oocytes (PNO+CAO) increased from 60.0% and 57.2% in the 
DWC and SC groups, to 80% and 86.7% after DHT treatment at 20 and 200 ng/L, 
respectively.  
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Figure 4.8. Effect of KT and DHT exposure on (A) maturation stage of the ovary, (B) dominant germ 
cell, and (C) most advanced stage of oogenesis. Stage 0: Undeveloped, entirely immature phases 
(oogonia to Perinucleolar oocytes), and no cortical alveoli; Stage 1: Early development, vast majority 
(e.g., >90%) were pre-vitellogenic follicles, predominantly perinucleolar through cortical alveolar; 
Stage 2: Mid-development, at least half of observed follicles were early and mid-vitellogenic; Stage 3: 
Late development, majority of developing follicles were late vitellogenic; Intersex: ovary showing 
presence of spermatogenic tissue (US EPA, 2006).  
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Figure 4.9. Transverse sections of fathead minnow ovaries (A, D) from the Solvent Control group and (C, D, E, F) from the DHT group (200 ng/L), showing 
the presence of masculinised tissue within the gonad, characterized by the presence of multiple stages of spermatogenesis, from spermatogonia to 
spermatozoa. On the other hand, KT did not induce any appearance of spermatogenic tissue in any of the ovaries of exposed female (figure not shown). 
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4.4.6 Quantitative assessment of the size of oocytes  
Analysis of the cross-sectional area of oocytes indicated a complex pattern of response (Table 
4.6). KT at 20 ng/L produced a significant increase in the dimensions of all the classes of 
oocytes (p < 0.01). While the same steroid at 200 ng/L induced a significant size increase in 
PNOs and mid-late vitellogenic oocytes (M-LVOs), a decrease in early vitellogenic oocytes 
(EVOs), and a contrasting pattern of response in CAOs, with a size increase in 2 out of 3 
maturation stages, and a decrease in 1 out of 3 (p < 0.01). 
Exposure to DHT at the low dose (20 ng/L) did not have any effect on the cross-sectional area 
of PNOs and EVOs, but induced a significant increase in M-LVOs size, and a complex 
response in CAOs, with different responses in different maturations stages (p < 0.01). 
Intersex samples were analyzed separately, and did not show any significant variation in the 
sizes of PNOs and CAOs (the only two classes present). The exposure to the highest dose of 
DHT (200 ng/L) caused a significant decrease in size in EVOs, and a increase in M-LVOs (p 
< 0.01), while in the fish with intersex gonads, DHT induced a significant size decrease in 
PNOs and an increase in CAOs (p < 0.01).     
Table 4.6. Effect of KT and DHT exposure on the cross-sectional area of oocytes according to class 
and ovary maturation stage. The arrows ↑ and ↓ represent, respectively, a statistically significant (p < 
0.01) increase or decrease when compared to the Solvent Control group. The cross-sectional area of 
oocytes was statistically compared and analyzed among ovaries at the same stage of maturation, in 
order to avoid the confounding effect of gonad maturation stage on oocyte dimensions. 
PNO: Perinucleolar Oocytes; CAO: Cortico Alveolar Oocytes; EVO: Early Vitellogenic Oocytes; M-
LVO: Mid-Late Vitellogenic Oocytes.IS: Intersex; “↔ “: no significant difference; “-“: Not 
Available. 
 
Treatment Germ Cell Type  
 PNO CAO EVO M-LVO 
 Maturation stage 
 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 
KT 20 ng/L ↔ ↑ ↑ ↑ - ↔ ↔ ↑ - ↑ ↔ ↔ - - ↔ ↑ 
KT 200 ng/L ↔ ↔ ↑ ↔ - ↓ ↑ ↑ - - ↔ ↓ - - ↑ ↔ 
DHT 20 ng/L ↔ ↔ ↔ ↔ - ↔ ↓ ↑ - - ↔ ↔ - - ↔ ↑ 
DHT 200 ng/L ↔ - - ↔ - - - ↔ - ↔ - ↓ - - - ↑ 
DHT 200 ng/L - IS ↓ ↔ - ↓ - ↑ - ↑ - - - ↔ - - - - 
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4.5 Discussion 
In the present study, we investigated and compared the androgenic effects of KT and DHT on 
juvenile fathead minnows. The first steroid is considered the most important androgen in 
teleost fish, while the second one is the most active in higher vertebrates, but is not generally 
considered present or active in fish.  
As hypothesized by a comparison of the properties of several teleost fish ARs, DHT caused 
effects on fathead minnow juveniles, showing an in vivo androgenic potency comparable to 
KT in males and higher than KT in females.  Exposure to 20 and 200 ng/L of both androgens 
during the juvenile phase (60-105 dph) accelerated fish growth, induced the appearance of 
male SSCs in both males and females, and stimulated spermatogenesis and testis maturation 
in males. However, only DHT exposure caused the appearance of spermatogenic tissue in 
ovaries of females.  
Experiments conducted on African catfish and Japanese eel showed that DHT did not have 
any effect on spermatogenic processes and KT was the only androgen capable of inducing full 
spermatogenesis (Borg, 1994; Cavaco et al., 1998, 2001; Miura et al., 1991). However, our 
results show a different response in fathead minnow, suggesting a species-specific response, 
presumably related to the AR characteristics, in particular AR/steroid binding affinities and 
the abilities of steroids to induce AR transcription.   
The AR is a nuclear receptor characterized by the ability to bind androgens and to mediate 
androgen-induced male specific behaviour, sexual development, and maturation (Lindzey et 
al., 1994; Zhou et al., 1994).  DHT showed higher AR binding affinity than KT in several 
teleost species, such as fathead minnow (Wilson et al., 2007), zebrafish (Jorgensen et al., 
2007), rainbow  trout (Takeo and Yamashita, 2000), kelp bass (Paralabrax clathratus) (Staub 
and DeBeer, 1997), Atlantic croacker (Micropogonias undulatus) (Sperry and Thomas, 1999, 
2000), stickleback (Olsson et al., 2005) and Japanese eel (Ikeuchi et al., 2001). A more 
complex situation arises from an analysis of the abilities of steroids to induce transcriptional 
activity of the AR. DHT was a stronger inducer than KT in Japanese eel (AR subtype 1) 
(Ikeuchi et al., 1999), and in the rainbow trout (Takeo and Yamashita, 2000), while KT was 
the most potent inducer in stickleback (Olsson et al., 2005), mosquitofish (Gambusia affinis) 
(Katsu et al., 2007), and Japanese eel (AR subtype 2) (Ikeuchi et al., 1999; Todo et al., 1999).  
This variability in the properties of the AR, together with the potential presence of multiple 
AR isoforms with different characteristics in some species, as shown in Atlantic croacker, 
kelp bass and Japanese eel (Ikeuchi et al., 2001; Sperry and Thomas 1999a, 1999b), may 
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suggest that different androgens could mediate the androgenic response in different tissues, 
according to the species and to the differential expression and abundance of AR isoforms in 
each tissue (Sperry and Thomas, 2000).  
Table 4.7. Comparison of log effective concentrations of various steroids at 50% displacement 
(EC50) and relative binding affinity (RBA) for the androgen receptor in human (hAR), rainbow trout 
(rtAR) and fathead minnow (fhAR). KT and DHT values are highlighted in red (from Wilson et al., 
2007). Note the differences in the DHT/KT RBA ratios in the three species, in particular between 
rainbow trout (0.48) and fathead minnow (1.70). 
 
 
In the present study, both KT and DHT accelerated somatic growth processes, increasing both 
length and weight, and exerted an anabolic effect, as already observed in several studies 
involving the exposure of fish to androgens. For example, addition of KT (10 mg/Kg) to the 
diet stimulated the growth of juvenile tilapia (Oreochromis mossambicus) (Davis et al., 
2010); T and KT exposure caused an increase of muscle size in the plainfin midshipman fish 
(Porichthys notatus) (Brantley et al., 1993a), and an increase of length and weight was 
recorded in juvenile goldfish and juvenile guppy (Poecilia reticulata) exposed to the synthetic 
androgen trenbolone acetate (TBA) (Herrera et al., 2008; Zamora et al., 2008). The presence 
of AR in muscles and bones suggest a direct effect of androgens on these tissues (Hofbauer 
and Khosla, 1999; Hossain et al., 2008; Wiren et al., 1997), causing, for example, muscle 
hypertrophy and formation of new muscle fibers (Griggs et al., 1989; Kadi, 2000), and 
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inducing proliferation, differentiation, and mineralization of osteoblastic lineage cells, as 
shown in vitro (Kearns and Khosla, 2004).  
The different somatic growth response of males and females to different androgen doses could 
be due to differential and sex-specific expression of AR in tissues such as muscles, skeleton, 
and brain. Such differences could account for why 20 ng/L of both androgens significantly 
stimulated growth of males, but not females, in this study. Although no data are available for 
fathead minnow, a sex-specific abundance of the AR has been demonstrated in zebrafish 
tissues, including muscles (de Waal et al., 2008; Hossain et al., 2008), with higher 
concentrations in males. 
SSCs in male fathead minnows are affected by circulating levels of androgens, and females 
exposed to androgenic compounds can develop male SSCs (Ankley et al., 2003; Panter et al., 
2004). In our study, SSCs were induced by both KT and DHT, including the appearance of 
nuptial tubercles in some treated male and female fish. The same effect was observed on adult 
pre-spawning fathead minnow (135-150 dph) exposed to 6-8.6 μg/L of DHT for 14 days 
(Panter et al., 2004), whereas in female sticklebacks DHT (>2µg/L) has been shown to induce 
the synthesis of spiggin, a male-specific glue protein produced by the kidney and used as 
cementing substance for the building of the nest (Katsiadaki et al., 2002). Interestingly, the 
two androgens showed different potencies at inducing the dorsal fin colouration, such that 
92% of males and 75% of females exposed to DHT (200 ng/L) had a black spot on the dorsal 
fin, a typical male characteristic (Parrot et al., 2004; Paulos et al., 2010), whereas only 27% 
of males and no females exposed to the same concentration of KT had fin spots. The 
variability in the potency of the two androgens on this specific endpoint could indicate that 
the process of colouration of the dorsal fin in fathead minnow may not be controlled by KT. 
In other fish species, plasma levels of T and KT reflect colour pattern, colour intensity and 
dominance status (Dijkstra et al., 2007; Korzan et al., 2008; Pottinger and Pickering, 1985). 
Adachi et al. (2010) showed that in juvenile red seabream (Pagros major), eumelanin 
accumulation was induced by oral treatment with the synthetic androgen methyl-testosterone 
(MT), while females bitterlings (Rhodeus ocellatus) treated with KT or MT showed male-type 
nuptial coloration in skin and fins (Kobayashi et al., 2009). Androgen regulation of skin 
pigmentation is also common in higher vertebrates (Slominski et al., 2004); for example, 
human genital melanocytes are androgen target cells, expressing the AR in their nuclei, and 
they also had high levels of 5αR activities, the enzyme that converts T into DHT (Tadokoro et 
al., 1997). Furthermore, prepubertal male Syrian hamsters treated with DHT exhibited 
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increased pigmentation on their dorsal costovertebral spots and scrotal skin (Diaz et al., 
1986).  
One of the most important outcomes of the present study was that DHT stimulated 
spermatogenesis in immature testes of fathead minnow in a comparable way to KT, which is 
different from what has been shown in other teleost species. In fact, DHT failed to stimulate 
spermatogenesis in juvenile African catfish in vivo (Cavaco et al., 1998), and showed no 
effect on spermatogonia mitotic activity of Japanese eel testis in vitro (Miura et al., 1991). 
The latter result does not have a clear explanation, since Japanese eel ARs have higher 
affinity to DHT than KT, and their transcriptional activity is strongly induced by DHT 
(Ikeuchi et al., 2001). So far, the effect of DHT on fish spermatogenesis has been investigated 
only in a limited number of teleost species, but it is evident that currently there is a 
discrepancy between the molecular data (AR binding and activation by DHT) and 
physiological data (stimulation of spermatogenesis). In our study, both KT and DHT had a 
positive effect on the spermatogenic processes, in particular inducing a dose-dependent 
advancement from the juvenile stage (gonad with only spermatogonia) to Stage 0 
(spermatogonia to spermatids) and Stage 1 (early spermatogenic, containing spermatozoa). It 
is important to note that only DHT (200 ng/L) induced the appearance of spermatozoa in more 
than 80% of male fish, versus 35.7% of fish exposed to the same concentration of KT. These 
results suggest that the influence of DHT on fathead minnow spermatogenesis is at least 
comparable, or even stronger, to the one induced by the putative physiological androgen KT.            
A surprising effect was the development of spermatogenic tissue in more than 80% of the 
ovaries of juvenile females exposed to DHT (200 ng/L) and even in one individual exposed to 
20 ng/L. On the contrary, KT did not induce any similar disruption. This severe effect could 
be linked to the different potencies of the two androgens at inducing androgenic molecular 
and physiological responses. Ovarian masculinisation has been recorded in several studies 
involving exposure to androgens. TBA induced the appearance of spermatogenic tissue in 
ovaries of female juvenile mosquitofish (Sone et al., 2005), and irreversible masculinisation 
of female zebrafish exposed between 0 and 60 dph (Morthost et al., 2010). Furthermore, an 
irreversible masculinisation was observed in zebrafish exposed to the aromatase inhibitor 
fadrozole during gonad differentiation, probably due to an accumulation of androgens during 
a critical process, such as gonad differentiation (Fenske and Segner, 2004). 
The mechanisms of action by which androgens masculinise ovaries are not clearly 
understood. Some evidence suggests that androgen-induced masculinisation acts through the 
suppression of steroidogenic enzyme expression, including P450-aromatase, and that the 
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action is probably mediated by the AR. In fact, several studies have observed an androgen-
induced suppression of P450-aromatase gene/protein expression (Bhandari et al., 2006; 
Devlin and Nagahama, 2002; Govoroun et al., 2001; Vizziano et al., 2008). Furthermore, the 
5‟-flanking region of the ovarian form of P450-aromatase contains an androgen responsive 
element (ARE) (Tong and Chung, 2003). The consequent inhibition of estrogen production 
probably leads to the down-regulation of key genes involved in differentiation of the ovary 
(foxl2a, fst, fshb), and at the same time the over-expression of some testicular genes, such as 
nr0b1 and dmrt1 (Vizziano et al., 2008), which show distinct expression patterns during 
testicular differentiation in the rainbow trout (Marchand et al., 2000), tilapia (Guan et al., 
2000), medaka (Kobayashi et al., 2004), and black porgy (Wu et al., 2005).  
The variability along the longitudinal axis of the ovaries, or between left and right ovary, is 
probably due to the fact that the intersex condition develops as a local in situ disruption, with 
exogenous steroids acting locally and directly on germ cell development (Devlin and 
Nagahama, 2002), and underlines the importance of screening the ovary at different points 
along the longitudinal axis when looking for this kind of disruption in juvenile fish.  
The failure of KT to induce severe disruption in the ovary, such as the intersex condition, 
suggests that KT and DHT could have different interaction characteristics with the ovary AR. 
The presence of AR in the female reproductive tissues of many vertebrates, including fish, 
suggests that androgens could play an important role in the regulation of female physiology 
(Nitta et al., 1991; Staub and DeBeer, 1997; Tetsuka and Hiller, 1996). The androgen KT has 
also been found in several female fish (Lokman et al., 2002); however, its physiological role, 
if any, in females is still unclear. There is some evidence showing that KT plays a role in 
controlling growth of pre-vitellogenic oocytes in immature female fish (Kortner et al., 2008; 
Matsubara et al., 2003), and these data are confirmed in our study. At 20 ng/L, KT caused an 
increase in the size of all classes of oocytes, but showed mixed responses at 200 ng/L in 
different oocyte classes, with both size increases and decreases. This effect could be explained 
assuming that, at low dose, KT plays a stimulating role, while at high dose the androgenic 
action appears to be more relevant, causing the regression of ovaries toward previtellogenic 
stages. DHT, on the other hand, showed only limited effects on oocyte growth, such as an 
increase in the dimensions of M-LVOs; however, caution is needed when interpreting this 
result, because there were only a few ovaries not containing spermatogenic tissue that were 
available for analysis.  
The feedback caused by KT and DHT on plasma circulating T was positive in males, and 
negative in females. The increase of plasma T levels in males exposed to both androgens 
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could be a consequence of a positive feedback on the HPG axis, or of an increase of T 
producing cells (Leydig cells) in the stimulated testis. In females, a similar reduction of 
plasma T was recorded by Ankley et al. (2003) after exposure of reproductively active fathead 
minnow to the androgen TBA for 21 days, and by Sharpe et al. (2004), who exposed 
mummichog to MT. This result is probably a direct consequence of negative feedback on the 
HPG axis, but is not clearly linked with the masculinisation of the ovaries.  
In conclusion, the results described in this Chapter show for the first time, to our knowledge, 
that DHT has an in vivo androgenic potency comparable to that of KT in juvenile male 
fathead minnows, acting on somatic growth, SSCs expression, and spermatogenesis; whereas 
in females, DHT caused completely different effects than KT, inducing severe disruption of 
ovarian physiology and morphology, including the development of spermatogenic tissue. 
These results strengthen the hypothesis that the concentrations of DHT quantified in the 
plasma of both male and female fathead minnows during the experiments described in 
Chapter 3 are physiologically relevant. 
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CHAPTER 5 : EFFECTS OF DUTASTERIDE ON THE 
EARLY LIFE STAGES OF THE FATHEAD MINNOW 
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5.1 Introduction 
Fish embryo development and early life stages represent a critical window of sensitivity for 
the action of endocrine disruptors (van Aerle et al., 2002). The fathead minnow is commonly 
employed in partial life-cycle tests to determine lethal and sub-lethal effects both of single 
chemicals and complex mixtures (Ankley and Villeneuve, 2006). In particular, in recent 
years, increasing attention has been paid to the early life-stages toxicity tests, as a growing 
number of studies suggest that data obtained exposing fish to toxicants during early 
development can be predictive of chemical effects in adults (McKim, 1977).  
Several regulatory agencies have developed standardized toxicity tests in order to assess the 
potential toxicity of chemicals on fish early life stages (ASTM, 2000; OECD, 1992; USEPA 
1989; USEPA, 2002). A summary of fathead minnow life-stages, protection status, and 
duration of standard OECD toxicity tests is represented in Figure 5.1 (Embry et al., 2010). In 
particular, OECD Test 210 has been used as the reference test for the experiments described 
later in this chapter. During the test, fish early-life stages are exposed to a range of 
concentrations of a test substance dissolved in water, preferably under flow-through 
conditions. At the beginning of the test, fertilised eggs are placed in the test vessels and 
exposed at least until all the control fish are capable of  external feeding (often until 30 dph). 
Lethal and sub-lethal effects are assessed, and the lowest observed effect concentration 
(LOEC) and the no observed effect concentration (NOEC) are determined (OECD, 1992).  
Exposure of fish to endocrine disruptors during the embryo development phase and early life 
stages could affect critical processes such as gonadal sex determination (the genetic or 
environmental process by which the sex of an individual is established) and the associated sex 
differentiation (the process of gonad development after sex has been determined). The 
genetic, molecular, biochemical and environmental factors regulating these important 
processes are extensively described by several reviews (Baroiller et al., 2009; Devlin and 
Nagahama, 2002; Nakamura, 2010; Penman and Piferrer, 2008; Piferrer and Guiguen, 2008; 
Sandra and Norma, 2010), thus in the following sections, only an overview of the main 
developmental processes occurring during fish early life stages will be provided.  
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Figure 5.1. Fish life-stages, protection status, and duration of standard toxicity tests. Solid arrows 
indicate the duration of the referenced tests; the dashed arrow indicates the additional duration of the 
“extended” fish embryo test (FET), which includes the eleutheroembryo stage. FEET stands for fish 
eleutheroembryo toxicity test (from Embry et al., 2010). 
5.1.1 Fathead minnow embryo development 
The development of fathead minnow is basically similar to that of zebrafish and other teleost 
fish (Manner and Dewese, 1974); some differences are present in the timing of development, 
and are probably due to the different temperatures set as optimal for each species. The main 
embryo developmental stages are represented in Figure 5.2, and include blastulation, 
gastrulation, completion of somites and optic cup formation, spontaneous contraction and tail 
detachment, retinal pigmentation, hearth beating, body pigmentation and commencement of 
hatching. 
5.1.2 Endocrine and molecular control of sex differentiation 
Endocrine control of sex differentiation involves a complex bi-directional link between brain 
and gonad, along the HPG axis. This link is estabilished through signal molecules such as 
gonadotropins, produced by gonadotrope cells of the pituitary gland, and steroids produced in 
gonads and brain (Le Page et al., 2010; Nagahama, 1994; Nagahama, 2005). Sex steroids 
exert a local and direct action on germ-cell development, but also act by influencing other cell 
types and organs involved in sex differentiation. A large number of biochemical, neurological, 
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and physiological pathways are involved in this complex multilevel control process, and this 
complexity is of critical importance to provide the necessary plasticity to the developing 
gonad, which allows it to proceed in a dynamic way with the influence of intrinsic and 
environmental factors, but at the same time, provides many levels at which the system can be 
disrupted by chemicals with endocrine interfering properties (Devlin and Nagahama, 2002; 
Penman and Piferrer, 2008; Piferrer and Guiguen, 2008).  
A broad debate is occurring on whether sex steroids play a fundamental role in the sex 
determination mechanism of teleost fish, or if the latter is only regulated by intrinsic genetic 
processes, independently from the surrounding endocrine environment. Medaka is one of the 
few species of teleost fish in which a clear genetic mechanism of sex determination 
has been discovered, with a sex-specific gene linked to the Y-chromosome, called dmy, 
which is required for testicular development, as happens in mammals with the SRY gene 
(Matsuda et al., 2002). Iwamatsu et al. (2006) demonstrated that genetic XX females 
without dmy can be sex-reversed to functional males if exposed to androgens during the pre-
hatch phase (0-10 dpf), long before the beginning of gonadal sex differentiation. Furthermore, 
several pieces of evidence are available indicating that a few hours of exposure of embryos at 
the morula stage to sex steroids (androgens and estrogens) can respectively induce sex 
reversal of genotypic females into phenotypic males (Kobayashi and Iwamatsu, 2005), and 
the contrary (Iwamatsu et al., 2005). A very large literature on the manipulation of sex 
differentiation in fish with exogenous steroids is available and it has been reviewed by many 
authors (Nakamura, 2010; Pandian and Sheela, 1995; Piferrer, 2001). Moreover, the exposure 
to an aromatase inhibitor during early developmental stages can lead to the masculinisation of 
female fish as a consequence of the inhibition of E2 biosynthesis (Afonso et al., 2001; 
Guiguen et al., 1999; Kitano et al., 2000; Piferrer et al., 1993). These results seem to confirm 
that the action of sex steroids appears to affect definitive sex determination of embryos during 
a short period of the early developmental stage. In particular, the mechanism proposed by 
Iwamatsu et al. (2006) suggests that independently from the expression of Y chromosomal 
dmy, sex steroids alter the cascade of expression of gonad-specific genes (e.g. dmrt1) 
involved in the differentiation of the somatic cells surrounding primordial germ cells, acting 
as regulatory elements in the sex-determining pathway. 
5.1.3 Ontogenesis of steroid production in fish 
It is currently unknown how sex-determination mechanisms influence the gonadal 
developmental processes leading to steroid production and gonad differentiation (Devlin and 
Nagahama, 2002). Generally, developing fish embryos have relatively high levels of sex 
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steroids just after fertilization, declining levels during yolk sac absorption, and increasing 
levels during the fry stage (Feist and Schreck, 1990; Feist et al., 1990; Rothbard et al., 1987; 
Yeoh et al., 1996). Feist and Schreck (1996) suggested that the temporal changes in steroid 
levels during development reflect an initial metabolism of maternal steroids by embryos, 
followed by endogenous steroid synthesis by the newly hatched individuals.  
Changes in the levels of endogenous steroids during development are due to ontogenetic 
changes in the enzymes involved in steroid biosynthesis and metabolism (Antila, 1984; 
Goldstone et al., 2010; Hsu et al., 2009; Yeoh et al., 1996). Molecular, histochemical and 
ultrastructural studies have shown that steroidogenic enzymes and steroid producing cells 
occur at specific times during early development in several teleost species (Hsu et al., 2009; 
Nakamura and Nagahama, 1993; Takahash and Iwasaki, 1973; Trant et al., 2001). Changes in 
the levels of steroids in developing larvae before histological evidence of gonadal 
differentiation suggest as well that sex steroids may play a role in the sex differentiation 
process (Feist and Schreck, 1990; Feist and Schreck, 1996; Feist et al., 1990; Yeoh et al., 
1996). A related theory has been proposed by Bogart (1987), suggesting that the local ratio 
androgens:estrogens determines the gonadal sex. However, other authors argue that sex 
steroid production in teleosts is possible only after the occurrence of gonadal differentiation 
mechanisms (Antila, 1984; Rothbard et al., 1987; Takahash and Iwasaki, 1973; Takahash and 
Iwasaki, 1973; Vandenhurk et al., 1982), and that steroids are not sex determining factors, but 
only the result of sexual differentiation (Wilson et al., 1981). Experiments involving exposing 
medaka to aromatase inhibitors and antiestrogens showed that ovary development may occur 
independently from the action of estrogens (Kawahara and Yamashita, 2000).  Further support 
for this hypothesis is the fact that steroid producing cells are generally not histologically 
evident before testicular or ovarian differentiation (Nakamura and Nagahama, 1985), as 
demonstrated in medaka (Satoh, 1974), even if there are some exceptions, like some poeciliid 
species, where differentiation of somatic tissues  precedes the germ cell differentiation 
(Kramer and Kallman, 1985).  
Independently from the exact initiation mechanisms of the sex determination and 
differentiation, an objective fact is that steroids are strictly correlated with all the early steps 
of sex determination and gonadal differentiation, and if steroid synthesis is disrupted, these 
processes can be disregulated.  
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5.1.4 Hormonal control of sexual maturation 
During sexual maturation, the dramatic changes occurring in steroid biosynthetic activity have 
profound effects on both somatic and germinal tissues (Devlin and Nagahama, 2002; Kagawa, 
2010; Kramer and Kallman, 1985; Piferrer et al., 2005; Villeneuve et al., 2010).  In males, 
plasma levels of steroid hormones show important variations during gonad maturation. 
Generally, estrogens, like E2, are present in blood at low concentrations (Amer et al., 2001; 
Chaves-Pozo et al., 2008; Miura et al., 1994). E2 plasma levels show a temporary increase 
during the spawning period in male roach (Geraudie et al., 2010). Androgens (T, KT) increase 
gradually with the progression of spermatogenesis, and then decrease at spermiation (Schulz 
et al., 2010). Androgens are critically important in the spermatogenic process, in particular 
during some specific events, such as spermatogonial multiplication, spermatocytes formation 
and maturation (Borg, 1994; Nagahama et al., 1994; Schulz et al., 2010; Schulz and Miura, 
2002). They may also have a key role in the initiation of puberty (Cavaco et al., 1998; Goos 
and Schulz, 1997; Schulz and Goos, 1999), and in the induction of spermiation in some 
species, even if they seem to be less effective than progestins (Miura et al., 2006; Miura and 
Miura, 2008). In fact, high levels of circulating progestins are observed during the 
spermiation phase, and these hormones appear to regulate several testicular functions (Schulz 
et al., 2010; Miura and Miura, 2008). For example, 17α, 20β-dihydroxy-4-pregnen-3-one 
(DHP) is able to stimulate and induce spermiation (Miura et al., 1991), increase milt 
production (Baynes and Scott, 1985; Yueh and Chang, 1997), and stimulate spermatozoa 
motility (Miura et al., 1992; Tubbs and Thomas, 2008). 
In females, the production of T and E2 during sexual maturation is generally reduced, and 
production of 17,20β-dihydroxypregn-4-en-3-one (17,20β-P) is highly enhanced (Nagahama, 
1994; Nagahama, 1997). The rise in 17,20β-P concentration during the final phases of sexual 
maturation is responsible for inducing final maturation of oocytes (Kobayashi et al., 1987; 
Nagahama, 1987; Nagahama, 1997). Other steroids capable of inducing oocyte maturation 
(e.g. 17,20β, 21-trihydroxy-4-pregnen-3-one) have also been identified (Scott and Canario, 
1992; Trant et al., 1986), suggesting that different steroids may play the role of ovarian 
maturation hormones in different fish species (Devlin and Nagahama, 2002). 
5.1.5 Fathead minnow histological sex differentiation  
A detailed histological description of the timing and morphology of testicular and ovarian 
development in the fathead minnow has been published by van Aerle et al. (2004), and is 
represented in Figure 5.3. The beginning of ovarian differentiation was first seen at 10 dph, 
when gonads of some of the fry contained cysts of pre-meiotic cells located in the centre of 
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the gonad. The ovaries developed rapidly and at 25 dph the ovaries contained germ cells of all 
stages up to the primary oocyte stage.  
On the other hand, germ cell differentiation in the testis occurred only after 90-120 days post-
hatch. This gap in the timing of gonad development, where the ovary in the female develops 
earlier than the testis in males, has been observed in many gonochoristic fishes (Nakamura et 
al., 1998). 
In teleost fish, the spatial distribution of somatic cells in the gonad during the period of sex 
differentiation is often gender-specific, and this factor can be used to identify the sex of the 
gonad (Nakamura et al., 1998). This spatial specificity was also observed by van Aerle et al. 
(2004) in the fathead minnow prior to the presence of definitive sex cells; in ovaries, pre-
meiotic cells occurred in the centre of the gonad with somatic cells at the gonad periphery, 
whereas in males somatic cells were scattered throughout the gonad amongst the germ cells. 
The spatial organization of germ and somatic cells, together with the development of sex-
specific morphological characters of the gonad, such as the sperm duct, can indicate the 
occurrence of a male gender before germ cell differentiation is histologically evident.  
5.2 Aim of the study 
Fish embryo development and early life stages represent a critical window of sensitivity for 
the action of endocrine disruptors (van Aerle et al., 2002). The majority of the scientific 
literature on the action of endocrine disruptors on fish early life stages is based on the effects 
caused by steroid agonists, and only sparse information is available on the effects of anti-
steroids on these critical life stages.  
The major aim of the study was to assess the potential effects of dutasteride on fathead 
minnow embryo development, larval growth and survival. Furthermore, we designed an 
experiment in order to clarify if an early life stage exposure to the drug could have long term 
effects on adult fish, for example impairing gonad differentiation processes. Moreover, thanks 
to the highly specific mechanism of action of the drug (i.e. inhibition of 5αR Type 1 and Type 
2), a further aim was to obtain precious information about the potential role of DHT in fathead 
minnow sex differentiation. 
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Figure 5.2. Photographs showing specific stages in the early development of zebrafish (from Kimmel 
et al., 1995). 
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Figure 5.3. Presence of the various sex cell types in gonads of fathead minnow females (F) and males 
(M) in relation to (a) age, (b) fork length and (c) mass (from van Aerle et al., 2004). 
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5.3 Methods 
5.3.1 Test species 
Fathead minnow newly fertilized embryos (collected at < 6 h post fertilization) were obtained 
from a stock held at Brunel University, London, UK. During the early life stages tests, fry 
were fed twice a day with a combination of pelleted fish food SDS 100 (80-200 μm particles) 
(Special Diet Service, UK) and Artemia salina nauplii, and as the fry developed, A. salina 
were supplemented with increasing size of pelleted fish food SDS 200-300-400 ad libitum 
(150-800 µm particles) (Special Diet Service, UK). After 40 dph, fish were fed twice a day 
with a combination of flake food and frozen (thawed before use) brine shrimp ad libitum. 
5.3.2 Test substances and dilution water 
Dutasteride (CAS number 164656-23-9) was obtained from GlaxoSmithKline (GSK) as 
99.9% pure. Concentrated stock test solutions were prepared in N,N-Dimethylformamide 
(DMF, CAS number 68-12-2, ≥99%) (Sigma, Poole, UK). One master concentrated stock 
solution (5.0 g/L) was made in DMF, stored at +4 
°
C, and used weekly to make up fresh 
dosing stock solutions at 0.089, 0.28, 0.89, and 2.78 g/L.       
The dilution water was monitored for general parameters (e.g. pH, hardness, conductivity). 
During the exposure studies, mean water pH ranged from 7.6 to 8.2, temperature from 24.91 
to 26.32 ºC, and dissolved oxygen from 6.79 to 7.92 mg/L. 
5.3.3 Test conditions and exposure protocol 
5.3.3.1 Fish early life test 1 (ELS Test 1)  
The fish ELS Test protocol was based on the OECD Test Guideline 210 (OECD, 1992). The 
experiments were carried out using a continuous flow-through system. The test apparatus 
comprised glass fish tanks (4 per treatment) with a working volume of 10.5 L, and two 
embryo incubation mesh baskets (Cadisch Ltd, UK) suspended in each test vessel. 
Thermostatically heated (25 ± 1
o
C) dechlorinated tap water from a header tank flowed 
through 6 flow-meters into 6 mixing chamber at a rate of 333.3 mL/min. The same chambers 
also received the test chemical stock solution in DMF at a rate of 0.012 mL/min, in order to 
achieve the desired nominal concentrations. Separate lines from each mixing chambers 
supplied about 9 tank volume changes per day to each of the four replicate tanks. The final 
experimental set up included six groups: one dilution water control group (DWC), one solvent 
control group (SC), and four dutasteride exposed groups (3.2, 10, 32, 100 μg/L). Each SC 
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tank received DMF at the same rate as the exposed groups, such that the water in all test 
vessels contained DMF at 0.0036% (OECD suggested limit: 0.0095%). The described 
experimental set up was run for 4 days before the beginning of the embryos exposure, in order 
to allow the system to equilibrate. The test was run at a nominal water temperature of 25 ± 1 
°C, with a photoperiod of 16 hours light: 8 hours of dark, and with 20 minute dawn/dusk 
transition periods. The light intensity was measured by a lux meter (Lutron, LX-101) once a 
week during the study. 
Fertilized eggs from a minimum of six adult pairs were gently removed from the PVC tiles, 
collected and pooled in a Petri dish. Under light microscopy observation, groups of 10 
embryos were randomly selected and transferred to each incubation basket until reaching a 
sample size of 60 embryos in each replicate tank (30 embryos in each incubation basket). All 
the embryos were no older than 6 hours post fertilization (early cleavage to blastula stage). 
The numbers of dead and hatched embryos were recorded daily, and any dead embryo was 
discarded to avoid fungi contamination. When hatching was at least 90% complete, or 24 
hours after the first hatch (approximately after 4-6 days), larvae were released in the tank, 
hatching time recorded, and baskets removed. Daily observations of mortality, behaviour and 
appearance were made and recorded.  
The exposure period was terminated after 28 dph, when 8 fish from each replicate (32 fish per 
treatment) were sacrificed by exposure to an overdose of anaesthetic (500 mg/L of MS222, 
adjusted to pH 7.5 using 1 M NaOH), measured for fork length and wet weight, followed by 
trans-spinal severance. The CI was calculated as described in Section 4.3.3. Whole fish were 
then placed in sterile tubes and stored at -80ºC for future molecular analysis. 
5.3.3.2 Fish recovery study in clean water 
Remaining fish from the ELS Test 1 were transferred to 30 L test vessels and kept in clean 
dilution water until the end of the study. A schematic picture of the dosing regime and 
sampling time is shown in Figure 5.4.  
At 120 dph, 10 fish per tank (40 per treatment) were randomly sacrificed by exposure to an 
overdose of anaesthetic. Due to the lower number of surviving individuals, only 8 fish per 
replicate (32 per treatment) were sampled from the group exposed to 100 µg dutasteride/L. 
Blood was collected, and after trans-spinal severance, fork length and wet weight were 
measured, and CI calculated as described in Section 4.3.3. Since at this stage only a few fish 
had developed external SSCs in each treatment group, it was not possible to externally 
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distinguish males and females, and SSCs assessment was not applied. The body cavity was 
opened and sex was assigned according to visual inspection of the appearance of the gonads. 
Since exposure to the high dose of dutasteride (100 μg/L) in the ELS Test 1 caused decreased 
fish survival (see Results, Section 5.4.2), at 120 dph, only for this group, two (rather than 
four) new replicate tanks were created, pooling fish in replicate tanks 1 and 2, in pool 100A, 
and fish in replicate tanks 3 and 4, in pool 100B. This protocol modification was required 
since it is known that fish density in the test vessel can cause variation in the growth of 
individuals, because of the consequent competition for food and space (an effect known as 
“growth depensation” or “size hierarchy effect”) (Brown, 1957; Woltering, 1984).  
A further sampling was performed at 160 dph, when 8 males and 8 females per treatment 
were randomly collected, and sacrificed by exposure to an overdose of anaesthetic. Blood was 
collected from the caudal vein, standard length and wet weight recorded, and CI calculated as 
described in Section 4.3.3. After SSCs assessment, each fish was slit ventrally in order to 
allow the fixative to penetrate the body cavity, prior to fixation in Bouin‟s and subsequent 
storage in 70% IMS, for histopathological analyses.    
5.3.3.3 Fish early life stage test 2 (ELS Test 2) 
A repeat of an ELS Test was performed with the same test conditions and experimental 
procedure, as described in Section 5.3.3.1, with the following modifications. Only three 
dutasteride concentration were tested (10, 32 and 100 μg/L), the number of embryos allocated 
in each test vessel was 25 (6 replicates for the groups DWC, SC and 100 µg/L; 4 replicates for 
the groups 10 and 32 µg/L), and the exposure period was terminated at 14 dph, when fish 
were sacrificed by exposure to an overdose of anaesthetic, and 15 randomly selected fish per 
replicate were measured for fork length and wet weight. Considering the small size of the 
sampled fish, pools of three fish were used for the wet weight determination, in order to 
obtain a more accurate measurement (to 0.010 mg).  CI calculated as described in Section 
4.3.3. 
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Figure 5.4.  Experimental design for exposure of early life stage fathead minnows to dutasteride. For 
each control and treatment group there were four replicate tanks. Endpoints measured were: Day 0 - 
hatching time, hatching success; Day 28 – survival, growth; Day 120: growth; Day 160: growth, 
plasma steroids, gonad histopathology, and secondary sexual characteristics.   
5.3.4 Gonadal histopathology 
Three slices of 3-4 mm thickness were transversally cut from the each gonad, dividing it in 
anterior, median, and posterior parts. Slices were prepared for the histopathology analyses 
following the method detailed in Section 4.3.6, and analysed according to the EPA guideline 
described in the same section (EPA, 2006).  
5.3.5 Determination of circulating plasma steroid concentrations 
Circulating plasma levels of T and KT in fish sampled at 160 dph were quantified by specific 
radioimmunoassays, as described in Section 4.3.5. 
5.3.6 Chemical analyses of water concentrations of dutasteride 
Water samples were randomly collected from two out of four replicates per treatment on day 
0, 4, 7, and then weekly for the duration of the study. Water samples were diluted with 
acetonitrile (50:50 v/v) and analysed by liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS). The samples were quantified against standards of dutasteride. 
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The LC-MS/MS technique is based on the same principles described in section 4.4.1.4., with 
the only difference that the mobile phase used during the separation phase is a liquid instead 
of a gas.     
The LC-MS/MS apparatus included an HPLC Agilent 1050 Series (Agilent Technologies, 
Waldbronn, Germany), equipped with a Perkin Elmer autosampler 200 Series. The LC 
separation was achieved using an Ascentis C18 column (3 µm, 50 mm × 3 mm). The mobile 
phase used was a mixture of 10 mM ammonium formate buffer/acetonitrile (15/85 v/v, pH 
adjusted to 3.0 with formic acid), which was pumped at a flow-rate of 0.2 mL/min. Mass 
spectrometric detection was performed on an API 365 triple quadrupole instrument (ABI-
SCIEX, Toronto, Canada) with a turbo electrospray interface in positive ionization mode. The 
main working parameters of the mass spectrometer are summarized in Table 5.1. Data 
processing was performed on Analyst 1.3 software package (SCIEX). 
 
Table 5.1. Tandem mass-spectrometer main working parameters used for the quantification of 
dutasteride in the water samples. 
Parameter Value 
Source temperature (ºC) 300 
Dwell time per transition (ms) 1000 
Curtain gas (psi) 8 
Collision gas (psi) 4 
Ion spray voltage (V) 4800 
Entrance potential (V) 10 
Declustering potential (DP) (V) 54 
Collision energy (V) 50 
Collision cell exit potential (V) 15 
Mode of analysis Positive 
Ion transition for dutasteride (m/z) 529.1/461.3 
 
5.3.7 Statistical analyses 
Statistical analyses were conducted using SigmaStat software (version 3.5, Systat Software 
Inc., Germany). Data for hatching success, survival, wet weight, fork length, condition factor, 
SSCs and plasma steroids concentrations were analysed for normality (Kolmogorov-Smirnov 
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test) and variance homogeneity (Levene‟s test). Where assumptions of normality and 
homogeneity were met, one-way analysis of variance (ANOVA) was followed by the 
Dunnett‟s test to compare the treatment means with respective controls. Where the 
assumptions were not met, data were analysed using a non-parametric test, Kruskal–Wallis 
ANOVA on Ranks, followed by Dunn‟s post-hoc test (Zar, 1999). Survival was analyzed by 
Kaplan-Meier Survival Analysis (Log-Rank). Statistical comparisons were made to determine 
if there were significant differences between the DWC and SC groups, by t-test or, in case of 
non-normal and non-homogeneous data, by Mann-Whitney Rank Sum test; all treatment 
comparisons were made against the SC group. At 160 dph, all the data were analysed 
according to the sex of the fish.  
Effects of treatments on gonadal developmental stage, most advanced stage of gametogenesis, 
and dominant germ cell were analysed using a variation of the chi-squared test, the 
randomization test of goodness of fit with Montecarlo simulation (n = 10,000) (McDonald, 
2009).  
Where necessary, data were log-transformed for normalization and to reduce variance 
heterogeneity; percentage data were arc sine transformed. The results are reported as means ± 
standard error of the mean to indicate the precision of the mean estimate. Statistical 
significance was set at a level of p = 0.05, unless otherwise indicated. 
5.4 Results 
5.4.1 Water concentrations of dutasteride 
Water analysis showed that fish were exposed to the test substance in the expected range of 
concentrations and that there was no contamination of control tanks with dutasteride. In ELS 
Test 1, concentrations ranged from 70% to 156% of the nominal values (Table 5.2), and in 
ELS Test 2 from 68% to 138% (Table 5.3).  
5.4.2 Hatching success, hatching time and survival. 
Dutasteride didn‟t have any significant effect on hatching success and hatching time in both 
ELS Test 1 and ELS Test 2 (Figure 5.5). The detailed results for each replicate tank are shown 
in Table 5.4. Considering the effects of dutasteride on larvae survival and growth (see below), 
it is plausible that the embryo chorion acted as a barrier to the penetration of the drug.  
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After the embryos hatched, the highest dutasteride concentration (100 µg/L) had a significant 
negative effect on larval survival (Figure 5.6). The same survival dynamics were recorded in 
both ELS Test 1 (p < 0.0001) and ELS Test 2 (p = 0.0004). In the first experiment, at the end 
of the exposure period (28 dph) only 55.20% ± 10.3 of fish had survived in the highest 
concentration group, while in the second experiment, at 14 dph, only 65.44% ± 7.38 of fish 
survived with the same treatment (100 µg/L), compared to a mean survival value higher than 
80% in all the other groups, in both experiments (Table 5.4). 
Table 5.2. Measured water concentrations (µg/L) of dutasteride during the fathead minnow early-life-
stage exposure study 1. 
* The analysis detection limit is quoted. 
 
 
 
 
 
 
 
 
 
Exposure 
Day 
 
 
Replicate 
Nominal concentrations of dutasteride (µg/L) 
*DWC *SC 3.2    10 32 100 
0 
A 
B 
 
 
 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
3.84 
4.03 
14.25 
5.32 
 
32.11 
12.12 
 
    96.33 
75.24 
 
3 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
<0.5 
 
4.22 
4.47 
 
12.58 
10.83 
 
32.58 
29.26 
 
129.77 
125.59 
7 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
3.91 
4.28 
 
11.31 
12.43 
 
24.13 
33.06 
 
123.50 
78.09 
 
14 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
3.67 
5.02 
 
14.16 
11.34 
34.01 
29.26 
 
87.59 
60.99 
 
21 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
3.80 
5.51 
 
11.12 
12.85 
35.15 
27.74 
 
87.78 
91.96 
 
32 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
3.25 
4.20 
 
8.63 
9.39 
 
34.39 
41.23 
 
93.67 
101.08 
 Mean Values (µg/L) < 0.5 < 0.5 4.18 ± 0.33 11.18 ± 1.45 3   30.43 ± 5.09   95.97 ± 19.12 
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Table 5.3. Measured water concentrations (µg/L) of dutasteride during the fathead minnow early-life-
stage exposure Study 2. 
* The analysis detection limit is quoted. 
 
 
 
 
 
 
 
 
 
 
Exposure 
Day 
 
 
Replicate 
Nominal concentrations of dutasteride (µg/L) 
*DWC *SC     10             32             100 
0 A               
B 
C 
< 0.1 
< 0.1 
-- 
< 0.1 
< 0.1 
-- 
13.36 
13.89 
-- 
31.35 
34.77 
-- 
98.59 
91.80 
101.52 
 
7 A 
B 
C 
< 0.1 
< 0.1 
-- 
< 0.1 
< 0.1 
-- 
11.95 
9.69 
-- 
23.75 
25.08 
-- 
91.20 
123.01 
76.40 
14 A 
B 
C 
< 0.1 
< 0.1 
-- 
< 0.1 
< 0.1 
-- 
11.70 
9.29 
-- 
30.40 
24.70 
-- 
74.80 
68.40 
71.60 
 
Mean Values (ng/L) < 0.1 < 0.1          7.76 ± 5.59        28.34 ± 4.38           88.59 ± 14.71 
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Figure 5.5. Effect of different concentrations of dutasteride on (A) the hatching success and (B) 
hatching time of fathead minnow embryos exposed from 4-6 hours post fertilisation to hatch. Data 
were obtained from two independent experiments, and are expressed as means ± SD. The number of 
starting embryos per treatment was n = 240 for experiment 1, and n = 125 for experiment 2. 
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Figure 5.6. Effect of different concentrations of dutasteride on the survival of fathead minnow exposed 
from 4-6 hours post fertilisation to (A) 28 or (B) 14 days post hatching. Data were obtained from two 
independent experiments, and are expresses as means ± SD. The asterisk (*) indicates a significant 
difference (Kaplan-Meier Survival Plus Log Rank Mantel-Cox Analysis;:  Study 1: p < 0.0001; Study 
2: p = 0.0004).   
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Table 5.4 Hatching success and survival of fathead minnows exposed from embryo stage to 28 dph to dutasteride (3.2, 10, 32 and 100 µg/L). 
40.822042.862151.022571.433581.67494960R424
65.383467.313571.153778.854186.67525260R323
60.422960.422964.583181.253980.00484860R222
10.6355.20
54.1726
10.3257.23
58.3328
8.9963.88
68.7533
5.1978.71
83.3340
3.1582.08
80.00484860R121
100
87.234189.364293.624497.874678.33474760R412
76.473976.473986.274498.045085.00515160R311
81.634083.674183.6741100.004981.67494960R210
4.7682.69
85.4241
5.3983.73
85.4241
4.3088.29
89.5843
1.1898.98
100.0048
2.8581.25
80.00484860R19
32
82.983985.114091.4943100.004778.33474760R416
80.004080.004082.004196.004883.33505060R315
85.714287.764389.804495.924781.67494960R214
3.4684.17
88.0044
3.7285.22
88.0044
4.6488.82
92.0046
2.3397.98
100.0050
2.3681.67
83.33505060R113
10
85.424185.424191.674497.924780.00484860R48
80.394180.394182.3542100.005185.00515160R37
80.004082.004186.004398.004983.33505060R26
3.9183.45
88.0044
3.4283.95
88.0044
3.8987.00
88.0044
1.1898.98
100.0050
2.1082.92
83.33505060R15
3.2
85.114085.114091.494397.874678.33474760R420
80.394180.394180.3941100.005185.00515160R319
87.764389.804489.804493.884681.67494960R218
3.5985.37
88.2445
4.1585.88
88.2445
5.4788.46
92.1647
2.8997.94
100.0051
3.1982.50
85.00515160R117
SC
82.004184.004288.0044100.005083.33505060R44
78.003980.004080.0040100.005083.33505060R33
85.714285.714291.8445100.004981.67494960R22
3.2382.26
83.3340
2.3983.26
83.3340
4.9586.83
87.5042
1.0499.48
97.9247
1.6082.08
80.00484860R11
DWC
SDAverage %%Number of fishSDAverage %%Number of fishSDAverage %%Number of fishSDAverage %%Number of fishSDPooled repl.Indiv. Repl.ReleasedHatched 
Survival at 30 dphSurvival at 21 dphSurvival at 14 dphSurvival at 7 dphPercentage hatchNumber of larvae
Number 
of eggs at 
start
Replica
te
Tank 
number
Dutasteride     
conc. ( g/L) 
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5.4.3 Somatic growth at the end of the ELS Tests 
At the end of ELS Test 1 (28 dph), significantly reduced length and weight were recorded in 
fish exposed to 32 and 100 µg/L (p < 0.001), as well as in the DWC group (p < 0.001). A 
significant decrease of the condition index was observed in fish exposed to 100 µg 
dutasteride/L (p = 0.005), and in the DWC group (p < 0.001) (Figure 5.7). 
The second ELS Test was carried out for a shorter period, until 14 dph, and it replicated the 
results obtained with the Experiment 1, with a significant decrease of length and weight in the 
DWC, 32 µg/L, and 100µg/L (p < 0.001) groups, except for the condition index, which was 
significantly higher (p = 0.032) in fish exposed to the high dutasteride concentration 
(100µg/L) (Figure 5.7). However, the condition index calculated for ELS Test 2 is based on 
weight values measured in triplicate, while the length was measured for each individual. This 
is probably the cause of the unexpected results (CI increase), making this result unreliable.  
5.4.4 Fish recovery in clean water. Somatic growth and SSCs. 
After the end of the exposure period, surviving fish from ELS Test 1 were transferred in clean 
water, and kept until sexual maturation. The first sampling time was set at 120 dph. Fish 
showed a full recovery in growth parameters, with no significant differences among groups in 
length, weight or condition index (Figure 5.8). At 120 dph, only a very small number of fish 
had developed secondary sexual characteristics, and also visual inspection of the gonads 
didn‟t always give reliable results. For these reasons, an additional sampling was performed at 
160 dph, when 8 males and 8 females were randomly sampled from each treatment. Data 
obtained from the last sampling confirmed the full recovery of growth parameters in fish 
exposed to dutasteride during the early life stages (Figure 5.9). Sampled females showed a 
non significant increasing trend in length and weight, and females exposed to 3.2 µg/L during 
the early life stages showed a significant increase of condition index (p = 0.048), which is 
probably a random effect not linked to the dutasteride exposure. 
No significant differences were observed among treatments in number and grade of nuptial 
tubercles, fatpad index, and fatpad height in males, as well as in the ovipositor length in 
females (data not shown). 
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Figure 5.7. Box plots of (A,B) length, (C,D) weight and (E,F) condition index of fathead minnow 
juveniles exposed to different concentrations of dutasteride. Data were obtained from two independent 
experiments. Fish were exposed to the drug from 4-6 hours post fertilisation to 28 days post hatching  
in experiment 1 (A,C,E), and from 4-6 hours post fertilisation to 14 days post hatch in experiment 2 
(B,D,F). Boxes represent median (full line), and mean (dashed line) with 25th and 75th percentiles. 
The bars extend to the 10th and 90th percentiles with outliers represented as dots. Sample size is 
indicated above each treatment label on the x-axis. * p < 0.05 compared to the Solvent Control group. 
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Figure 5.8. Box plots of length (A), weight (B), and condition index (C) of fathead minnow juveniles 
exposed to different concentrations of dutasteride from 4-6 hours post fertilisation to 28 days post 
hatching, and then kept in clean water until the sampling time (120 dph). Boxes represent median (full 
line), and mean (dashed line) with 25th and 75th percentiles. The bars extend to the 10th and 90th 
percentiles, with outliers represented as dots. Sample size is indicated above each treatment label on 
the x-axis.     
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Figure 5.9. Box plots of length, weight and condition index of fathead minnow males (A,C,E) and 
females (B,D,F) exposed to different concentrations of dutasteride from 4-6 hours post fertilisation to 
28 days post hatching, and then kept in clean water until the sampling time (160 dph). Boxes represent 
median (full line), and mean (dashed line) with 25th and 75th percentiles. The bars extend to the 10th 
and 90th percentiles, with outliers represented as dots. * p < 0.05 compared to the Solvent Control 
group. Sample size: n = 8. 
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5.4.5 Fish recovery in clean water. Gonad histopathology. 
Histopathological analyses were performed to assess the effect of an early life stage exposure 
to dutasteride on gonadal differentiation and maturation processes in adult fish occurring after 
a relatively long period of time from the end of the exposure. 
5.4.5.1 Males 
Male fathead minnows sampled at 160 dph presented testes at different maturation stages, 
with a general dominance of early spermatogenic stages (Stage 0 + Stage 1), but also with 
individuals with late spermatogenic gonads (Figures 5.10 & 5.11). Males in the 100 µg/L 
group showed a significant retardation of the spermatogenic process (p = 0.005), presenting 
only undeveloped or early spermatogenic testes, with no individuals with testes at mid or late 
spermatogenic stages. This result was confirmed by the analysis of both dominant germ cell 
and most advanced stage of spermatogenesis, which showed how fish exposed to the highest 
concentration of dutasteride during early life spresented a “slower” gonad maturation process 
compared with other groups; in particular, spermatozoa were never observed as the dominant 
germ cell (p = 0.015), and represented the most advances stage of spermatogenesis only in 
33% of samples versus 100% and 87.5% in DWC and SC groups, respectively (p = 0.005). 
5.4.5.2 Females 
All the control females sampled at 160 dph had ovaries at the vitellogenic stage (Early, Mid-
Late or Hydrated), while treated fish were characterized by the occurrence of undeveloped 
ovaries, with an absence of cortical alveolar or vitellogenic oocytes (Figures 5.12 & 5.13). 
The proportion of fish at Stage 0 of maturation was significantly higher than control groups in 
fish exposed to 32 (p = 0.045) and 100 (p = 0.040) µg/L of dutasteride during the early life 
stages. In the same groups, previtellogenic oocytes represented the dominant germ cell 
respectively in 83.3% (p = 0.045) and 68.2% (p = 0.025) of samples. Furthermore, the same 
groups showed a significant reduction in the percentage of samples having late vitellogenic 
oocytes as the most advanced stage of oogenesis, from 100% in DWC and SC groups, to 
16.7% (p < 0.001) and 44.4% (p < 0.001), respectively, in the groups exposed to 32 and 100 
µg/L.    
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Figure 5.10. Effect of an early life stage exposure to dutasteride on the testis of adult fathead 
minnows. Fish were exposed to different concentrations of the drug from 4-6 hours post fertilisation to 
28 days post hatching, and then kept in clean water until the sampling time (160 dph). (A)Maturation 
stage of the testis, (B) dominant germ cell, and (C) most advanced stage of spermatogenesis are 
presented. Stage 0: Undeveloped, entirely immature phases (spermatogonia to spermatids) with no 
spermatozoa; Stage 1: Early spermatogenic: immature phases predominate, but spermatozoa may also 
be observed; Stage 2: Mid-spermatogenic: spermatocytes, spermatids, and spermatozoa are present in 
roughly equal proportions; Stage 3: Late spermatogenic, mature sperm predominate. Asterisks (*) 
represent significant differences compared to the SC group (p < 0.05). Sample size: n = 8. 
 165 
 
 
Figure 5.11. Transverse sections of fathead minnow testes from (A,B) the Solvent Control group  and (C,D) from the group exposed to the highest 
concentration of dutasteride (100 µg/L) during the period “fertilised egg-28 dph”. After the end of the treatment, fish were transferred into clean dilution 
water, and sampled at 160 dph. The testes in figures A and B represent examples of, respectively, advanced and early spermatogenic activity found in the 
testes of fish in the Solvent Control group. In the same group, spermatozoa were the most advanced stage of spermatogenesis in 87.5 % of samples, versus 
33% in the group exposed to 100µg/L of dutasteride. 
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Figure 5.12. Effect of an early life stage exposure to dutasteride on the ovaries of adult fathead 
minnows. Fish were exposed to different concentrations of the drug from 4-6 hours post fertilisation to 
28 days post hatching, and then kept in clean water until the sampling time (160 dph). (A) Maturation 
stage of the ovary, (B) dominant germ cell and (C) most advanced stage of oogenesis are presented. 
Stage 0: Undeveloped, entirely immature phases (oogonia to Perinucleolar oocytes), and no cortical 
alveoli; Stage 1: Early development, vast majority (e.g., >90%) were pre-vitellogenic follicles, 
predominantly perinucleolar through to cortical alveolar; Stage 2: Mid-development, at least half of 
520 observed follicles were early and mid-vitellogenic; Stage 3: Late development, majority of 
developing follicles were late vitellogenic; Stage 4: Late development/hydrated: majority of follicles 
are late vitellogenic and mature/spawning follicles. In figures b) and c) the classes of oocytes are 
indicated. Sample size: n = 8. Asterisks (*) represent significant differences compared to the SC group 
(p < 0.05). 
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Figure 5.13. Transverse sections of fathead minnow ovaries (A,D) from the Solvent Control group and from the groups exposed to (B, E) 32 µg/L and (C,F) 
100 µg/L of dutasteride during the period “fertilised egg-28 dph”. After the end of the treatment, fish were transferred into clean dilution water, and sampled 
at 160 dph. The ovary in figures A and D represents an example of ovaries containing late vitellogenic oocytes, which were present in 100% of fish in the 
Solvent Control group, versus 16.7% and 44.4%, respectively, in the groups exposed to 32 and 100µg/L of dutasteride. Figures B,C,D,F show examples of 
ovaries with reduced or completely absent vitellogenesis, found in fish exposed to 32 and 100 µg/L of dutasteride. 
 168 
 
5.4.6 Fish recovery in clean water. Plasma steroid concentrations. 
No significant differences were observed in plasma T concentrations of males and females, 
and in plasma KT concentrations of males, sampled at 160 dph (Fig. 5.14). 
  
  
Figure 5.14. Effect of an early life stage exposure to dutasteride on plasma concentrations of 
testosterone and 11-ketotestosterone in adult (A,C) male  and (B) female fathead minnows. Fish 
were exposed to different concentrations of the drug from 4-6 hours post fertilisation to 28 days 
post hatching, and then kept in clean water until the sampling time (160 dph). Boxes represent 
median (full line), and mean (dashed line) with 25th and 75th percentiles. The bars extend to the 
10th and 90th percentiles, with outliers represented as dots. Sample size: n = 8. 
5.5 Discussion 
In the present study we investigated the effects of dutasteride on the early life stages of 
fathead minnow (egg-28 dph), and the consequences of the exposure on the maturation of 
the gonads in the adult stage. Exposure to dutasteride did not cause any effect on embryos 
hatching rate and hatching time; however, significant effects on growth and survival were 
C) 
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recorded in the groups exposed, respectively, to ≥32 and 100 µg/L. Furthermore, fish 
exposed to 32 and 100 µg/L presented histologically-evident alterations of gametogenesis 
in the adult stage (160 dph). 
The effects caused by exposure to dutasteride arose only after the embryos hatched; in fact, 
neither hatching time nor hatching rate was affected by exposure to the drug. The 
difference of sensitivity between pre-hatch and post-hatch life stages was probably linked 
to the inability of the dutasteride to penetrate the chorion which surrounds the developing 
embryos (Manner et al., 1977). The teleost fish egg chorion is an acellular multilayered 
envelope composed mainly of polysaccharides, proteins and glycoproteins. The exact 
biochemical composition varies during different stages of development, from the 
unfertilized egg up to hatching time, and both the number of layers and thickness present 
species-specific variability (Bonsignorio et al., 1996; Brivio et al, 1991). The chorion 
provide a protective barrier between the developing embryo and the external environment, 
however, the isolation of the embryo is not complete, since a large number of pores 
traverse the chorion structure (Hart and Donovan, 1983; Zhang and Rawson, 1996). The 
chorion of zebrafish contains approximately 7 million pores, with an outer diameter of 0.2 
and 0.7 µm (Hart and Donovan, 1983; Rawson et al., 2000), and is freely permeable to 
water, electrolytes and a range of cryoprotectants such as methanol, dimethyl sulfoxide 
(DMSO), ethylene glycol, propane-1,2-diol (Zhang and Rawson, 1996; Harvey et al., 
1983), but also to E2 and polyethylene-glycols up to a molecular weight of 40,000 
(Lillicrap, 2010).   
A number of factors can determine if a substance is able to penetrate the chorion, such as 
molecular weight, steric properties, electrical charge, hydrophylicity, and osmotic pressure. 
The molecular weight of dutasteride is 528.5, and its molecular dimensions are smaller 
than those of other molecules able to penetrate into the embryo (Lillicrap, 2010), hence 
dimensional and steric factors can‟t explain the inability of the drug to penetrate the 
chorion. However, dutasteride has a very high lipophylicity (logP: 5.45, ALOGPS; 5.09, 
GSK), which may cause a dimensional increase of the molecule, by binding organic matter 
dissolved or suspended in the water and forming aggregates, which in turn would prevent 
dutasteride from crossing the pores. Furthermore, other studies indicated that the barrier 
function of the chorion increases with the lipophilicity of the target compound (Braunbeck 
et al., 2005). Other potential explanations for the insensitivity of fathead minnow embryos 
to dutasteride are that the drug penetrated the chorion only partially, without reaching an 
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intra-embryonic concentration high enough to exert physiological effects, or that the drug 
did fully penetrate the chorion, but it did not have any effect on hatching.       
In our study the growth of juvenile fish exposed to dutasteride was significantly reduced at 
concentrations ≥ 32 µg/L; a similar effect has been reported when fish were exposed, at 
early life stages, to other anti-androgens. For example, the AR antagonists vinclozolin and 
cyproterone acetate caused reduced growth in fathead minnow (at 1200 µg/L) (Makynen et 
al., 2000) and Japanse medaka (at 1 µg/L) (Kiparissis et al., 2003). No data are available in 
the literature concerning the effects of 5α-reductase inhibitors (finasteride or dutasteride) 
on other fish species. Dutasteride has been tested on other animal species, in order to 
assess its toxicity on the early life stages exposed via maternal administration, and in 
particular, in an embryo-fetus development study with the rat, oral administration of 
dutasteride at doses of 0.05. 2.5, 12.5, and 30 mg/kg/day resulted in a feminization of male 
fetuses and male offspring at all doses, along with a decreased fetal body weight, and delay 
of ossification process at 2.5 and 30 mg/kg/day (15 to 111-fold the expected clinical 
exposure) (GSK, 2001). It should be noted that the cross-species comparison (teleost fish 
vs other vertebrates) of the effects caused by dutasteride may not necessarily be 
informative, since in vertebrates, except teleost fish, DHT is generally the major 
circulating androgen, while in fish this role is played by KT (Borg, 1994). 
One of the most obvious effects caused by dutasteride (100 µg/L) was the decrease of 
larval survival at 28 dph in the ELS Test 1. In order to assess the repeatability of this result, 
and to exclude the possibility that the mortality was linked to other accidental factors, we 
performed a second ELS Test, which terminated at 14 dph (instead of 28 dph), confirming 
the effects on both growth and survival. In a recent study, Owen et al. (2010) highlighted 
the importance of replication when performing toxicological tests, showing how two 
independent studies performed with the aim to assess the effects of clofibric acid on 
growth rates of the rainbow trout, lead to completely contrasting results (significant effect 
at all the concentration in the first study; no effect at all the concentrations in the second 
study). The second study was statistically more robust than the first one; however, both of 
them had enough statistical power to meet the criteria set by the OECD protocol 215. 
Within this perspective, our study showed a very good repeatability between ELS Test 1 
and ELS Test 2, so we can argue with confidence that the effects of dutasteride on larval 
growth and survival rate were caused by the exposure to dutasteride, and not by other 
environmental or accidental factors.      
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At the end of the exposure period, fish were moved into clean water, grown up and 
sampled at 120 and 160 dph, with the aim to assess the persistence of the effects caused by 
the early life stages exposure to dutasteride. At both sampling times, the fish that at the end 
of the exposure period had shown decreased growth, recovered completely all the growth 
parameters (length, weight and condition index), so that there were not any significant 
differences among groups. This response could be explained by the concept of catch-up 
growth, which is usually defined as an accelerated growth observed during recovery by a 
stress condition that caused the growth inhibition, such as food deprivation, non-optimal 
temperature, hypoxia (Ali et al., 2003; Kajimura et al., 2005; Wootton, 2004), and 
chemical exposure (Moens et al., 2007). This phenomenon has been observed not only in 
fish, but also in many animal species, including humans (Ali et al., 2003; Kay‟s et al., 
2006). Interestingly, male rats exposed in utero to the 5α-reductase inhibitor finasteride, 
exhibited catch-up growth after birth (Clark et al., 1990).  
The sensitivity of fish early life stages to endocrine disruptors is well known (van Aerle et 
al., 2002), and short periods of exposure during these critical life stages can cause 
disruption of the normal sexual development and maturation processes, which can persist 
into adulthood, even if the exposure to the chemical had been terminated. The 
histopathological analyses of the gonads represent a very powerful tool to assess these 
effects, as well as being one of the most sensitive endpoints of endocrine disruption. For 
example, in our study, fish sampled in the adult stage (160 dph), after an initial 32 days 
exposure to dutasteride (egg-28 dph), presented significant histopathological alterations, 
despite both morphometric data and plasma concentrations of T and KT not showing any 
significant differences among treatment groups. In particular, all the histopathological 
parameters employed in the analyses (gonad maturation stage, dominant germ cell, most 
advanced stage of gamatogenesis) confirmed the retardation in gonad maturation and sex 
cell progression, in both males and females. However, whereas males were affected only 
when exposed to 100 µg/L of dutasteride, females showed a significant delay in maturation 
when exposed to 32 µg/L. This result suggests that in the fathead minnow the ovary may 
be more sensitive to disruption of DHT biosynthesis than the testis. A more extended 
discussion on the sensitivity of ovaries to disruption of androgen biosynthesis disruption 
will be discussed in Chapter 7.  
Unfortunately, as with the growth data, it was not possible to compare our histopathology 
results with similar studies, since no published information concerning the effects of 5α-
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reductase inhibitors (finasteride or dutasteride) on fish is available in the literature so far. 
Furthermore, even broadening the comparison to other anti-androgens, such as flutamide 
or viclozolin, only very few studies involved exposing fish during early life stages (Bayley 
et al., 2002; Kiparissis et al., 2003; Makynen et al., 2000), and in the only one which 
employed histopathological endpoints (Kiparissis et al., 2003), the exposure period (egg-
100 dph) was much longer than the one used in our study.  Results from the latter study 
showed both an inhibition of spermatogenesis in the testes of medaka, caused by 
vinclozolin (2500 µg/L) and cyproterone acetate (1 and 10 µg/L), and a retarded oogenesis 
in females exposed to cyproterone acetate (1 and 10 µg/L), with a decrease in the 
proportion of females with ovaries at advances stages of oogenesis.  
Interestingly, the observed retardation of gametogenesis, in particular in the ovary, 
occurred when adult fish were exposed to several anti-androgens, such as vinclozolin 
(Makynen et al., 2000), cyproterone acetate (Kiparissis et al., 2003; Rouse et al., 1977), 
and flutamide (Jensen et al., 2004; Kinnberg and Toft, 2003). These results may indicate 
that during the early life stage exposure (egg-28 dph), dutasteride disrupted some key 
processes regulating the maturation of the gonad, and that disruption was strong enough to 
be present even 5 months after the end of the exposure; furthermore, even if the identity of 
the disrupted process is unknown, it would be possible that the disruption of the 
androgenic system, caused both by 5α-reductase inhibitors and AR antagonists, may affect 
a shared set of molecular/physiological process that regulate the normal gonad maturation.  
Despite the identity of the exact disrupted processes being unknown, the possibility of 
inducing long-term effects by exposing fish only during the early life stages to endocrine 
disruptors has been broadly demonstrated by exposing fish to sex steroids. In particular, 
van Aerle et al. (2001) determined the window of sensitivity for the estrogenic effects of 
EE2 on early-life stages of fathead minnow, showing how short exposures (egg-20, egg-5, 
5-10, 10-15, 15-20 dph) to environmental concentrations of EE2 (10 ng/L) lead to 
disruption in gonad development in adult fish, causing vitellogenin synthesis induction, 
formation of ovarian-like cavity and spermatogenesis retardation in males. Furthermore, 
three-spined stickleback exposed to EE2 (1.75 and 27.7 ng/L) for the first 4 weeks post-
hatch, exhibited alterations of adult reproductive performances, even in fish without 
histopathological alteration of the gonad (e.g. intersex) (Maunder et al., 2007).       
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A further factor to take into consideration is the potential bioaccumulation of the drug in 
the fish; in fact, dutasteride is a highly lipophilic molecule, and excretion studies 
performed in humans showed 55% of the administered dose is subject to bioaccumulation 
in the patient‟s body (range 5% to 97%); furthermore, terminal elimination half-life of 
dutasteride was approximately 5 weeks at steady state, and serum concentrations of 
dutasteride remained detectable for up to 4 to 6 months after termination of the treatment. 
If a similar bioaccumulation pattern happened in fish, dutasteride may have exerted its 
effects even weeks after the termination of the exposure. However, the weight of the fish at 
the end of the exposure (28 dph) was approximately 100 times lower than the weight of 
fish sampled at 160 dph, suggesting that the potentially bio-accumulated dutasteride would 
have been subject to “dilution” with the passing of time.   
5.6 Conclusions  
In this study we have demonstrated that the exposure to dutasteride during early life stages 
of fathead minnow can negatively affect larval/juvenile growth and survival. However, the 
drug exerted these effects only after the embryos hatched, suggesting that the chorion 
surrounding the developing embryo may act as a barrier to the penetration of dutasteride 
into the embryo. The LOEC survival and LOEC growth were respectively of 100 and 32 µg/L. 
Interestingly, the exposure of the fish to dutasteride from egg to 28 dph produced long term 
effect on the gametogenic processes of adult fish, providing new interesting details on the 
consequences of the exposure of fish to anti-androgens, and raising new questions on their 
mechanisms of action. 
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CHAPTER 6 : EFFECTS OF DUTASTERIDE ON 
FATHEAD MINNOW REPRODUCTION AND F1 
GENERATION HATCHABILITY 
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6.1 Introduction 
6.1.1 Vertebrate reproduction and endocrine disrupting chemicals  
The development of a reliable testing system able to identify chemical compounds with the 
capability to interfere with reproductive functions is one of the highest priorities among 
scientists and environmental/regulatory agencies, because of the growing awareness of the 
potential long-term effects of EDCs on wildlife and human reproductive health.  
Reproduction of vertebrates is regulated by the hypothalamic-pituitary-gonadal (HPG) axis 
through a cascade of hormones and feedback control mechanisms, as described in Chapter 1. 
Any interference with this complex, multi-organ, biochemical/molecular network could 
negatively affect vertebrate reproduction, with a consequent alteration of population 
dynamics. Furthermore, since human reproduction is controlled by the same signalling system 
as in other vertebrates, the same interference (e.g. environmental pollutants) could also 
influence human reproduction, for example, by causing a decrease of fertility, or, more 
generally, playing an important role in the aetiology of human pathologies strictly correlated 
to alterations of the endocrine homeostasis (e.g. cancer of prostate, testis, breast).  
During the last two decades, human fertility rates – defined as births per woman - have been 
showing a general declining trend all over the world (Skakkebaek et al., 2005; World Bank, 
2011). However, it is generally assumed that these trends are driven by social and economic 
changes, such as the spread of contraception systems, women‟s emancipation and 
participation to the work force, or increased education level (Skakkebaek et al., 2005). The 
role of biological/environmental factors in the process of declining fertility rates has been 
poorly considered, even in cases where the drop of the fertility rates is so dramatic to suggest 
an alternative or additional explanation to the more classic ones, like the increased use of 
contraceptive systems (Andersen and Erb, 2006; Rosenfield and Schwartz, 2005).  
It is nevertheless true that there has been a continuous increase in the amount of 
epidemiological evidence that human reproductive health, particularly in the Western world, 
is declining. A striking example is the case of Denmark, where the reproductive status of the 
population has been monitored and deeply studied for decades. Sperm counts in the infertile 
range are present in more than 10% of Danish men, and up to 30% of them have sperm counts 
in the sub-fertile range (Jorgensen et al., 2006). The decline of fertility is parallel to the 
significant increase in the number of couples undergoing infertility treatments in Western 
Countries, and particularly in Denmark, where during 2002–2004 more than 6% of children 
were born thanks to assisted reproduction (Andersen and Erb, 2006). It is important to 
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highlight that among the various treatments to cure infertility, a significant increase in 
demand for intra-cytoplasmatic sperm injection (ICS) has occurred, which suggest an 
increasing number of couples with male fertility problems, in particular poor semen quality 
and testicular failure (Andersen and Erb, 2006; Skakkebaek et al., 2005). In the same country, 
epidemiological studies showed how, during the last century, there has been an increase in 
pathological conditions like congenital genital abnormalities (e.g. cryptorchidism and 
hypospadias), testis cancer, and infertility (Moller, 1993; Richiardi et al., 2004; Toppari et al., 
2001), which taken altogether constitute the pathology named as “testicular dysgenesis 
syndrome” (TDS) (Sharpe & Skakkebaek, 2003; Skakkebaek et al., 2001). There is growing 
evidence that these conditions are related to an impaired fetal gonadal development and 
function, due to maternal exposure to environmental chemicals (Hardell et al., 2003; Fisher et 
al., 2003; Foster et al., 2001; Skakkebaek et al., 1987). 
Other data suggest that the female reproductive system, in some Western countries, is also 
facing important changes which could be caused by environmental factors, including 
chemicals in the environment, but their impact on fertility/fecundity is difficult to quantify. 
For example, in Europe and United States, median age at menarche and first breast 
development are steadily decreasing, and estrogenic chemicals present in the environment 
could have a role in this trend (Aksglaede et al., 2009; Herman-Giddens et al., 1997; Parent et 
al., 2003; Partsch and Sippell, 2001; Proos et al., 1991). However, there are many 
controversies about the use of the endocrine disruption hypothesis to explain the decrease of 
human fertility (in particular in males), and a considerable debate is currently ongoing in the 
scientific community. For example, Joffe (2010) argued that the influence of environmental 
endocrine disruptors on male fertility is very minor compared to other factors, like DNA 
damage of germ cells (spermatids) via oxidative stress caused by a number of etiological 
agents present in the environment or in the food, like tobacco smoking,  cis-unsaturated fatty 
acids, glycidamide - a metabolic product of acrylamide especially present in starchy food 
cooked at high temperature (including chips and crisps) (Wang et al., 2010) - and heat (e.g. 
increase of intra-scrotal temperature caused by sedentary life-style) (Aitken et al., 2006; 
Bujan et al., 2000; Mieusset et al., 2007). 
A further issue is the difficulty in proving that one or a few specific chemicals present into the 
environment are directly linked with a negative health effect, since humans, like wildlife, are 
exposed to hundreds or thousands of chemical compounds simultaneously, so isolating the 
effects caused by one or few of them will always be very difficult. However, this multi-
exposure should increase the concern, and the critical question is whether or not wildlife and 
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human health is at risk from chronic exposure to low doses of these compounds, either alone 
or in mixtures (Brian et al., 2005; Sumpter and Johnson, 2008). 
Despite all the controversies, characterizing the toxicity profile of chemicals introduced into 
the environment or in the food chain has a critical importance in terms of human and wildlife 
health preservation; in particular, when these chemicals have the potential ability to disrupt 
critical processes, such as reproduction. 
6.1.2 Teleost fish reproduction in the regulatory context 
From the regulatory point of view, the OECD has recently approved two Test Guidelines 
(TGs) for the testing and assessment of endocrine active chemicals on fish reproduction: 
TG229 and TG230, known also as “Fish Short Term Reproduction Assay“, and “21-day Fish 
Assay”, respectively (OECD, 2009). TG230 is designed to screen only substances with 
estrogenic, androgenic, and aromatase inhibitor activity, while TG229 is designed to detect 
the action of substances that impact reproduction of fish by different mechanisms of action, 
including endocrine interference. TG229 includes a higher number of endpoint compared to 
TG230, including fecundity and gonad histopathology. 
6.1.3 Fish reproduction and anti-androgens 
The importance of androgens in fish sex differentiation, development, puberty and sexual 
maturation was described in Chapter 5. Androgens also have a critical role during the 
reproductive phase, acting both directly and indirectly, as precursors in the synthesis of other 
steroids, on many physiological processes. In adult males, testicular androgens are required 
for the maintenance of many reproductive functions, including sperm production, sex 
accessory gland secretion, muscle mass and strength, and behavior. The latter is of critical 
importance, since the disruption of processes like courtship, territoriality, and aggression 
could indirectly affect reproductive activity (Borg, 1994; Breton and Sambroni, 1996; 
Trudeau et al., 1991). The presence of the AR in the reproductive tissues of many female 
vertebrates, including fish, suggests that androgens could play an important role in the 
regulation of female physiology (Nitta et al., 1991; Staub and DeBeer, 1997; Tetsuka and 
Hiller, 1996). The androgen KT has also been found in several female fish (Lokman et al., 
2002); however, its physiological role, if any, in females is still unclear. There is some 
evidence showing that KT plays a role in controlling growth of pre-vitellogenic oocytes in 
immature female fish (Kortner et al., 2008; Matsubara et al., 2003), and these data were 
confirmed in our experiments, as described in Chapter 4.  
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Several EDCs have been tested for reproductive toxicity in fish short-term reproduction 
assays using fathead minnow, zebrafish, and medaka. The majority of these studies conducted 
up to 2009 are listed in the review published by Dang et al. (2011), and the list is 
continuously growing. Among the various anti-androgens, the human pharmaceutical 
flutamide has been proposed as a model AR antagonist for EDCs research, on the basis of 
studies in mammalian systems (Ankley et al., 2004). Flutamide and/or its 2-hydroxylated 
metabolite bind with high affinity to mammalian ARs in vitro and is able to block the 
expression of AR-mediated responses in vivo (Katchen and Buxbaum, 1975; Neri, 1989). 
Flutamide has been tested on fish with the hypothesis being that it exerts its effects via the 
same MoA as it displays in mammals, and some in vivo studies have partially confirmed this 
hypothesis (Bayley et al. 2002; Jensen et al., 2004; Kang et al., 2006; OECD, 2006; Sebire et 
al., 2008). Considering the binding affinity to fish ARs, some studies indicate that flutamide 
and it metabolite, hydroxyflutamide, bind fathead minnow AR, and that the metabolite has 
higher affinity than the parent compound (Ankley et al., 2004; Makynen et al., 2000), while 
other studies indicate little specific binding of flutamide to ARs present in cytosolic fractions 
of rainbow trout and goldfish (Wells and Van der Kraak, 2000).  
Another AR antagonist tested on fish was vinclozolin, a fungicide commonly used in 
vineyards. It has been shown that exposure to this compound can alter fish reproduction at 
different organisational levels, for example, courtship behavior of male guppy (Baatrup and 
Junge, 2001), or fecundity and gonadal condition (GSI, histology) of female fathead minnows 
(Makynen et al., 2000; Martinovic et al., 2008). However, Makynen et al. (2000) found little 
competitive binding affinity of vinclozolin or its metabolites to the fathead minnow AR at the 
concentrations tested in vivo. 
Other than the chemicals directly interacting with the androgen receptor, few other 
compounds with different mechanisms of androgen inhibition have been tested in fish. 
Inhibitors of steroidogenic cytochrome P450s (CYPs), including fadrozole, prochloraz, and 
ketoconazole, caused reduced fecundity of fathead minnows over the course of a 21-day 
reproduction test (Ankley et al., 2002, 2005, 2007). The reproductive impact of this class of 
inhibitors is consistent with the important roles played by their enzymatic targets. For 
example, CYP11A (cholesterol side chain cleavage) and aromatase (CYP19a, CYP19b) are 
involved in the production of steroids and E2, respectively. CYP17 α-hydroxylase/17, 20-
lyase is a key element in the steroidogenic pathway that produces progestin, which is needed 
to support final germ cell maturation (Miller, 1988, 2005; Pandey and Miller, 2005; Patiño et 
al., 2001; Scott et al., 2010; Villeneuve et al., 2008).  
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Up to date, only one study is available in the scientific literature investigating the effects of 
the inhibition of hydroxysteroid dehydrogenases (HSD) on fish reproduction (Villeneuve et 
al., 2008), which involved exposing fathead minnow to trilostane, a human pharmaceutical 
acting through specific inhibition of 3β-hydroxysteroid dehydrogenase (3β-HSD), and  which 
is mainly used for treatment of Cushing's disease and breast cancer.  The HSD family play 
critical roles in the steroidogenic process (Miller, 1988, 2005), and in particular, 3β-HSD/Δ5-
Δ4 isomerase converts Δ5-3β-hydroxysteroids (e.g., pregnenolone, 17α-
hydroxypregnenolone) into Δ4-3-ketosteroids (e.g., progesterone, 17α-hydroxyprogesterone, 
androstenedione) (Norris, 2007). The potential relevance of inhibition of other steroidogenic 
enzymes is less clear. 
6.2 Aim 
Chemical interference with the vertebrate hypothalamic-pituitary-gonadal (HPG) axis can 
cause several adverse developmental and reproductive effects. To date, the majority of the 
work with HPG-disrupting chemicals in fish has focused on those interacting with the ER 
(agonists and antagonists), and to a lesser extent, the AR. However, alterations in the 
synthesis of key molecules within the axis, including DHT, can also perturb the HPG 
function. Dutasteride is a pharmaceutical used as inhibitor of the 5α-reductases, the enzymes 
converting T into DHT, and is usually employed in the treatment of prostatic diseases (e.g. 
prostate enlargement, prostate cancer). While it is unlikely to be environmentally relevant as a 
contaminant, dutasteride is well suited as a model chemical since it is a highly specific 
inhibitor of 5α-reductases (GSK, 2001). Given the specificity of the mode of action, this study 
represents the first robust test of the hypothesis that interference with the synthesis of DHT, 
through the inhibition of 5α-reductases, could cause reproductive dysfunction in the teleost 
fathead minnow. 
6.3 Methods 
6.3.1 Test species 
Fathead minnows were supplied from breeding stocks maintained at Brunel University, 
London, UK. Two weeks before the beginning of the study, sexually mature males and 
females were separated to prevent any spawning activity and acclimated to the test conditions. 
Fish were fed three times per day, once with adult brine shrimp (Tropical Marine Centre, 
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Gamma irradiated) and twice with flake food (King British Tropical flake food, Lillico, 
Surrey). Fish were not fed on the sampling day. 
6.3.2 Test substances and dilution water 
The test substance, dutasteride (CAS number 164656-23-9), was obtained from 
GlaxoSmithkline (GSK) as 99.9% pure. Concentrated stock test solutions were prepared in 
N,N-Dimethylformamide (DMF, CAS number 68-12-2, ≥99%) (Sigma, Poole, UK). One 
master concentrated stock solution (10.0 g/L) was made in DMF, stored at +4
◦
C, and used to 
make up fresh dosing stock solutions at 0.4, 1.28, and 4 g/L. Fresh dosing stock solutions 
were made up weekly, in order to avoid potential degradation in the stock bottle.  The dilution 
water was monitored for general parameters (e.g. pH, hardness, conductivity). During the 
exposure studies, mean water pH ranged from 7.6 to 8.1, temperature from 24.79 to 26.12 ºC, 
and dissolved oxygen from 7.06 to 7.95 mg/L. 
6.3.3 Test conditions – Fish short term reproduction assay 
The 21-days reproduction study was performed using a protocol proposed by Harries et al 
(2000) and Ankley et al (2001), and subsequently adapted by Winter et al (2008). The 
experiment was carried out using a continuous flow-through system, as described in Chapter 
4. The test apparatus was comprised of glass fish tanks (8 per treatment) with a working 
volume of 10.5 L. A spawning U-shaped PVC tile and a collection tray were placed in each 
tank. The collection tray consisted of a rectangular glass tray (110mm×110mm×20mm) 
covered with a 0.5 cm
2
 stainless steel mesh. The tile was used as the nest-site for spawning, 
while any eggs that fell off the tile were collected in the underneath tray; the mesh allowed 
eggs to be trapped into the tray, without them being affected by the fish (Fig. 6.1). Thorpe et 
al. (2007) demonstrated that this type of system of egg collection is highly robust and reduces 
the variability of egg numbers produced per couple per batch. Screens were placed between 
all test vessels to prevent fish visually interacting with those in neighbouring tanks and to 
minimize disturbance due to operator movements.  
 181 
 
 
Figure 6.1. Spawning tank with male and female fathead minnow. Following male courtship 
behaviour, females lay adherent eggs on the undersurface of the tile. Males guard the spawning site 
and are strongly territorial during the spawning period. The spawning site is made of (A) spawning 
tile, (B) metal mesh and (C) glass tray. The base is designed to contain any eggs that do not adhere to 
the tile surface and would therefore fall to the bottom of the tank (or those eggs laid directly onto the 
flat metal base). 
Thermostatically heated (25 ± 1
o
C) dechlorinated tap water from a header tank flowed 
through 6 flow-meters into six glass mixing chambers at a rate of 600 mL/min. The same 
chambers also received test chemicals stock solution in DMF at a rate of 0.015 mL/min, in 
order to achieve the desired nominal concentrations. Separate lines from each mixing chamber 
supplied about 12 tank volumes changes per day to each of eight replicate test vessels. The 
final experimental set up included five groups: one dilution water control group (DWC), one 
solvent control group (SC), and three dutasteride exposed groups (10, 32, 100 μg/L). The SC 
vessel received the same rate of addition of DMF, such that the water in all test vessels 
contained DMF at 0.0025% (OECD suggested limit: 0.0095%).  The test was run at a nominal 
water temperature of 25 ± 1 °C, with a photoperiod of 16 hours light: 8 hours of dark, and 
with 20 minute dawn/dusk transition periods. The light intensity at the surface of the test 
vessels was measured by a lux meter (Lutron, LX-101) once a week during the study, and was 
740 ± 120 lux (n = 6). 
 
 
A 
C 
B 
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6.3.4 Exposure protocol 
To initiate the test, one male and one female fish were randomly selected and placed in each 
tests vessel; there were eight pairs for each concentration of dutasteride and for the control 
groups. The fish were then left to acclimate with minimal disturbance for 3 d, during which 
the fish were just fed (no cleaning or measurement of any reproductive parameters were 
undertaken). After 3 d, the fish were then left for a further 11 d to assess breeding 
compatibility via observations of normal breeding behaviour, egg number, egg quality (e.g. 
viability and the presence of abnormalities) and spawning success (e.g. whether the female 
laid eggs on the spawning tile). During this pre-acclimation period, “spare” pairs of fish were 
held under identical conditions as the others, until successful breeding was confirmed in all 
test vessels. Any fish that did not meet these requirements was replaced by one of the spare 
fish, with all movements being recorded. The spawning data from this period, although 
recorded, were not used in the final analysis to assess the effect of the test chemical on 
reproductive performance. 
After the acclimation period of 14 days, fish reproductive performances were assessed during 
a 21-day pre-exposure period, a 3-day transition (when dosing of dutasteride was started to 
allow the system equilibration), and a further 21 days of exposure to dutasteride. Each day the 
spawning tiles and the collection trays were removed from each tank, and if eggs had been 
laid, the apparatus was replaced with a clean set. Under microscope observation, the number 
of fertilized, non-fertilized, and dead eggs were counted, with the help of a ticker counter. 
Furthermore, fish behaviour was daily monitored (e.g. feeding behaviour, male 
aggressiveness), and any abnormal situation recorded. A schematic representation of the 
experimental protocol is represented in Figure 6.2. 
 
Figure 6.2. Schematic representation of the fish short term reproduction assay, showing the different 
phases of the experiment, including the acclimation phase, breeding compatibility assessment, 
baseline, transitional and exposure periods. Only data from the baseline and exposure period were 
analysed. Data from the transitional period were collected, but not used for the statistical analyses. 
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6.3.5 Fish sampling  
After 21 days of exposure to dutasteride, fish were terminally anaesthetized using Ethyl 3-
Aminobenzoate Methanesulfonate salt (MS-222, 0.5 g/L; adjusted to pH 7.5 with 1M NaOH) 
(Sigma, Poole, UK; CAS No: 144-55-8). Once the male appeared to be listing and hence 
under anaesthesia, sperm samples were collected using a 5 l graduated capillary tube (Sigma 
Aldrich, Z611239-250EA) with the volume collected noted, using the protocol described by 
Kime et al. (2001) and Hala et al. (2010). Briefly, the fish was removed from the anaesthetic 
solution and its ventral surface dried by using absorbent paper, in order to avoid potential 
activation of sperm motility by inadvertently contaminating the milt sample obtained with 
water. The male was subsequently placed onto its dorsal surface and held firmly within a slit 
cut into a normal domestic dish-washing sponge. The lower abdomen surrounding the 
urogenital opening was once again dried of excess moisture, and milt was obtained by gently 
compressing the abdomen uni-directionally from just below the pectoral fins toward the uro-
genital opening. The collected milt was expelled into a microfuge tube and diluted 1:50 in 
cold Catfish extender (94mM Sodium Chloride, 27 mM Potassium Chloride, 15mM Trizma 
Hydrochloric Acid and 50 mM Glycine pH to 7.5) and then stored at +4 
o
C until density and 
motility analyses were conducted (22 hours later).  
After trans-spinal severance, blood samples were collected from each fish via the caudal 
peduncle using 75 μl heparinized capillary tubes and decanted into eppendorfs containing 
aprotinin (Sigma), then stored on ice until centrifugation at 7,000 × g for 5 min at 4ºC. The 
resulting plasma samples were subsequently stored at −20 °C until analysis for steroid levels 
by radioimmunoassay (RIA) (Scott et al., 1984), and determination of VTG protein levels by 
ELISA (Biosense Laboratories AS, Bergen, Norway). After blood collection, all fish were 
measured for wet weight (g) and fork length (mm), and these parameters were used to 
calculate the CI as described in Section 4.3.3. The liver was immediately extracted for 
molecular analyses, promptly weighed and then frozen in liquid nitrogen before being stored 
at -80
o
C. Its weight was used to calculate the hepatosomatic index (HSI = liver weight (g) / 
body weight (g) × 100).  The gonads were subsequently extracted, weighed to determine the 
GSI (GSI= gonad weight (g) / body weight (g) × 100), fixed in Bouin‟s solution for 6 hours, 
and stored in IMS 70% until histopathological analyses. Finally, the expression of SSCs was 
recorded for every fish, including number and prominence of nuptial tubercles, black dorsal 
fin spot occurrence, fatpad presence and weight (Smith, 1978). 
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6.3.6 F1 generation hatchability trials  
In addition to assessing adult fish reproductive performance, specific batches of eggs were 
subjected to hatchability trials to assess early embryo-larval development, during both 
baseline and exposure periods. The protocol used was a modification of the one described by 
Winter et al. (2008). During the baseline period, all the fish pairs were assessed in order to 
define the quality of the spawning batches (e.g. number of dead or non-fertilized eggs) and 
embryos hatchability success. After the first two spawning assessment, the 3 best couples in 
each treatment group were selected, and the following hatchability trials were performed only 
on batches of egg from those fish pairs until the end of the study. This strategy was required 
because a great variability was observed in the quality of embryos spawned by different fish 
pairs.  
During the baseline period, for each hatchability trial, 60 viable embryos were randomly 
selected from the tile, and these were placed in 3 replicate wells of a sterile 6 well plate 
(Greiner Bio-One Ltd., UK) with a total volume of 16 mL/well, and incubated at 25 
◦
C (20 
embryos per well). Embryos were incubated in the water taken from the parental tank, and the 
incubation solution in each well was replaced daily. If the number of eggs on the tile was 
insufficient to provide 60 fertilized eggs, they were taken from the tile and/or the mesh. For 
each fish pair, a gap of one spawning event was included between two hatchability trials. 
Embryos were observed daily for mortalities and abnormalities, and dead ones were removed 
in order to prevent fungal infections. Embryos were incubated until complete hatching, and 
when at least 90% of embryos were hatched, the hatching time was recorded. The newly 
hatched larvae were assessed for morphological abnormalities, and survival until hatching 
was complete (normally within 2 days from the first hatching event). Following the 
assessment of hatchability, all larvae were sacrificed using an overdose of anaesthetic (0.5 g/L 
MS222 in dilution water, adjusted to pH 7.5 with 1M NaOH). 
During the exposure period, the hatching trials were performed as described before, with only 
one modification of the protocol. During this phase, and only for the pairs exposed to 
dutasteride, 120 eggs were collected from each spawning event, and randomly allocated in 6 
replicate wells containing 20 embryos each. Three replicate were incubated in clean dilution 
water, while the other three were incubated in parental tank water (containing dutasteride), in 
order to evaluate the effect of the drug on the hatching ability. All the incubation solutions 
were replaced daily.     
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6.3.7 Sperm analyses  
6.3.7.1 Sperm samples preparation and motility video-recording  
A video-camera mounted Olympus BH-2 microscope (Olympus, Tokia, Japam), with 
negative phase contrast and heated stage, was attached to a monitor and a compact-disc (CD) 
recorder was used to observe and record the motility of fathead minnow spermatozoa. Diluted 
milt samples (1:50) in microfuge tubes were resuspended, and a 10 μl aliquot of the sperm 
suspension was diluted a further 1:2 with 10 μl of aquaria tank water (maintained at 25oC) in 
order to induce motility. Immediately after this dilution step, a 1 μl aliquot was taken and 
placed onto a single well of a dipped multi-well slide (12- Well Multi-Test Slide, ICN 
Biomedicals Inc., Cat. No. 6041205E) and covered with a Bovine Serum Albumin (BSA, 
Sigma, Cas. No. 9048-46-8) coated coverslip (prepared by washing in 1% BSA). Motile 
sperm cells visible within the frame of view (10X objective with a 2.2 column) were recorded 
for 5 minutes. The heated stage of the microscope was maintained at 25
o
C throughout the 
duration of the sperm cell motility recordings.  
6.3.7.2 Sperm Tracking and the CASA System  
The sperm tracking was carried out using The Hobson Sperm Tracker (Hobson Vision 
Systems, Sheffield, UK). The computer-assisted sperm analysis (CASA) system was used to 
record the movement of sperm. The recordings were replayed and tracked for set time 
increments using tracking software which tracks individual spermatozoa and calculates 
various motility parameters (Kime et al. 2001). Sperm quantity and quality parameters 
included milt volume (µL), sperm concentration (cells/ml) and sperm motility parameters 
(Fig. 6.3), including:  
VCL (µm s
-1
) = Curvilinear Velocity, which constitutes the sum of incremental 
distances moved by a spermatozoa along a trajectory for each time frame divided by the 
time taken to cover that particular trajectory.  
VAP (µm s
-1
) = Average Path Velocity, which is a velocity over a calculated, smoothed 
path, i.e. a shorter distance than that used for calculating VCL. 
VSL (µm s
-1
) = Straight Line Velocity, the straight-line distance between the start and 
end of a trajectory divided by the total track time.  
LIN (%) = Percentage Linearity of motion, expressed as a percentage, is described as 
the straight-line distance between the start and endpoints of a track divided by the sum 
of the incremental distances along the path of trajectory (VSL/VCL×100). 
 186 
 
STR (%) = Straightness, the straightness of the average path (VSL/VAP×100). 
MOT (%) = percent motility expressed as a percentage, it is the number of motile cells 
divided by the total numbers of cells visible in the analysis field (motile and immotile).  
The recorded video sequences of motile sperm cells were tracked in 15 second time 
increments up to 2 minutes (Kime et al. 2001).  
6.3.7.3 Calculation of sperm concentration    
Sperm counts were conducted on a Neubauer haemocytometer by diluting the already diluted 
milt (1:50) a further 1:2 in cold catfish extender (10 l diluted milt + 10 l extender) in a 
microfuge tube. A 15 l aliquot of this diluted milt was allowed to flood one chamber of the 
Neubauer haemocytometer. Spermatozoa were counted after allowing 1-2 minutes for the 
cells to settle. Sperm cells were counted on an Olympus (BX50) microscope (with a 40X 
objective) coupled to a camera and JVC TV monitor. Sperm cells occupying the central grid 
of 25 hatched squares (5x5 squares) of the flooded chamber were observed. Within this grid 
of 25 squares, spermatozoa were firstly counted in the first square of the grid (top/left corner 
of the 25 hatched squares) using the following rules: if < 10 spermatozoa were counted in this 
first square, then a total cell count was conducted in all 25 squares and averaged; if 10-40 
spermatozoa were counted then total counts in 10 squares were averaged; if >40 spermatozoa 
were counted, then total counts of 5 squares were averaged. The average number of 
spermatozoa counted within the volume of the 25 square counting grid (0.1 l) were 
expressed as counts x 10
4 
cells/ml (average spermatozoa counts in 0.1 l x 10 000 = cells in a 
1 ml volume). This count was finally corrected for the 1:50 dilution of milt in extender and 
then the 1:2 dilution prior to conducting the cell counts (Fig. 6.4). 
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Figure 6.3. Quantification of sperm motility using computer-assisted sperm analysis (CASA). a) 
Example of fish sperm observed using an Olympus BH-2 microscope equipped with a negative phase 
contrast objective (10X). b) Definition of sperm tracks and related parameters. VCL, curvilinear 
velocity; VSL, straight-line velocity; VAP, average path velocity. The blue circles show the position of 
the sperm head centroid in each frame (from Tablado et al., 1996). 
 
 
 
 
A) 
B) 
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Figure 6.4. View of the haemocytometer grid system, with a progressive zoom on the area if interest. 
The green colour indicates the area of the grid used for the sperm count. (A) The haemocytometer is 
0.1 mm deep and the 25 large squares represent an area of 1 square mm; the volume above the 25 
squares shown is 0.1 µl.(B) Assuming that the count of the sperm was performed in 5 squares, it gives 
an estimate of the sperm present in 0.02 µl (0.1/5 = 0.02). (C) Each of the 5 squares is divided in 16 
further squares. This value multiplied by 50,000 gives the number of spermatozoa present in 1.0 ml. A 
visual example of sperm counted in one of the 5 squares is illustrated in (D). 
6.3.8 Gonad histopathology 
Three slices of 3-4 mm thickness were transversally cut from the each gonad, dividing it in 
anterior, median, and posterior parts. Slices were prepared for the histopathology analyses 
following the method detailed in Section 4.3.6, and analysed according to the EPA guideline 
described in the same section (EPA, 2006).  
6.3.9 Determination of circulating plasma steroid concentrations 
Circulating plasma levels of T, KT and E2 in males and females were quantified by specific 
radioimmunoassays, as described in Section 4.3.5.  
 
 
A) 
D) 
B) 
C) 
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6.3.10 Plasma vitellogenin quantification 
VTG protein levels were quantified using a specific fathead minnow VTG ELISA kit 
(Biosense Laboratories AS, Bergen, Norway), following the instruction of the manufacturer. 
6.3.11 Chemical analyses of water concentrations of dutasteride 
Water samples were randomly collected from four out of eight replicates per treatment on day 
0, 4, 7, 14 and 21.  The concentrations of dutasteride were measured by LC-MS/MS.  
6.3.12 General statistical analyses   
Statistical analyses were conducted using SigmaStat software (version 3.5, Systat Software 
Inc., Germany). Data for sperm cell count, wet weight, standard length, condition factor, GSI, 
HIS, SSCs, VTG in females, and plasma steroid concentrations were analysed for normality 
(Kolmogorov-Smirnov test) and variance homogeneity (Levene‟s test). Where assumptions of 
normality and homogeneity were met, one-way analysis of variance (ANOVA) was followed 
by the Dunnett‟s test to compare the treatment means with respective controls. Where the 
assumptions were not met, data were analysed using a non-parametric test, Kruskal–Wallis 
ANOVA on Ranks, followed by Dunn‟s post-hoc test (Zar, 1999). Effects of treatments on 
the most advanced stage of gametogenesis, and dominant germ cell, were analysed using a 
variation of the chi-squared test, the randomization test of goodness of fit with Montecarlo 
simulation (n = 10,000) (McDonald, 2009). Statistical comparisons were made to determine if 
there were significant differences between the DWC and SC, by t-test or, in case of non-
normal and non-homogeneous data, by Mann-Whitney Rank Sum test. 
Reproductive performances, in particular total and mean (both per pair and per treatment) egg 
production, number of batches of eggs, fertilization success, F1 hatchability and larval fish 
survival (% of hatched fish that survive to 48 h post-hatch), were analyzed to compare pre-
exposure versus exposure data within and among treatment groups. Where assumptions of 
normality and homogeneity were met, t-test and One-Way ANOVA followed by a Dunnett‟s 
test were performed to compare, respectively, two or multiple groups; if the assumptions were 
not met, data were analysed using non-parametric Mann-Whitney Rank Sum test and 
Kruskal–Wallis ANOVA on Ranks followed by Dunn‟s test for pairwise or multiple 
comparisons respectively. 
Where necessary, data were log-transformed for normalization and to reduce variance 
heterogeneity and percentage data were arc sine transformed. The results are reported as 
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means ± standard error of the mean to indicate the precision of the mean estimate. Statistical 
significance was set at a level of p = 0.05, unless otherwise indicated. 
6.3.13 Statistical analyses of sperm motility data  
6.3.13.1 Analysis of motility parameters (VCL, VAP, VSL, LIN, STR, MOT). 
Approach 1: Sperm populations from all the replicates in each treatment were considered and 
analysed as a single group (n = 8). 
Approach 2: Mean values of each parameter was calculated for the sperm population of each 
single fish, and combined according to the treatment (n = 8). 
Approach 3: Mean values of each parameter was calculated for the sperm population of each 
single fish, and combined according to the treatment (n = 8). In each treatment group, samples 
presenting a number of tracks < 35 were removed (DWC = 0, SC = 1, D10 = 2, D32 = 2, 
D100 = 2). 
All the data were tested for normality and equal variance (percentage values were log 
transformed). Where assumptions of normality and homogeneity were met, one-way analysis 
of variance (ANOVA) was followed by the Dunnett‟s test to compare the treatment means 
with respective controls. Where the assumptions were not met, data were analysed using a 
non-parametric test, Kruskal–Wallis ANOVA on Ranks, followed by Dunn‟s post-hoc test.  
6.3.13.2 Pattern Analysis:  PATN 
A detailed description of the analyses is given by Abaigar et al. (1999) and Holt at al. (2001). 
The motility data from all replicates were merged and subjected to multivariate analysis using 
the software PATN (CSIRO, Canberra, Australia) (Belbin, 1993). The program analyzes and 
compares the motility parameter values associated with each spermatozoon and identifies 
subgroups within the sperm population (“patterns”), which are successively subject to 
hierarchical classification. All the procedure is carried out by the program entirely 
independently of the investigator. In the present study, the groups were distinguished on the 
basis of multivariate combinations of the following motility parameters: VCL, VAP, VSL, 
LIN, and STR. 
After completion of the PATN analysis, each individual spermatozoon is categorized as 
belonging to one of the sub-groups, and the relative percentages of spermatozoa belonging to 
each group were calculated.  
 
 191 
 
6.3.13.3 Statistics of PATN results. 
Approach 1: Analysis was applied to the whole dataset, considering the sperm populations 
obtained from all the replicates as a single group (n = 8). Data were analyzed using a chi-
square test for goodness-of-fit (McDonald, 2009). 
Approach 2: Relative percentages of sperm classified into different groups were calculated for 
each individual sample. The single values were combined by treatment, log transformed, 
checked for normality and homogeneity, and analyzed by One-Way ANOVA (n = 8) followed 
by Dunnett‟s Test.     
6.3.13.4 Analysis of sperm populations in a 2-dimensional graph (LIN by VAP). 
Sperm populations from all the replicates in each treatment were considered as a single group 
(n = 8).      
6.4 Results 
6.4.1 Water concentrations of dutasteride 
Water analysis showed that fish were exposed to the test substance in the expected range of 
concentrations and that there was no contamination of control tanks with dutasteride (Table 
6.1).  
6.4.2 Morphometric endpoints 
At the end of the exposure phase, the somatic endpoints (length, weight, CI, GSI, HSI) were 
not significantly affected in male and female fish exposed to dutasteride, when compared to 
the SC, except the GSI of females exposed to the highest concentration of the drug (100 
µg/L), which showed a significant increase (p = 0.034) (Table 6.2).   
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Table 6.1. Measured water concentrations (µg/L) of dutasteride during the exposure period, measured 
by LC-MS-MS. 
 
 
Exposure Day 
 
 
Replicate 
Nominal concentrations of dutasteride (µg/L) 
  DWC   SC     10     32        100 
0 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
14.4 
13.0 
 
37.8 
35.3 
 
116.9 
125.5 
 
C 
D 
< 0.5 
< 0.5 
< 0.5 
< 0.5 
 
13.9 
-- 
 
39.5 
37.1 
 
125.6 
104.2 
 
7 
A 
B 
< 0.5 
< 0.5 
  
< 0.5 
< 0.5 
12.6 
12.0 
 
44.8 
34.0 
 
108.0 
100.6 
 
C 
D 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
15.3 
12.2 
 
40.7 
39.1 
134.8 
112.9 
 
14 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
12.3 
11.2 
 
40.7 
39.9 
 
109.2 
130.6 
 
C 
D 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
16.0 
9.8 
 
37.6 
39.5 
 
126.2 
120.4 
 
21 
A 
B 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
  
6.9 
13.2 
 
22.4 
20.2 
 
83.2 
61.8 
 
C 
D 
< 0.5 
< 0.5 
 
< 0.5 
< 0.5 
 
15.0    
11.2 
30.9  
-- 
57.6 
54.8 
          Mean Values (µg/L) < 0.5 < 0.5 12.6 ± 0.9 35.3 ± 7.2 104.3 ± 26.9 
“--” = Sample Not Available. 
Table 6.2. Mean values (±SD) of fish fork length, wet weight, condition factor (CI), gonadosomatic 
index (GSI), and hepatosomatic index (HSI) for male and female fathead minnows exposed to 
dutasteride (10, 32, 100 µg/L) during a short term reproduction assay. 
Dutasteride (µg/L) Sex Morphometric endpoints 
  Length (mm) Weight (g) CI GSI HSI 
DWC 
M 68.00±4.28 5.97±1.28 1.88±0.25 1.79±0.27 2.38±0.58 
F 51.13±3.04 2.16±0.69 1.59±0.33 12.70±3.44 3.18±0.67 
SC 
M 67.25±5.23 6.04±1.51 1.96±0.25 1.90±0.51 2.65±0.58 
F 51.00±1.85 2.05±0.19 1.56±0.25 13.13±3.12 3.28±0.73 
10 
M 64.50±5.88 4.78±1.02 1.77±0.20 1.87±0.47 2.33±0.35 
F 53.63±2.72 2.27±0.42 1.47±0.15 13.08±3.45 3.21±0.96 
32 
M 68.50±6.67 5.87±1.93 1.76±0.18 1.73±0.40 2.24±0.53 
F 51.00±3.16 2.21±0.48 1.59±0.28 14.94±1.92 3.43±0.83 
100 
M 65.13±3.36 4.75±0.80 1.72±0.22 2.34±0.59 2.60±0.73 
F 52.88±2.90 2.27±0.31 1.55±0.24 16.57±2.69 3.08±0.90 
Asterisks (*) represent a significant difference compared to the Solvent Control (SC) (*: p < 0.05). 
* 
 193 
 
6.4.3 Effects on reproductive performance 
Cumulative egg production during both the baseline (pre-exposure) and exposure periods of 
21 days each are shown in Fig. 6.5. Egg production was similar in all five treatments in the 
baseline period. In the exposure period, the control groups – both SC and DWC - continued to 
lay eggs at the same rate as before. In contrast, egg production was significantly reduced in 
the groups exposed to dutasteride. A very pronounced effect was produced by 100 µg 
dutasteride/L (p < 0.001), with egg production slowing very markedly within the first 7 days 
of exposure. Interestingly, within this exposure group, fish responses presented a range of 
severity: two pairs had the last spawning event during the transitional period (3 days) (when 
dosing of the chemical began and its concentration was allowed to stabilize in the dosing 
system), completely ceasing spawning activity thereafter, while the remaining pairs presented 
a more progressive slowing down of egg production, but still ceasing completely egg 
production after 14 days of exposure, except one pair, which spawned on the 19
th 
day of 
exposure. Dutasteride produced a statistically significant reduction in egg production (p = 
0.038) also at 32 µg/L. Also within this group, fish responses presented a range of severity, 
and 3 out of 8 pairs did not show any significant reduction of total egg production. The lowest 
concentration of dutasteride (10 µg/L) had no effect on egg production.  
At the same time, there was a significant reduction in the mean number of spawning events 
per pair in the group exposed to 100 µg dutasteride/L (p < 0.001) when compared to the pre-
exposure phase (from 6.3 ± 0.7 during the baseline period to 2.6 ± 1.7 in the exposure period) 
(Fig. 6.6A). A similar significant reduction was recorded in the mean number of eggs per 
spawning event in the groups exposed to both 32 µg/L (p = 0.019) and 100 µg/L (p = 0.008) 
(Fig. 6.6B). The mean number of eggs produced per pair in the pre-exposure and exposure 
phases was 387 ± 106 versus 313 ± 130, respectively, in the 32 µg dutasteride/L treatment 
group, while in the group exposed to 100 µg dutasteride/L it was 373 ± 88 versus 252 ± 154.  
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Figure 6.5. Effect of different concentrations of dutasteride on cumulative total egg production during 
the fathead minnow short term reproduction assay. During the pre-exposure period, the rate of egg 
production was similar across each treatment group. Concentration-dependent effects on egg 
production became apparent within a few days of chemical exposure. *: p < 0.05 compared to the SC 
group (n = 8). 
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Figure 6.6. (A) Number of spawning events and (B) mean number of eggs spawned per pair of fathead 
minnows (mean ± SD) during the pre-exposure and exposure phases. The asterisks (*) denote a 
significant difference in each treatment group between the exposure phase and the pre-exposure phase 
(p < 0.05; n = 8). 
The exposure to dutasteride did not cause any significant effect on the percentage of non-
fertilized eggs and dead embryos in each spawning event (Fig. 6.7). In the group exposed to 
100 µg/L of dutasteride, a non-significant increase of both endpoints during the exposure 
phase was recorded, when compared with the baseline period; however, this apparent increase 
was due to the fact that in this group the size of the egg batches spawned during the exposure 
period was much smaller than their size in the baseline period, and the  spawning events with 
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a very small number of eggs, in the statistical analysis, acted as outliers, producing the large 
standard deviation illustrated in Figure 6.7 in the 100 µg/L group (exposure period) in both 
endpoints.    
 
 
Figure 6.7. (A) Percentage of non-fertilized eggs and (B) dead embryos per spawning event (mean ± 
SD) during the pre-exposure and exposure phases (n = 8). 
6.4.4 Secondary sexual characteristics 
Among the SSCs used as endpoints in this study, the expression of nuptial tubercles in males 
was the most sensitive to the exposure to dutasteride, which caused a significant decrease of 
both tubercle prominence grade (p < 0.001) and tubercles number (p < 0.001) at 100 µg/L. A 
non-significant decreasing trend was already evident at 32 µg/L. This result was reinforced by 
the procedure employed in this study to assess SSCs, involving two independent operators, 
one of whom performed a blind analysis, without knowing the identity of the samples. The 
results obtained by the two operators were compared, and the statistical analysis did not show 
any significant difference (data not shown). On the other hand, fatpad height and index in 
males, and ovipositor length in females, did not show any significant variation after the 
exposure to dutasteride (Fig. 6.8).    
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Figure 6.8. Expression of secondary sexual characteristics in fish exposed to dutasteride during a 21-
days reproduction test. (A) The grade of prominence of nuptial tubercles, (B) tubercle number, (C) 
fatpad index  and (D) fatpad height were assessed in male fish, while the ovipositor length (E) was 
assessed in females (n = 8). *: p < 0.05 compared to the SC group (n = 8). 
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6.4.5 Plasma steroid and vitellogenin concentrations 
Dutasteride induced different responses in males and females (Fig. 6.9). In males, plasma 
concentrations of T were significantly reduced by the exposure to 100 µg dutasteride/L (p = 
0.016); while KT concentration was reduced at both 32 µg/L (p = 0.025) and 100 µg/L (p = 
0.002). The exposure to 100 µg dutasteride/L produced a reduction of both androgens 
concentrations of 50% circa compared to the concentrations detected in the SC group. 
Concentrations of plasma E2 were not affected by the exposure to the drug in males, even if a 
non-significant decrease was observed in fish exposed to 32 and 100 µg/L. 
In females, the exposure to 100 µg dutasteride/L caused a significant decrease of circulating 
E2 (p = 0.042) and increase of T (p = 0.011), while VTG concentrations in the plasma were 
not affected by any of the dutasteride concentrations used in this study.  
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Figure 6.9.  Effect of dutasteride exposure on plasma concentrations of (A) E2, (B) T and (C) KT in males and on plasma concentrations of (D) E2, (E) T and (F) VTG in 
females at the end of a fathead minnow short term reproduction assay. Boxes represent median (full line), and mean (dashed line) with 25th and 75th percentiles. *: p < 
0.05 (n = 8). 
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6.4.6 Gonad histopathology 
6.4.6.1 Males 
Histological assessment of the testes did not show any significant differences among 
treatments. All the testes were at an advanced stage of spermatogenesis, spermatozoa were 
abundant and represented the dominant germ cell in all the samples (Fig. 6.10). No signs of 
pathological conditions were present in any treatment group. The thickness of the germinal 
epithelium, consisting of multiple spermatocysts in various phases of development, showed 
similar variability range among treatments; furthermore, no significant differences were 
observed in the proportional distribution of spermatogenic cell types.      
 
 
Figure 6.10. Transverse sections of fathead minnow testes (A,C ) from the Solvent Control group and 
(B,D) from the group exposed for 21 days to the highest concentration of dutasteride (100 µg/L). At the 
end of the exposure phase, the males in all the treatment groups had testes in an advanced stage of 
spermatogenesis; spermatozoa were abundant and represented the dominant germ cells in all the 
samples. No signs of pathological conditions were present in any treatment group. 
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6.4.6.2 Females 
The ovaries of female fathead minnow exposed to 100 µg dutasteride/L exhibited a 
significantly decreased proportion of vitellogenic oocytes when compared with fish in the SC 
group (p = 0.048) or DWC group (p = 0.007) (Fig. 6.11 & 6.12). The ratio between the 
number of vitellogenic and pre-vitellogenic oocytes ranged between 0.93-4.64% in the SC 
group versus 0.03-1.65% in the group exposed to the highest concentration of dutasteride; this 
decrease was mainly due to a significant reduction in the proportion of early vitellogenic 
oocytes (p < 0.001), and an increase in the number of perinucleolar oocytes (p = 0.047). The 
proportions of cortical alveolar and mid-late vitellogenic oocytes were not affected by the 
treatment, even if the latter showed a significant decrease when compared to the DWC group 
(p = 0.046) (Fig. 6.12). 
Exclusively in the group exposed to 100 µg dutasteride/L, several histopathological 
conditions were observed (Fig. 6.13 & 6.14). All the exposed fish showed the presence of 
atretic follicles, characterised by clumping, perforation or degeneration of the chorion (or 
vitelline envelope), fragmentation of the nucleus, disorganization of the ooplasm, abnormal 
proliferation of interstitial/somatic tissue, and vacuolar hypertrophy of the surrounding 
granulose cells due to phagocytic processes (EPA, 2006). In vitellogenic follicles, one of the 
first morphological signs of atresia was a change in the appearance of the yolk (Saidapur, 
1978), due to proteolysis of yolk proteins by cathepsins within the oocyte (Carnevali et al., 
2003; Eykelbosh and Van der Kraak, 2010; Wood and Van Der Kraak, 2003).  
The resorption activity was also characterised by the proliferation of interstitial tissue 
containing macrophage aggregates. These cell clusters presented with small condensed 
eccentric or peripheralized nuclei, and their physiological presence has been shown to be 
enhanced by exposure to environmental toxicants or infectious agents (Blazer et al., 1987). 
The presence of mitotically dividing oogonia was also observed, appearing as packets of cells 
resembling spermatocytes at first sight, but with a smaller nucleus. Accumulation of lipidic 
tissue was observed in seven out of eight fish from the same group, and interstitial 
proteinaceus fluid in three out of eight samples. The latter was visible as homogenous dark 
pink material, presumably VTG, in interstitial spaces among follicles.       
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Figure 6.11. Ratio between the proportions of vitellogenic and pre-vitellogenic oocytes in female 
fathead minnows exposed to different concentrations of dutasteride for 21 days. Boxes represent 
median (full line), and mean (dashed line) with 25th and 75th percentiles. *: p < 0.05 (n = 8). 
   
   
Figure 6.12. Proportions of oocytes at different stages of maturation in female fathead minnows 
exposed to different concentrations of dutasteride for 21 days; in detail, perinucleolar oocytes (A), 
cortical-alveolar oocytes (B), early vitellogenic oocytes (C) and mid-late vitellogenic oocytes. Boxes 
represent median (full line), and mean (dashed line) with 25th and 75th percentiles. *: p < 0.05 (n=8).
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Figure 6.13. Transverse sections of fathead minnow ovaries (A) from the Solvent Control group and (B, C) from the group exposed to 100 µg/L of dutasteride for 21 days 
during a short term reproduction assay. The ovary in figure A represents a typical example of an ovary from an actively spawning female, mainly containing late vitellogenic 
oocytes. Figures B and C show examples of ovaries with significant histopathological alterations found in fish exposed to 100 µg/L of dutasteride. Note the decreased number 
of vitellogenic oocytes, the presence of atretic oocytes and proteinaceus fluid, and the increased presence of interstitial tissue (somatic or adipose) in (B) and (C), compared to 
the ovary from the female in the Solvent Control group (A).  
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Figure 6.14. Examples of histopathological conditions found in ovaries of female fathead minnow exposed to 100 µg dutasteride/L for 21 days. The observed alterations 
included (A,B,C) abnormal tissue resorption activity characterised by the proliferation of interstitial tissue containing macrophage aggregates, (D) presence of interstitial 
proteinaceus fluid, (E) increased presence of lipidic tissue, (D,E,F) increased occurrence of atretic follicle, characterized by clumping, perforation or degeneration of the 
chorion (or vitelline envelope), fragmentation of the nucleus, disorganization of the ooplasm, change in the appearance of the yolk. 
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6.4.7 Effects of dutasteride on fathead minnow sperm quality 
6.4.7.1 Sperm count, motility and viability 
The exposure to dutasteride for 21 days did not cause any significant effect on sperm cell 
count and volume of milt produced on the sampling day; however, a significant decrease of 
sperm motility was recorded in fish exposed to 32 and 100 g dutasteride/L (p = 0.006 and    
p = 0.01, respectively) (Fig. 6.15) Furthermore, the highest exposure concentration caused a 
significant increase of non-viable sperm (p = 0.004) up to circa 6-fold the baseline levels 
recorded in the control groups (SC: 1.2 ± 0.6%; 100µg/L group: 6.8 ± 6.7%).   
 
  
     
Figure 6.15. Changes in (A) sperm cell concentration, (B) milt volume, (C) % of motile sperm, and (D) 
% of non-viable sperm, of breeding male fathead minnows exposed to different concentrations of 
dutasteride for 21 days. Boxes represent median (full line), and mean (dashed line) with 25th and 75th 
percentiles. *: p < 0.05 (n = 8). 
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6.4.7.2 Sperm motility parameters 
The exposure to dutasteride for 21 days caused some effects on the sperm motility 
parameters; however, the significance of these effects was dependent on the statistical 
approach used to analyze the data. 
When sperm populations from all the replicates in each treatment were considered as a single 
group, highly significant results were obtained (Fig. 6.16). In particular, the highest 
concentration of dutasteride caused an increase of all the velocity parameters: VCL (p < 
0.001), VAP (p < 0.001), VSL (p < 0.001). Furthermore, both sperm linearity and 
straightness were reduced in fish exposed to 32 and 100 µg dutasteride/L (LIN: p < 0.05; 
STR: p < 0.001).     
In the second approach, mean and median values of the parameters were calculated for the 
sperm population of each single fish, then combined according to the treatment, and 
statistically analyzed. This method produced only some apparent trends, but none of the 
results were significant (Figure 6.17). 
Finally, to assess the influence of the few samples with the number of tracked spermatozoa < 
35, these samples were excluded from the analysis (DWC = 0, SC = 1, D10 = 2, D32 = 2, 
D100 = 2). After this step, mean and median values of the parameters were calculated for the 
sperm population of each single fish, and analyzed as described in the second approach. As a 
result, the non-significance persisted, except for the VAP of sperm in the group exposed to 
100 µg dutasteride/L, which showed a significant increase (p = 0.025) (data not shown).  
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Figure 6.16.  Effect of dutasteride on fathead minnow sperm motility parameters after 21 days of 
exposure. Boxes represent median (full line), and mean (dashed line) with 25th and 75
th
 percentiles. 
The bars extend to the 10th and 90th percentiles, with outliers represented as dots. (A) VCL, 
Curvilinear Velocity; (B) VAP, Average Path Velocity; (C) VSL, Straight-Line Velocity; (D) LIN, 
Linearity; (E) STR, Straightness.*: p < 0.05. (DWC: n = 1318; SC: n = 1747; Dutasteride 10 µg/L:    
n = 1346; Dutasteride 32 µg/L: n = 1378; Dutasteride 100 µg/L: n = 1985). 
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Figure 6.17. Effect of dutasteride on fathead minnow sperm motility parameters after 21 days of 
exposure. Data are presented as mean ± SD. (A) VCL, Curvilinear Velocity; (B) VAP, Average Path 
Velocity; (C) VSL, Straight-Line Velocity; (D) LIN, Linearity; (E) STR, Straightness; (n = 8). 
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6.4.7.3 PATN analysis – Group allocation frequency 
The effects caused by the exposure to dutasteride on fathead minnow sperm were investigated 
using the PATN technique, which identified four subgroups of spermatozoa across the whole 
dataset. The characteristics of the four subgroups are shown in Table 6.3, while the proportion 
of spermatozoa in each group is illustrated in Figure 6.18. PATN Group 1 was the most 
represented group in the sperm populations of all the treatments, with circa 80% of 
spermatozoa of fish in DWC and SC treatments classified in this group. Spermatozoa in 
Group 1 were characterised by high velocities (VCL, VAP, VSL), medium/high linearity and 
high straightness, indicating the occurrence of highly active and progressive spermatozoa 
(Holt et al., 2010). The remaining spermatozoa of fish in the SC group were classified as, 
Group 2 (5.8 ± 2.6%), Group 3 (13.4 ± 4.9%), and Group 4 (5.3 ± 3.1%).  These three groups 
were all characterised by low linearity, respectively 22.4 ± 4.1%, 17.9 ± 4.8%, and 8.7 ± 0.37, 
indicating a lower grade of sperm activity. The low percentages of spermatozoa falling 
outside Group 1 suggested an overall good quality of the sperm populations, even after 22 
hours from the sampling time, reinforcing the reliability of the results. 
Exposure to dutasteride caused moderate and non-significant effects on the group allocation 
frequency, using both statistical approaches described in the methodological section. The 
highest concentration of dutasteride (100 µg/L) caused a non-significant decrease of the 
proportion of spermatozoa allocated to Group 1 (p = 0.103), and consequently, a slight non-
significant increase in the proportion of spermatozoa allocated to Group 2 (p = 0.455) and 
Group 4 (p = 0.144). The same statistically non-significant result was confirmed when 
performing a G-goodness-of-fit test (a modification of the classic Chi-Squared test), with the 
extrinsic hypothesis that the proportion of sperm population allocated in each of the four 
groups would follow the pattern observed in the sperm populations from the fish in the SC 
group. Comparing the SC group with the group exposed to the highest concentration of 
dutasteride (100 µg/L), the statistical significance was p = 0.102.  
6.4.7.4 Analysis of sperm populations in a 2-dimensional graph (LIN by VAP) 
Figure 6.19 presents two-dimensional plots of average path velocity (VAP) versus linearity, in 
which individual spermatozoa appear as single dots. The majority of spermatozoa are situated 
in the left part of the graphs, curving toward the right at the top of the distribution 
(spermatozoa with high velocity and high linearity). 
If arbitrary thresholds are imposed on the graphs (linearity>70% and VAP>20μms−1), then the 
most rapid, but less progressive, spermatozoa can easily be identified as being within the 
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boxes representing the thresholds. Indeed, using this approach, the sperm population of fish 
exposed to 100 µg dutasteride/L demonstrate an enrichment of faster but less progressive 
spermatozoa, moving following more circular pathways, which were classified by PATN as 
Group 2. This graphical, two-dimensional treatment complemented the simple use of means 
and standard deviations to describe the PATN results, enhancing the visualization of the 
results.  
Table 6.3. Summary of fathead minnow sperm motility parameters for the groups identified by PATN 
analysis. 
Parameter & Groups Mean Minimum Maximum St. Dev. 
VCL (µm/sec)     
Group   1 27.62 13.86 44.35 12.33 
Group   2 37.16 27.19 47.12 9.96 
Group   3 12.80 9.50 19.23 4.55 
Group   4 20.15 13.57 26.74 6.58 
     
VAP (µm/sec)     
Group   1 20.45 5.91 39.58 12.65 
Group   2 25.50 17.69 33.30 7.80 
Group   3 8.281 7.00 9.34 0.97 
Group   4 15.00 11.79 18.21 3.21 
     
VSL (µm/sec)     
Group   1 16.30 3.28 37.67 11.40 
Group   2 7.56 6.86 8.25 0.70 
Group   3 1.80 1.18 2.21 0.45 
Group   4 1.44 0.99 1.88 0.44 
     
LIN (%)     
Group   1 54.86 26.99 87.43 20.54 
Group   2 22.36 18.21 26.50 4.14 
Group   3 17.90 13.56 24.59 4.80 
Group   4 8.74 8.366 9.10 0.37 
     
STR (%)     
Group   1 78.46 60.13 95.06 14.97 
Group   2 33.39 25.97 40.81 7.42 
Group   3 26.20 17.22 33.32 6.70 
Group   4 11.54 10.46 12.62 1.08 
VCL, curvilinear velocity; VAP, velocity along the average path; VSL, straight line velocity; LIN, 
Linearity of track; STR, Straightness along the average path. 
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Figure 6.18. The PATN analysis clustered the spermatozoa in each population in four different groups, 
characterised by the set of parameters described in Table 6.3.  The graphs represent the effects of 
dutasteride on the proportion of sperm population allocated to each group (Mean ± SD; n = 8). 
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Figure 6.19. Dot-plots showing the effect of dutasteride exposure on the distribution of fathead minnow sperm motility characteristics within each treatment. Path 
linearity (LIN: a reflection of progressive motility) is plotted against mean path velocity (VAP: a reflection of tail beating) for each individual sperm track analyzed. 
The two-dimensional representation reveals the presence of sperm subpopulations with different behaviours. Dots with low average path velocity (VAP) and linearity 
of track (LIN) values (bottom left of graphs) represent slow and non-linear sperm tracks, whereas dots plotted in the upper right portion of the graphs represent fast 
and highly progressive spermatozoa. The red lines are plotted at arbitrary thresholds to emphasise that the treatment with 100 µg dutasteride/L enriched the 
population of faster but less progressive spermatozoa (shown as dots within the boxes).  
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6.4.8 Effect of dutasteride on F1 hatchability  
A high variability was observed in the quality of the F1 generation produced by different 
fathead minnow pairs, in terms of F1 hatching success, and stability of the hatching rates 
during the baseline period. In each group, the three fathead minnow pairs which produced the 
highest quality F1 generation were followed until the end of the study, and only these pairs 
were analyzed for statistically significant effects (Table 6.4).  
All the selected pairs, in each treatment, produced batches of fertilized eggs with high 
hatching rates (between 78% and 93%) during the baseline period. There was no evidence that 
the exposure of fathead minnow breeding pairs (F0) to dutasteride affected the F1 generation 
hatching success (Fig. 6.20 & 6.21) or hatching time (Fig. 6.22), when the hatching trials 
were performed by transferring the fertilized eggs from parental tank water to clean dilution 
water. 
However, when the incubation of the embryos was performed using parental tank water, the 
hatching success of embryos in the highest concentration group (100 µg/L) was strongly 
reduced (A: p = 0.043; B: p < 0.001; C: p = 0.002). The hatching success of embryos 
produced by pairs A and C in two different testing times along the exposure phase is shown in 
Figure 6.21.  In the same treatment group, the embryos produced by only one of the three 
replicates showed an increase of the time required to hatch during the exposure period, both 
when incubating the embryos in clean dilution water and parental tank water (p = 0.049). 
However, the statistical significance was just below the set significance limit (0.05), and the 
lower number of spawning events recorded during the exposure period compared to the 
baseline one (4 versus 9) - on which an hatching trial was performed – would suggest a lack 
of relevance for this specific result.    
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Table 6.4. Number of hatching trials undertaken for each fathead minnow pair during the study. 
Concentration of 
dutasteride (µg/L) 
Baseline or exposure 
period 
Pair identity and number of trials undertaken 
  A B C 
DWC 
 
Baseline 
 
9 
 
9 
 
9 
Exposure - DW 9 9 9 
Exposure - PTW 9 9 9 
SC 
 
Baseline 
 
9 
 
9 
 
9 
Exposure - DW 12 9 9 
Exposure - PTW 9 9 9 
10 
 
Baseline 
 
9 
 
9 
 
9 
Exposure - DW 12 15 9 
Exposure - PTW 12 15 9 
32 
 
Baseline 
 
9 
 
9 
 
9 
Exposure - DW 9 9 9 
Exposure - PTW 9 9 9 
100 
 
Baseline 
 
9 
 
9 
 
9 
Exposure - DW 4 3 6 
Exposure – PTW 
 
3 
 
3 
 
6 
 
DW, Dilution Water; PTW, Parental Tank Water. 
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Figure 6.20. Effect of dutasteride on F1 hatchability. In each treatment (indicated at the bottom of 
each graph) three fathead minnow pairs were selected and followed until the end of the study. At every 
spawning event, F1 hatching success was estimated by transferring the fertilized embryos into 6 wells 
plates, containing as incubation medium either clean dilution water or parental tank water. The 
medium was replaced every 24 hours, and each trial was performed in triplicate. The number of 
embryos was n = 20 for each replicate. 
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Figure 6.21. Hatching rates of fathead minnow embryos obtained from fish pairs exposed to 100 µg 
dutasteride/L for 21 days, during two different times along the exposure phase: (A) day 6 and 15 for 
Pair A, and (B) day 10 and 18 for Pair C. As described in the legend, embryos from the same source 
were incubated in clean dilution water, and also in parental tank water containing the drug. Note the 
drop of hatching success between the first and second trial, as the study progressed. Each bar 
represent the mean of 3 trials, except in “Day 15 – Parental tank water” (n = 1). In each trial the 
number of embryos was n = 20 for each replicate. 
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Figure 6.22. Effect of dutasteride on F1 hatching time.  In each treatment (indicated at the bottom of 
each graph) three fathead minnow pairs were selected and followed until the end of the study. At every 
spawning event, F1 hatching time was estimated by transferring the fertilized embryos into 6 wells 
plates, containing as incubation medium either clean dilution water or parental tank water. The 
medium was replaced every 24 hours, and each trial was performed in triplicate. The number of 
embryos was n = 20 for each replicate. 
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6.5 Discussion 
The objective of the study described in this Chapter was to evaluate the effects of a non-
model anti-androgen, dutasteride, on reproductive biology of fathead minnow using a short 
term reproduction assay specifically designed to detect chemicals that affect pathways 
controlled by estrogens and/or androgens (Ankley et al., 2001; Harries et al., 2000; OECD, 
2006). Exposure to 32 and 100 µg dutasteride/L for 21 days significantly reduced fecundity of 
fish and affected different aspects of reproductive endocrine function in both males and 
females. For example, plasma steroids showed a sex-specific response; at the tissue level, 
spermatogenesis in males was not affected by dutasteride exposure, but there were significant 
alterations of female ovary histology, characterized by a decreased proportion of vitellogenic 
oocytes and increased ovarian atresia. Despite the absence of histological alterations in the 
testis, sperm quality was negatively affected by dutasteride, in terms of the proportions of 
motile sperm and non-viable sperm. Alterations of motility parameters were also observed, 
even if their biological significance remained unclear. Finally, F1 generation hatching success 
and time were not affected by the parental exposure to the drug; however, there was an 
apparent increase of sensitivity to dutasteride exposure in embryos produced by pairs exposed 
to the highest dose of dutasteride (100 µg/L). Based on these results, it is possible to conclude 
that reproductive endocrine function in the fathead minnow can be affected by chemicals that 
in mammalian models inhibit the enzymatic activity of 5α-reductases. 
Since there was a lack of published information concerning the effects of 5 -reductases 
inhibitors (dutasteride and finasteride) on fish, in order to better understand if the effects 
caused by dutasteride could be due to its anti-androgenic mechanism of action, this Chapter 
will provide a comparative perspective of the effects caused by selected anti-androgens in 
sexually mature fish, preferably during 21 days fish reproduction tests. The rationale to 
compare only experiments involving adult reproductively mature fish in was because the 
molecular and physiological status of breeding fish is different from that of juvenile or non-
breeding fish, so the same compound may cause effects on non-breeding fish different than 
the ones observed in a 21 days fish reproduction test.  
In previous works, the effect of anti-androgenic chemicals on the fathead minnow 
reproductive axis has mainly been studied by exposing fish to flutamide, a pharmaceutical 
considered as a classic androgen receptor antagonist in higher vertebrates. Other tested anti-
androgens have included cyproterone acetate (AR antagonist), vinclozolin (AR antagonist), 
trilostane (3β-hydroxysteroid dehydrogenase inhibitor), and ketoconazole (CYPs inhibitor and 
weak AR antagonist). A comparative perspective of their effects on fish is summarised in 
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Table 6.5. The listed compounds were selected for a comparative discussion, since all of 
them, except vinclozolin, are human pharmaceuticals; furthermore, they cover a broad range 
of modes of action, from AR antagonism to inhibition of steroidogenic enzymes. According 
to the scientific literature, flutamide is currently the most tested drug (13 studies), followed by 
vinclozolin (2 studies). The remaining compounds have been tested on fish reproduction only 
in one study. 
The overview of the effects caused by the selected compounds on reproduction of teleost fish 
shows how, according to the LOECs for fecundity, the potency rank appeared to be 
ketoconazole (25 µg/L) > dutasteride (32 µg/L) > vinclozolin (60 µg/L) > flutamide (651 
µg/L) > trilostane (1500 µg/L). Hence, the drug classically considered as a model anti-
androgen caused adverse effects on fecundity at concentrations about 20-fold higher than 
some of the inhibitors of steroidogenic enzymes, like ketoconazole or dutasteride, and about 
10-fold higher than another AR antagonist, vinclozolin, which is not a human drug but an 
agricultural fungicide. According to OECD (2006), medaka was most sensitive to flutamide, 
than fathead minnow and zebrafish, with LOECs for reproduction of 100, 1000 and >1000 
µg/L, respectively. However, OECD‟s results showed a very low replicability (the effect was 
detected only in 1 out of 4 independent experiments), and were not confirmed by other 
studies, like that of Kang et al. (2006), who recorded a LOEC for reproduction of 1560 µg/L 
using medaka as the experimental species. No published information was available in the 
scientific literature concerning the effects of cyproterone acetate on fish reproductive 
performance, but it should be noted that this drug showed a very high potency in fish, causing 
alteration of the levels of circulating plasma steroids at concentration as low as 10 ng/L 
(Sharpe et al., 2004).  
The effect of dutasteride on plasma steroids concentrations was sex-specific, however the 
response was different from the prediction made on the basis of the mammalian response. 
According to GSK (2001), in humans the daily administration of 0.5 mg of dutasteride 
produced a great reduction of serum DHT concentrations, up to 94% compared to the pre-
exposure levels. As a consequence, it was possible to observe an increase in serum T of circa 
18-22%. Furthermore, in healthy male volunteers, 52 weeks of treatment with 0.5 mg 
dutasteride/day resulted in no clinically significant change compared with placebo in plasma 
concentration of sex hormone-binding globulin, E2, luteinizing hormone, follicle-stimulating 
hormone, thyroxine (free T4), and dehydroepiandrosterone. No data were available on the 
effects of dutasteride on sex steroids in females.  
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Based on this information, the hypothesis was that exposing male fathead minnows to 
dutasteride would cause an increase of circulating T, followed by a potential increase of E2; 
however, in the present study there was a general negative feedback on steroid production, 
which led to a significant decrease of circulating T (at 100 µg/L) by 63% and KT (at 32 and 
100 µg/L) by 43% and 50%, respectively, and a non-significant decrease of circulating E2. 
Interestingly, the predicted increase of circulating T was observed in females exposed to the 
highest concentration of dutasteride; the same group also showed a decrease of circulating E2. 
Both steroids increased or decreased, respectively, by 50% compared to the levels recorded in 
the SC group. These results indicated a sex-specific induction of the hormonal feedback 
loops.  
The decrease in the concentration of circulating T, KT and E2 in males was observed with 
exposure to both dutasteride and cyproterone acetate (Sharpe et al., 2004), two drugs that act 
through two different mode of actions, 5α-reductases inhibition and AR antagonism, 
respectively. The response caused by the two drugs diverged when considering the response 
of T in females, which increased with dutasteride and decreased with cyproterone acetate. It 
should be noted that the described effects have been recorded in two different species, fathead 
minnow and mummichog; it is possible that the previously described similarity could be 
accidental, and due to a different species-specific feedback on the HPG axis.  
Other than cyproterone acetate, only flutamide affected circulating T levels, causing an 
increase in female fathead minnows exposed to 651 µg/L, but no effects were observed in 
male fish (Jensen et al., 2004). When considering the AR antagonists, the increase of plasma 
T can be explained by the ability of these anti-androgens to block negative feedback of T at 
the hypothalamic and pituitary level, leading to an increase in luteinizing hormone secretion, 
and consequently increased T concentrations (O‟Connor et al., 2002), while in the case of 
dutasteride the mechanism that lead to T increase was probably different, since the drug does 
not act through the AR, hence the classical explanation would be that the increase of T 
derives from the inhibited conversion of T into DHT. However, some theoretical gaps make 
this explanation unclear; for example, circulating DHT concentrations in females are unlikely 
to be high enough to produce, once its synthesis is inhibited, an increase of T by 50%. 
Moreover, the concomitant decrease of circulating E2 does not fit with the simple explanation 
of the equilibrium of steroid ratios. It is possible that unknown feedback mechanisms 
produced the effects observed in females.  
The observed decrease of circulating concentrations of androgens in fathead minnow males 
also explain the phenotypic effect of dutasteride on male SSCs expression, characterized by a 
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significant decrease of both number and prominence of nuptial tubercles. The effect was 
statistically significant only in fish exposed to 100 µg dutasteride/L, but the decreasing trend 
was already detectable at 32 µg dutasteride/L. Fatpad properties were not affected by 
dutasteride exposure. The higher sensitivity of nuptial tubercles to androgens/anti-androgens, 
compared to the fatpad, was also confirmed in other studies (Martinovic et al., 2008). Other 
than dutasteride, the only previously listed anti-androgen that caused effects on male SSCs 
was vinclozolin (Martinovic et al., 2008). Flutamide, in one study (OECD, 2006), caused a 
decrease of tubercle number in fathead minnow exposed to 754 µg/L, but this result was 
equivocal since this effect was not observed in the other two laboratories replicating the 
experiment (OECD, 2006). 
It is known that VTG production is controlled by E2 (Sumpter and Jobling, 1995), but in this 
study, despite the highest concentrations of dutasteride causing a significant decrease of 
circulating E2 (by 50%) in females, plasma concentrations of VTG were not affected. 
Considering the experimental set up of the fish short term reproduction assay, which involves 
exposure of fish for 21 days, the sensitivity of VTG as biomarker of exposure to anti-
androgens is unclear, since only few studies detected significant alterations of its plasma 
concentrations; in particular, a significant VTG response in females has been detected only in 
2 out of 12 studies testing flutamide (LOEC: 651 µg/L for fathead minnow; 95.5 µg/L for 
medaka) (OECD, 2006), in 1 out of 2 studies testing vinclozolin (LOEC: 255 µg/L for fathead 
minnow) (Martinovic et al., 2008), and in one study testing trilostane (LOEC: 1500 µg/L for 
fathead minnow) (Villeneuve et al., 2008). 
An important consideration is that circulating VTG is a very stable protein in the plasma, as 
shown in male fathead minnows by Thorpe et al. (2007); in fact, male fish exposed to E2 for 
14 days showed a significant dose-related increase of plasma VTG concentrations, which 
remained elevated 70 days after cessation of exposure. In females in the active reproductive 
phase, one of the main mechanism of VTG elimination by the plasma is the uptake into the 
developing oocytes, rather than elimination through the kidneys (Thorpe et al., 2007). To 
explain the non-significant VTG response of fish to the exposure to dutasteride, it is possible 
to hypothesize that the reduced reproductive activity (e.g. reduced egg production and 
spawning frequency) caused a decreased excretion of VTG via deposition into the eggs; 
therefore, the decrease of VTG caused by decreased E2 concentrations could have been 
hidden by the high stability of basal plasma VTG levels, which cannot be cleared anymore by 
the process of uptake into developing oocytes. However, other studies recorded a decrease of 
the plasma VTG concentration in females concomitant with a decreased fecundity, and 
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sometimes decreased circulating E2, when exposing female fathead minnows to fadrozole 
(aromatase inhibitor) (Ankley et al., 2002), trilostane (β-HSD inhibitor) (Villeneuve et al., 
2008), and fenarimol (aromatase inhibitor & ER antagonist) (Thorpe et al., 2007).  
With regards to this comparison, the review of the literature revealed that the concentrations 
of circulating E2 in the females used in our study were higher when compared to the ones 
measured in other studies involving exposure of actively spawning fathead minnows to 
various chemicals. In particular, despite the fact that the E2 circulating in the females of our 
control groups (5-20 ng/mL) was in the “normal” range defined by Watanabe et al. (2007) for 
actively spawning fathead minnows (0.2-21.4 ng/mL), the mean values (DWC: 12.7 ng/mL; 
SC: 14.3 ng/mL) were higher than the ones recorded in other studies, even ones previously 
performed in our laboratory, which were in the range of 3-7 ng/mL (Ankley et al., 2002; 
Ankley et al., 2005; Makynen et al., 2000; Martinovic et al., 2008; Runnalls, personal 
communication; Paulos et al., 2010). The reason for these differences is not known, but after 
a deep review of all the technical and mathematical steps performed for the assay, it was 
possible to conclude that the measured values are likely to be real; moreover, the same assay 
was performed to measure E2 in both male and female samples, and the values obtained for 
males agreed perfectly with all the other published studies. The “higher” than normal E2 
concentration in females could represent an additional factor that led to a non-significant 
result for the VTG data, and a drop in plasma concentration of E2 from 14.3 ng/mL (SC) to 
7.2 ng/mL (100 µg dutasteride/L) may not be enough to produce a negative effect on vtg gene 
expression.           
In male fish, despite the observed decrease of circulating T and KT concentrations, exposure 
to dutasteride did not cause any histopathological alterations of the testis. Toxicity studies 
conducted in rats and dogs showed how daily administration of high doses of dutasteride (up 
to 500 mg/kg/day in males rats and up to 50 mg/kg/day in male dogs respectively) induced 
treatment-related alterations in male reproductive organs, including a decrease in the size of 
the prostate of rats and dogs, epithelial atrophy and decreased secretion of the seminal 
vesicles in rats, decreased epididymis weight in the rat and histopathological changes 
consistent with atrophy in the epididymis in dogs. However, the effects on the testis were 
limited to an increase in testis weight in rats, and there were no significant changes in 
spermatogenesis in either species (GSK, 2001). 
Among the anti-androgen listed at the beginning of the Chapter, only flutamide and 
ketoconazole caused histopathological alteration of the testes in male fish during the 21 days 
experiment, including the appearance of clusters of pycnotic and degenerating cells in the 
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seminiferous tubule epithelium (the reliability of this result is unclear, due to the small 
number of fish used for the analyses, n = 3) (Jensen et al; 2004), decreased number of 
spermatogenic cysts (Kinnberg and Toft, 2006), increased proportion of spermatogonia, and 
increased number of interstitial cells (Leydig cells) (Ankley et al., 2007; OECD, 2006). In 
addition, inhibition of the late spermatogenic stages has been observed in mature male 
sticklebacks exposed to cyproterone acetate (Rouse et al., 1977). 
On the other hand, dutasteride (100µg/L) caused obvious histological alterations in the ovary, 
including a decreased proportion of early vitellogenic oocytes, an increased proportion of 
perinucleolar oocytes, an increased occurrence of atretic follicles, an abnormal proliferation of 
interstitial/somatic tissue, vacuolar hypertrophy of the surrounding granulose cells due to 
phagocytic processes, proliferation of interstitial tissue containing macrophages aggregates, 
the presence of mitotically dividing oogonia, an accumulation of adipose tissue, and the 
presence of interstitial proteinaceus fluid. These results confirmed the higher sensitivity of the 
ovary to dutasteride compared to the testis. It is important to remember than the affected fish 
also had a significant increase of the concentration of circulating T, coupled with a decrease 
of E2, which could explain the previously described histopathological alteration. 
Toxicity studies on rats and dogs showed treatment-related effects on female reproductive 
organs, including decreased ovary and uterus/cervix weights, increased incidence of dioestrus 
or increased occurrence of ovarian (follicular) cysts in rats, microscopic changes in the uterus 
and shifts in the oestrus cycle to the luteal phase in dogs; however, there was no available 
information specifically concerning the histopathological effects of dutasteride in higher 
female vertebrates (GSK, 2001). 
Interestingly, the increase of atretic oocytes, and the decreased proportion of vitellogenic 
oocytes caused by dutasteride, were also observed in fish exposed to flutamide and 
vinclozolin (Jensen et al., 2004; Martinovic et al, 2008; OECD, 2006), supporting the 
hypothesis of a high sensitivity of the ovary to the disruption of the androgenic pathways. A 
further factor should be taken into account to explain the increased occurrence of atresia in 
fish exposed to 100 g dutasteride/L; in fact, it is known that atresia can be also induced by 
decreased or absent spawning activity (McCormick et al., 1989), due to alterations of male 
behaviour, such as a decrease of male aggressiveness and lack of interest in the female or in 
spawning. Therefore, the observed histological alterations of fathead minnow ovaries could 
be due to a combination of factors, directly or indirectly induced by the exposure to 
dutasteride, and mediated by the alteration of T and E2 biosynthesis.  
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 The sensitivity of the ovary to disruption of androgen biosynthesis has been confirmed in all 
the studies presented in this Thesis; moreover, the histopathological endpoints were found to 
be the most sensitive to detect the effects of anti-androgens, and also the most reliable; in fact, 
obvious histological alterations were detected in 11 out of 12 studies on AR antagonists and 
in 2 out of 3 studies on enzymatic inhibitors.  The role of androgen in female fish is still 
unclear; however, androgens such as KT, seem to be involved in the growth of perinucleolar 
oocytes (Chapter 4, Kortner et al., 2008), and AR-mediated signalling is known to affect 
expression of several regulators of folliculogenesis (Drummond, 2006). For example, it has 
been shown that the disabling of AR-mediated androgen signalling caused the down-
regulation of several genes involved in folliculogenesis, which consequently produced an 
increased occurrence of atretic follicles and infertility in that species (fish or mammals) 
(Shiina et al., 2006). 
Exposure to dutasteride did not affect sperm cell count or milt volume; however, it reduced 
the percentage of motile sperm by 32% and 27%, respectively, at 32 and 100 µg/L, and 
lowered the percentage of viable sperm slightly but significantly, from 98.8% in the SC group 
to 93.2% in the group exposed to 100 µg dutasteride/L. The analysis of the sperm motility 
parameters gave different levels of statistical significance depending on the statistical 
approach used. The treatment caused significant alteration only if the data were treated in 
order to keep the high variability, which is characteristic of sperm populations. In contrast, 
when the variability was summarised by mean values and standard deviations, all the 
significance was lost. This observation was confirmed by Holt et al. (2007), who noticed that 
although it is common practice to use the mean and standard errors provided by CASA 
systems as inputs to statistical analyses, a deeper examination of a typical set of sperm 
motility data reveals that this is not an appropriate approach, since there is a great amount of 
information that is ignored when means are derived. This observation is exemplified by the 
great variability recorded for velocity parameters, such as VSL. In fact, Holt et al. (2007), 
analysing the dynamics of VSL in sperm populations, found that there is no simple linear 
relationship between the mean VSL value and the maximum value, and that the difference 
between the two values is often large, up to 3 to 4-fold. The maximum values may carry 
important information; for example, the subpopulation of sperm showing very fast movement 
(e.g. high VSL) could also have a competitive advantage over the slower subpopulations in 
the fertilization process, and this is one of the reasons why it is important to keep the whole 
sperm population variability in the statistical analysis. The authors also presented interesting 
examples of how the persistent presence in the scientific literature of inadequate statistical 
analyses, presented in support of various hypotheses, led to erroneous conclusions.  
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Within this perspective, the biological significance of the result obtained in our study is not 
clear. The analysis of the single motility parameters showed a significant increase of all the 
velocity parameters (at 100 µg/L), and a decrease of linearity and straightness (at 32 and 100 
µg/L), suggesting that dutasteride induced a faster but more circular movement of the 
spermatozoa. This deduction was only partially confirmed by the PATN analysis, which 
showed only non-significant trends, suggesting a decrease in the proportion of fast and highly 
linear sperm, and a consequent increase of frequency of fast/circular and slow/circular sperm. 
It has been proven that CASA parameters are well correlated with fertilization and hatching 
rates in fish (Gage et al., 2004; Lahnsteiner et al., 1998; Rurangwa et al., 1998); however, the 
complete absence of negative effects caused by dutasteride on fertilization rates and 
proportion of dead embryos suggest that the alteration recorded in the sperm motility 
parameters did not have consequences on male fertility.  
Particular attention was given to the study of the sperm quality, since the decrease of male 
fertility and sperm quality is one of the side-effects of the daily administration of dutasteride 
in mammals. For example, in humans the therapeutic dose of 0.5 mg/day caused a sharp drop 
in sperm count, sperm concentration, sperm motility, sperm morphology and semen volume 
after 24-28 week of treatment. Similar effects were also observed with administration of 5 
mg/day of finasteride (GSK, 2001). However, in a fertility study performed on male rats 
treated orally with dutasteride (0.05 to 500 mg/kg/day) for up to 31 weeks, no effects were 
noted in the testis, and sperm concentration and motility were unaffected by treatment (GSK, 
2001). It is important to note that the results described in this Chapter were obtained from a 
study involving only 21 days of exposure to dutasteride.  
In order to test the effects of dutasteride on the F1 generation hatching processes, the three F0 
pairs in each group producing the best quality F1 batches of eggs during the baseline period 
were chosen and followed until the end of the study. During the exposure phase, embryos 
were incubated in two different medium. Firstly, in clean dilution water, in order to assess the 
effect of any potential parental transfer of dutasteride from the breeding pair to the fertilized 
embryos. This hypothesis was supported by the fact that dutasteride is a highly lipophilic drug 
(LogP 5.45), which can accumulate into the body, and has been shown to be present in sperm 
samples of men treated with dutasteride. The semen dutasteride steady-state concentration has 
been shown to be about 10% of that of the serum concentration (circa 3.3 ng/mL of semen); 
the highest concentration recorded in the semen was 14 ng/mL (GSK, 2001). Different from 
humans or other mammals, in fathead minnow the fertilization of the eggs is external, so that 
there is no milt potentially containing dutasteride transferred into the female body; however, 
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female fathead minnows exposed to the drug could show a potential accumulation of the drug 
into the ovary and into the developing eggs. However, the hatching trials did not show any 
evidences of any alteration in the hatchability success and hatching time of the F1 generation.  
Other than clean dilution water, F1 embryos were also exposed to parental tank water, 
containing dutasteride. In these trials, there was a significant decrease of hatchability success 
for the embryos produced by pairs exposed to 100 µg dutasteride/L. The effect was consistent 
in all three replicates. It is important to remember that dutasteride did not affect the 
hatchability of embryos in the two early-life stages studies described in Chapter 5. The result 
obtained with the F1 generation could be interpreted in two ways. Firstly, the decreased 
hatchability could be caused by factors unrelated to the drug exposure, such as oxygen 
concentration in the medium, temperature, pH. However, the incubation temperature was 
controlled by an automatic incubator, and it was similar to the water temperature recorded in 
the fish tanks (25 ± 1ºC), the medium was replaced every 24 hours, and even if neither 
oxygen concentration nor pH in the incubation wells were measured, they were tested in the 
source tank just before the transfer of the parental tank water from the tank to the incubation 
wells, without showing any significant variation from the SC parameters. Although is not 
possible to completely exclude the possibility that some environmental factors affected 
embryos hatching, there was evidence that the hatchability success decreased with the 
progress of the study, strongly supporting the hypothesis that dutasteride progressively 
accumulated in the F0 females, and was subsequently transferred to the developing eggs, and 
hence to the fertilized embryos. The presence of dutasteride in the F1 embryos could explain 
the increased sensitivity to a second exposure to the drug during the F1 hatching trials.    
In conclusion, the results of the short term reproduction study with fathead minnow 
demonstrated that dutasteride, a mammalian anti-androgen and 5α-reductase inhibitor, can 
affect reproductive endocrine function in fish, and that the observed effects are consistent 
with an anti-androgenic mode-of-action. Furthermore, its potency to negatively affect fathead 
minnow reproduction was about 20-fold higher than that of flutamide, a human 
pharmaceutical considered as a model anti-androgen. These results very strongly suggest that 
DHT could have an important physiological role in this species.   
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Table 6.5. Effects of anti-androgenic chemicals, acting through different mode of action, on fish reproductive activity. For each effect, the LOEC is indicated (measured 
concentrations). 
Drug and 
MoA 
LogP Species 
Nominal 
Tested Conc. 
Fecundity Fertilization Vitellogenin E2 T KT SSCs Gonad histopathology Reference 
Flutamide: 
 
AR 
antagonist 
2.6 
Fathead 
minnow 
50,500 651 - ↓ No effect 
♂: 651 - ↑ 
 
♀: 651 - ↑ 
♂: No effect 
(651, non sig. ↑) 
 
♀: No effect 
(651, non sig. ↑) 
 
♂: No effect 
 
♀: 651 - ↑ 
 
♂ : 651, KT:T - ↑ No effects 
♀: 
Atresia - 651 - ↑ 
Vitellogenic follicles - 651 - ↓ 
Jensen et al., 
2004 
Fathead 
minnow 
100,500,1000 754 - ↓ (3/3)  
♂: No effect 
 
♀: No effect 
   
Tubercles: 
754 -  
(1/3) 
♂: 
Spermatogonia - 464 - ↑ (1/3) 
Spermatocytes – 940 - ↓ (1/3) 
Testicular stage - 754 - ↑ (3/3) 
 
♀: 
Atresia – 88.8 - ↑ (1/3) 
Ovarian stage – 354 ↓ (1/3) 
OECD, 2006 
Medaka 100,500,1000 95.5 - ↓ (1/4)  
♂: 95.5 - ↑ 
(1/4) 
 
♀: 95.5 - ↑ 
(1/4) 
   No effect 
♂: Testicular stage - 95.5 -↑(3/3) 
 
♀: Post-ovulatory follicles - 97.4 
      -  (1/3) 
OECD, 2006 
Medaka 
101,202,397,
787,1560 
1560 -  1560 -  No effect     ♂: Testis-ova - 202 Kang et l., 2006 
Zebrafish 100,500,1000 No effect  
♂: No effect 
 
♀: No effect 
    
♂ 
Interstitial cells -250 - ↑ (2/3) 
Spermatogonia – 788 -  (2/3) 
Testicular stage - 949 -  (1/3) 
 
♀: No effect 
 
OECD, 2006 
Stickleback 100,500,1000   
♂: No effect 
 
♀: No effect 
   
Spiggin:   
500 -  
 
Sebire et al., 
2008 
Vinclozolin: 
 
AR 
antagonist 
3.0 
Fathead 
minnow 
200,700 Problems in the control group  
♂: 700 -  
 
♀: No effect 
   
♂: No effect 
 
♀: Pre-vitellog. oocytes - 700 -  
 
Makyenn et al., 
2000 
Fathead 
minnow 
100,400,700 60 -  No effect 
♂: No effect 
 
♀: 255 – ↑ 
 
♂: No effect 
 
♀: No effect 
 
Tubercles: 
255 -  
 
Fatpad: 
450 -  
♂: No effect (GSI – 255 - ) 
 
♀: Atresia - 60 -  
Martinovic et 
al., 2008 
Cyproterone 
acetate 
 
AR 
antagonist & 
weak PR & 
GR agonist 
3.8 Mummichog     ♂: 0.25 -  
♂: 0.1 -  
 
♀: 0.01 -  
♂: 0.1 -  
 
  
Sharpe et al., 
2004 
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Drug & MoA  LogP Species 
Nominal 
Tested Conc. 
Fecundity Fertilization Vitellogenin E2 T KT SSCs Gonad histopathology Reference 
Dutasteride: 
 
5 Rs 
inhibitor 
5.5 
Fathead 
minnow 
10,32,100 32 - ↓ No effect No effect 
 
♂: No effect 
(32 – Non. Sig. ) 
 
♀: 100 -  
 
 
♂: 100 –  
 
♀: 100 -  
 
♂: 32–  
 
 
Tubercles: 
32 -  
♂: No effect 
 
♀: 
Pre-vitellogenic oocytes – 100 -
 
Atresia - 100 -  
Interstitial tissue - 100 -  
Proteinaceus fluid - 100 -  
Lipidic tissue - 100 -  
Macrophages - 100 -  
 
Chapter 6 of 
this Thesis  
Trilostane 
 
3 -HSD 
inhibitor 
3.0 
Fathead 
minnow 
60,300,1500 1500 - ↓ No effect ♀: 1500 -  
♂: 1500 - ↑ 
 
♀: No effect 
(1500, non sig. ) 
 
  No effect 
♂: No effect (GSI - 60 - ) 
 
♀: No effect 
 
Villeneuve et 
al., 2008 
Ketaconazole  
 
CYPs inhibitor 
 
Weak AR 
antagonist 
4.0 
Fathead 
minnow 
6-25-100-400 25-  No effect 
♂: No effect 
 
♀: No effects 
♂: No effect 
 
♀: No effects 
♂: No effect 
 
♀: No effect 
♂: No effect 
 
♀: No effect 
No effect 
♂: Interstitial cells - 7 -  
 
♀: No effect 
Ankley et al., 
2008 
MoA, Mode of Action; Conc., Concentration; E2, Estradiol; T, Testosterone; KT, 11-Ketotestosterone; SSCs, Secondary Sexual Characteristics  AR, Androgen Receptor; PR, 
Progesterone Receptor; GR. Glucocorticoid Receptor; Non Sig., Non Significant. The fractions in brackets (e.g.1/4) indicate that the effect has been recorded only in some of the 
replicate studies performed. (e.g 1 out of 4). 
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CHAPTER 7 :  GENERAL DISCUSSION 
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7.1 General considerations on the environmental risk assessment of steroids and 
anti-steroids 
The analysis of the clinical use of the human pharmaceuticals classified as steroids and anti-
steroids discussed in Chapter 2 showed that steroid hormones and antagonists of endogenous 
steroids are widely used as pharmaceuticals, although the amounts used are much lower than 
the amounts of some other pharmaceuticals in widespread use, such as some analgesics, 
cardiovascular drugs, anti-inflammatories, and antibiotics. However, it should not be 
forgotten that although the annual use of EE2 in the UK is less than 25 kg, this 
pharmaceutical is of ecotoxicological concern (Caldwell et al. 2008), demonstrating that 
basing environmental risk assessment strategies on amounts of drugs used is not wise or 
defensible. Similar to EE2, some synthetic progestogens, which are prescribed in amounts up 
to approximately 500 kg/year, can inhibit fish reproduction at very low (ng/Litre, or even sub-
ng/L) environmental concentrations (Paulos et al. 2010; Zeilinger et al. 2009). 
Although much is still to be learnt about concentrations of steroid hormones in the aquatic 
environment, the picture that is emerging is a reasonably consistent one. Effluent 
concentrations are likely to be in the low ng/L range, which in most cases would give rise to 
sub-ng/L concentrations in rivers. Only in situations where the degree of dilution of effluent is 
low (as it can be in densely-populated areas with relatively small rivers) are river 
concentrations of steroid hormones likely to be in the ng/L range (Sumpter and Johnson 
2005). However, the total concentration (of the different progestogens or glucocorticoids, for 
example) is probably the most relevant exposure parameter, because pharmaceuticals with 
similar mechanisms of action are likely to act additively (Brian et al. 2005). Thus, 
environmentally-relevant concentrations of some steroid hormones may be in the tens of ng/L 
range in heavily impacted locations. 
The information provided in Chapter 2 suggests that when attempting to prioritize 
pharmaceuticals for potential environmental impact, and hence research, then synthetic 
steroid hormones merit serious attention. This is based on the fact that they are present in the 
aquatic environment, and that they can affect fish at low concentrations. Currently, 
knowledge of the risk posed by steroid hormones (and possibly also their antagonists) is 
limited; a lot is known about EE2 (e.g., Caldwell et al. 2008), but very little, if anything, is 
known about the other groups of steroid hormones. Research on potential chronic effects of 
these pharmaceuticals is urgently required, in order that an informed, balanced assessment of 
their (potential) ecotoxicological effects can be formed.  
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In general, despite the fact that human pharmaceuticals are regularly detected in the aquatic 
environment, there is still no evidence of any significant effects on aquatic wildlife species at 
the population level. The vast majority of the effects caused by pharmaceuticals on fish have 
been observed in laboratory studies at concentrations exceeding the environmentally relevant 
ones. The only two cases where pharmaceuticals have been directly linked to a disruption of 
wildlife populations dynamics are (a) the fish sexual disruption caused by steroid agonist, in 
particular estrogens and EE2, that have been shown to contribute to the feminisation of wild 
roach populations in UK Rivers (Jobling et al., 2006); (b) the high mortality of vultures 
caused by diclofenac in Asia (Oaks et al., 2004). However, the effect of intersex - the most 
evident exposure-related disruption - on fish population dynamics and reproductive success is 
still unclear, since a large study performed by Harris et al. (2011) with wild roach 
demonstrated that the majority of intersex fish were able to breed, albeit with varying degrees 
of success, suggesting that if severely intersex fish are present in a river, there could be 
implications for the fish population dynamics, whereas if only mildly intersex fish are present, 
the effects (if there are any) will be less severe. 
For all other pharmaceuticals, there is no evidence for adverse effects caused by their 
occurrence in the environment on wild fish populations, even if there are many experimental 
and scientific aspects that have to be improved before drawing a definitive conclusion; for 
example, the need for long-term chronic studies in order to increase the confidence for the 
absence of harmful effects, or the potential effect of bioaccumulated pharmaceuticals on both 
human health and wildlife. Moreover, the vast majority of the toxicity studies involving 
human pharmaceuticals have been performed on a limited group of fish species, but it is 
known that the inter-species sensitivity to a specific API can be significant; therefore, some 
precautions and awareness should be used in the attempt to extrapolate toxicity information 
from one fish species, with the aim to apply it to other species, or even to species in other 
phyla. The growing availability of -omic information for an increasing number of species 
could provide a fundamental help to understand the issue of species sensitivity, playing an 
important role in the risk assessment process. 
The physiological relevance of the endpoints assessed during toxicity studies should also be 
considered in the process of environmental risk assessment, since retarded sexual maturation 
or an interruption of reproductive functions will have a different influence on the population 
dynamics than the alteration of the expression of a specific gene or of the activity of specific 
enzymes, which could be only transitional responses.    
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Finally, one of the most important issues to face in the future is the toxicity of mixtures of 
pharmaceuticals. Additive effects of chemicals have been observed in fish, demonstrating the 
capacity for chemicals to act together to affect reproductive performance of fathead minnow, 
even when individual components were present below the threshold of detectable effects 
(Brian et al., 2007). 
7.2 Use of integrated testing strategies to assess the potential adverse effects 
caused by dutasteride in the fathead minnow 
The work presented in this Thesis addressed the question of whether or not dutasteride, a 
human pharmaceutical mainly used for the treatment of benign prostatic hyperplasia, may 
cause adverse effects in the fathead minnow by inhibiting the activity of both isoforms of 
5αR, the enzyme which converts T into DHT. At the beginning of the Ph.D. project, a 
significant theoretical issue came to light, since a general assumption in fish endocrinology is 
that DHT is not synthesized in teleost fish, or if it is, it has a modest or no physiological 
relevance (Borg, 1994). Hence, the question arising was: “why study the effects of 
dutasteride, a 5αR inhibitor, in fathead minnow, if this species seems to lack the biochemical 
apparatus targeted by the drug?” 
In order to avoid random testing strategies, which carry the risk of producing only partial 
results which can be difficult to interpret, and to enhance the scientific reliability of the whole 
study, an integrated testing strategy was adopted.  The theoretical framework used to guide 
the design of the experimental studies described in this Thesis was based on the combination 
of several conceptual approaches, including the study of the evolutionary degree of 
conservation of the drug targets, the study of the conservation of functionality of the drug 
target in the experimental model chosen for the experimental studies, and the cross-species 
extrapolation of pharmacological and toxicological information generated during pre-clinical 
and clinical studies in mammals during drug development.  
These approaches have been recently suggested by some authors as key factors that should be 
taken in account in order to enhance the reliability of environmental risk assessment (Ankley 
et al., 2007; Berninger and Brooks, 2010; Christen et al., 2010; Gunnarsson et al, 2008; 
Kostich and Lazorchak, 2008; Owen et al., 2007; Seiler, 2002; Winter et al., 2009), and have 
been extensively applied by Owen et al. (2007) for the study of the effects of β-blockers in 
fish.  
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7.3 Utility of bioinformatics tools to fill the gaps in the background knowledge  
A number of pieces of evidence collected during the preliminary phase of the Ph.D. project – 
both experimentally and from the literature - strongly suggested that DHT has a physiological 
role in the fathead minnow. The evidence includes the expression of 5αR genes in tissues 
such as the testis, and the occurrence of circulating DHT at concentrations similar to the ones 
detected in humans, and represented the rationale for testing the effects of dutasteride, a dual 
5αR inhibitor, in the fathead minnow. 
The use of bioinformatics tools not only allowed the identification of putative genes coding 
for 5αRs in the fathead minnow, but gave a surprisingly wide overview of the evolutionary 
degree of conservation of 5αR in many phyla, including plants, bacteria and fungi. 
Interestingly, plants (Arabidopsis sp.) carrying a mutation in the gene coding for 5αR, which 
in turn causes defective brassinolide biosynthesis, were characterized by several abnormal 
conditions including dwarfism, reduced male fertility, and delayed senescence and flowering 
(Chory et al., 1991; Li et al., 1996; Altmann, 1998; Clouse and Sasse, 1998). These results 
allow us to speculate that if dutasteride was able to enter into the plant (by uptake from water 
or ground), and exert its inhibitory effects on the activity of 5αR, it may affect key 
physiological processes, such as male fertility.     
Generally APIs will be pharmacologically active in organisms in which the molecular targets 
(primary or secondary) are expressed and functional (Gunnarsson et al., 2008; Seiler, 2002). 
The high degree of functional conservation of 5αR in such diverse phyla strongly suggests 
that this factor should be taken in account in the environmental risk assessment of dutasteride.  
In particular, within this perspective, a further key element arising from this Thesis is the 
issue of species-sensitivity. In fact, even inside the teleost fish taxon, the degree of 
conservation of 5αR showed a wide range of variability, with zebrafish and fathead minnow 
having a higher degree of similarity to human 5αRs than other fish species, such as medaka 
and stickleback. It is not known if this variability in the degree of similarity – at nucleotide 
and protein level - also reflects variability of function (i.e. 5αR expression, activity rates, 
kinetics). However, it is possible to hypothesise that the effects caused by dutasteride will 
have different levels of severity according to the species used as the experimental model, and 
that the study of the evolutionary conservation of functionality of the target would help to 
identify the potentially more sensitive species. 
5αRs and the product of their activity (DHT) represent a good example of the issue of species 
sensitivity. In fact, not only 5αRs do show a significant variability in the degree of 
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evolutionary conservation among teleost fish, but, as described in Chapter 3, such variability 
is also present in the fish AR, the component which transduces the presence of DHT into 
molecular and physiological responses. Hence, the degree of evolutionary and functional 
conservation should be evaluated not only for the specific target of the drug, but, if possible, 
also for other key components of the pathways affected by the drug.    
7.4  Effects of dutasteride on the fathead minnow 
The collection of toxicity data and side effects occurring in mammals, including humans, 
suggested that exposure to dutasteride may affect mainly the following physiological 
processes: sex determination and sex maturation; male fertility; steroid hormone dynamics. In 
order to test the hypothesis that similar physiological processes could also be affected in 
fathead minnows exposed to dutasteride, the following studies were performed: 
- Early life stage toxicity tests to determine the effects of dutasteride on hatching, 
growth, and survival (Chapter 5);      
- Early life stage toxicity test plus recovery period in clean water to determine the 
potential long term effects of an early life stage exposure to dutasteride (e.g. sex 
determination, sex maturation; sex steroid hormone dynamics in the plasma) (Chapter 
5); 
- 21 days reproduction test to determine the effects of dutasteride on reproductive 
functions (e.g. fertility, fecundity, sperm quality; sex steroid hormone dynamics in the 
plasma) (Chapter 6); 
- F1 generation hatchability trials to determine the potential susceptibility of the F1 
generation to dutasteride after parental (F0) exposure (e.g. through maternal transfer of 
dutasteride to embryos) (Chapter 6). 
Dutasteride caused significant adverse effects in fathead minnow in all the in vivo studies 
performed during the project, and all the tested life stages were sensitive to the inhibition of 
5αRs activity. A resume of the NOEC and LOEC for each endpoint is provided in Table 7.2. 
All the results obtained during the project strongly suggest that dutasteride exerts its effect, 
both in the fathead minnow and in humans, by acting by a highly specific mechanism of 
action, the inhibition of 5αRs activity. In order to exclude any potential interaction of 
dutasteride with the fathead minnow AR, a Yeast Androgen Screen (YAS) was kindly 
performed by Satwant Kaur at Brunel University. No interaction between AR and dutasteride 
was detected at concentrations ranging between 0.0005 and 1 mM. 
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None of the observed adverse effects occurred at concentrations of exposure lower than 32 
µg/L, with the NOEC at 10 µg/L.  
When possible, the response of the endpoints used in the fish studies was compared with 
similar endpoints in humans. For example, particular attention was given to the study of 
sperm quality, since the decrease of male fertility and sperm quality is one of the side-effects 
of the daily administration of dutasteride in mammals. In fathead minnow, dutasteride caused 
some alteration of sperm motility parameters, and decreased sperm motility and viability; 
however, the biological significance of these results was not clear, since no negative 
consequence on fertilization rates and occurrence of dead embryos was observed, thus 
excluding the occurrence of negative alterations of male fertility even when fish are exposed 
to high concentrations of dutasteride (100 µg/L). 
Interestingly, the effect of dutasteride on plasma steroids concentrations was sex-specific; 
however, the response was different from the prediction made on the basis of the mammalian 
response. According to GSK (2001), in men the daily administration of 0.5 mg of dutasteride 
produced a major reduction of serum DHT concentrations, up to 94%, a consequent increase 
in serum T of circa 18-22%, and no clinically significant changes in plasma concentrations of 
sex hormone-binding globulin, E2, LH, and FSH. Based on this information, the hypothesis 
was that exposing male fathead minnows to dutasteride would cause an increase of circulating 
T, followed by a potential increase of E2; however, in the present study there was a general 
negative feedback on steroid production in male fish, which led to a significant decrease of 
circulating concentrations of T and KT, and a non-significant decrease of circulating E2. 
Notably, the predicted increase of circulating T was observed in females exposed to the 
highest concentration of dutasteride; the same group showed also a decrease of circulating E2. 
These differences suggest that the system of hormonal feedback mechanisms may work 
differently in humans and fathead minnow.     
According to the so-called “read-across hypothesis” (Gunnarsson et al., 2008; Winter et al., 
2009), human pharmaceuticals cause the same effects in fish as they do in humans, and these 
effects occur only if plasma concentration of the pharmaceuticals in fish reach approximately 
the same concentration required in humans to exert their therapeutic effects.  
During this Ph.D. project, the plasma concentration of dutasteride  in fathead minnows 
exposed to the drug were not experimentally quantified; however, one of the approaches 
employed to test the read-across hypothesis involved the use of a mathematical model 
developed by Huggett and co-workers (Huggett et al., 2003), and known as the “fish plasma 
 236 
 
model” (FPM). This model aims to predict the uptake of pharmaceuticals from the 
surrounding water into fish plasma. Conceptually, the FPM estimates the “fish steady-state 
plasma concentration” (FSSPC) of a drug, on the basis of a given water concentration (e.g. 
predicted environmental concentration, PEC). FSSPC is successively compared with the 
human/mammalian therapeutic plasma concentration (HTPC) (known to give a 
pharmacological response), in order to obtain an “effect ratio” (ER = HTPC/FSSPC), that 
represents an indication of risk. In other words, if the model predicts that a specific 
pharmaceutical, at environmentally relevant concentrations, can accumulate in fish plasma, 
reaching concentrations similar or higher than the HTPC (ER ≤ 1), there is an obvious risk that 
the compound could exert its pharmacological effect in exposed fish.   
The parameters and the equations used in the model are showed in Table 7.1. In the FPM, the 
major parameter that drives the uptake of a compound from the water into the blood of fish is 
its lipophilicity, expressed by a partitioning factor (e.g. Log Kow). This parameter is not used 
directly by the FPM, but it is first converted into a more specific estimation of partitioning 
between the aqueous phase and the arterial blood (Log Pblood:water), as described by 
Fitzsimmons et al. (2001):  
Log Pblood:water = 0.73 × Log Kow – 0.88 
The latter coefficient is then used to estimate the FSSPC (Huggett et al., 2003):  
FSSPC = PEC × Pblood:water 
A large variability in the Log Kow of dutasteride was observed when comparing estimated and 
experimental values; therefore, in order to take in account this uncertainty, values from both 
sources were used to run the FPM. Furthermore, the polar nature of many pharmaceuticals, 
including dutasteride, indicates that Log Kow may not represent the most realistic option. 
Several authors suggested that the distribution coefficient Log D, measured at physiological 
pH (7.4), is probably a more realistic indicator of uptake potential in fish than Log Kow, at 
least for compounds that can have variable degrees of ionization at different pH conditions 
(Cunningham, 2004; Owen et al., 2009; Winter et al., 2008). Therefore, taking into account 
these suggestions, Log D7.4 was the third partitioning factor used to run the model. 
The second important parameter required for the application of the FPM is the HTPC of the 
drug that is taken into consideration. This value (or range of values) is usually available in the 
reports published by the manufacturing company and are obtained during the drug 
development process. The HTPC is usually expressed as “maximum concentration” (Cmax) or 
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“area under the curve” (AUC) values, describing the presence of a drug in the systemic 
circulatory system at either a single point in time (Cmax) or as a function of time (AUC) 
(Hardman and Limbird, 1996). Cmax values for dutasteride were obtained from the official 
documentation published by GSK (2001). Since the HTPC depends on the duration of the 
treatment, I considered two different values obtained from two different clinical studies: a 
long-term treatment (12 months) and a short-term treatment (28 days). Parameters such as 
Cmax are often available as a range of values, and the lowest value is chosen in order to obtain 
a conservative estimate, according to the precautionary principle.  
In this section I describe the application of the FPM with the aim to estimate if the 
concentrations of dutasteride used in the experiments described in Chapter 6 would produce a 
concentration of drug in the plasma of fathead minnow similar to the HTPC, providing a 
theoretical justification for the biological effects observed during the toxicity studies 
performed during this Ph.D. project. In order to achieve this aim, the equations of the model 
were inverted to calculate 1) the water concentration of dutasteride required to produce FSSPC 
= HTPC, and 2) to estimate the concentrations of dutasteride in the plasma of fathead minnow 
exposed to 10, 32 and 100 µg dutasteride/L.  
The FPM indicated that the water concentration of dutasteride required to obtain FSSPC = 
HTPC varies significantly as a consequence of the partition coefficient used to run the model. 
In fact, the bioconcentration coefficient “Pblood:water”, calculated by the equation of 
Fitzsimmons et al. (2004), was 12589, 1259, and 89, respectively, if calculated using 
experimental Log Kow, predicted Log Kow or Log D7.4. It is evident that there is a large 
difference (~140-fold) between the first and the last value. 
When the model was run using Log Kow (both experimental and predicted), the concentrations 
of dutasteride required to obtain FSSPC = HTPC were in the range of 2-32 ng/L, more than 
1000-fold lower than the LOEC (32 µg/L) obtained in the experiments described in this 
Thesis, suggesting that a significant inhibition of the 5αR activity would occur at those very 
low concentrations. On the other hand, using Log D7.4, this value goes up to 265-500 ng/L, 
which is still 64-107 times lower than the LOEC. Furthermore, according to the model (based 
on Log D7.4), the latter would produce a FSSPC approximately 69-fold and 121-fold higher 
than, respectively, the HTPC at 12 months and 28 days. 
Apparently, these predictions do not fit with the biological effects observed during the 
experiments previously described in this Thesis, suggesting that the FPM could overestimate 
the bioaccumulation process. However, it is important to remember that the model does not 
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predict if the potentially occurring pharmacological effect is an adverse effect. It is possible to 
hypothesise that an increase in the incidence of the adverse effects would be correlated with 
the increase of the blood concentration of the drug. For example, histopathological alteration 
of the ovary were present in the 12.5% and 87.5% of the female fathead minnows exposed, 
respectively, to 32 and 100 µg dutasteride/L, while egg production was affected, respectively, 
in the 50% and 100% of the females in the same treatment groups. Since the endpoints 
considered during the study can be considered as severe adverse effect, they are likely to 
appear at plasma concentrations higher than the therapeutic ones. 
The discrepancy between the prediction made by the FPM and the experimental observations 
of the adverse effects could also be partially explained by the high lipophilicity of dutasteride. 
It is possible to hypothesise that a significant fraction of dutasteride was not bioavailable, due 
to adsorption to any organic matter present into the fish tanks, including excrements, food 
breakdown products, suspended bacterial population, and bacterial biofilm. Although many 
efforts were made to minimize the presence of organic matter in the exposure set-up (e.g. by 
daily cleaning and aspiration of the sedimented organic fraction), the use of a solvent for the 
delivery of the drug (i.e. DMF) promoted bacterial growth, which became visible after only a 
few days of exposure, and even if three days of dosing were allowed to “chemically” saturate 
the system, daily inputs of “fresh” organic matter were represented by food administration 
and excretion processes. 
It should also be noted that the FPM does not take into account the factor “time” and other 
processes that prevent, decrease or increase the bioaccumulation rate, such as drug hepatic 
metabolism, elimination, and binding to plasma proteins (e.g. steroids binding to SSBG), 
which, taken all together, contribute to the complexity of the real bioaccumulation dynamics. 
In conclusion, the FPM is currently in an early stage of development and incorporates major 
assumptions that still require further experimental validation. Among the few studies which 
experimentally tested the model, Owen et al. (2009) and Winter et al. (2008) found a 
reasonably good degree of agreement between predicted and measured plasma concentrations 
of two β-blockers (propranolol and atenolol). The Log Kow values of these two compounds 
are, respectively, ~ 3.0 and ~ 0.5, much lower than the 5.5 - 6.8 of dutasteride. Brown et al. 
(2007) compared the modelled and measured concentrations of five human pharmaceuticals 
(ibuprofen, naproxen, diclofenac, ketoprofen, gemfibrozil) in the blood of rainbow trout 
exposed for 48 hours in a laboratory set-up, or for 14-23 days to sewage treatment plant 
effluent. The five drugs had Log Kow values ranging between 3.0 and 4.8. In the short-term 
laboratory exposure, the concentrations predicted by the FPM were between 6.6 and 17.15-
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fold higher than the measured ones, except for ketoprofen (166-fold). No clear correlation was 
observed between the Log Kow and the ratio modelled:measured concentration; for example, 
the concentration of gemfibrozil predicted by the FPM had the same degree of over-
estimation as naproxen, despite a difference of 1.7 in their Log Kow values. It is unclear if the 
short length of the exposure (48 hours) could have played a role in the lack of the previously 
mentioned correlation. Finally, in the same experiment, all the pharmaceuticals, except 
ibuprofen, had equal, lower or considerably lower Bioaccumulation Factors (BCF) than 
predicted by the FPM, supporting the hypothesis previously described in this Chapter that the 
FPM could overestimates the bioaccumulation process, at least in some cases. A further 
confirmation of this hypothesis was provided by Fick et al. (2010), who highlighted how the 
FPM overestimated the rainbow trout plasma BCF for 11 out of 21 pharmaceuticals analyzed 
after exposure of the fish to sewage effluents.    
It is clear that in order to define the reliability of the FPM applied to pharmaceuticals, a larger 
number of compounds with a larger range of physicochemical characteristics needs to be 
experimentally tested. The development of correction factors (e.g. accounting for pH, 
concentration of organic matter in the system, temperature, affinity to plasma binding 
proteins, etc.) is probably needed to improve reliability of the FPM. In fact, if it is true that the 
overestimation features of the FPM could not be considered negative in general terms, in the 
perspective of the “precautionary principle” used in the environmental risk assessment, the 
same model limitations could lead to an underestimation, with all the relative negative 
consequences, as demonstrated by Fick et al. (2010) for levonorgestrel (a synthetic 
progestogen). The authors obtained an experimental fish plasma BCF 185 to 260-fold higher 
than the predicted one, probably due to the high affinity of this compound to the SSBG 
present into the gills of fish. In this case, it is likely that the affinity of the drug to the binding 
proteins present in the plasma, and not the Log KOW, represented the major factor driving the 
uptake dynamics, suggesting the need for more complex mathematical models.     
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Table 7.1. Parameters and equations used for the calculation of the predicted concentration of 
dutasteride in the water that would give a concentration in the plasma of fish equal to the human 
therapeutic concentration in humans, according to the fish plasma model developed by Hugget et al. 
(2003). A description of the method is provided in Section 7.4. 
Parameters 
HTPC following administration of 0.5 mg/d for different periods of time: 
HTPC (A) = Steady State after 12 months = 40 ng/mL 
HTPC (B) = Cmax after 28d of treatment with 0.5 mg.day = 23.6 ng/mL 
Partitioning Coefficients: 
Log Kow = 6.8 (Experimental: PhysProp) 
Log Kow = 5.45 (Predicted: ALOGPS) 
Log D7.4 = 3.87 (Cunningham et al., 2009) 
Equations 
1) Log PBlood:Water = 0.73 × Log Kow – 0.88 (Fitzsimmons et al., 2004) 
PBlood:Water = 12589 (based on Experimental Log Kow) 
PBlood:Water = 1259 (based on Predicted Log Kow) 
PBlood:Water = 89 (based on Log D7.4) 
2) FSSPC = EC × (PBlood:Water) (Hugget et al., 2003) 
 
The environmental concentration required to obtain FSSPC = HTPC: 
With  HTPC = 40.0 ng/mL and 
 
1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
 EC = 3.1 
 EC = 32 
 EC = 500 
 EC = 1.9 
 EC = 18.7 
 EC = 265 
 
ng/L 
ng/L 
ng/L 
ng/L 
ng/L 
ng/L 
 
With  HTPC = 23.6 ng/mL and 
 
FSSPC of dutasteride estimated at different exposure concentrations: 
With  EC = 10 µg/L    and 
                     
 
1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
 FSSPC = 125890 
 FSSPC = 12590 
 FSSPC = 890 
ng/mL 
ng/mL 
ng/mL 
With  EC = 32 µg/L    and 1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
 FSSPC = 402845 
 FSSPC = 40288 
 FSSPC = 2848 
ng/mL 
ng/mL 
ng/mL 
With EC = 100 µg/L   and 
 
 
 
With EC = 0.03
*
 ng/L and 
 
 
1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
 
1) Experimental Log Kow 
2) Predicted Log Kow 
3) Log D7.4 
 FSSPC = 1258900 
 FSSPC = 125900 
 FSSPC = 8900 
 
 FSSPC = 0.3777 
 FSSPC = 0.0378 
 FSSPC = 0.0027 
ng/mL 
ng/mL 
ng/mL 
 
ng/mL 
ng/mL 
ng/mL 
* = Predicted Environmental Concentration (Cunningham et al., 2009) 
 241 
 
7.5 Female fish are highly susceptible to the disruption of androgenic pathways    
At the beginning of the project, the use of female fathead minnows to test the effects caused 
by exposure to dutasteride was underestimated. In fact, it was not clear if this species would 
express functional 5αR at all; therefore, the attention was focused on males. However, after 
the first in vivo study to assess the potency and effects of DHT and KT on sexual maturation 
of juvenile fathead minnow, the high sensitivity of female fish to the disruption of the 
androgenic pathways came to the light, confirming the high androgenic potency of DHT in 
this species, which in females was higher than the potency of KT (e.g. only the females 
exposed to DHT had masculinised ovaries). This sensitivity was confirmed also by all the 
following in vivo studies involving exposing fish to dutasteride, (i.e. inhibiting the 
biosynthesis of DHT). The histopathology of the ovary was one of the most sensitive 
endpoints, and the physiology of this organ was affected even months after termination of an 
early life stage exposure (e.g. retardation of oogenesis) (Chapter 5). A potential explanation 
for the sensitivity of females could be that DHT is a physiological important hormone in 
female physiology, as confirmed by the analytic detection of DHT circulating in female fish 
plasma at concentrations 2 to 10-fold higher than in humans. On the other hand, KT was not 
detected in any of the female plasma samples analysed by Ultrasensitive GC-MS/MS. 
Moreover, it is important to note that the sensitivity of female fish to the disruption of the 
androgenic pathways was also confirmed by other studies testing various anti-androgens, as 
discussed in Chapter 6.  
 In this case, the utility of mammalian toxicity studies to predict the effects of dutasteride in 
female fish was limited. In fact, studies on rats and dogs showed treatment-related effects in 
female reproductive organs, including decreased ovary and uterus/cervix weights, increased 
incidence of dioestrus or increased occurrence of ovarian (follicular) cysts in rats, microscopic 
changes in the uterus and shifts in the oestrus cycle to the luteal phase in dogs; however, there 
was no information available specifically concerning the histopathological effects of 
dutasteride in higher female vertebrates (GSK, 2001). 
Despite the lack of knowledge of the effect of dutasteride on ovarian histopathology in 
vertebrates, some speculations can be made on the similarity between the human pathological 
condition named Polycystic Ovary Syndrome (PCOS) and the alterations recorded in the 
ovaries of female fish exposed to dutasteride during a 21 d reproduction test (Chapter 6). The 
factor shared between these two conditions is the hyperandrogenism. In fact, PCOS - the most 
common cause of anovulatory infertility in women - is characterized by hyperandrogenism, 
oligo-/anovulation, cessation of oocyte growth, and follicle dysfunction (Shi et al., 2009). 
 242 
 
Affected ovaries present ovarian hypertrophy, and a number of histopathological conditions, 
including an increased number of primary growing follicles, thickened follicle capsule, 
hyperplasia and fibrosis of ovarian stroma, decreased thickness of granulose layer, increased 
thickness of the internal theca, and atresia. It has been proposed that these morphological 
alterations are driven by an excess of androgens (Azziz et al., 2007; Chang and Razer, 2009; 
Goodarzi et al., 2011).  
Some of these histological alterations were also observed in female fathead minnows exposed 
to dutasteride, in particular a decreased proportion of early vitellogenic oocytes, an increased 
proportion of perinucleolar oocytes, an increased occurrence of atretic follicles, abnormal 
proliferation of interstitial/somatic tissue, vacuolar hypertrophy of the surrounding granulose 
cells due to phagocytic processes, proliferation of interstitial tissue containing macrophage 
aggregates, the presence of mitotically dividing oogonia, accumulation of lipidic tissue, and 
presence of interstitial proteinaceus fluid. Interestingly, the same female fish had decreased 
concentrations of circulating E2 and increased concentrations of T. A similar concomitance 
(ovary histological alteration and increased plasma T concentration) was also observed by 
Jensen et al. (2004) when they exposed fathead minnows to flutamide. In conclusion, it is 
possible to hypothesise that, as happens in humans, the excess of circulating or in situ 
androgens caused by the exposure to dutasteride could be the causal factor that explains the 
histological alterations of the ovary in the fathead minnow.    
The results presented in the present Thesis suggest that female fish would be of great utility 
for the evaluation of potential adverse effects caused by anti-androgens in the fathead 
minnow, and quite possibly other species of fish as well.  
7.6 General considerations on the environmental risk assessment of dutasteride 
No information is available on the occurrence of dutasteride in surface waters or WWTP‟s 
effluents; however, according to Cunningham et al. (2009), the predicted environmental 
concentration (PEC) of dutasteride in surface water is 0.02 ng/L in Europe, and 0.03 ng/L in 
US. These values were derived using the PhATE™ model (Pharmaceutical Assessment and 
Transport Evaluation) for North America and the GREAT-ER (Geo-referenced Regional 
Exposure Assessment Tool for European Rivers) model for Europe. 
The list of “Environmentally Classified Pharmaceuticals” published every year by the 
Stockholm County Council (2011) expresses the environmental hazard of each API using the 
so called PBT index, composed of three factors: 
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- Persistence – ability to resist degradation in the aquatic environment; 
- Bioaccumulation – accumulation in adipose tissue of aquatic organisms; 
- Toxicity – the potential to poison aquatic organisms; 
To each of these characteristics is assigned a numerical value (0–3), and the total of these 
values constitutes the PBT Index for the substance (0-9). According to this list, dutasteride 
has a PBT index equal to 8, and its environemntal risk, defined as the risk of toxicity to the 
aquatic environment and based on the ratio between PEC and the highest concentration of the 
substance that does not have a harmful effect in the environment (PNEC), is classified as 
“Cannot be excluded”, meaning that the information provided by the manyfacturer was 
insufficient for the assessment of the risk. 
Cunningham et al.  (2009) performed a human risk assessment for 44 APIs marketed by 
GlaxoSmithKline (GSK), focusing attention on the potential risk deriving from drinking water 
and fish consumption. The assessment considered the highest dose of pharmaceutical derived 
from fish consumption, in conjunction with the highest possible acceptable dose deriving 
from drinking water, and compared it to the acceptable daily intake (ADI), defined as “the 
level of daily intake that should not result in an adverse human health effect from direct 
exposure in a population, including particularly sensitive individuals”. Considering children 
as the most sensitive group of the general population, the ADI for dutasteride was 0.0016 
µg/kg/day, the predicted no effect concentration for drinking water (PNEC) was 23 ng/L, the 
PNEC for fish consumption was 19 ng/L (taking into account the fish BCF), and the 
combined PNEC (drinking water + fish consumption) was 10 ng/L.  
In conclusion, the low volume of drug prescribed every year (5.07 kg in the UK in 2006), and 
the relatively high concentration required to elict any significant adverse effect on fathead 
minnow (approximately 32 µg/L) suggest that, at present, the potential presence of dutasteride 
in the environment does not represent a threat to either wild fish populations or humans. 
However, a potentially significant reason of concern is the high bioaccumualtion factor of the 
compound (BCFfish = 190.5; Log P = 5.45), exemplified by the fact that approximately 55% 
of the daily dose (0.5 mg) is potentially bioaccumulated in humans. This suggest that further 
studies should be performed in order to elucidate the potential risk arising from the 
bioaccumualtion process in both humans and fish populations.  
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7.7 Limitations of the project and recommendations for future work 
7.7.1 Analytical determination of circulating DHT in fathead minnow plasma 
The use of Ultrasensitive GC-MS/MS allowed the detection of circulating DHT in plasma of 
both male and female fathead minnows. Due to time and resources limitiations, only a 
relatively limited number of samples was analysed, in particular for juvenile fish. One of the 
main technical limitation of GC-MS/MS was the high volume of plasma required for the 
analysis (200 µL), which is much higher than the average volume normally collected from 
individual fish (20-80 µL). The necessity to pool several plasma samples for the analysis lead 
to a loss of information usually provided by inter-individual variability. This method seems at 
the moment unsuitable for routine analysis of plasma steroids in small fish species, used as 
the model species in toxicological tests. However, the concentrations of DHT detected in the 
plasma of fathead minnow suggest that a specific RIA could be suitable for this kind of 
purpose.  
Additional experiments should be performed in order to evaluate the onthogenesis of DHT 
biosynthesis, since DHT was not detected in the single sample of plasma collected from 
juvenile fish (pool of 4 individual samples). Furhtermore, future experimental designs should 
try to detect any difference between the plasma DHT concentration of adult fish in active 
reproduction phase and adult fish kept without sexual stimuli, in order to clarify if DHT 
synthesis is stimulated by reproductive activity. Finally, plasma samples collected from fish 
exposed to dutasteride would represent an ideal negative control, as well as providing a 
potential estimate of the rate of DHT inhibition following an exposure to dutasteride. 
7.7.2 Gene expression study    
The study of srd5a1 ans srd5a2 gene expression in different tissues of the fathead minnow at 
different life stages was planned but not performed, due to the higher priority given to in vivo 
studies aimed at assessing the effects of dutasteride on fish. The hypothesis behind the 
planned study was that knowledge of the sites of expression of the two genes could have been 
of high predictive value for the the assessment of the effects of dutasterie in the following  in 
vivo toxicity studies. For example, it is possible to hypothesise that the detection of high 
levels of expression of the two target genes in the ovary of fathead minnow would have 
helped to predict the high sensitivity of female fish to dutasteride, in particular at the level of 
the ovary. This approach could also give precious information on the onthogenesis of DHT 
biosynthesis in the fathead minnow.      
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7.7.3 Bioaccumulation of dutasteride in the fathead minnow 
The high BCF of dutasteride in fish suggest that the bioaccumulation of this compound in 
specific tissues, such as testis or ovary, could play an important role in conditions of chronic 
exposure.  A bioaccumulation test was not performed during the project; however, some 
indications of  potential maternal transfer of dutasteride from adult (F0) females to the F1 
generation were collected during the F1 hatchability trials preformed during the 21 days 
reproduction test (Chapter 6). In order to clarify the possible occurrence of maternal transfer, 
future studies should include a more robust experimental desing, involving an higher number 
of breeding couples, together with the analytical determination by LC-MS/MS of the 
concentrations of dutasteride potentially bioaccumulated in F1 fertilized embryos.     
7.7.4 Concentration of dutasteride in the plasma of fathead minnow 
One of the key paradigms of the “read-across” hypothesis is that human pharmaceuticals will 
cause the same effects in fish as they do in humans when they are present at similar plasma 
concentrations. The measurment of dutasteride concentration in fathead minnow plasma was 
not performed during the project, and the application of the fish plasma model (Hugget et al., 
2003), previously described in this Chapter, estimated that water concentrations between 2 
and 500 ng dutasteride/L would be enough to obtain a concentration of drug into the plasma 
of fish similar to the human therapeutic plasma concentration. These estimates are much 
lower than the LOEC obtained in the toxicity studies described in this Thesis, allowing to 
hypothesise that the FPM applied to dutasteride produced an over-estimation of the 
bioaccumulation process. Using dutasteride as target drug, an experimental comparison 
between modelled and measured concentrations would represent a significant test case for the 
assessment of the the reliability of the FPM applied to highly lipophilic human 
pharmaceuticals. 
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Table 7.2. Resume of LOECs and NOECs for each endpoint used during the in vivo studies carried out 
in this Ph.D. project.   
Study 
Life stage  
& Sex 
Endpoint 
LOEC 
(µg/L) 
NOEC 
(µg/L) 
Early life stage test 1 + 
evaluation of long term 
effects 
Embryos 
Hatching success >100 100 
Hatching time >100 100 
28 dph  
Mixed sex 
Survival  100 32 
Length  32 10 
Weight 32 10 
CI 100 32 
120 dph 
Mixed sex 
Length  >100 100 
Weight >100 100 
CI >100 100 
160 dph 
Males 
Length  >100 100 
Weight >100 100 
CI >100 100 
160 dph  
Female 
Length  >100 100 
Weight >100 100 
CI >100 100 
160 dph 
Male 
Testis histology 100 32 
160 dph 
Male 
N° of tubercles >100 100 
Tubercles grade >100 100 
Fatpad index >100 100 
Fatpad height >100 100 
160 dph  
Female 
Ovipositor Length >100 100 
160 dph  
Female 
Ovary histology 32 10 
160 dph 
Male 
Testosterone >100 100 
160 dph 
Male 
11-Ketotestosterone >100 100 
160 dph 
Female 
Testosterone >100 100 
Early life stage test 2 
Embryos 
Hatching success >100 100 
Hatching time >100 100 
14 dph  
Mixed sex 
Survival  100 32 
Length  32 10 
Weight 32 10 
CI >100 100 
 
 
 
 
 
Short term  
reproduction test 
 
 
 
180 dph 
Male 
Length  >100 100 
Weight >100 100 
CI >100 100 
GSI >100 100 
HSI >100 100 
180 dph 
Female 
Length  >100 100 
Weight >100 100 
CI >100 100 
GSI 100 32 
HSI >100 100 
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Short term  
reproduction test 
 
Cumulative egg 
production 
32 10 
180 dph 
Male+Female 
N° of spawnings per 
pair 
100 32 
N° of eggs per spawning  32 10 
180 dph 
Male 
Fertilization >100 100 
F1 Embryos % of dead embryos >100 100 
180 dph 
Male 
N° of tubercles 100 32 
Tubercles grade 100 32 
Fatpad index >100 100 
Fatpad height >100 100 
180 dph 
Female 
Ovipositor Length >100 100 
180 dph 
Male 
Testosterone 100 32 
11-Ketotestosterone 32 10 
Estradiol >100 100 
180 dph 
Female 
Testosterone 100 32 
Estradiol 100 32 
Vitellogenin >100 100 
180 dph  
Male 
Testis histology >100 100 
180 dph 
Female 
Ovary histology 100 32 
180 dph  
Male 
Sperm cell count >100 100 
% of motile sperm 32 10 
% of viable sperm 100 32 
Milt volume >100 100 
Sperm motility  
(by CASA) 
32 10 
F1 Hatching trials in 
dilution water 
F1 Embryos 
F1 Hatching success >100 100 
F1 Hatching time >100 100 
F1 Hatching trials in 
parental tank water 
F1 Hatching success 100 32 
F1 Hatching time 100 32 
CI, Condition Index; GSI, Gonadosomatic Index; HIS, Hepatosomatic Index.  
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